Aop:1	Event:1	occurrence	CL	CL:0000001	N/A	VT	VT:0000001	N/A	process
Aop:1	Event:2	disrupted	MESH	MESH:0000002	Hyperplasia	HP	HP:0000002	Hyperplasia	process
Aop:1	Event:3	morphological change	UBERON	UBERON:0000003	Proliferation	GO	GO:0000003	Proliferation	process
Aop:1	Event:4	increased	PR	PR:0000004	Promotion	MP	MP:0000004	Promotion	process
Aop:2	Event:5	occurrence	CL	CL:0000005	Binding of inhibitor	VT	VT:0000005	Binding of inhibitor	process
Aop:2	Event:6	disrupted	MESH	MESH:0000006	Inhibition	HP	HP:0000006	Inhibition	process
Aop:2	Event:7	morphological change	UBERON	UBERON:0000007	Mitochondrial dysfun	GO	GO:0000007	Mitochondrial dysfun	process
Aop:2	Event:8	increased	PR	PR:0000008	Impaired	MP	MP:0000008	Impaired	process
Aop:2	Event:9	decreased	CHEBI	CHEBI:0000009	Neuroinflammation	VT	VT:0000009	Neuroinflammation	process
Aop:2	Event:10	occurrence	CL	CL:0000010	Degeneration of dopa	HP	HP:0000010	Degeneration of dopa	process
Aop:2	Event:11	disrupted	MESH	MESH:0000011	Parkinsonian motor d	GO	GO:0000011	Parkinsonian motor d	process
Aop:3	Event:12	occurrence	CL	CL:0000012	Increase	VT	VT:0000012	Increase	process
Aop:3	Event:13	disrupted	MESH	MESH:0000013	Increase	HP	HP:0000013	Increase	process
Aop:3	Event:14	morphological change	UBERON	UBERON:0000014	Increase	GO	GO:0000014	Increase	process
Aop:3	Event:15	increased	PR	PR:0000015	Decrease	MP	MP:0000015	Decrease	process
Aop:3	Event:16	decreased	CHEBI	CHEBI:0000016	Decrease	VT	VT:0000016	Decrease	process
Aop:3	Event:17	occurrence	CL	CL:0000017	Decrease	HP	HP:0000017	Decrease	process
Aop:3	Event:18	disrupted	MESH	MESH:0000018	Decrease	GO	GO:0000018	Decrease	process
Aop:3	Event:19	morphological change	UBERON	UBERON:0000019	Decrease	MP	MP:0000019	Decrease	process
Aop:3	Event:20	increased	PR	PR:0000020	Increase	VT	VT:0000020	Increase	process
Aop:3	Event:21	decreased	CHEBI	CHEBI:0000021	Increase	HP	HP:0000021	Increase	process
Aop:4	Event:103	increased	GO	GO:0008230	ecdysone receptor holocomplex	GO	GO:0035076	ecdysone receptor-mediated signaling pathway
Aop:4	Event:988	decreased				GO	GO:0008255	ecdysis-triggering hormone activity
Aop:4	Event:990	increased	CHEBI	CHEBI:17029	chitin	GO	GO:0006031	chitin biosynthetic process
Aop:4	Event:993	increased				GO	GO:0006936	muscle contraction
Aop:4	Event:1264	increased	MESH	C061375	Eip75B protein, Drosophila	GO	GO:0010467	gene expression
Aop:4	Event:1265	increased	PR	PR:P33244	nuclear hormone receptor FTZ-F1 (fruit fly)	GO	GO:0010467	gene expression
Aop:4	Event:1266	decreased	PR	PR:Q9VCW0	cardioactive peptide (fruit fly)	GO	GO:0002790	peptide secretion
Aop:4	Event:1267	decreased	CL	CL:0000100	motor neuron	GO	GO:0019226	transmission of nerve impulse
Aop:4	Event:1268	decreased				GO	GO:0060079	excitatory postsynaptic potential
Aop:4	Event:350	increased				MESH	D009026	mortality
Aop:5	Event:22	occurrence	CL	CL:0000022	Binding of antagonist	VT	VT:0000022	Binding of antagonist	process
Aop:5	Event:23	disrupted	MESH	MESH:0000023	stabilization	HP	HP:0000023	stabilization	process
Aop:5	Event:24	morphological change	UBERON	UBERON:0000024	Decreased	GO	GO:0000024	Decreased	process
Aop:5	Event:25	increased	PR	PR:0000025	Fatty Acid Beta Oxidation	MP	MP:0000025	Fatty Acid Beta Oxidation	process
Aop:5	Event:26	decreased	CHEBI	CHEBI:0000026	Decreased	VT	VT:0000026	Decreased	process
Aop:5	Event:27	occurrence	CL	CL:0000027	Not Increased	HP	HP:0000027	Not Increased	process
Aop:5	Event:28	disrupted	MESH	MESH:0000028	Increased	GO	GO:0000028	Increased	process
Aop:5	Event:29	morphological change	UBERON	UBERON:0000029	Decreased	MP	MP:0000029	Decreased	process
Aop:6	Event:30	occurrence	CL	CL:0000030	reduction in ovarian granulosa cells	VT	VT:0000030	reduction in ovarian granulosa cells	process
Aop:6	Event:31	disrupted	MESH	MESH:0000031	Reduction	HP	HP:0000031	Reduction	process
Aop:6	Event:32	morphological change	UBERON	UBERON:0000032	Reduction	GO	GO:0000032	Reduction	process
Aop:6	Event:33	increased	PR	PR:0000033	decreased	MP	MP:0000033	decreased	process
Aop:6	Event:34	decreased	CHEBI	CHEBI:0000034	disrupted	VT	VT:0000034	disrupted	process
Aop:7	Event:35	occurrence	CL	CL:0000035	Activation	VT	VT:0000035	Activation	process
Aop:7	Event:36	disrupted	MESH	MESH:0000036	Induction	HP	HP:0000036	Induction	process
Aop:7	Event:37	morphological change	UBERON	UBERON:0000037	Increased	GO	GO:0000037	Increased	process
Aop:7	Event:38	increased	PR	PR:0000038	Thyroxine (T4) in serum	MP	MP:0000038	Thyroxine (T4) in serum	process
Aop:7	Event:39	decreased	CHEBI	CHEBI:0000039	Thyroxine (T4) in neuronal tissue	VT	VT:0000039	Thyroxine (T4) in neuronal tissue	process
Aop:7	Event:40	occurrence	CL	CL:0000040	Hippocampal gene expression	HP	HP:0000040	Hippocampal gene expression	process
Aop:7	Event:41	disrupted	MESH	MESH:0000041	Hippocampal anatomy	GO	GO:0000041	Hippocampal anatomy	process
Aop:7	Event:42	morphological change	UBERON	UBERON:0000042	Hippocampal Physiology	MP	MP:0000042	Hippocampal Physiology	process
Aop:7	Event:43	increased	PR	PR:0000043	Loss	VT	VT:0000043	Loss	process
Aop:8	Event:44	occurrence	CL	CL:0000044	Binding at picrotoxin site	VT	VT:0000044	Binding at picrotoxin site	process
Aop:8	Event:45	disrupted	MESH	MESH:0000045	Reduction	HP	HP:0000045	Reduction	process
Aop:8	Event:46	morphological change	UBERON	UBERON:0000046	Reduction	GO	GO:0000046	Reduction	process
Aop:8	Event:47	increased	PR	PR:0000047	Generation	MP	MP:0000047	Generation	process
Aop:8	Event:48	decreased	CHEBI	CHEBI:0000048	Occurrence	VT	VT:0000048	Occurrence	process
Aop:8	Event:49	occurrence	CL	CL:0000049	Occurrence	HP	HP:0000049	Occurrence	process
Aop:9	Event:50	occurrence	CL	CL:0000050	Activation	VT	VT:0000050	Activation	process
Aop:10	Event:51	occurrence	CL	CL:0000051	Binding of antagonist	VT	VT:0000051	Binding of antagonist	process
Aop:10	Event:52	disrupted	MESH	MESH:0000052	Inhibition	HP	HP:0000052	Inhibition	process
Aop:10	Event:53	morphological change	UBERON	UBERON:0000053	Decreased	GO	GO:0000053	Decreased	process
Aop:10	Event:54	increased	PR	PR:0000054	Reduced levels of BD	MP	MP:0000054	Reduced levels of BD	process
Aop:10	Event:55	decreased	CHEBI	CHEBI:0000055	Increase	VT	VT:0000055	Increase	process
Aop:10	Event:56	occurrence	CL	CL:0000056	Neuroinflammation	HP	HP:0000056	Neuroinflammation	process
Aop:10	Event:57	disrupted	MESH	MESH:0000057	N/A	GO	GO:0000057	N/A	process
Aop:10	Event:58	morphological change	UBERON	UBERON:0000058	Impairment	MP	MP:0000058	Impairment	process
Aop:11	Event:59	occurrence	CL	CL:0000059	Binding of antagonist	VT	VT:0000059	Binding of antagonist	process
Aop:11	Event:60	disrupted	MESH	MESH:0000060	Decreased	HP	HP:0000060	Decreased	process
Aop:11	Event:61	morphological change	UBERON	UBERON:0000061	Inhibition	GO	GO:0000061	Inhibition	process
Aop:11	Event:62	increased	PR	PR:0000062	Reduced levels of BD	MP	MP:0000062	Reduced levels of BD	process
Aop:11	Event:63	decreased	CHEBI	CHEBI:0000063	Aberrant	VT	VT:0000063	Aberrant	process
Aop:11	Event:64	occurrence	CL	CL:0000064	Decrease of synaptog	HP	HP:0000064	Decrease of synaptog	process
Aop:11	Event:65	disrupted	MESH	MESH:0000065	Decrease of neuronal	GO	GO:0000065	Decrease of neuronal	process
Aop:11	Event:66	morphological change	UBERON	UBERON:0000066	Reduced	MP	MP:0000066	Reduced	process
Aop:11	Event:67	increased	PR	PR:0000067	Increase	VT	VT:0000067	Increase	process
Aop:11	Event:68	decreased	CHEBI	CHEBI:0000068	Impairment	HP	HP:0000068	Impairment	process
Aop:12	Event:69	occurrence	CL	CL:0000069	Activation	VT	VT:0000069	Activation	process
Aop:12	Event:70	disrupted	MESH	MESH:0000070	Inhibition	HP	HP:0000070	Inhibition	process
Aop:12	Event:71	morphological change	UBERON	UBERON:0000071	Suppression	GO	GO:0000071	Suppression	process
Aop:12	Event:72	increased	PR	PR:0000072	Decreased	MP	MP:0000072	Decreased	process
Aop:12	Event:73	decreased	CHEBI	CHEBI:0000073	Induction	VT	VT:0000073	Induction	process
Aop:12	Event:74	occurrence	CL	CL:0000074	Suppression	HP	HP:0000074	Suppression	process
Aop:12	Event:75	disrupted	MESH	MESH:0000075	Increased	GO	GO:0000075	Increased	process
Aop:13	Event:76	occurrence	CL	CL:0000076	Alkylation	VT	VT:0000076	Alkylation	process
Aop:13	Event:77	disrupted	MESH	MESH:0000077	Inadequate DNA repai	HP	HP:0000077	Inadequate DNA repai	process
Aop:13	Event:78	morphological change	UBERON	UBERON:0000078	Increase	GO	GO:0000078	Increase	process
Aop:13	Event:79	increased	PR	PR:0000079	Increase	MP	MP:0000079	Increase	process
Aop:14	Event:80	occurrence	CL	CL:0000080	Acetylcholinesterase	VT	VT:0000080	Acetylcholinesterase	process
Aop:14	Event:81	disrupted	MESH	MESH:0000081	Acetylcholine accumu	HP	HP:0000081	Acetylcholine accumu	process
Aop:14	Event:82	morphological change	UBERON	UBERON:0000082	Increased Cholinergi	GO	GO:0000082	Increased Cholinergi	process
Aop:14	Event:83	increased	PR	PR:0000083	Respiratory distress	MP	MP:0000083	Respiratory distress	process
Aop:14	Event:84	decreased	CHEBI	CHEBI:0000084	Dysregulation of hea	VT	VT:0000084	Dysregulation of hea	process
Aop:14	Event:85	occurrence	CL	CL:0000085	Increased Mortality	HP	HP:0000085	Increased Mortality	process
Aop:14	Event:86	disrupted	MESH	MESH:0000086	Decrease	GO	GO:0000086	Decrease	process
Aop:15	Event:87	occurrence	CL	CL:0000087	Binding	VT	VT:0000087	Binding	process
Aop:15	Event:88	disrupted	MESH	MESH:0000088	Decreased protection	HP	HP:0000088	Decreased protection	process
Aop:15	Event:89	morphological change	UBERON	UBERON:0000089	Oxidative Stress	GO	GO:0000089	Oxidative Stress	process
Aop:15	Event:90	increased	PR	PR:0000090	Glutamate dyshomeost	MP	MP:0000090	Glutamate dyshomeost	process
Aop:15	Event:91	decreased	CHEBI	CHEBI:0000091	Increase	VT	VT:0000091	Increase	process
Aop:15	Event:92	occurrence	CL	CL:0000092	Neuroinflammation	HP	HP:0000092	Neuroinflammation	process
Aop:15	Event:93	disrupted	MESH	MESH:0000093	Tissue resident cell	GO	GO:0000093	Tissue resident cell	process
Aop:15	Event:94	morphological change	UBERON	UBERON:0000094	Increased Pro-inflam	MP	MP:0000094	Increased Pro-inflam	process
Aop:15	Event:95	increased	PR	PR:0000095	Decrease of neuronal	VT	VT:0000095	Decrease of neuronal	process
Aop:15	Event:96	decreased	CHEBI	CHEBI:0000096	Impairment	HP	HP:0000096	Impairment	process
Aop:16	Event:97	occurrence	CL	CL:0000097	Activation	VT	VT:0000097	Activation	process
Aop:16	Event:98	disrupted	MESH	MESH:0000098	Decrease	HP	HP:0000098	Decrease	process
Aop:16	Event:99	morphological change	UBERON	UBERON:0000099	Reduction	GO	GO:0000099	Reduction	process
Aop:16	Event:100	increased	PR	PR:0000100	Reduction	MP	MP:0000100	Reduction	process
Aop:16	Event:101	decreased	CHEBI	CHEBI:0000101	Decrease	VT	VT:0000101	Decrease	process
Aop:16	Event:102	occurrence	CL	CL:0000102	Decrease	HP	HP:0000102	Decrease	process
Aop:16	Event:103	disrupted	MESH	MESH:0000103	decreased	GO	GO:0000103	decreased	process
Aop:16	Event:104	morphological change	UBERON	UBERON:0000104	Malformation	MP	MP:0000104	Malformation	process
Aop:17	Event:105	occurrence	CL	CL:0000105	Antagonism	VT	VT:0000105	Antagonism	process
Aop:17	Event:106	disrupted	MESH	MESH:0000106	Alteration	HP	HP:0000106	Alteration	process
Aop:17	Event:107	morphological change	UBERON	UBERON:0000107	Feminisation or incomplete development	GO	GO:0000107	Feminisation or incomplete development	process
Aop:17	Event:108	increased	PR	PR:0000108	Altered	MP	MP:0000108	Altered	process
Aop:17	Event:109	decreased	CHEBI	CHEBI:0000109	N/A	VT	VT:0000109	N/A	process
Aop:18	Event:110	occurrence	CL	CL:0000110	Activation	VT	VT:0000110	Activation	process
Aop:18	Event:111	disrupted	MESH	MESH:0000111	dimerization	HP	HP:0000111	dimerization	process
Aop:18	Event:112	morphological change	UBERON	UBERON:0000112	Increase	GO	GO:0000112	Increase	process
Aop:18	Event:113	increased	PR	PR:0000113	Altered	MP	MP:0000113	Altered	process
Aop:18	Event:114	decreased	CHEBI	CHEBI:0000114	Increase	VT	VT:0000114	Increase	process
Aop:19	Event:115	occurrence	CL	CL:0000115	Agonism	VT	VT:0000115	Agonism	process
Aop:19	Event:116	disrupted	MESH	MESH:0000116	Reduction	HP	HP:0000116	Reduction	process
Aop:19	Event:117	morphological change	UBERON	UBERON:0000117	Reduction	GO	GO:0000117	Reduction	process
Aop:19	Event:118	increased	PR	PR:0000118	Reduction	MP	MP:0000118	Reduction	process
Aop:19	Event:119	decreased	CHEBI	CHEBI:0000119	Reduction	VT	VT:0000119	Reduction	process
Aop:19	Event:120	occurrence	CL	CL:0000120	Reduction	HP	HP:0000120	Reduction	process
Aop:19	Event:121	disrupted	MESH	MESH:0000121	Reduction	GO	GO:0000121	Reduction	process
Aop:19	Event:122	morphological change	UBERON	UBERON:0000122	Reduction	MP	MP:0000122	Reduction	process
Aop:19	Event:123	increased	PR	PR:0000123	Reduction	VT	VT:0000123	Reduction	process
Aop:19	Event:124	decreased	CHEBI	CHEBI:0000124	Decrease	HP	HP:0000124	Decrease	process
Aop:20	Event:125	occurrence	CL	CL:0000125	Inhibition	VT	VT:0000125	Inhibition	process
Aop:20	Event:126	disrupted	MESH	MESH:0000126	Reduction	HP	HP:0000126	Reduction	process
Aop:20	Event:127	morphological change	UBERON	UBERON:0000127	Reduction	GO	GO:0000127	Reduction	process
Aop:20	Event:128	increased	PR	PR:0000128	Reduction	MP	MP:0000128	Reduction	process
Aop:20	Event:129	decreased	CHEBI	CHEBI:0000129	Reduction	VT	VT:0000129	Reduction	process
Aop:20	Event:130	occurrence	CL	CL:0000130	Reduction	HP	HP:0000130	Reduction	process
Aop:20	Event:131	disrupted	MESH	MESH:0000131	Reduction	GO	GO:0000131	Reduction	process
Aop:20	Event:132	morphological change	UBERON	UBERON:0000132	Decrease	MP	MP:0000132	Decrease	process
Aop:21	Event:133	occurrence	CL	CL:0000133	Inhibition	VT	VT:0000133	Inhibition	process
Aop:21	Event:134	disrupted	MESH	MESH:0000134	Increase	HP	HP:0000134	Increase	process
Aop:21	Event:135	morphological change	UBERON	UBERON:0000135	Disruption	GO	GO:0000135	Disruption	process
Aop:21	Event:136	increased	PR	PR:0000136	Decrease	MP	MP:0000136	Decrease	process
Aop:21	Event:137	decreased	CHEBI	CHEBI:0000137	Increase	VT	VT:0000137	Increase	process
Aop:21	Event:138	occurrence	CL	CL:0000138	Decreased	HP	HP:0000138	Decreased	process
Aop:21	Event:139	disrupted	MESH	MESH:0000139	Decreased	GO	GO:0000139	Decreased	process
Aop:21	Event:140	morphological change	UBERON	UBERON:0000140	Oxidative Stress	MP	MP:0000140	Oxidative Stress	process
Aop:22	Event:141	occurrence	CL	CL:0000141	Inhibition	VT	VT:0000141	Inhibition	process
Aop:22	Event:142	disrupted	MESH	MESH:0000142	Activation of specific nuclear receptors	HP	HP:0000142	Activation of specific nuclear receptors	process
Aop:22	Event:143	morphological change	UBERON	UBERON:0000143	Bile accumulation	GO	GO:0000143	Bile accumulation	process
Aop:22	Event:144	increased	PR	PR:0000144	Release	MP	MP:0000144	Release	process
Aop:22	Event:145	decreased	CHEBI	CHEBI:0000145	Increase	VT	VT:0000145	Increase	process
Aop:22	Event:146	occurrence	CL	CL:0000146	Increase	HP	HP:0000146	Increase	process
Aop:22	Event:147	disrupted	MESH	MESH:0000147	Peptide Oxidation	GO	GO:0000147	Peptide Oxidation	process
Aop:22	Event:148	morphological change	UBERON	UBERON:0000148	Cholestasis	MP	MP:0000148	Cholestasis	process
Aop:23	Event:149	occurrence	CL	CL:0000149	Inhibition	VT	VT:0000149	Inhibition	process
Aop:23	Event:150	disrupted	MESH	MESH:0000150	Reduction	HP	HP:0000150	Reduction	process
Aop:23	Event:151	morphological change	UBERON	UBERON:0000151	Reduction	GO	GO:0000151	Reduction	process
Aop:23	Event:152	increased	PR	PR:0000152	Reduction	MP	MP:0000152	Reduction	process
Aop:23	Event:153	decreased	CHEBI	CHEBI:0000153	N/A	VT	VT:0000153	N/A	process
Aop:23	Event:154	occurrence	CL	CL:0000154	N/A	HP	HP:0000154	N/A	process
Aop:24	Event:155	occurrence	CL	CL:0000155	Agonism	VT	VT:0000155	Agonism	process
Aop:24	Event:156	disrupted	MESH	MESH:0000156	Reduction	HP	HP:0000156	Reduction	process
Aop:24	Event:157	morphological change	UBERON	UBERON:0000157	Increase	GO	GO:0000157	Increase	process
Aop:24	Event:158	increased	PR	PR:0000158	Increase	MP	MP:0000158	Increase	process
Aop:24	Event:159	decreased	CHEBI	CHEBI:0000159	Increase	VT	VT:0000159	Increase	process
Aop:24	Event:160	occurrence	CL	CL:0000160	Decrease	HP	HP:0000160	Decrease	process
Aop:24	Event:161	disrupted	MESH	MESH:0000161	Altered	GO	GO:0000161	Altered	process
Aop:24	Event:162	morphological change	UBERON	UBERON:0000162	Altered	MP	MP:0000162	Altered	process
Aop:24	Event:163	increased	PR	PR:0000163	Impaired development of	VT	VT:0000163	Impaired development of	process
Aop:25	Event:164	occurrence	CL	CL:0000164	Antagonism	VT	VT:0000164	Antagonism	process
Aop:25	Event:165	disrupted	MESH	MESH:0000165	Reduction	HP	HP:0000165	Reduction	process
Aop:25	Event:166	morphological change	UBERON	UBERON:0000166	Reduction	GO	GO:0000166	Reduction	process
Aop:25	Event:167	increased	PR	PR:0000167	Reduction	MP	MP:0000167	Reduction	process
Aop:25	Event:168	decreased	CHEBI	CHEBI:0000168	Reduction	VT	VT:0000168	Reduction	process
Aop:25	Event:169	occurrence	CL	CL:0000169	Decrease	HP	HP:0000169	Decrease	process
Aop:26	Event:170	occurrence	CL	CL:0000170	N/A	VT	VT:0000170	N/A	process
Aop:26	Event:171	disrupted	MESH	MESH:0000171	Altered regulation	HP	HP:0000171	Altered regulation	process
Aop:26	Event:172	morphological change	UBERON	UBERON:0000172	Oxidative Stress	GO	GO:0000172	Oxidative Stress	process
Aop:26	Event:173	increased	PR	PR:0000173	Damaging	MP	MP:0000173	Damaging	process
Aop:26	Event:174	decreased	CHEBI	CHEBI:0000174	Formation	VT	VT:0000174	Formation	process
Aop:26	Event:175	occurrence	CL	CL:0000175	Down Regulation	HP	HP:0000175	Down Regulation	process
Aop:26	Event:176	disrupted	MESH	MESH:0000176	Increase	GO	GO:0000176	Increase	process
Aop:26	Event:177	morphological change	UBERON	UBERON:0000177	Increase	MP	MP:0000177	Increase	process
Aop:26	Event:178	increased	PR	PR:0000178	N/A	VT	VT:0000178	N/A	process
Aop:26	Event:179	decreased	CHEBI	CHEBI:0000179	N/A	HP	HP:0000179	N/A	process
Aop:27	Event:180	occurrence	CL	CL:0000180	Production	VT	VT:0000180	Production	process
Aop:27	Event:181	disrupted	MESH	MESH:0000181	Induction	HP	HP:0000181	Induction	process
Aop:27	Event:182	morphological change	UBERON	UBERON:0000182	Inhibition	GO	GO:0000182	Inhibition	process
Aop:27	Event:183	increased	PR	PR:0000183	Induction	MP	MP:0000183	Induction	process
Aop:27	Event:184	decreased	CHEBI	CHEBI:0000184	Induction	VT	VT:0000184	Induction	process
Aop:27	Event:185	occurrence	CL	CL:0000185	Formation	HP	HP:0000185	Formation	process
Aop:28	Event:186	occurrence	CL	CL:0000186	Activation	VT	VT:0000186	Activation	process
Aop:28	Event:187	disrupted	MESH	MESH:0000187	N/A	HP	HP:0000187	N/A	process
Aop:28	Event:188	morphological change	UBERON	UBERON:0000188	Increased	GO	GO:0000188	Increased	process
Aop:29	Event:189	occurrence	CL	CL:0000189	Activation	VT	VT:0000189	Activation	process
Aop:29	Event:190	disrupted	MESH	MESH:0000190	peroxisome prolifera	HP	HP:0000190	peroxisome prolifera	process
Aop:29	Event:191	morphological change	UBERON	UBERON:0000191	Up Regulation	GO	GO:0000191	Up Regulation	process
Aop:29	Event:192	increased	PR	PR:0000192	Increase	MP	MP:0000192	Increase	process
Aop:29	Event:193	decreased	CHEBI	CHEBI:0000193	Activation	VT	VT:0000193	Activation	process
Aop:29	Event:194	occurrence	CL	CL:0000194	Activation	HP	HP:0000194	Activation	process
Aop:29	Event:195	disrupted	MESH	MESH:0000195	Activation	GO	GO:0000195	Activation	process
Aop:29	Event:196	morphological change	UBERON	UBERON:0000196	Activation	MP	MP:0000196	Activation	process
Aop:29	Event:197	increased	PR	PR:0000197	Synthesis	VT	VT:0000197	Synthesis	process
Aop:29	Event:198	decreased	CHEBI	CHEBI:0000198	Accumulation	HP	HP:0000198	Accumulation	process
Aop:29	Event:199	occurrence	CL	CL:0000199	Mitochondrial dysfun	GO	GO:0000199	Mitochondrial dysfun	process
Aop:29	Event:200	disrupted	MESH	MESH:0000200	N/A	MP	MP:0000200	N/A	process
Aop:30	Event:201	occurrence	CL	CL:0000201	Accumulation	VT	VT:0000201	Accumulation	process
Aop:30	Event:202	disrupted	MESH	MESH:0000202	Disruption	HP	HP:0000202	Disruption	process
Aop:31	Event:203	occurrence	CL	CL:0000203	Decreased	VT	VT:0000203	Decreased	process
Aop:31	Event:204	disrupted	MESH	MESH:0000204	Decreased	HP	HP:0000204	Decreased	process
Aop:31	Event:205	morphological change	UBERON	UBERON:0000205	Decreased	GO	GO:0000205	Decreased	process
Aop:31	Event:206	increased	PR	PR:0000206	Accumulation	MP	MP:0000206	Accumulation	process
Aop:31	Event:207	decreased	CHEBI	CHEBI:0000207	Decreased	VT	VT:0000207	Decreased	process
Aop:31	Event:208	occurrence	CL	CL:0000208	Decrease	HP	HP:0000208	Decrease	process
Aop:31	Event:209	disrupted	MESH	MESH:0000209	Decreased	GO	GO:0000209	Decreased	process
Aop:31	Event:210	morphological change	UBERON	UBERON:0000210	Increased	MP	MP:0000210	Increased	process
Aop:32	Event:211	occurrence	CL	CL:0000211	Activation	VT	VT:0000211	Activation	process
Aop:32	Event:212	disrupted	MESH	MESH:0000212	Increase	HP	HP:0000212	Increase	process
Aop:32	Event:213	morphological change	UBERON	UBERON:0000213	Increase	GO	GO:0000213	Increase	process
Aop:32	Event:214	increased	PR	PR:0000214	Increase	MP	MP:0000214	Increase	process
Aop:32	Event:215	decreased	CHEBI	CHEBI:0000215	Increase	VT	VT:0000215	Increase	process
Aop:33	Event:216	occurrence	CL	CL:0000216	Alkylation	VT	VT:0000216	Alkylation	process
Aop:33	Event:217	disrupted	MESH	MESH:0000217	Increase	HP	HP:0000217	Increase	process
Aop:33	Event:218	morphological change	UBERON	UBERON:0000218	Tissue resident cell	GO	GO:0000218	Tissue resident cell	process
Aop:33	Event:219	increased	PR	PR:0000219	Increased Pro-inflam	MP	MP:0000219	Increased Pro-inflam	process
Aop:33	Event:220	decreased	CHEBI	CHEBI:0000220	Activation	VT	VT:0000220	Activation	process
Aop:33	Event:221	occurrence	CL	CL:0000221	Accumulation	HP	HP:0000221	Accumulation	process
Aop:33	Event:222	disrupted	MESH	MESH:0000222	N/A	GO	GO:0000222	N/A	process
Aop:34	Event:223	occurrence	CL	CL:0000223	Covalent Binding	VT	VT:0000223	Covalent Binding	process
Aop:34	Event:224	disrupted	MESH	MESH:0000224	Increased	HP	HP:0000224	Increased	process
Aop:34	Event:225	morphological change	UBERON	UBERON:0000225	Activation	GO	GO:0000225	Activation	process
Aop:34	Event:226	increased	PR	PR:0000226	Activation/Proliferation	MP	MP:0000226	Activation/Proliferation	process
Aop:34	Event:227	decreased	CHEBI	CHEBI:0000227	Increase	VT	VT:0000227	Increase	process
Aop:35	Event:228	occurrence	CL	CL:0000228	Covalent Binding	VT	VT:0000228	Covalent Binding	process
Aop:35	Event:229	disrupted	MESH	MESH:0000229	Activation	HP	HP:0000229	Activation	process
Aop:35	Event:230	morphological change	UBERON	UBERON:0000230	Activation	GO	GO:0000230	Activation	process
Aop:35	Event:231	increased	PR	PR:0000231	Activation/Proliferation	MP	MP:0000231	Activation/Proliferation	process
Aop:35	Event:232	decreased	CHEBI	CHEBI:0000232	sensitisation	VT	VT:0000232	sensitisation	process
Aop:36	Event:233	occurrence	CL	CL:0000233	Activation	VT	VT:0000233	Activation	process
Aop:36	Event:234	disrupted	MESH	MESH:0000234	N/A	HP	HP:0000234	N/A	process
Aop:36	Event:235	morphological change	UBERON	UBERON:0000235	Changes/Inhibition	GO	GO:0000235	Changes/Inhibition	process
Aop:36	Event:236	increased	PR	PR:0000236	Alterations	MP	MP:0000236	Alterations	process
Aop:36	Event:237	decreased	CHEBI	CHEBI:0000237	Formation	VT	VT:0000237	Formation	process
Aop:37	Event:238	occurrence	CL	CL:0000238	Thyroperoxidase	VT	VT:0000238	Thyroperoxidase	process
Aop:37	Event:239	disrupted	MESH	MESH:0000239	Thyroid hormone synthesis	HP	HP:0000239	Thyroid hormone synthesis	process
Aop:37	Event:240	morphological change	UBERON	UBERON:0000240	Thyroxine (T4) in serum	GO	GO:0000240	Thyroxine (T4) in serum	process
Aop:37	Event:241	increased	PR	PR:0000241	Thyroxine (T4) in neuronal tissue	MP	MP:0000241	Thyroxine (T4) in neuronal tissue	process
Aop:37	Event:242	decreased	CHEBI	CHEBI:0000242	Hippocampal gene expression	VT	VT:0000242	Hippocampal gene expression	process
Aop:37	Event:243	occurrence	CL	CL:0000243	Hippocampal anatomy	HP	HP:0000243	Hippocampal anatomy	process
Aop:37	Event:244	disrupted	MESH	MESH:0000244	Hippocampal Physiology	GO	GO:0000244	Hippocampal Physiology	process
Aop:37	Event:245	morphological change	UBERON	UBERON:0000245	Cognitive function	MP	MP:0000245	Cognitive function	process
Aop:38	Event:246	occurrence	CL	CL:0000246	Inhibition	VT	VT:0000246	Inhibition	process
Aop:38	Event:247	disrupted	MESH	MESH:0000247	Reduction	HP	HP:0000247	Reduction	process
Aop:38	Event:248	morphological change	UBERON	UBERON:0000248	Impairment	GO	GO:0000248	Impairment	process
Aop:38	Event:249	increased	PR	PR:0000249	Insufficiency	MP	MP:0000249	Insufficiency	process
Aop:38	Event:250	decreased	CHEBI	CHEBI:0000250	Increased	VT	VT:0000250	Increased	process
Aop:39	Event:313	increased				MESH	D012130	Respiratory Hypersensitivity
Aop:39	Event:398	increased				GO	GO:0001775	cell activation
Aop:39	Event:398	increased				GO	GO:0002396	MHC protein complex assembly
Aop:39	Event:272	increased	CL	CL:0000084	T cell	GO	GO:0042110	T cell activation
Aop:39	Event:272	increased	CL	CL:0000813	memory T cell	GO	GO:0008283	cell proliferation
Aop:39	Event:396	increased	CHEBI	CHEBI:59739	electrophilic reagant	GO	GO:0005515	protein binding
Aop:39	Event:1496	increased	FMA	FMA:84050	Cytokine	GO	GO:0002534	cytokine production involved in inflammatory response
Aop:39	Event:1496	increased	FMA	FMA:241981	Chemokine	GO	GO:0090195	chemokine secretion
Aop:39	Event:1496	increased				GO	GO:0006956	complement activation
Aop:39	Event:1496	increased	FMA	FMA:86578	Interleukin			
Aop:40	Event:396	increased	CHEBI	CHEBI:59739	electrophilic reagant	GO	GO:0005515	protein binding
Aop:40	Event:826	increased				GO	GO:0032980	keratinocyte activation
Aop:40	Event:826	increased				GO	GO:0002534	cytokine production involved in inflammatory response
Aop:40	Event:398	increased				GO	GO:0001775	cell activation
Aop:40	Event:398	increased				GO	GO:0002396	MHC protein complex assembly
Aop:40	Event:272	increased	CL	CL:0000084	T cell	GO	GO:0042110	T cell activation
Aop:40	Event:272	increased	CL	CL:0000813	memory T cell	GO	GO:0008283	cell proliferation
Aop:41	Event:251	occurrence	CL	CL:0000251	Formation	VT	VT:0000251	Formation	process
Aop:41	Event:252	disrupted	MESH	MESH:0000252	Increased	HP	HP:0000252	Increased	process
Aop:41	Event:253	morphological change	UBERON	UBERON:0000253	Metabolism of AFB1	GO	GO:0000253	Metabolism of AFB1	process
Aop:41	Event:254	increased	PR	PR:0000254	Clonal Expansion/Cell Proliferation	MP	MP:0000254	Clonal Expansion/Cell Proliferation	process
Aop:41	Event:255	decreased	CHEBI	CHEBI:0000255	Increased	VT	VT:0000255	Increased	process
Aop:41	Event:256	occurrence	CL	CL:0000256	Tumorigenesis	HP	HP:0000256	Tumorigenesis	process
Aop:42	Event:257	occurrence	CL	CL:0000257	Binding of agonist	VT	VT:0000257	Binding of agonist	process
Aop:42	Event:258	disrupted	MESH	MESH:0000258	Mitochondrial dysfun	HP	HP:0000258	Mitochondrial dysfun	process
Aop:42	Event:259	morphological change	UBERON	UBERON:0000259	Increase	GO	GO:0000259	Increase	process
Aop:42	Event:260	increased	PR	PR:0000260	N/A	MP	MP:0000260	N/A	process
Aop:42	Event:261	decreased	CHEBI	CHEBI:0000261	Overactivation	VT	VT:0000261	Overactivation	process
Aop:42	Event:262	occurrence	CL	CL:0000262	Increased	HP	HP:0000262	Increased	process
Aop:42	Event:263	disrupted	MESH	MESH:0000263	Decreased	GO	GO:0000263	Decreased	process
Aop:42	Event:264	morphological change	UBERON	UBERON:0000264	Neuroinflammation	MP	MP:0000264	Neuroinflammation	process
Aop:42	Event:265	increased	PR	PR:0000265	Impairment	VT	VT:0000265	Impairment	process
Aop:43	Event:266	occurrence	CL	CL:0000266	Activation	VT	VT:0000266	Activation	process
Aop:43	Event:267	disrupted	MESH	MESH:0000267	Increase	HP	HP:0000267	Increase	process
Aop:43	Event:268	morphological change	UBERON	UBERON:0000268	Hyperplasia	GO	GO:0000268	Hyperplasia	process
Aop:43	Event:269	increased	PR	PR:0000269	Increase proliferation	MP	MP:0000269	Increase proliferation	process
Aop:43	Event:270	decreased	CHEBI	CHEBI:0000270	Decrease	VT	VT:0000270	Decrease	process
Aop:43	Event:271	occurrence	CL	CL:0000271	Reduction	HP	HP:0000271	Reduction	process
Aop:43	Event:272	disrupted	MESH	MESH:0000272	Reduction	GO	GO:0000272	Reduction	process
Aop:43	Event:273	morphological change	UBERON	UBERON:0000273	decreased	MP	MP:0000273	decreased	process
Aop:44	Event:274	occurrence	CL	CL:0000274	Agonism	VT	VT:0000274	Agonism	process
Aop:44	Event:275	disrupted	MESH	MESH:0000275	skewed	HP	HP:0000275	skewed	process
Aop:45	Event:276	occurrence	CL	CL:0000276	Agonism	VT	VT:0000276	Agonism	process
Aop:45	Event:277	disrupted	MESH	MESH:0000277	Increased	HP	HP:0000277	Increased	process
Aop:45	Event:278	morphological change	UBERON	UBERON:0000278	Increase	GO	GO:0000278	Increase	process
Aop:45	Event:279	increased	PR	PR:0000279	Increased	MP	MP:0000279	Increased	process
Aop:45	Event:280	decreased	CHEBI	CHEBI:0000280	Increased	VT	VT:0000280	Increased	process
Aop:45	Event:281	occurrence	CL	CL:0000281	Increased	HP	HP:0000281	Increased	process
Aop:46	Event:282	occurrence	CL	CL:0000282	Inhibition	VT	VT:0000282	Inhibition	process
Aop:46	Event:283	disrupted	MESH	MESH:0000283	Decrease of Thyroida	HP	HP:0000283	Decrease of Thyroida	process
Aop:46	Event:284	morphological change	UBERON	UBERON:0000284	Thyroid hormone synthesis	GO	GO:0000284	Thyroid hormone synthesis	process
Aop:46	Event:285	increased	PR	PR:0000285	Thyroxine (T4) in serum	MP	MP:0000285	Thyroxine (T4) in serum	process
Aop:46	Event:286	decreased	CHEBI	CHEBI:0000286	Thyroxine (T4) in neuronal tissue	VT	VT:0000286	Thyroxine (T4) in neuronal tissue	process
Aop:46	Event:287	occurrence	CL	CL:0000287	Reduced levels of BD	HP	HP:0000287	Reduced levels of BD	process
Aop:46	Event:288	disrupted	MESH	MESH:0000288	Decrease of GABAergi	GO	GO:0000288	Decrease of GABAergi	process
Aop:46	Event:289	morphological change	UBERON	UBERON:0000289	Decrease of synaptog	MP	MP:0000289	Decrease of synaptog	process
Aop:46	Event:290	increased	PR	PR:0000290	Decrease of neuronal	VT	VT:0000290	Decrease of neuronal	process
Aop:46	Event:291	decreased	CHEBI	CHEBI:0000291	Impairment	HP	HP:0000291	Impairment	process
Aop:47	Event:292	occurrence	CL	CL:0000292	Activation	VT	VT:0000292	Activation	process
Aop:47	Event:293	disrupted	MESH	MESH:0000293	Suppression	HP	HP:0000293	Suppression	process
Aop:47	Event:294	morphological change	UBERON	UBERON:0000294	Inhibition	GO	GO:0000294	Inhibition	process
Aop:47	Event:295	increased	PR	PR:0000295	Accumulation	MP	MP:0000295	Accumulation	process
Aop:47	Event:296	decreased	CHEBI	CHEBI:0000296	Decreased	VT	VT:0000296	Decreased	process
Aop:47	Event:297	occurrence	CL	CL:0000297	Accumulation	HP	HP:0000297	Accumulation	process
Aop:47	Event:298	disrupted	MESH	MESH:0000298	Up Regulation	GO	GO:0000298	Up Regulation	process
Aop:47	Event:299	morphological change	UBERON	UBERON:0000299	Increased	MP	MP:0000299	Increased	process
Aop:47	Event:300	increased	PR	PR:0000300	Up Regulation	VT	VT:0000300	Up Regulation	process
Aop:47	Event:301	decreased	CHEBI	CHEBI:0000301	Increased	HP	HP:0000301	Increased	process
Aop:47	Event:302	occurrence	CL	CL:0000302	Up Regulation	GO	GO:0000302	Up Regulation	process
Aop:47	Event:303	disrupted	MESH	MESH:0000303	Up Regulation	MP	MP:0000303	Up Regulation	process
Aop:47	Event:304	morphological change	UBERON	UBERON:0000304	Increased	VT	VT:0000304	Increased	process
Aop:48	Event:305	occurrence	CL	CL:0000305	Suppression	VT	VT:0000305	Suppression	process
Aop:48	Event:306	disrupted	MESH	MESH:0000306	Inhibition	HP	HP:0000306	Inhibition	process
Aop:48	Event:307	morphological change	UBERON	UBERON:0000307	Activation	GO	GO:0000307	Activation	process
Aop:48	Event:308	increased	PR	PR:0000308	peroxisome prolifera	MP	MP:0000308	peroxisome prolifera	process
Aop:48	Event:309	decreased	CHEBI	CHEBI:0000309	Activation	VT	VT:0000309	Activation	process
Aop:48	Event:310	occurrence	CL	CL:0000310	Activation	HP	HP:0000310	Activation	process
Aop:48	Event:311	disrupted	MESH	MESH:0000311	Increased	GO	GO:0000311	Increased	process
Aop:48	Event:312	morphological change	UBERON	UBERON:0000312	Increased	MP	MP:0000312	Increased	process
Aop:48	Event:313	increased	PR	PR:0000313	Up Regulation	VT	VT:0000313	Up Regulation	process
Aop:48	Event:314	decreased	CHEBI	CHEBI:0000314	Up Regulation	HP	HP:0000314	Up Regulation	process
Aop:48	Event:315	occurrence	CL	CL:0000315	Up Regulation	GO	GO:0000315	Up Regulation	process
Aop:48	Event:316	disrupted	MESH	MESH:0000316	Inhibition	MP	MP:0000316	Inhibition	process
Aop:48	Event:317	morphological change	UBERON	UBERON:0000317	Accumulation	VT	VT:0000317	Accumulation	process
Aop:48	Event:318	increased	PR	PR:0000318	Up Regulation	HP	HP:0000318	Up Regulation	process
Aop:48	Event:319	decreased	CHEBI	CHEBI:0000319	Increased	GO	GO:0000319	Increased	process
Aop:48	Event:320	occurrence	CL	CL:0000320	Increased	MP	MP:0000320	Increased	process
Aop:49	Event:321	occurrence	CL	CL:0000321	Suppression	VT	VT:0000321	Suppression	process
Aop:50	Event:322	occurrence	CL	CL:0000322	Activation	VT	VT:0000322	Activation	process
Aop:50	Event:323	disrupted	MESH	MESH:0000323	Inhibition	HP	HP:0000323	Inhibition	process
Aop:50	Event:324	morphological change	UBERON	UBERON:0000324	Decrease	GO	GO:0000324	Decrease	process
Aop:50	Event:325	increased	PR	PR:0000325	Down Regulation	MP	MP:0000325	Down Regulation	process
Aop:50	Event:326	decreased	CHEBI	CHEBI:0000326	Down Regulation	VT	VT:0000326	Down Regulation	process
Aop:50	Event:327	occurrence	CL	CL:0000327	Up Regulation	HP	HP:0000327	Up Regulation	process
Aop:50	Event:328	disrupted	MESH	MESH:0000328	Up Regulation	GO	GO:0000328	Up Regulation	process
Aop:50	Event:329	morphological change	UBERON	UBERON:0000329	Increased	MP	MP:0000329	Increased	process
Aop:50	Event:330	increased	PR	PR:0000330	Decreased	VT	VT:0000330	Decreased	process
Aop:50	Event:331	decreased	CHEBI	CHEBI:0000331	Increased	HP	HP:0000331	Increased	process
Aop:50	Event:332	occurrence	CL	CL:0000332	Accumulation	GO	GO:0000332	Accumulation	process
Aop:50	Event:333	disrupted	MESH	MESH:0000333	Increased	MP	MP:0000333	Increased	process
Aop:51	Event:334	occurrence	CL	CL:0000334	Activation	VT	VT:0000334	Activation	process
Aop:51	Event:335	disrupted	MESH	MESH:0000335	Activation	HP	HP:0000335	Activation	process
Aop:51	Event:336	morphological change	UBERON	UBERON:0000336	Activation	GO	GO:0000336	Activation	process
Aop:51	Event:337	increased	PR	PR:0000337	Activation	MP	MP:0000337	Activation	process
Aop:51	Event:338	decreased	CHEBI	CHEBI:0000338	Decreased	VT	VT:0000338	Decreased	process
Aop:51	Event:339	occurrence	CL	CL:0000339	Inhibition	HP	HP:0000339	Inhibition	process
Aop:51	Event:340	disrupted	MESH	MESH:0000340	Activation	GO	GO:0000340	Activation	process
Aop:51	Event:341	morphological change	UBERON	UBERON:0000341	Inhibition	MP	MP:0000341	Inhibition	process
Aop:51	Event:342	increased	PR	PR:0000342	Activation	VT	VT:0000342	Activation	process
Aop:51	Event:343	decreased	CHEBI	CHEBI:0000343	Increased	HP	HP:0000343	Increased	process
Aop:51	Event:344	occurrence	CL	CL:0000344	Increased	GO	GO:0000344	Increased	process
Aop:51	Event:345	disrupted	MESH	MESH:0000345	Increased	MP	MP:0000345	Increased	process
Aop:51	Event:346	morphological change	UBERON	UBERON:0000346	Increased	VT	VT:0000346	Increased	process
Aop:52	Event:347	occurrence	CL	CL:0000347	systemic inflammatio	VT	VT:0000347	systemic inflammatio	process
Aop:52	Event:348	disrupted	MESH	MESH:0000348	Activation	HP	HP:0000348	Activation	process
Aop:52	Event:349	morphological change	UBERON	UBERON:0000349	Activation	GO	GO:0000349	Activation	process
Aop:52	Event:350	increased	PR	PR:0000350	Increased	MP	MP:0000350	Increased	process
Aop:53	Event:351	occurrence	CL	CL:0000351	Inhibition	VT	VT:0000351	Inhibition	process
Aop:53	Event:352	disrupted	MESH	MESH:0000352	Decrease	HP	HP:0000352	Decrease	process
Aop:53	Event:353	morphological change	UBERON	UBERON:0000353	Reduced	GO	GO:0000353	Reduced	process
Aop:53	Event:354	increased	PR	PR:0000354	Reduced	MP	MP:0000354	Reduced	process
Aop:53	Event:355	decreased	CHEBI	CHEBI:0000355	Decrease	VT	VT:0000355	Decrease	process
Aop:54	Event:356	occurrence	CL	CL:0000356	Glucocorticoid Receptor Agonist	VT	VT:0000356	Glucocorticoid Receptor Agonist	process
Aop:54	Event:357	disrupted	MESH	MESH:0000357	Repressed expression	HP	HP:0000357	Repressed expression	process
Aop:54	Event:358	morphological change	UBERON	UBERON:0000358	Increased apoptosis	GO	GO:0000358	Increased apoptosis	process
Aop:54	Event:359	increased	PR	PR:0000359	Reduction	MP	MP:0000359	Reduction	process
Aop:54	Event:360	decreased	CHEBI	CHEBI:0000360	Decrease	VT	VT:0000360	Decrease	process
Aop:54	Event:361	occurrence	CL	CL:0000361	Decreased sperm quantity or quality in the adult	HP	HP:0000361	Decreased sperm quantity or quality in the adult	process
Aop:54	Event:362	disrupted	MESH	MESH:0000362	decreased	GO	GO:0000362	decreased	process
Aop:55	Event:363	occurrence	CL	CL:0000363	Inhibition	VT	VT:0000363	Inhibition	process
Aop:55	Event:364	disrupted	MESH	MESH:0000364	Thyroid hormone synthesis	HP	HP:0000364	Thyroid hormone synthesis	process
Aop:55	Event:365	morphological change	UBERON	UBERON:0000365	Thyroxine (T4) in serum	GO	GO:0000365	Thyroxine (T4) in serum	process
Aop:55	Event:366	increased	PR	PR:0000366	Thyroxine (T4) in neuronal tissue	MP	MP:0000366	Thyroxine (T4) in neuronal tissue	process
Aop:55	Event:367	decreased	CHEBI	CHEBI:0000367	Altered	VT	VT:0000367	Altered	process
Aop:55	Event:368	occurrence	CL	CL:0000368	Altered	HP	HP:0000368	Altered	process
Aop:55	Event:369	disrupted	MESH	MESH:0000369	Cognitive function	GO	GO:0000369	Cognitive function	process
Aop:56	Event:370	occurrence	CL	CL:0000370	Decreased testosterone by the fetal Leydig cells	VT	VT:0000370	Decreased testosterone by the fetal Leydig cells	process
Aop:56	Event:371	disrupted	MESH	MESH:0000371	Decreased testosterone by the fetal Leydig cells	HP	HP:0000371	Decreased testosterone by the fetal Leydig cells	process
Aop:56	Event:372	morphological change	UBERON	UBERON:0000372	Decreased testosterone by the fetal Leydig cells	GO	GO:0000372	Decreased testosterone by the fetal Leydig cells	process
Aop:56	Event:373	increased	PR	PR:0000373	Decreased	MP	MP:0000373	Decreased	process
Aop:56	Event:374	decreased	CHEBI	CHEBI:0000374	Decreased testosterone by the fetal Leydig cells	VT	VT:0000374	Decreased testosterone by the fetal Leydig cells	process
Aop:56	Event:375	occurrence	CL	CL:0000375	Decreased sperm quantity / quality in the adult	HP	HP:0000375	Decreased sperm quantity / quality in the adult	process
Aop:57	Event:376	occurrence	CL	CL:0000376	Decreased testosterone by the fetal Leydig cells	VT	VT:0000376	Decreased testosterone by the fetal Leydig cells	process
Aop:57	Event:377	disrupted	MESH	MESH:0000377	Decreased testosterone by the fetal Leydig cells	HP	HP:0000377	Decreased testosterone by the fetal Leydig cells	process
Aop:57	Event:378	morphological change	UBERON	UBERON:0000378	Decreased testosterone by the fetal Leydig cells	GO	GO:0000378	Decreased testosterone by the fetal Leydig cells	process
Aop:57	Event:379	increased	PR	PR:0000379	decreased testosterone by fetal Leydig cells	MP	MP:0000379	decreased testosterone by fetal Leydig cells	process
Aop:57	Event:380	decreased	CHEBI	CHEBI:0000380	Decreased	VT	VT:0000380	Decreased	process
Aop:57	Event:381	occurrence	CL	CL:0000381	Decreased sperm quantity / quality in the adult	HP	HP:0000381	Decreased sperm quantity / quality in the adult	process
Aop:58	Event:382	occurrence	CL	CL:0000382	Decreased testosterone by the fetal Leydig cells	VT	VT:0000382	Decreased testosterone by the fetal Leydig cells	process
Aop:58	Event:383	disrupted	MESH	MESH:0000383	Decreased testosterone by the fetal Leydig cells	HP	HP:0000383	Decreased testosterone by the fetal Leydig cells	process
Aop:58	Event:384	morphological change	UBERON	UBERON:0000384	Decreased testosterone by the fetal Leydig cells	GO	GO:0000384	Decreased testosterone by the fetal Leydig cells	process
Aop:58	Event:385	increased	PR	PR:0000385	Decreased	MP	MP:0000385	Decreased	process
Aop:58	Event:386	decreased	CHEBI	CHEBI:0000386	Decreased sperm quantity / quality in the adult	VT	VT:0000386	Decreased sperm quantity / quality in the adult	process
Aop:59	Event:387	occurrence	CL	CL:0000387	Decreased Cholesterol	VT	VT:0000387	Decreased Cholesterol	process
Aop:59	Event:388	disrupted	MESH	MESH:0000388	Decreased Cholesterol	HP	HP:0000388	Decreased Cholesterol	process
Aop:59	Event:389	morphological change	UBERON	UBERON:0000389	Decreased Cholesterol	GO	GO:0000389	Decreased Cholesterol	process
Aop:59	Event:390	increased	PR	PR:0000390	Decreased Cholesterol	MP	MP:0000390	Decreased Cholesterol	process
Aop:59	Event:391	decreased	CHEBI	CHEBI:0000391	Decreased Cholesterol	VT	VT:0000391	Decreased Cholesterol	process
Aop:60	Event:392	occurrence	CL	CL:0000392	Decreased steroidogenesis	VT	VT:0000392	Decreased steroidogenesis	process
Aop:60	Event:393	disrupted	MESH	MESH:0000393	Decreased	HP	HP:0000393	Decreased	process
Aop:60	Event:394	morphological change	UBERON	UBERON:0000394	Decreased steroidogenesis	GO	GO:0000394	Decreased steroidogenesis	process
Aop:60	Event:395	increased	PR	PR:0000395	Decreased steroidogenesis	MP	MP:0000395	Decreased steroidogenesis	process
Aop:60	Event:396	decreased	CHEBI	CHEBI:0000396	Decreased sperm quantity or quality in the adult	VT	VT:0000396	Decreased sperm quantity or quality in the adult	process
Aop:61	Event:397	occurrence	CL	CL:0000397	Stimulation of adult Leydig cells via the Adrenal Corticosterone	VT	VT:0000397	Stimulation of adult Leydig cells via the Adrenal Corticosterone	process
Aop:61	Event:398	disrupted	MESH	MESH:0000398	Apoptosis of adult Leydig cells	HP	HP:0000398	Apoptosis of adult Leydig cells	process
Aop:61	Event:399	morphological change	UBERON	UBERON:0000399	Glucocorticoid Receptor mediated alterations in steriodogenic enzymes	GO	GO:0000399	Glucocorticoid Receptor mediated alterations in steriodogenic enzymes	process
Aop:61	Event:400	increased	PR	PR:0000400	Direct effects of Corticosterone on steroidogenesis	MP	MP:0000400	Direct effects of Corticosterone on steroidogenesis	process
Aop:61	Event:401	decreased	CHEBI	CHEBI:0000401	Decreased sperm quantity or quality in the adult	VT	VT:0000401	Decreased sperm quantity or quality in the adult	process
Aop:62	Event:402	occurrence	CL	CL:0000402	peroxisome prolifera	VT	VT:0000402	peroxisome prolifera	process
Aop:62	Event:403	disrupted	MESH	MESH:0000403	chronic high fat die	HP	HP:0000403	chronic high fat die	process
Aop:62	Event:404	morphological change	UBERON	UBERON:0000404	Activation of specific nuclear receptors	GO	GO:0000404	Activation of specific nuclear receptors	process
Aop:62	Event:405	increased	PR	PR:0000405	activation of CCAAT/	MP	MP:0000405	activation of CCAAT/	process
Aop:62	Event:406	decreased	CHEBI	CHEBI:0000406	increased adipogenes	VT	VT:0000406	increased adipogenes	process
Aop:62	Event:407	occurrence	CL	CL:0000407	decreased dopamine	HP	HP:0000407	decreased dopamine	process
Aop:62	Event:408	disrupted	MESH	MESH:0000408	decreased reward	GO	GO:0000408	decreased reward	process
Aop:62	Event:409	morphological change	UBERON	UBERON:0000409	decreased DNA methyl	MP	MP:0000409	decreased DNA methyl	process
Aop:62	Event:410	increased	PR	PR:0000410	decreased methylatio	VT	VT:0000410	decreased methylatio	process
Aop:62	Event:411	decreased	CHEBI	CHEBI:0000411	obesity	HP	HP:0000411	obesity	process
Aop:63	Event:412	occurrence	CL	CL:0000412	Inhibition	VT	VT:0000412	Inhibition	process
Aop:63	Event:413	disrupted	MESH	MESH:0000413	Decreased	HP	HP:0000413	Decreased	process
Aop:63	Event:414	morphological change	UBERON	UBERON:0000414	Decreased	GO	GO:0000414	Decreased	process
Aop:63	Event:415	increased	PR	PR:0000415	Decreased	MP	MP:0000415	Decreased	process
Aop:63	Event:416	decreased	CHEBI	CHEBI:0000416	Decreased	VT	VT:0000416	Decreased	process
Aop:63	Event:417	occurrence	CL	CL:0000417	Delayed	HP	HP:0000417	Delayed	process
Aop:63	Event:418	disrupted	MESH	MESH:0000418	Decreased	GO	GO:0000418	Decreased	process
Aop:63	Event:419	morphological change	UBERON	UBERON:0000419	Altered	MP	MP:0000419	Altered	process
Aop:63	Event:420	increased	PR	PR:0000420	Abnormal	VT	VT:0000420	Abnormal	process
Aop:63	Event:421	decreased	CHEBI	CHEBI:0000421	Altered	HP	HP:0000421	Altered	process
Aop:63	Event:422	occurrence	CL	CL:0000422	Decreased	GO	GO:0000422	Decreased	process
Aop:64	Event:423	occurrence	CL	CL:0000423	Decreased testosterone by the fetal Leydig cells	VT	VT:0000423	Decreased testosterone by the fetal Leydig cells	process
Aop:64	Event:424	disrupted	MESH	MESH:0000424	Decreased testosterone by the fetal Leydig cells	HP	HP:0000424	Decreased testosterone by the fetal Leydig cells	process
Aop:64	Event:425	morphological change	UBERON	UBERON:0000425	Decreased testosterone by the fetal Leydig cells	GO	GO:0000425	Decreased testosterone by the fetal Leydig cells	process
Aop:64	Event:426	increased	PR	PR:0000426	Decreased testosterone by the fetal Leydig cells	MP	MP:0000426	Decreased testosterone by the fetal Leydig cells	process
Aop:64	Event:427	decreased	CHEBI	CHEBI:0000427	Decreased fertility in the adult	VT	VT:0000427	Decreased fertility in the adult	process
Aop:65	Event:428	occurrence	CL	CL:0000428	Activation	VT	VT:0000428	Activation	process
Aop:65	Event:429	disrupted	MESH	MESH:0000429	Mitochondrial dysfun	HP	HP:0000429	Mitochondrial dysfun	process
Aop:65	Event:430	morphological change	UBERON	UBERON:0000430	Impairment	GO	GO:0000430	Impairment	process
Aop:65	Event:431	increased	PR	PR:0000431	Abnormal	MP	MP:0000431	Abnormal	process
Aop:65	Event:432	decreased	CHEBI	CHEBI:0000432	Weakened	VT	VT:0000432	Weakened	process
Aop:65	Event:433	occurrence	CL	CL:0000433	Altered	HP	HP:0000433	Altered	process
Aop:65	Event:434	disrupted	MESH	MESH:0000434	Death/Failure	GO	GO:0000434	Death/Failure	process
Aop:66	Event:435	occurrence	CL	CL:0000435	Activation	VT	VT:0000435	Activation	process
Aop:66	Event:436	disrupted	MESH	MESH:0000436	Mitochondrial dysfun	HP	HP:0000436	Mitochondrial dysfun	process
Aop:66	Event:437	morphological change	UBERON	UBERON:0000437	Decrease of neuronal	GO	GO:0000437	Decrease of neuronal	process
Aop:66	Event:438	increased	PR	PR:0000438	Impairment	MP	MP:0000438	Impairment	process
Aop:66	Event:439	decreased	CHEBI	CHEBI:0000439	Abnormal	VT	VT:0000439	Abnormal	process
Aop:66	Event:440	occurrence	CL	CL:0000440	Reduced	HP	HP:0000440	Reduced	process
Aop:66	Event:441	disrupted	MESH	MESH:0000441	impaired	GO	GO:0000441	impaired	process
Aop:66	Event:442	morphological change	UBERON	UBERON:0000442	Death/Failure	MP	MP:0000442	Death/Failure	process
Aop:67	Event:443	occurrence	CL	CL:0000443	Activation	VT	VT:0000443	Activation	process
Aop:67	Event:444	disrupted	MESH	MESH:0000444	Mitochondrial dysfun	HP	HP:0000444	Mitochondrial dysfun	process
Aop:67	Event:445	morphological change	UBERON	UBERON:0000445	impaired	GO	GO:0000445	impaired	process
Aop:67	Event:446	increased	PR	PR:0000446	Weakened	MP	MP:0000446	Weakened	process
Aop:67	Event:447	decreased	CHEBI	CHEBI:0000447	Death/Failure	VT	VT:0000447	Death/Failure	process
Aop:68	Event:448	occurrence	CL	CL:0000448	Activation	VT	VT:0000448	Activation	process
Aop:68	Event:449	disrupted	MESH	MESH:0000449	Mitochondrial dysfun	HP	HP:0000449	Mitochondrial dysfun	process
Aop:68	Event:450	morphological change	UBERON	UBERON:0000450	Accumulation	GO	GO:0000450	Accumulation	process
Aop:68	Event:451	increased	PR	PR:0000451	Accelerated	MP	MP:0000451	Accelerated	process
Aop:68	Event:452	decreased	CHEBI	CHEBI:0000452	Overwhelmed	VT	VT:0000452	Overwhelmed	process
Aop:68	Event:453	occurrence	CL	CL:0000453	Decrease	HP	HP:0000453	Decrease	process
Aop:68	Event:454	disrupted	MESH	MESH:0000454	impaired	GO	GO:0000454	impaired	process
Aop:68	Event:455	morphological change	UBERON	UBERON:0000455	Death/Failure	MP	MP:0000455	Death/Failure	process
Aop:69	Event:456	occurrence	CL	CL:0000456	Increase	VT	VT:0000456	Increase	process
Aop:69	Event:457	disrupted	MESH	MESH:0000457	Increased	HP	HP:0000457	Increased	process
Aop:69	Event:458	morphological change	UBERON	UBERON:0000458	Abnormal	GO	GO:0000458	Abnormal	process
Aop:69	Event:459	increased	PR	PR:0000459	Decrease	MP	MP:0000459	Decrease	process
Aop:69	Event:460	decreased	CHEBI	CHEBI:0000460	Death/Failure	VT	VT:0000460	Death/Failure	process
Aop:70	Event:461	occurrence	CL	CL:0000461	Abnormal	VT	VT:0000461	Abnormal	process
Aop:70	Event:462	disrupted	MESH	MESH:0000462	Reduced	HP	HP:0000462	Reduced	process
Aop:70	Event:463	morphological change	UBERON	UBERON:0000463	impaired	GO	GO:0000463	impaired	process
Aop:70	Event:464	increased	PR	PR:0000464	Death/Failure	MP	MP:0000464	Death/Failure	process
Aop:71	Event:465	occurrence	CL	CL:0000465	Suppression	VT	VT:0000465	Suppression	process
Aop:71	Event:466	disrupted	MESH	MESH:0000466	Increased	HP	HP:0000466	Increased	process
Aop:71	Event:467	morphological change	UBERON	UBERON:0000467	impaired	GO	GO:0000467	impaired	process
Aop:71	Event:468	increased	PR	PR:0000468	Decrease	MP	MP:0000468	Decrease	process
Aop:71	Event:469	decreased	CHEBI	CHEBI:0000469	impaired	VT	VT:0000469	impaired	process
Aop:71	Event:470	occurrence	CL	CL:0000470	Death/Failure	HP	HP:0000470	Death/Failure	process
Aop:72	Event:471	occurrence	CL	CL:0000471	Suppression	VT	VT:0000471	Suppression	process
Aop:72	Event:472	disrupted	MESH	MESH:0000472	Increased	HP	HP:0000472	Increased	process
Aop:72	Event:473	morphological change	UBERON	UBERON:0000473	Abnormal	GO	GO:0000473	Abnormal	process
Aop:72	Event:474	increased	PR	PR:0000474	Decrease	MP	MP:0000474	Decrease	process
Aop:72	Event:475	decreased	CHEBI	CHEBI:0000475	Death/Failure	VT	VT:0000475	Death/Failure	process
Aop:73	Event:476	occurrence	CL	CL:0000476	Decreased	VT	VT:0000476	Decreased	process
Aop:73	Event:477	disrupted	MESH	MESH:0000477	Decreased	HP	HP:0000477	Decreased	process
Aop:73	Event:478	morphological change	UBERON	UBERON:0000478	Reduced	GO	GO:0000478	Reduced	process
Aop:73	Event:479	increased	PR	PR:0000479	Abnormal	MP	MP:0000479	Abnormal	process
Aop:73	Event:480	decreased	CHEBI	CHEBI:0000480	Reduced	VT	VT:0000480	Reduced	process
Aop:73	Event:481	occurrence	CL	CL:0000481	impaired	HP	HP:0000481	impaired	process
Aop:73	Event:482	disrupted	MESH	MESH:0000482	Death/Failure	GO	GO:0000482	Death/Failure	process
Aop:74	Event:483	occurrence	CL	CL:0000483	Activation	VT	VT:0000483	Activation	process
Aop:74	Event:484	disrupted	MESH	MESH:0000484	Mitochondrial dysfun	HP	HP:0000484	Mitochondrial dysfun	process
Aop:74	Event:485	morphological change	UBERON	UBERON:0000485	Impairment	GO	GO:0000485	Impairment	process
Aop:74	Event:486	increased	PR	PR:0000486	Abnormal	MP	MP:0000486	Abnormal	process
Aop:74	Event:487	decreased	CHEBI	CHEBI:0000487	Weakened	VT	VT:0000487	Weakened	process
Aop:74	Event:488	occurrence	CL	CL:0000488	Abnormal	HP	HP:0000488	Abnormal	process
Aop:74	Event:489	disrupted	MESH	MESH:0000489	Altered	GO	GO:0000489	Altered	process
Aop:74	Event:490	morphological change	UBERON	UBERON:0000490	Death/Failure	MP	MP:0000490	Death/Failure	process
Aop:75	Event:491	occurrence	CL	CL:0000491	Activation	VT	VT:0000491	Activation	process
Aop:75	Event:492	disrupted	MESH	MESH:0000492	Impairment	HP	HP:0000492	Impairment	process
Aop:75	Event:493	morphological change	UBERON	UBERON:0000493	Abnormal	GO	GO:0000493	Abnormal	process
Aop:75	Event:494	increased	PR	PR:0000494	Desensitization	MP	MP:0000494	Desensitization	process
Aop:75	Event:495	decreased	CHEBI	CHEBI:0000495	Weakened	VT	VT:0000495	Weakened	process
Aop:75	Event:496	occurrence	CL	CL:0000496	Altered	HP	HP:0000496	Altered	process
Aop:75	Event:497	disrupted	MESH	MESH:0000497	Death/Failure	GO	GO:0000497	Death/Failure	process
Aop:76	Event:498	occurrence	CL	CL:0000498	Activation	VT	VT:0000498	Activation	process
Aop:76	Event:499	disrupted	MESH	MESH:0000499	Desensitization	HP	HP:0000499	Desensitization	process
Aop:76	Event:500	morphological change	UBERON	UBERON:0000500	Altered	GO	GO:0000500	Altered	process
Aop:76	Event:501	increased	PR	PR:0000501	Impairment	MP	MP:0000501	Impairment	process
Aop:76	Event:502	decreased	CHEBI	CHEBI:0000502	Abnormal	VT	VT:0000502	Abnormal	process
Aop:76	Event:503	occurrence	CL	CL:0000503	Weakened	HP	HP:0000503	Weakened	process
Aop:76	Event:504	disrupted	MESH	MESH:0000504	Abnormal	GO	GO:0000504	Abnormal	process
Aop:76	Event:505	morphological change	UBERON	UBERON:0000505	Death/Failure	MP	MP:0000505	Death/Failure	process
Aop:77	Event:506	occurrence	CL	CL:0000506	Activation	VT	VT:0000506	Activation	process
Aop:77	Event:507	disrupted	MESH	MESH:0000507	Impairment	HP	HP:0000507	Impairment	process
Aop:77	Event:508	morphological change	UBERON	UBERON:0000508	Abnormal	GO	GO:0000508	Abnormal	process
Aop:77	Event:509	increased	PR	PR:0000509	Reduced	MP	MP:0000509	Reduced	process
Aop:77	Event:510	decreased	CHEBI	CHEBI:0000510	Desensitization	VT	VT:0000510	Desensitization	process
Aop:77	Event:511	occurrence	CL	CL:0000511	Decrease of neuronal	HP	HP:0000511	Decrease of neuronal	process
Aop:77	Event:512	disrupted	MESH	MESH:0000512	impaired	GO	GO:0000512	impaired	process
Aop:77	Event:513	morphological change	UBERON	UBERON:0000513	Death/Failure	MP	MP:0000513	Death/Failure	process
Aop:78	Event:514	occurrence	CL	CL:0000514	Inhibition	VT	VT:0000514	Inhibition	process
Aop:78	Event:515	disrupted	MESH	MESH:0000515	Decreased	HP	HP:0000515	Decreased	process
Aop:78	Event:516	morphological change	UBERON	UBERON:0000516	Reduced	GO	GO:0000516	Reduced	process
Aop:78	Event:517	increased	PR	PR:0000517	Reduced	MP	MP:0000517	Reduced	process
Aop:78	Event:518	decreased	CHEBI	CHEBI:0000518	Increased	VT	VT:0000518	Increased	process
Aop:78	Event:519	occurrence	CL	CL:0000519	Reduced	HP	HP:0000519	Reduced	process
Aop:79	Event:520	occurrence	CL	CL:0000520	Inhibition	VT	VT:0000520	Inhibition	process
Aop:79	Event:521	disrupted	MESH	MESH:0000521	Decreased	HP	HP:0000521	Decreased	process
Aop:79	Event:522	morphological change	UBERON	UBERON:0000522	Reduced	GO	GO:0000522	Reduced	process
Aop:79	Event:523	increased	PR	PR:0000523	Increased	MP	MP:0000523	Increased	process
Aop:80	Event:524	occurrence	CL	CL:0000524	Inhibition	VT	VT:0000524	Inhibition	process
Aop:80	Event:525	disrupted	MESH	MESH:0000525	Increased	HP	HP:0000525	Increased	process
Aop:80	Event:526	morphological change	UBERON	UBERON:0000526	Respiratory distress	GO	GO:0000526	Respiratory distress	process
Aop:80	Event:527	increased	PR	PR:0000527	N/A	MP	MP:0000527	N/A	process
Aop:80	Event:528	decreased	CHEBI	CHEBI:0000528	Decreased	VT	VT:0000528	Decreased	process
Aop:80	Event:529	occurrence	CL	CL:0000529	Increased	HP	HP:0000529	Increased	process
Aop:81	Event:530	occurrence	CL	CL:0000530	Inhibition	VT	VT:0000530	Inhibition	process
Aop:81	Event:531	disrupted	MESH	MESH:0000531	Decreased	HP	HP:0000531	Decreased	process
Aop:81	Event:532	morphological change	UBERON	UBERON:0000532	Reduced	GO	GO:0000532	Reduced	process
Aop:81	Event:533	increased	PR	PR:0000533	Reduced	MP	MP:0000533	Reduced	process
Aop:81	Event:534	decreased	CHEBI	CHEBI:0000534	Increased	VT	VT:0000534	Increased	process
Aop:81	Event:535	occurrence	CL	CL:0000535	Reduced	HP	HP:0000535	Reduced	process
Aop:82	Event:536	occurrence	CL	CL:0000536	modulation	VT	VT:0000536	modulation	process
Aop:82	Event:537	disrupted	MESH	MESH:0000537	prolonged	HP	HP:0000537	prolonged	process
Aop:82	Event:538	morphological change	UBERON	UBERON:0000538	Overactivation	GO	GO:0000538	Overactivation	process
Aop:82	Event:539	increased	PR	PR:0000539	Overactivation	MP	MP:0000539	Overactivation	process
Aop:82	Event:540	decreased	CHEBI	CHEBI:0000540	Increased	VT	VT:0000540	Increased	process
Aop:82	Event:541	occurrence	CL	CL:0000541	Increased Mortality	HP	HP:0000541	Increased Mortality	process
Aop:83	Event:542	occurrence	CL	CL:0000542	Inhibition	VT	VT:0000542	Inhibition	process
Aop:83	Event:543	disrupted	MESH	MESH:0000543	Increased	HP	HP:0000543	Increased	process
Aop:83	Event:544	morphological change	UBERON	UBERON:0000544	Increased	GO	GO:0000544	Increased	process
Aop:83	Event:545	increased	PR	PR:0000545	Increased	MP	MP:0000545	Increased	process
Aop:83	Event:546	decreased	CHEBI	CHEBI:0000546	Depletion	VT	VT:0000546	Depletion	process
Aop:83	Event:547	occurrence	CL	CL:0000547	Increased	HP	HP:0000547	Increased	process
Aop:83	Event:548	disrupted	MESH	MESH:0000548	Increased	GO	GO:0000548	Increased	process
Aop:83	Event:549	morphological change	UBERON	UBERON:0000549	Increased	MP	MP:0000549	Increased	process
Aop:83	Event:550	increased	PR	PR:0000550	Increase	VT	VT:0000550	Increase	process
Aop:83	Event:551	decreased	CHEBI	CHEBI:0000551	Decrease	HP	HP:0000551	Decrease	process
Aop:84	Event:552	occurrence	CL	CL:0000552	Inhibition	VT	VT:0000552	Inhibition	process
Aop:84	Event:553	disrupted	MESH	MESH:0000553	Increased	HP	HP:0000553	Increased	process
Aop:84	Event:554	morphological change	UBERON	UBERON:0000554	Decreased	GO	GO:0000554	Decreased	process
Aop:84	Event:555	increased	PR	PR:0000555	Decreased	MP	MP:0000555	Decreased	process
Aop:84	Event:556	decreased	CHEBI	CHEBI:0000556	Increased	VT	VT:0000556	Increased	process
Aop:85	Event:557	occurrence	CL	CL:0000557	Antagonism	VT	VT:0000557	Antagonism	process
Aop:85	Event:558	disrupted	MESH	MESH:0000558	Decrease	HP	HP:0000558	Decrease	process
Aop:85	Event:559	morphological change	UBERON	UBERON:0000559	N/A	GO	GO:0000559	N/A	process
Aop:85	Event:560	increased	PR	PR:0000560	Decreased	MP	MP:0000560	Decreased	process
Aop:85	Event:561	decreased	CHEBI	CHEBI:0000561	Impairment	VT	VT:0000561	Impairment	process
Aop:85	Event:562	occurrence	CL	CL:0000562	Decreased	HP	HP:0000562	Decreased	process
Aop:85	Event:563	disrupted	MESH	MESH:0000563	Increased	GO	GO:0000563	Increased	process
Aop:86	Event:564	occurrence	CL	CL:0000564	Inhibition	VT	VT:0000564	Inhibition	process
Aop:86	Event:565	disrupted	MESH	MESH:0000565	Reduced	HP	HP:0000565	Reduced	process
Aop:86	Event:566	morphological change	UBERON	UBERON:0000566	Reduced	GO	GO:0000566	Reduced	process
Aop:86	Event:567	increased	PR	PR:0000567	Reduced	MP	MP:0000567	Reduced	process
Aop:86	Event:568	decreased	CHEBI	CHEBI:0000568	Reduced	VT	VT:0000568	Reduced	process
Aop:86	Event:569	occurrence	CL	CL:0000569	Reduced	HP	HP:0000569	Reduced	process
Aop:86	Event:570	disrupted	MESH	MESH:0000570	Decrease	GO	GO:0000570	Decrease	process
Aop:87	Event:571	occurrence	CL	CL:0000571	Inhibition	VT	VT:0000571	Inhibition	process
Aop:87	Event:572	disrupted	MESH	MESH:0000572	Reduced	HP	HP:0000572	Reduced	process
Aop:87	Event:573	morphological change	UBERON	UBERON:0000573	Reduced	GO	GO:0000573	Reduced	process
Aop:87	Event:574	increased	PR	PR:0000574	Decreased	MP	MP:0000574	Decreased	process
Aop:87	Event:575	decreased	CHEBI	CHEBI:0000575	Reduced	VT	VT:0000575	Reduced	process
Aop:87	Event:576	occurrence	CL	CL:0000576	Reduced	HP	HP:0000576	Reduced	process
Aop:87	Event:577	disrupted	MESH	MESH:0000577	Decrease	GO	GO:0000577	Decrease	process
Aop:88	Event:578	occurrence	CL	CL:0000578	Inhibition	VT	VT:0000578	Inhibition	process
Aop:88	Event:579	disrupted	MESH	MESH:0000579	Reduced	HP	HP:0000579	Reduced	process
Aop:88	Event:580	morphological change	UBERON	UBERON:0000580	Reduced	GO	GO:0000580	Reduced	process
Aop:88	Event:581	increased	PR	PR:0000581	Reduced	MP	MP:0000581	Reduced	process
Aop:88	Event:582	decreased	CHEBI	CHEBI:0000582	Reduced	VT	VT:0000582	Reduced	process
Aop:88	Event:583	occurrence	CL	CL:0000583	Reduced	HP	HP:0000583	Reduced	process
Aop:88	Event:584	disrupted	MESH	MESH:0000584	Reduced	GO	GO:0000584	Reduced	process
Aop:88	Event:585	morphological change	UBERON	UBERON:0000585	Increased	MP	MP:0000585	Increased	process
Aop:88	Event:586	increased	PR	PR:0000586	Reduced	VT	VT:0000586	Reduced	process
Aop:88	Event:587	decreased	CHEBI	CHEBI:0000587	Decrease	HP	HP:0000587	Decrease	process
Aop:89	Event:588	occurrence	CL	CL:0000588	Inhibition	VT	VT:0000588	Inhibition	process
Aop:89	Event:589	disrupted	MESH	MESH:0000589	Reduced	HP	HP:0000589	Reduced	process
Aop:89	Event:590	morphological change	UBERON	UBERON:0000590	Reduced	GO	GO:0000590	Reduced	process
Aop:89	Event:591	increased	PR	PR:0000591	Reduced	MP	MP:0000591	Reduced	process
Aop:89	Event:592	decreased	CHEBI	CHEBI:0000592	Reduced	VT	VT:0000592	Reduced	process
Aop:89	Event:593	occurrence	CL	CL:0000593	Reduced	HP	HP:0000593	Reduced	process
Aop:89	Event:594	disrupted	MESH	MESH:0000594	Upregulated	GO	GO:0000594	Upregulated	process
Aop:89	Event:595	morphological change	UBERON	UBERON:0000595	Increased	MP	MP:0000595	Increased	process
Aop:89	Event:596	increased	PR	PR:0000596	Reduced	VT	VT:0000596	Reduced	process
Aop:89	Event:597	decreased	CHEBI	CHEBI:0000597	Decrease	HP	HP:0000597	Decrease	process
Aop:90	Event:598	occurrence	CL	CL:0000598	impaired	VT	VT:0000598	impaired	process
Aop:90	Event:599	disrupted	MESH	MESH:0000599	Altered	HP	HP:0000599	Altered	process
Aop:90	Event:600	morphological change	UBERON	UBERON:0000600	Increased	GO	GO:0000600	Increased	process
Aop:90	Event:601	increased	PR	PR:0000601	Increased Mortality	MP	MP:0000601	Increased Mortality	process
Aop:91	Event:602	occurrence	CL	CL:0000602	Increased	VT	VT:0000602	Increased	process
Aop:91	Event:603	disrupted	MESH	MESH:0000603	Increased	HP	HP:0000603	Increased	process
Aop:91	Event:604	morphological change	UBERON	UBERON:0000604	Increase	GO	GO:0000604	Increase	process
Aop:91	Event:605	increased	PR	PR:0000605	Increase	MP	MP:0000605	Increase	process
Aop:91	Event:606	decreased	CHEBI	CHEBI:0000606	Increase	VT	VT:0000606	Increase	process
Aop:91	Event:607	occurrence	CL	CL:0000607	Increase	HP	HP:0000607	Increase	process
Aop:92	Event:608	occurrence	CL	CL:0000608	Binding	VT	VT:0000608	Binding	process
Aop:92	Event:609	disrupted	MESH	MESH:0000609	Disruption	HP	HP:0000609	Disruption	process
Aop:92	Event:610	morphological change	UBERON	UBERON:0000610	Disorganization	GO	GO:0000610	Disorganization	process
Aop:92	Event:611	increased	PR	PR:0000611	Altered	MP	MP:0000611	Altered	process
Aop:92	Event:612	decreased	CHEBI	CHEBI:0000612	Altered	VT	VT:0000612	Altered	process
Aop:92	Event:613	occurrence	CL	CL:0000613	Increase	HP	HP:0000613	Increase	process
Aop:93	Event:614	occurrence	CL	CL:0000614	Activation	VT	VT:0000614	Activation	process
Aop:93	Event:615	disrupted	MESH	MESH:0000615	Altered gene expression specific to CAR activation	HP	HP:0000615	Altered gene expression specific to CAR activation	process
Aop:93	Event:616	morphological change	UBERON	UBERON:0000616	Increase	GO	GO:0000616	Increase	process
Aop:93	Event:617	increased	PR	PR:0000617	Increase	MP	MP:0000617	Increase	process
Aop:93	Event:618	decreased	CHEBI	CHEBI:0000618	Increase	VT	VT:0000618	Increase	process
Aop:94	Event:619	occurrence	CL	CL:0000619	Inhibition	VT	VT:0000619	Inhibition	process
Aop:94	Event:620	disrupted	MESH	MESH:0000620	Increase	HP	HP:0000620	Increase	process
Aop:94	Event:621	morphological change	UBERON	UBERON:0000621	Peptide Oxidation	GO	GO:0000621	Peptide Oxidation	process
Aop:94	Event:622	increased	PR	PR:0000622	Increased	MP	MP:0000622	Increased	process
Aop:94	Event:623	decreased	CHEBI	CHEBI:0000623	Increase	VT	VT:0000623	Increase	process
Aop:94	Event:624	occurrence	CL	CL:0000624	Increase	HP	HP:0000624	Increase	process
Aop:95	Event:625	occurrence	CL	CL:0000625	Increase	VT	VT:0000625	Increase	process
Aop:95	Event:626	disrupted	MESH	MESH:0000626	Increase	HP	HP:0000626	Increase	process
Aop:95	Event:627	morphological change	UBERON	UBERON:0000627	Increase	GO	GO:0000627	Increase	process
Aop:95	Event:628	increased	PR	PR:0000628	Increase	MP	MP:0000628	Increase	process
Aop:95	Event:629	decreased	CHEBI	CHEBI:0000629	Increase	VT	VT:0000629	Increase	process
Aop:96	Event:630	occurrence	CL	CL:0000630	Inhibition	VT	VT:0000630	Inhibition	process
Aop:96	Event:631	disrupted	MESH	MESH:0000631	Thyroid hormone synthesis	HP	HP:0000631	Thyroid hormone synthesis	process
Aop:96	Event:632	morphological change	UBERON	UBERON:0000632	Thyroxine (T4) in serum	GO	GO:0000632	Thyroxine (T4) in serum	process
Aop:96	Event:633	increased	PR	PR:0000633	Increased	MP	MP:0000633	Increased	process
Aop:96	Event:634	decreased	CHEBI	CHEBI:0000634	Increase	VT	VT:0000634	Increase	process
Aop:96	Event:635	occurrence	CL	CL:0000635	Increase	HP	HP:0000635	Increase	process
Aop:96	Event:636	disrupted	MESH	MESH:0000636	Increase	GO	GO:0000636	Increase	process
Aop:97	Event:637	occurrence	CL	CL:0000637	Decrease	VT	VT:0000637	Decrease	process
Aop:97	Event:638	disrupted	MESH	MESH:0000638	Decreased	HP	HP:0000638	Decreased	process
Aop:97	Event:639	morphological change	UBERON	UBERON:0000639	Increase	GO	GO:0000639	Increase	process
Aop:97	Event:640	increased	PR	PR:0000640	Increased	MP	MP:0000640	Increased	process
Aop:97	Event:641	decreased	CHEBI	CHEBI:0000641	Increase	VT	VT:0000641	Increase	process
Aop:98	Event:642	occurrence	CL	CL:0000642	Increase	VT	VT:0000642	Increase	process
Aop:98	Event:643	disrupted	MESH	MESH:0000643	Decreased	HP	HP:0000643	Decreased	process
Aop:98	Event:644	morphological change	UBERON	UBERON:0000644	Agonism	GO	GO:0000644	Agonism	process
Aop:98	Event:645	increased	PR	PR:0000645	Decreased	MP	MP:0000645	Decreased	process
Aop:98	Event:646	decreased	CHEBI	CHEBI:0000646	Increase	VT	VT:0000646	Increase	process
Aop:98	Event:647	occurrence	CL	CL:0000647	Increase	HP	HP:0000647	Increase	process
Aop:99	Event:648	occurrence	CL	CL:0000648	Activation	VT	VT:0000648	Activation	process
Aop:99	Event:649	disrupted	MESH	MESH:0000649	Increased	HP	HP:0000649	Increased	process
Aop:99	Event:650	morphological change	UBERON	UBERON:0000650	hyperpolarisation	GO	GO:0000650	hyperpolarisation	process
Aop:99	Event:651	increased	PR	PR:0000651	N/A	MP	MP:0000651	N/A	process
Aop:99	Event:652	decreased	CHEBI	CHEBI:0000652	Increased Mortality	VT	VT:0000652	Increased Mortality	process
Aop:99	Event:653	occurrence	CL	CL:0000653	Decreased	HP	HP:0000653	Decreased	process
Aop:100	Event:654	occurrence	CL	CL:0000654	Inhibition	VT	VT:0000654	Inhibition	process
Aop:100	Event:655	disrupted	MESH	MESH:0000655	Increased	HP	HP:0000655	Increased	process
Aop:100	Event:656	morphological change	UBERON	UBERON:0000656	Increase	GO	GO:0000656	Increase	process
Aop:100	Event:657	increased	PR	PR:0000657	Increase	MP	MP:0000657	Increase	process
Aop:100	Event:658	decreased	CHEBI	CHEBI:0000658	Increase	VT	VT:0000658	Increase	process
Aop:100	Event:659	occurrence	CL	CL:0000659	Increase	HP	HP:0000659	Increase	process
Aop:101	Event:660	occurrence	CL	CL:0000660	Increase	VT	VT:0000660	Increase	process
Aop:101	Event:661	disrupted	MESH	MESH:0000661	Increase	HP	HP:0000661	Increase	process
Aop:101	Event:662	morphological change	UBERON	UBERON:0000662	Increase	GO	GO:0000662	Increase	process
Aop:101	Event:663	increased	PR	PR:0000663	Increase	MP	MP:0000663	Increase	process
Aop:101	Event:664	decreased	CHEBI	CHEBI:0000664	Increase	VT	VT:0000664	Increase	process
Aop:102	Event:665	occurrence	CL	CL:0000665	Increase	VT	VT:0000665	Increase	process
Aop:102	Event:666	disrupted	MESH	MESH:0000666	Increase	HP	HP:0000666	Increase	process
Aop:102	Event:667	morphological change	UBERON	UBERON:0000667	Increase	GO	GO:0000667	Increase	process
Aop:102	Event:668	increased	PR	PR:0000668	Increase	MP	MP:0000668	Increase	process
Aop:103	Event:669	occurrence	CL	CL:0000669	Agonism	VT	VT:0000669	Agonism	process
Aop:103	Event:670	disrupted	MESH	MESH:0000670	Increase	HP	HP:0000670	Increase	process
Aop:103	Event:671	morphological change	UBERON	UBERON:0000671	Increase	GO	GO:0000671	Increase	process
Aop:103	Event:672	increased	PR	PR:0000672	Increase	MP	MP:0000672	Increase	process
Aop:104	Event:673	occurrence	CL	CL:0000673	Increase	VT	VT:0000673	Increase	process
Aop:104	Event:674	disrupted	MESH	MESH:0000674	Increase	HP	HP:0000674	Increase	process
Aop:104	Event:675	morphological change	UBERON	UBERON:0000675	Increase	GO	GO:0000675	Increase	process
Aop:104	Event:676	increased	PR	PR:0000676	Increase	MP	MP:0000676	Increase	process
Aop:105	Event:677	occurrence	CL	CL:0000677	Thyroperoxidase	VT	VT:0000677	Thyroperoxidase	process
Aop:105	Event:678	disrupted	MESH	MESH:0000678	Thyroid hormone synthesis	HP	HP:0000678	Thyroid hormone synthesis	process
Aop:105	Event:679	morphological change	UBERON	UBERON:0000679	Thyroxine (T4) in serum	GO	GO:0000679	Thyroxine (T4) in serum	process
Aop:105	Event:680	increased	PR	PR:0000680	Increased	MP	MP:0000680	Increased	process
Aop:105	Event:681	decreased	CHEBI	CHEBI:0000681	Increase	VT	VT:0000681	Increase	process
Aop:105	Event:682	occurrence	CL	CL:0000682	Increase	HP	HP:0000682	Increase	process
Aop:105	Event:683	disrupted	MESH	MESH:0000683	Increase	GO	GO:0000683	Increase	process
Aop:106	Event:684	occurrence	CL	CL:0000684	Inhibition	VT	VT:0000684	Inhibition	process
Aop:106	Event:685	disrupted	MESH	MESH:0000685	Increased	HP	HP:0000685	Increased	process
Aop:106	Event:686	morphological change	UBERON	UBERON:0000686	Increase	GO	GO:0000686	Increase	process
Aop:106	Event:687	increased	PR	PR:0000687	Decrease	MP	MP:0000687	Decrease	process
Aop:106	Event:688	decreased	CHEBI	CHEBI:0000688	Increase	VT	VT:0000688	Increase	process
Aop:107	Event:689	occurrence	CL	CL:0000689	Increase	VT	VT:0000689	Increase	process
Aop:107	Event:690	disrupted	MESH	MESH:0000690	Increase	HP	HP:0000690	Increase	process
Aop:107	Event:691	morphological change	UBERON	UBERON:0000691	Increase	GO	GO:0000691	Increase	process
Aop:107	Event:692	increased	PR	PR:0000692	Increase	MP	MP:0000692	Increase	process
Aop:107	Event:693	decreased	CHEBI	CHEBI:0000693	Increase	VT	VT:0000693	Increase	process
Aop:108	Event:694	occurrence	CL	CL:0000694	Inhibition	VT	VT:0000694	Inhibition	process
Aop:108	Event:695	disrupted	MESH	MESH:0000695	Increased	HP	HP:0000695	Increased	process
Aop:108	Event:696	morphological change	UBERON	UBERON:0000696	Decreased	GO	GO:0000696	Decreased	process
Aop:108	Event:697	increased	PR	PR:0000697	Reduction	MP	MP:0000697	Reduction	process
Aop:108	Event:698	decreased	CHEBI	CHEBI:0000698	Reduction	VT	VT:0000698	Reduction	process
Aop:108	Event:699	occurrence	CL	CL:0000699	Reduction	HP	HP:0000699	Reduction	process
Aop:108	Event:700	disrupted	MESH	MESH:0000700	Reduction	GO	GO:0000700	Reduction	process
Aop:108	Event:701	morphological change	UBERON	UBERON:0000701	Reduction	MP	MP:0000701	Reduction	process
Aop:108	Event:702	increased	PR	PR:0000702	Reduction	VT	VT:0000702	Reduction	process
Aop:108	Event:703	decreased	CHEBI	CHEBI:0000703	Decrease	HP	HP:0000703	Decrease	process
Aop:109	Event:704	occurrence	CL	CL:0000704	modulation	VT	VT:0000704	modulation	process
Aop:109	Event:705	disrupted	MESH	MESH:0000705	Increased	HP	HP:0000705	Increased	process
Aop:109	Event:706	morphological change	UBERON	UBERON:0000706	Increased	GO	GO:0000706	Increased	process
Aop:109	Event:707	increased	PR	PR:0000707	Decreased	MP	MP:0000707	Decreased	process
Aop:109	Event:708	decreased	CHEBI	CHEBI:0000708	Reduction	VT	VT:0000708	Reduction	process
Aop:109	Event:709	occurrence	CL	CL:0000709	Reduction	HP	HP:0000709	Reduction	process
Aop:109	Event:710	disrupted	MESH	MESH:0000710	Reduction	GO	GO:0000710	Reduction	process
Aop:109	Event:711	morphological change	UBERON	UBERON:0000711	Reduction	MP	MP:0000711	Reduction	process
Aop:109	Event:712	increased	PR	PR:0000712	Reduction	VT	VT:0000712	Reduction	process
Aop:109	Event:713	decreased	CHEBI	CHEBI:0000713	Reduction	HP	HP:0000713	Reduction	process
Aop:109	Event:714	occurrence	CL	CL:0000714	Decrease	GO	GO:0000714	Decrease	process
Aop:110	Event:715	occurrence	CL	CL:0000715	Inhibition	VT	VT:0000715	Inhibition	process
Aop:110	Event:716	disrupted	MESH	MESH:0000716	Decreased	HP	HP:0000716	Decreased	process
Aop:110	Event:717	morphological change	UBERON	UBERON:0000717	Decreased	GO	GO:0000717	Decreased	process
Aop:110	Event:718	increased	PR	PR:0000718	Decrease	MP	MP:0000718	Decrease	process
Aop:110	Event:719	decreased	CHEBI	CHEBI:0000719	malformed	VT	VT:0000719	malformed	process
Aop:110	Event:720	occurrence	CL	CL:0000720	Decrease	HP	HP:0000720	Decrease	process
Aop:111	Event:721	occurrence	CL	CL:0000721	Inhibition	VT	VT:0000721	Inhibition	process
Aop:111	Event:722	disrupted	MESH	MESH:0000722	Decreased	HP	HP:0000722	Decreased	process
Aop:111	Event:723	morphological change	UBERON	UBERON:0000723	Decreased	GO	GO:0000723	Decreased	process
Aop:111	Event:724	increased	PR	PR:0000724	Decreased	MP	MP:0000724	Decreased	process
Aop:111	Event:725	decreased	CHEBI	CHEBI:0000725	Decreased	VT	VT:0000725	Decreased	process
Aop:111	Event:726	occurrence	CL	CL:0000726	Delayed	HP	HP:0000726	Delayed	process
Aop:111	Event:727	disrupted	MESH	MESH:0000727	Decreased	GO	GO:0000727	Decreased	process
Aop:111	Event:728	morphological change	UBERON	UBERON:0000728	Altered	MP	MP:0000728	Altered	process
Aop:111	Event:729	increased	PR	PR:0000729	Abnormal	VT	VT:0000729	Abnormal	process
Aop:111	Event:730	decreased	CHEBI	CHEBI:0000730	Altered	HP	HP:0000730	Altered	process
Aop:111	Event:731	occurrence	CL	CL:0000731	Decreased	GO	GO:0000731	Decreased	process
Aop:112	Event:732	occurrence	CL	CL:0000732	Thyroid hormone synthesis	VT	VT:0000732	Thyroid hormone synthesis	process
Aop:112	Event:733	disrupted	MESH	MESH:0000733	Thyroxine (T4) in serum	HP	HP:0000733	Thyroxine (T4) in serum	process
Aop:112	Event:734	morphological change	UBERON	UBERON:0000734	Increased	GO	GO:0000734	Increased	process
Aop:112	Event:735	increased	PR	PR:0000735	Occurrence	MP	MP:0000735	Occurrence	process
Aop:112	Event:736	decreased	CHEBI	CHEBI:0000736	Occurrence	VT	VT:0000736	Occurrence	process
Aop:112	Event:737	occurrence	CL	CL:0000737	Occurrence	HP	HP:0000737	Occurrence	process
Aop:112	Event:738	disrupted	MESH	MESH:0000738	Decreased	GO	GO:0000738	Decreased	process
Aop:112	Event:739	morphological change	UBERON	UBERON:0000739	Decreased	MP	MP:0000739	Decreased	process
Aop:112	Event:740	increased	PR	PR:0000740	Decreased	VT	VT:0000740	Decreased	process
Aop:112	Event:741	decreased	CHEBI	CHEBI:0000741	Decreased	HP	HP:0000741	Decreased	process
Aop:112	Event:742	occurrence	CL	CL:0000742	Occurrence	GO	GO:0000742	Occurrence	process
Aop:113	Event:743	occurrence	CL	CL:0000743	Inhibition	VT	VT:0000743	Inhibition	process
Aop:113	Event:744	disrupted	MESH	MESH:0000744	Damage	HP	HP:0000744	Damage	process
Aop:113	Event:745	morphological change	UBERON	UBERON:0000745	Disturbance	GO	GO:0000745	Disturbance	process
Aop:113	Event:746	increased	PR	PR:0000746	Mitochondrial dysfun	MP	MP:0000746	Mitochondrial dysfun	process
Aop:113	Event:747	decreased	CHEBI	CHEBI:0000747	Occurrence	VT	VT:0000747	Occurrence	process
Aop:113	Event:748	occurrence	CL	CL:0000748	Occurrence	HP	HP:0000748	Occurrence	process
Aop:113	Event:749	disrupted	MESH	MESH:0000749	Occurrence	GO	GO:0000749	Occurrence	process
Aop:113	Event:750	morphological change	UBERON	UBERON:0000750	Induction	MP	MP:0000750	Induction	process
Aop:113	Event:751	increased	PR	PR:0000751	Formation	VT	VT:0000751	Formation	process
Aop:113	Event:752	decreased	CHEBI	CHEBI:0000752	Occurrence	HP	HP:0000752	Occurrence	process
Aop:113	Event:753	occurrence	CL	CL:0000753	Formation	GO	GO:0000753	Formation	process
Aop:114	Event:754	occurrence	CL	CL:0000754	Activation	VT	VT:0000754	Activation	process
Aop:114	Event:755	disrupted	MESH	MESH:0000755	Induction	HP	HP:0000755	Induction	process
Aop:114	Event:756	morphological change	UBERON	UBERON:0000756	Oxidation	GO	GO:0000756	Oxidation	process
Aop:114	Event:757	increased	PR	PR:0000757	Inhibition	MP	MP:0000757	Inhibition	process
Aop:114	Event:758	decreased	CHEBI	CHEBI:0000758	Accumulation	VT	VT:0000758	Accumulation	process
Aop:114	Event:759	occurrence	CL	CL:0000759	Uroporphyria	HP	HP:0000759	Uroporphyria	process
Aop:115	Event:760	occurrence	CL	CL:0000760	Inhibition	VT	VT:0000760	Inhibition	process
Aop:115	Event:761	disrupted	MESH	MESH:0000761	Thyroid hormone synthesis	HP	HP:0000761	Thyroid hormone synthesis	process
Aop:115	Event:762	morphological change	UBERON	UBERON:0000762	Decrease of Thyroida	GO	GO:0000762	Decrease of Thyroida	process
Aop:115	Event:763	increased	PR	PR:0000763	Thyroxine (T4) in serum	MP	MP:0000763	Thyroxine (T4) in serum	process
Aop:115	Event:764	decreased	CHEBI	CHEBI:0000764	Thyroxine (T4) in neuronal tissue	VT	VT:0000764	Thyroxine (T4) in neuronal tissue	process
Aop:115	Event:765	occurrence	CL	CL:0000765	Hippocampal gene expression	HP	HP:0000765	Hippocampal gene expression	process
Aop:115	Event:766	disrupted	MESH	MESH:0000766	Hippocampal anatomy	GO	GO:0000766	Hippocampal anatomy	process
Aop:115	Event:767	morphological change	UBERON	UBERON:0000767	Hippocampal Physiology	MP	MP:0000767	Hippocampal Physiology	process
Aop:115	Event:768	increased	PR	PR:0000768	Cognitive function	VT	VT:0000768	Cognitive function	process
Aop:116	Event:769	occurrence	CL	CL:0000769	Decrease	VT	VT:0000769	Decrease	process
Aop:116	Event:770	disrupted	MESH	MESH:0000770	Increase	HP	HP:0000770	Increase	process
Aop:116	Event:771	morphological change	UBERON	UBERON:0000771	Increase	GO	GO:0000771	Increase	process
Aop:116	Event:772	increased	PR	PR:0000772	Increase	MP	MP:0000772	Increase	process
Aop:116	Event:773	decreased	CHEBI	CHEBI:0000773	Increase	VT	VT:0000773	Increase	process
Aop:116	Event:774	occurrence	CL	CL:0000774	Increase	HP	HP:0000774	Increase	process
Aop:116	Event:775	disrupted	MESH	MESH:0000775	Increase	GO	GO:0000775	Increase	process
Aop:117	Event:776	occurrence	CL	CL:0000776	Inhibition	VT	VT:0000776	Inhibition	process
Aop:117	Event:777	disrupted	MESH	MESH:0000777	Increased	HP	HP:0000777	Increased	process
Aop:117	Event:778	morphological change	UBERON	UBERON:0000778	Occurrence	GO	GO:0000778	Occurrence	process
Aop:117	Event:779	increased	PR	PR:0000779	Increased	MP	MP:0000779	Increased	process
Aop:117	Event:780	decreased	CHEBI	CHEBI:0000780	Occurrence	VT	VT:0000780	Occurrence	process
Aop:117	Event:781	occurrence	CL	CL:0000781	Occurrence	HP	HP:0000781	Occurrence	process
Aop:117	Event:782	disrupted	MESH	MESH:0000782	Oxidative Stress	GO	GO:0000782	Oxidative Stress	process
Aop:117	Event:783	morphological change	UBERON	UBERON:0000783	Increased Mortality	MP	MP:0000783	Increased Mortality	process
Aop:117	Event:784	increased	PR	PR:0000784	Decrease	VT	VT:0000784	Decrease	process
Aop:118	Event:785	occurrence	CL	CL:0000785	Alkylation	VT	VT:0000785	Alkylation	process
Aop:118	Event:786	disrupted	MESH	MESH:0000786	Inadequate DNA repai	HP	HP:0000786	Inadequate DNA repai	process
Aop:118	Event:787	morphological change	UBERON	UBERON:0000787	Increase	GO	GO:0000787	Increase	process
Aop:118	Event:788	increased	PR	PR:0000788	Increase	MP	MP:0000788	Increase	process
Aop:119	Event:789	occurrence	CL	CL:0000789	Alkylation	VT	VT:0000789	Alkylation	process
Aop:119	Event:790	disrupted	MESH	MESH:0000790	Inadequate DNA repai	HP	HP:0000790	Inadequate DNA repai	process
Aop:119	Event:791	morphological change	UBERON	UBERON:0000791	Increase	GO	GO:0000791	Increase	process
Aop:119	Event:792	increased	PR	PR:0000792	Increase	MP	MP:0000792	Increase	process
Aop:120	Event:793	occurrence	CL	CL:0000793	Endocytotic lysosoma	VT	VT:0000793	Endocytotic lysosoma	process
Aop:120	Event:794	disrupted	MESH	MESH:0000794	Disruption	HP	HP:0000794	Disruption	process
Aop:120	Event:795	morphological change	UBERON	UBERON:0000795	Mitochondrial dysfun	GO	GO:0000795	Mitochondrial dysfun	process
Aop:120	Event:796	increased	PR	PR:0000796	Increase	MP	MP:0000796	Increase	process
Aop:120	Event:797	decreased	CHEBI	CHEBI:0000797	Increased Pro-inflam	VT	VT:0000797	Increased Pro-inflam	process
Aop:120	Event:798	occurrence	CL	CL:0000798	Leukocyte recruitmen	HP	HP:0000798	Leukocyte recruitmen	process
Aop:120	Event:799	disrupted	MESH	MESH:0000799	Activation	GO	GO:0000799	Activation	process
Aop:120	Event:800	morphological change	UBERON	UBERON:0000800	Accumulation	MP	MP:0000800	Accumulation	process
Aop:120	Event:801	increased	PR	PR:0000801	N/A	VT	VT:0000801	N/A	process
Aop:121	Event:793	increased	MESH	D002137	Calculi	MP	MP:0011625	cystolithiasis
Aop:121	Event:794	increased	CL	CL:0000731	urothelial cell	GO	GO:0008219	cell death
Aop:121	Event:795	increased	CL	CL:0000731	urothelial cell	GO	GO:0008283	cell proliferation
Aop:121	Event:796	increased	CL	CL:0000731	urothelial cell	MESH	D006965	hyperplasia
Aop:121	Event:797	increased	MESH	D000236	Adenoma			
Aop:121	Event:797	increased	MESH	D002277	Carcinoma			
Aop:122	Event:802	occurrence	CL	CL:0000802	Activation	VT	VT:0000802	Activation	process
Aop:122	Event:803	disrupted	MESH	MESH:0000803	Increase	HP	HP:0000803	Increase	process
Aop:122	Event:804	morphological change	UBERON	UBERON:0000804	Increase	GO	GO:0000804	Increase	process
Aop:122	Event:805	increased	PR	PR:0000805	Decrease	MP	MP:0000805	Decrease	process
Aop:123	Event:806	occurrence	CL	CL:0000806	Peptide Oxidation	VT	VT:0000806	Peptide Oxidation	process
Aop:123	Event:807	disrupted	MESH	MESH:0000807	KE1 : S-Glutathionylation	HP	HP:0000807	KE1 : S-Glutathionylation	process
Aop:123	Event:808	morphological change	UBERON	UBERON:0000808	KE2 : Decrease	GO	GO:0000808	KE2 : Decrease	process
Aop:123	Event:809	increased	PR	PR:0000809	KE3 : Decrease	MP	MP:0000809	KE3 : Decrease	process
Aop:123	Event:810	decreased	CHEBI	CHEBI:0000810	KE4 : Uncoupling	VT	VT:0000810	KE4 : Uncoupling	process
Aop:123	Event:811	occurrence	CL	CL:0000811	KE6 : Depletion	HP	HP:0000811	KE6 : Depletion	process
Aop:123	Event:812	disrupted	MESH	MESH:0000812	KE7 : Impaired	GO	GO:0000812	KE7 : Impaired	process
Aop:123	Event:813	morphological change	UBERON	UBERON:0000813	KE8 : Increase	MP	MP:0000813	KE8 : Increase	process
Aop:123	Event:814	increased	PR	PR:0000814	KE5 : Decrease	VT	VT:0000814	KE5 : Decrease	process
Aop:123	Event:815	decreased	CHEBI	CHEBI:0000815	Hypertension	HP	HP:0000815	Hypertension	process
Aop:124	Event:816	occurrence	CL	CL:0000816	Activation	VT	VT:0000816	Activation	process
Aop:124	Event:817	disrupted	MESH	MESH:0000817	dimerization	HP	HP:0000817	dimerization	process
Aop:124	Event:818	morphological change	UBERON	UBERON:0000818	reduced dimerization	GO	GO:0000818	reduced dimerization	process
Aop:124	Event:819	increased	PR	PR:0000819	reduced production	MP	MP:0000819	reduced production	process
Aop:124	Event:820	decreased	CHEBI	CHEBI:0000820	Impairment	VT	VT:0000820	Impairment	process
Aop:124	Event:821	occurrence	CL	CL:0000821	Altered	HP	HP:0000821	Altered	process
Aop:124	Event:822	disrupted	MESH	MESH:0000822	Increase	GO	GO:0000822	Increase	process
Aop:125	Event:823	occurrence	CL	CL:0000823	Activation	VT	VT:0000823	Activation	process
Aop:125	Event:824	disrupted	MESH	MESH:0000824	dimerization	HP	HP:0000824	dimerization	process
Aop:125	Event:825	morphological change	UBERON	UBERON:0000825	reduced dimerization	GO	GO:0000825	reduced dimerization	process
Aop:125	Event:826	increased	PR	PR:0000826	reduced production	MP	MP:0000826	reduced production	process
Aop:125	Event:827	decreased	CHEBI	CHEBI:0000827	abnormal	VT	VT:0000827	abnormal	process
Aop:125	Event:828	occurrence	CL	CL:0000828	increase	HP	HP:0000828	increase	process
Aop:125	Event:829	disrupted	MESH	MESH:0000829	increase	GO	GO:0000829	increase	process
Aop:126	Event:830	occurrence	CL	CL:0000830	Binding	VT	VT:0000830	Binding	process
Aop:126	Event:831	disrupted	MESH	MESH:0000831	Displacement	HP	HP:0000831	Displacement	process
Aop:126	Event:832	morphological change	UBERON	UBERON:0000832	Increased	GO	GO:0000832	Increased	process
Aop:126	Event:833	increased	PR	PR:0000833	Increased	MP	MP:0000833	Increased	process
Aop:126	Event:834	decreased	CHEBI	CHEBI:0000834	Increased	VT	VT:0000834	Increased	process
Aop:126	Event:835	occurrence	CL	CL:0000835	Thyroxine (T4) in serum	HP	HP:0000835	Thyroxine (T4) in serum	process
Aop:126	Event:836	disrupted	MESH	MESH:0000836	Thyroxine (T4) in neuronal tissue	GO	GO:0000836	Thyroxine (T4) in neuronal tissue	process
Aop:126	Event:837	morphological change	UBERON	UBERON:0000837	Hippocampal gene expression	MP	MP:0000837	Hippocampal gene expression	process
Aop:126	Event:838	increased	PR	PR:0000838	Hippocampal anatomy	VT	VT:0000838	Hippocampal anatomy	process
Aop:126	Event:839	decreased	CHEBI	CHEBI:0000839	Hippocampal Physiology	HP	HP:0000839	Hippocampal Physiology	process
Aop:126	Event:840	occurrence	CL	CL:0000840	Cognitive function	GO	GO:0000840	Cognitive function	process
Aop:127	Event:841	occurrence	CL	CL:0000841	Inhibition of Aromatase Enzyme	VT	VT:0000841	Inhibition of Aromatase Enzyme	process
Aop:127	Event:842	disrupted	MESH	MESH:0000842	Reduction	HP	HP:0000842	Reduction	process
Aop:127	Event:843	morphological change	UBERON	UBERON:0000843	Reduction	GO	GO:0000843	Reduction	process
Aop:127	Event:844	increased	PR	PR:0000844	Decrease	MP	MP:0000844	Decrease	process
Aop:127	Event:845	decreased	CHEBI	CHEBI:0000845	Decreased Kisspeptin release from neurons in AVPV	VT	VT:0000845	Decreased Kisspeptin release from neurons in AVPV	process
Aop:127	Event:846	occurrence	CL	CL:0000846	Decreased GnRH Release	HP	HP:0000846	Decreased GnRH Release	process
Aop:127	Event:847	disrupted	MESH	MESH:0000847	Decreased LH release from Anterior Pituitary	GO	GO:0000847	Decreased LH release from Anterior Pituitary	process
Aop:127	Event:848	morphological change	UBERON	UBERON:0000848	Ovulation of oocytes Reduced	MP	MP:0000848	Ovulation of oocytes Reduced	process
Aop:127	Event:849	increased	PR	PR:0000849	Decreased fertility	VT	VT:0000849	Decreased fertility	process
Aop:128	Event:850	occurrence	CL	CL:0000850	Inhibition	VT	VT:0000850	Inhibition	process
Aop:128	Event:851	disrupted	MESH	MESH:0000851	Interference	HP	HP:0000851	Interference	process
Aop:128	Event:852	morphological change	UBERON	UBERON:0000852	Reduction	GO	GO:0000852	Reduction	process
Aop:128	Event:853	increased	PR	PR:0000853	Suppression	MP	MP:0000853	Suppression	process
Aop:128	Event:854	decreased	CHEBI	CHEBI:0000854	Impairment	VT	VT:0000854	Impairment	process
Aop:129	Event:855	occurrence	CL	CL:0000855	Inhibition	VT	VT:0000855	Inhibition	process
Aop:129	Event:856	disrupted	MESH	MESH:0000856	Decreased	HP	HP:0000856	Decreased	process
Aop:129	Event:857	morphological change	UBERON	UBERON:0000857	Reduced	GO	GO:0000857	Reduced	process
Aop:129	Event:858	increased	PR	PR:0000858	Reduced	MP	MP:0000858	Reduced	process
Aop:129	Event:859	decreased	CHEBI	CHEBI:0000859	Increased Mortality	VT	VT:0000859	Increased Mortality	process
Aop:129	Event:860	occurrence	CL	CL:0000860	Decrease	HP	HP:0000860	Decrease	process
Aop:130	Event:861	occurrence	CL	CL:0000861	Inhibition	VT	VT:0000861	Inhibition	process
Aop:130	Event:862	disrupted	MESH	MESH:0000862	Decreased	HP	HP:0000862	Decreased	process
Aop:130	Event:863	morphological change	UBERON	UBERON:0000863	Reduced	GO	GO:0000863	Reduced	process
Aop:130	Event:864	increased	PR	PR:0000864	Reduced	MP	MP:0000864	Reduced	process
Aop:130	Event:865	decreased	CHEBI	CHEBI:0000865	Increased Mortality	VT	VT:0000865	Increased Mortality	process
Aop:130	Event:866	occurrence	CL	CL:0000866	Decrease	HP	HP:0000866	Decrease	process
Aop:131	Event:867	occurrence	CL	CL:0000867	Inhibition	VT	VT:0000867	Inhibition	process
Aop:131	Event:868	disrupted	MESH	MESH:0000868	Decreased	HP	HP:0000868	Decreased	process
Aop:131	Event:869	morphological change	UBERON	UBERON:0000869	Reduced	GO	GO:0000869	Reduced	process
Aop:131	Event:870	increased	PR	PR:0000870	Reduced	MP	MP:0000870	Reduced	process
Aop:131	Event:871	decreased	CHEBI	CHEBI:0000871	Increased Mortality	VT	VT:0000871	Increased Mortality	process
Aop:131	Event:872	occurrence	CL	CL:0000872	Decrease	HP	HP:0000872	Decrease	process
Aop:132	Event:873	occurrence	CL	CL:0000873	Inhibition	VT	VT:0000873	Inhibition	process
Aop:132	Event:874	disrupted	MESH	MESH:0000874	Decreased	HP	HP:0000874	Decreased	process
Aop:132	Event:875	morphological change	UBERON	UBERON:0000875	Reduced	GO	GO:0000875	Reduced	process
Aop:132	Event:876	increased	PR	PR:0000876	Reduced	MP	MP:0000876	Reduced	process
Aop:132	Event:877	decreased	CHEBI	CHEBI:0000877	Increased Mortality	VT	VT:0000877	Increased Mortality	process
Aop:132	Event:878	occurrence	CL	CL:0000878	Decrease	HP	HP:0000878	Decrease	process
Aop:133	Event:879	occurrence	CL	CL:0000879	Thyroperoxidase	VT	VT:0000879	Thyroperoxidase	process
Aop:133	Event:880	disrupted	MESH	MESH:0000880	Thyroid hormone synthesis	HP	HP:0000880	Thyroid hormone synthesis	process
Aop:133	Event:881	morphological change	UBERON	UBERON:0000881	Thyroxine (T4) in serum	GO	GO:0000881	Thyroxine (T4) in serum	process
Aop:133	Event:882	increased	PR	PR:0000882	Decreased	MP	MP:0000882	Decreased	process
Aop:133	Event:883	decreased	CHEBI	CHEBI:0000883	Reduced	VT	VT:0000883	Reduced	process
Aop:133	Event:884	occurrence	CL	CL:0000884	Reduced	HP	HP:0000884	Reduced	process
Aop:133	Event:885	disrupted	MESH	MESH:0000885	Increased Mortality	GO	GO:0000885	Increased Mortality	process
Aop:133	Event:886	morphological change	UBERON	UBERON:0000886	Decrease	MP	MP:0000886	Decrease	process
Aop:134	Event:887	occurrence	CL	CL:0000887	Activation	VT	VT:0000887	Activation	process
Aop:134	Event:888	disrupted	MESH	MESH:0000888	Increased	HP	HP:0000888	Increased	process
Aop:134	Event:889	morphological change	UBERON	UBERON:0000889	Induction	GO	GO:0000889	Induction	process
Aop:134	Event:890	increased	PR	PR:0000890	Increased	MP	MP:0000890	Increased	process
Aop:134	Event:891	decreased	CHEBI	CHEBI:0000891	Increased	VT	VT:0000891	Increased	process
Aop:134	Event:892	occurrence	CL	CL:0000892	Inhibition	HP	HP:0000892	Inhibition	process
Aop:134	Event:893	disrupted	MESH	MESH:0000893	Increased Mortality	GO	GO:0000893	Increased Mortality	process
Aop:135	Event:894	occurrence	CL	CL:0000894	Activation	VT	VT:0000894	Activation	process
Aop:135	Event:895	disrupted	MESH	MESH:0000895	Increased	HP	HP:0000895	Increased	process
Aop:135	Event:896	morphological change	UBERON	UBERON:0000896	Increased	GO	GO:0000896	Increased	process
Aop:135	Event:897	increased	PR	PR:0000897	Inhibition	MP	MP:0000897	Inhibition	process
Aop:135	Event:898	decreased	CHEBI	CHEBI:0000898	Increased	VT	VT:0000898	Increased	process
Aop:135	Event:899	occurrence	CL	CL:0000899	Induction	HP	HP:0000899	Induction	process
Aop:135	Event:900	disrupted	MESH	MESH:0000900	Increased Mortality	GO	GO:0000900	Increased Mortality	process
Aop:136	Event:901	occurrence	CL	CL:0000901	Induction	VT	VT:0000901	Induction	process
Aop:136	Event:902	disrupted	MESH	MESH:0000902	Increased	HP	HP:0000902	Increased	process
Aop:136	Event:903	morphological change	UBERON	UBERON:0000903	Thyroxine (T4) in serum	GO	GO:0000903	Thyroxine (T4) in serum	process
Aop:136	Event:904	increased	PR	PR:0000904	Increased	MP	MP:0000904	Increased	process
Aop:136	Event:905	decreased	CHEBI	CHEBI:0000905	Increase	VT	VT:0000905	Increase	process
Aop:136	Event:906	occurrence	CL	CL:0000906	Increase	HP	HP:0000906	Increase	process
Aop:136	Event:907	disrupted	MESH	MESH:0000907	Increase	GO	GO:0000907	Increase	process
Aop:137	Event:908	occurrence	CL	CL:0000908	Activation of specific nuclear receptors	VT	VT:0000908	Activation of specific nuclear receptors	process
Aop:137	Event:909	disrupted	MESH	MESH:0000909	Increased	HP	HP:0000909	Increased	process
Aop:137	Event:910	morphological change	UBERON	UBERON:0000910	Increased	GO	GO:0000910	Increased	process
Aop:137	Event:911	increased	PR	PR:0000911	Increased	MP	MP:0000911	Increased	process
Aop:137	Event:912	decreased	CHEBI	CHEBI:0000912	Increased	VT	VT:0000912	Increased	process
Aop:137	Event:913	occurrence	CL	CL:0000913	Increased	HP	HP:0000913	Increased	process
Aop:137	Event:914	disrupted	MESH	MESH:0000914	Increased	GO	GO:0000914	Increased	process
Aop:137	Event:915	morphological change	UBERON	UBERON:0000915	Increased	MP	MP:0000915	Increased	process
Aop:138	Event:916	occurrence	CL	CL:0000916	Activation	VT	VT:0000916	Activation	process
Aop:138	Event:917	disrupted	MESH	MESH:0000917	Increased activity	HP	HP:0000917	Increased activity	process
Aop:138	Event:918	morphological change	UBERON	UBERON:0000918	relaxation	GO	GO:0000918	relaxation	process
Aop:138	Event:919	increased	PR	PR:0000919	Proliferation/Clonal Expansion	MP	MP:0000919	Proliferation/Clonal Expansion	process
Aop:138	Event:920	decreased	CHEBI	CHEBI:0000920	Hypertrophy/hyperplasia	VT	VT:0000920	Hypertrophy/hyperplasia	process
Aop:138	Event:921	occurrence	CL	CL:0000921	Promotion	HP	HP:0000921	Promotion	process
Aop:139	Event:922	occurrence	CL	CL:0000922	Decreased	VT	VT:0000922	Decreased	process
Aop:139	Event:923	disrupted	MESH	MESH:0000923	Suppression	HP	HP:0000923	Suppression	process
Aop:139	Event:924	morphological change	UBERON	UBERON:0000924	Increased	GO	GO:0000924	Increased	process
Aop:139	Event:925	increased	PR	PR:0000925	Increased	MP	MP:0000925	Increased	process
Aop:139	Event:926	decreased	CHEBI	CHEBI:0000926	Increased	VT	VT:0000926	Increased	process
Aop:139	Event:927	occurrence	CL	CL:0000927	Hyperplasia	HP	HP:0000927	Hyperplasia	process
Aop:139	Event:928	disrupted	MESH	MESH:0000928	Hyperplasia	GO	GO:0000928	Hyperplasia	process
Aop:139	Event:929	morphological change	UBERON	UBERON:0000929	Decrease	MP	MP:0000929	Decrease	process
Aop:139	Event:930	increased	PR	PR:0000930	Promotion	VT	VT:0000930	Promotion	process
Aop:139	Event:931	decreased	CHEBI	CHEBI:0000931	Promotion	HP	HP:0000931	Promotion	process
Aop:140	Event:932	occurrence	CL	CL:0000932	Increased	VT	VT:0000932	Increased	process
Aop:140	Event:933	disrupted	MESH	MESH:0000933	Decreased	HP	HP:0000933	Decreased	process
Aop:140	Event:934	morphological change	UBERON	UBERON:0000934	Increased	GO	GO:0000934	Increased	process
Aop:140	Event:935	increased	PR	PR:0000935	Alteration	MP	MP:0000935	Alteration	process
Aop:140	Event:936	decreased	CHEBI	CHEBI:0000936	prolonged	VT	VT:0000936	prolonged	process
Aop:140	Event:937	occurrence	CL	CL:0000937	Increased	HP	HP:0000937	Increased	process
Aop:140	Event:938	disrupted	MESH	MESH:0000938	Increased	GO	GO:0000938	Increased	process
Aop:141	Event:939	occurrence	CL	CL:0000939	Agonism	VT	VT:0000939	Agonism	process
Aop:141	Event:940	disrupted	MESH	MESH:0000940	Sine oculis homeobox 1 gene expression	HP	HP:0000940	Sine oculis homeobox 1 gene expression	process
Aop:141	Event:941	morphological change	UBERON	UBERON:0000941	Sine oculis homeobox 1 protein expression	GO	GO:0000941	Sine oculis homeobox 1 protein expression	process
Aop:141	Event:942	increased	PR	PR:0000942	Promotion	MP	MP:0000942	Promotion	process
Aop:141	Event:943	decreased	CHEBI	CHEBI:0000943	Proliferation/Clonal Expansion	VT	VT:0000943	Proliferation/Clonal Expansion	process
Aop:141	Event:944	occurrence	CL	CL:0000944	squamous metaplasia	HP	HP:0000944	squamous metaplasia	process
Aop:141	Event:945	disrupted	MESH	MESH:0000945	Increased	GO	GO:0000945	Increased	process
Aop:141	Event:946	morphological change	UBERON	UBERON:0000946	Increased	MP	MP:0000946	Increased	process
Aop:142	Event:947	occurrence	CL	CL:0000947	Decreased	VT	VT:0000947	Decreased	process
Aop:142	Event:948	disrupted	MESH	MESH:0000948	Decreased	HP	HP:0000948	Decreased	process
Aop:142	Event:949	morphological change	UBERON	UBERON:0000949	interruption	GO	GO:0000949	interruption	process
Aop:142	Event:950	increased	PR	PR:0000950	prolonged	MP	MP:0000950	prolonged	process
Aop:142	Event:951	decreased	CHEBI	CHEBI:0000951	Increased	VT	VT:0000951	Increased	process
Aop:142	Event:952	occurrence	CL	CL:0000952	Increased	HP	HP:0000952	Increased	process
Aop:142	Event:953	disrupted	MESH	MESH:0000953	Hyperplasia	GO	GO:0000953	Hyperplasia	process
Aop:142	Event:954	morphological change	UBERON	UBERON:0000954	Increased	MP	MP:0000954	Increased	process
Aop:142	Event:955	increased	PR	PR:0000955	Increased	VT	VT:0000955	Increased	process
Aop:143	Event:956	occurrence	CL	CL:0000956	Decreased	VT	VT:0000956	Decreased	process
Aop:143	Event:957	disrupted	MESH	MESH:0000957	Decreased	HP	HP:0000957	Decreased	process
Aop:143	Event:958	morphological change	UBERON	UBERON:0000958	prolonged	GO	GO:0000958	prolonged	process
Aop:143	Event:959	increased	PR	PR:0000959	interruption	MP	MP:0000959	interruption	process
Aop:143	Event:960	decreased	CHEBI	CHEBI:0000960	Increased	VT	VT:0000960	Increased	process
Aop:143	Event:961	occurrence	CL	CL:0000961	Increased	HP	HP:0000961	Increased	process
Aop:143	Event:962	disrupted	MESH	MESH:0000962	Increased	GO	GO:0000962	Increased	process
Aop:144	Event:963	occurrence	CL	CL:0000963	Decreased	VT	VT:0000963	Decreased	process
Aop:144	Event:964	disrupted	MESH	MESH:0000964	Increased	HP	HP:0000964	Increased	process
Aop:144	Event:965	morphological change	UBERON	UBERON:0000965	Increased	GO	GO:0000965	Increased	process
Aop:144	Event:966	increased	PR	PR:0000966	Increased	MP	MP:0000966	Increased	process
Aop:144	Event:967	decreased	CHEBI	CHEBI:0000967	Increased	VT	VT:0000967	Increased	process
Aop:145	Event:968	occurrence	CL	CL:0000968	persistent	VT	VT:0000968	persistent	process
Aop:145	Event:969	disrupted	MESH	MESH:0000969	Increased	HP	HP:0000969	Increased	process
Aop:145	Event:970	morphological change	UBERON	UBERON:0000970	Oxidative Stress	GO	GO:0000970	Oxidative Stress	process
Aop:145	Event:971	increased	PR	PR:0000971	Increased	MP	MP:0000971	Increased	process
Aop:145	Event:972	decreased	CHEBI	CHEBI:0000972	Increased	VT	VT:0000972	Increased	process
Aop:145	Event:973	occurrence	CL	CL:0000973	Increased	HP	HP:0000973	Increased	process
Aop:146	Event:974	occurrence	CL	CL:0000974	Substance interactio	VT	VT:0000974	Substance interactio	process
Aop:146	Event:975	disrupted	MESH	MESH:0000975	Increased	HP	HP:0000975	Increased	process
Aop:146	Event:976	morphological change	UBERON	UBERON:0000976	Increased	GO	GO:0000976	Increased	process
Aop:146	Event:977	increased	PR	PR:0000977	Loss of alveolar cap	MP	MP:0000977	Loss of alveolar cap	process
Aop:146	Event:978	decreased	CHEBI	CHEBI:0000978	Increased	VT	VT:0000978	Increased	process
Aop:146	Event:979	occurrence	CL	CL:0000979	Increased	HP	HP:0000979	Increased	process
Aop:146	Event:980	disrupted	MESH	MESH:0000980	Accumulation	GO	GO:0000980	Accumulation	process
Aop:146	Event:981	morphological change	UBERON	UBERON:0000981	Pulmonary fibrosis	MP	MP:0000981	Pulmonary fibrosis	process
Aop:147	Event:982	occurrence	CL	CL:0000982	Thyroperoxidase	VT	VT:0000982	Thyroperoxidase	process
Aop:147	Event:983	disrupted	MESH	MESH:0000983	Thyroid hormone synthesis	HP	HP:0000983	Thyroid hormone synthesis	process
Aop:147	Event:984	morphological change	UBERON	UBERON:0000984	Thyroxine (T4) in serum	GO	GO:0000984	Thyroxine (T4) in serum	process
Aop:147	Event:985	increased	PR	PR:0000985	Altered	MP	MP:0000985	Altered	process
Aop:148	Event:986	occurrence	CL	CL:0000986	Inhibition	VT	VT:0000986	Inhibition	process
Aop:148	Event:987	disrupted	MESH	MESH:0000987	Decrease of Thyroida	HP	HP:0000987	Decrease of Thyroida	process
Aop:148	Event:988	morphological change	UBERON	UBERON:0000988	Thyroid hormone synthesis	GO	GO:0000988	Thyroid hormone synthesis	process
Aop:148	Event:989	increased	PR	PR:0000989	Thyroxine (T4) in serum	MP	MP:0000989	Thyroxine (T4) in serum	process
Aop:148	Event:990	decreased	CHEBI	CHEBI:0000990	Altered	VT	VT:0000990	Altered	process
Aop:149	Event:991	occurrence	CL	CL:0000991	Inhibition	VT	VT:0000991	Inhibition	process
Aop:149	Event:992	disrupted	MESH	MESH:0000992	Decreased	HP	HP:0000992	Decreased	process
Aop:149	Event:993	morphological change	UBERON	UBERON:0000993	Occurrence	GO	GO:0000993	Occurrence	process
Aop:149	Event:994	increased	PR	PR:0000994	Occurrence	MP	MP:0000994	Occurrence	process
Aop:149	Event:995	decreased	CHEBI	CHEBI:0000995	Increased	VT	VT:0000995	Increased	process
Aop:149	Event:996	occurrence	CL	CL:0000996	Occurrence	HP	HP:0000996	Occurrence	process
Aop:149	Event:997	disrupted	MESH	MESH:0000997	Oxidative Stress	GO	GO:0000997	Oxidative Stress	process
Aop:149	Event:998	morphological change	UBERON	UBERON:0000998	Increased	MP	MP:0000998	Increased	process
Aop:149	Event:999	increased	PR	PR:0000999	Occurrence	VT	VT:0000999	Occurrence	process
Aop:149	Event:1000	decreased	CHEBI	CHEBI:0001000	Increased Mortality	HP	HP:0001000	Increased Mortality	process
Aop:149	Event:1001	occurrence	CL	CL:0001001	Decrease	GO	GO:0001001	Decrease	process
Aop:150	Event:1002	occurrence	CL	CL:0001002	Activation	VT	VT:0001002	Activation	process
Aop:150	Event:1003	disrupted	MESH	MESH:0001003	Mitochondrial dysfun	HP	HP:0001003	Mitochondrial dysfun	process
Aop:150	Event:1004	morphological change	UBERON	UBERON:0001004	Weakened	GO	GO:0001004	Weakened	process
Aop:150	Event:1005	increased	PR	PR:0001005	Death/Failure	MP	MP:0001005	Death/Failure	process
Aop:151	Event:1006	occurrence	CL	CL:0001006	Increased	VT	VT:0001006	Increased	process
Aop:151	Event:1007	disrupted	MESH	MESH:0001007	Weakened	HP	HP:0001007	Weakened	process
Aop:151	Event:1008	morphological change	UBERON	UBERON:0001008	Death/Failure	GO	GO:0001008	Death/Failure	process
Aop:152	Event:1009	occurrence	CL	CL:0001009	Abnormal	VT	VT:0001009	Abnormal	process
Aop:152	Event:1010	disrupted	MESH	MESH:0001010	Weakened	HP	HP:0001010	Weakened	process
Aop:152	Event:1011	morphological change	UBERON	UBERON:0001011	Death/Failure	GO	GO:0001011	Death/Failure	process
Aop:153	Event:1012	occurrence	CL	CL:0001012	Weakened	VT	VT:0001012	Weakened	process
Aop:153	Event:1013	disrupted	MESH	MESH:0001013	Death/Failure	HP	HP:0001013	Death/Failure	process
Aop:154	Event:1014	occurrence	CL	CL:0001014	Abnormal	VT	VT:0001014	Abnormal	process
Aop:154	Event:1015	disrupted	MESH	MESH:0001015	Weakened	HP	HP:0001015	Weakened	process
Aop:154	Event:1016	morphological change	UBERON	UBERON:0001016	Death/Failure	GO	GO:0001016	Death/Failure	process
Aop:155	Event:1017	occurrence	CL	CL:0001017	Increased	VT	VT:0001017	Increased	process
Aop:155	Event:1018	disrupted	MESH	MESH:0001018	Abnormal	HP	HP:0001018	Abnormal	process
Aop:155	Event:1019	morphological change	UBERON	UBERON:0001019	Weakened	GO	GO:0001019	Weakened	process
Aop:155	Event:1020	increased	PR	PR:0001020	Death/Failure	MP	MP:0001020	Death/Failure	process
Aop:156	Event:1021	occurrence	CL	CL:0001021	Abnormal	VT	VT:0001021	Abnormal	process
Aop:156	Event:1022	disrupted	MESH	MESH:0001022	Weakened	HP	HP:0001022	Weakened	process
Aop:156	Event:1023	morphological change	UBERON	UBERON:0001023	Death/Failure	GO	GO:0001023	Death/Failure	process
Aop:157	Event:1024	occurrence	CL	CL:0001024	Weakened	VT	VT:0001024	Weakened	process
Aop:157	Event:1025	disrupted	MESH	MESH:0001025	Death/Failure	HP	HP:0001025	Death/Failure	process
Aop:158	Event:1026	occurrence	CL	CL:0001026	Unknown	VT	VT:0001026	Unknown	process
Aop:158	Event:1027	disrupted	MESH	MESH:0001027	Increase	HP	HP:0001027	Increase	process
Aop:158	Event:1028	morphological change	UBERON	UBERON:0001028	Oxidative Stress	GO	GO:0001028	Oxidative Stress	process
Aop:158	Event:1029	increased	PR	PR:0001029	Occurrence	MP	MP:0001029	Occurrence	process
Aop:158	Event:1030	decreased	CHEBI	CHEBI:0001030	Increased	VT	VT:0001030	Increased	process
Aop:158	Event:1031	occurrence	CL	CL:0001031	Occurrence	HP	HP:0001031	Occurrence	process
Aop:158	Event:1032	disrupted	MESH	MESH:0001032	Increased Mortality	GO	GO:0001032	Increased Mortality	process
Aop:159	Event:1033	occurrence	CL	CL:0001033	Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139	VT	VT:0001033	Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139	process
Aop:159	Event:1034	disrupted	MESH	MESH:0001034	Uncoupling of oxidative phosphorylation	HP	HP:0001034	Uncoupling of oxidative phosphorylation	process
Aop:159	Event:1035	morphological change	UBERON	UBERON:0001035	Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone	GO	GO:0001035	Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone	process
Aop:159	Event:1036	increased	PR	PR:0001036	Under carboxylated clotting factors will not assemble on cell surfaces to form clot	MP	MP:0001036	Under carboxylated clotting factors will not assemble on cell surfaces to form clot	process
Aop:159	Event:1037	decreased	CHEBI	CHEBI:0001037	Failure in vascular repair mechanisms	VT	VT:0001037	Failure in vascular repair mechanisms	process
Aop:159	Event:1038	occurrence	CL	CL:0001038	Failure in gamma-glutamyl carboxylation of clotting factors II	HP	HP:0001038	Failure in gamma-glutamyl carboxylation of clotting factors II	process
Aop:159	Event:1039	disrupted	MESH	MESH:0001039	Blood loss and development of anemia	GO	GO:0001039	Blood loss and development of anemia	process
Aop:159	Event:1040	morphological change	UBERON	UBERON:0001040	Hemostasis	MP	MP:0001040	Hemostasis	process
Aop:159	Event:1041	increased	PR	PR:0001041	Reduced fitness or even mortality	VT	VT:0001041	Reduced fitness or even mortality	process
Aop:159	Event:1042	decreased	CHEBI	CHEBI:0001042	Osteoporosis and vascular calcification	HP	HP:0001042	Osteoporosis and vascular calcification	process
Aop:159	Event:1043	occurrence	CL	CL:0001043	Impaired recruitment 	GO	GO:0001043	Impaired recruitment 	process
Aop:160	Event:1044	occurrence	CL	CL:0001044	Inhibition	VT	VT:0001044	Inhibition	process
Aop:160	Event:1045	disrupted	MESH	MESH:0001045	Decrease of Thyroida	HP	HP:0001045	Decrease of Thyroida	process
Aop:160	Event:1046	morphological change	UBERON	UBERON:0001046	Thyroid hormone synthesis	GO	GO:0001046	Thyroid hormone synthesis	process
Aop:160	Event:1047	increased	PR	PR:0001047	Thyroxine (T4) in serum	MP	MP:0001047	Thyroxine (T4) in serum	process
Aop:160	Event:1048	decreased	CHEBI	CHEBI:0001048	Altered	VT	VT:0001048	Altered	process
Aop:161	Event:1049	occurrence	CL	CL:0001049	Inhibition	VT	VT:0001049	Inhibition	process
Aop:161	Event:1050	disrupted	MESH	MESH:0001050	Decreased	HP	HP:0001050	Decreased	process
Aop:161	Event:1051	morphological change	UBERON	UBERON:0001051	Decreased	GO	GO:0001051	Decreased	process
Aop:161	Event:1052	increased	PR	PR:0001052	Altered	MP	MP:0001052	Altered	process
Aop:162	Event:1053	occurrence	CL	CL:0001053	Inhibition	VT	VT:0001053	Inhibition	process
Aop:162	Event:1054	disrupted	MESH	MESH:0001054	Decreased	HP	HP:0001054	Decreased	process
Aop:162	Event:1055	morphological change	UBERON	UBERON:0001055	Increased	GO	GO:0001055	Increased	process
Aop:162	Event:1056	increased	PR	PR:0001056	Increased	MP	MP:0001056	Increased	process
Aop:162	Event:1057	decreased	CHEBI	CHEBI:0001057	Altered	VT	VT:0001057	Altered	process
Aop:162	Event:1058	occurrence	CL	CL:0001058	Altered	HP	HP:0001058	Altered	process
Aop:163	Event:1059	occurrence	CL	CL:0001059	Inhibition	VT	VT:0001059	Inhibition	process
Aop:163	Event:1060	disrupted	MESH	MESH:0001060	Increased	HP	HP:0001060	Increased	process
Aop:163	Event:1061	morphological change	UBERON	UBERON:0001061	Altered	GO	GO:0001061	Altered	process
Aop:163	Event:1062	increased	PR	PR:0001062	Altered	MP	MP:0001062	Altered	process
Aop:164	Event:1063	occurrence	CL	CL:0001063	Inhibition	VT	VT:0001063	Inhibition	process
Aop:164	Event:1064	disrupted	MESH	MESH:0001064	Thyroid hormone synthesis	HP	HP:0001064	Thyroid hormone synthesis	process
Aop:164	Event:1065	morphological change	UBERON	UBERON:0001065	Thyroxine (T4) in serum	GO	GO:0001065	Thyroxine (T4) in serum	process
Aop:164	Event:1066	increased	PR	PR:0001066	Altered	MP	MP:0001066	Altered	process
Aop:165	Event:1067	occurrence	CL	CL:0001067	Inhibition	VT	VT:0001067	Inhibition	process
Aop:165	Event:1068	disrupted	MESH	MESH:0001068	Thyroid hormone synthesis	HP	HP:0001068	Thyroid hormone synthesis	process
Aop:165	Event:1069	morphological change	UBERON	UBERON:0001069	Thyroxine (T4) in serum	GO	GO:0001069	Thyroxine (T4) in serum	process
Aop:165	Event:1070	increased	PR	PR:0001070	Altered	MP	MP:0001070	Altered	process
Aop:166	Event:1071	occurrence	CL	CL:0001071	Activation	VT	VT:0001071	Activation	process
Aop:166	Event:1072	disrupted	MESH	MESH:0001072	Increased	HP	HP:0001072	Increased	process
Aop:166	Event:1073	morphological change	UBERON	UBERON:0001073	Induction	GO	GO:0001073	Induction	process
Aop:166	Event:1074	increased	PR	PR:0001074	Increased	MP	MP:0001074	Increased	process
Aop:166	Event:1075	decreased	CHEBI	CHEBI:0001075	Thyroxine (T4) in serum	VT	VT:0001075	Thyroxine (T4) in serum	process
Aop:166	Event:1076	occurrence	CL	CL:0001076	Altered	HP	HP:0001076	Altered	process
Aop:167	Event:1077	occurrence	CL	CL:0001077	Inhibition	VT	VT:0001077	Inhibition	process
Aop:167	Event:1078	disrupted	MESH	MESH:0001078	Increased	HP	HP:0001078	Increased	process
Aop:167	Event:1079	morphological change	UBERON	UBERON:0001079	Increased	GO	GO:0001079	Increased	process
Aop:167	Event:1080	increased	PR	PR:0001080	induced spawning	MP	MP:0001080	induced spawning	process
Aop:167	Event:1081	decreased	CHEBI	CHEBI:0001081	Increased	VT	VT:0001081	Increased	process
Aop:167	Event:1082	occurrence	CL	CL:0001082	Increased	HP	HP:0001082	Increased	process
Aop:167	Event:1083	disrupted	MESH	MESH:0001083	Increase	GO	GO:0001083	Increase	process
Aop:167	Event:1084	morphological change	UBERON	UBERON:0001084	Increased	MP	MP:0001084	Increased	process
Aop:168	Event:1085	occurrence	CL	CL:0001085	TRPA1 activation	VT	VT:0001085	TRPA1 activation	process
Aop:168	Event:1086	disrupted	MESH	MESH:0001086	Opening of calcium channel	HP	HP:0001086	Opening of calcium channel	process
Aop:168	Event:1087	morphological change	UBERON	UBERON:0001087	Trigeminal nerve act	GO	GO:0001087	Trigeminal nerve act	process
Aop:168	Event:1088	increased	PR	PR:0001088	SP (Substance P) release	MP	MP:0001088	SP (Substance P) release	process
Aop:168	Event:1089	decreased	CHEBI	CHEBI:0001089	Increased CGRP	VT	VT:0001089	Increased CGRP	process
Aop:168	Event:1090	occurrence	CL	CL:0001090	Increased neurokinin	HP	HP:0001090	Increased neurokinin	process
Aop:168	Event:1091	disrupted	MESH	MESH:0001091	Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness	GO	GO:0001091	Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness	process
Aop:168	Event:1092	morphological change	UBERON	UBERON:0001092	Irritation of nasal 	MP	MP:0001092	Irritation of nasal 	process
Aop:168	Event:1093	increased	PR	PR:0001093	Increased Respiratory irritability and Chronic Cough	VT	VT:0001093	Increased Respiratory irritability and Chronic Cough	process
Aop:169	Event:1094	occurrence	CL	CL:0001094	Inhibition	VT	VT:0001094	Inhibition	process
Aop:169	Event:1095	disrupted	MESH	MESH:0001095	Decreased	HP	HP:0001095	Decreased	process
Aop:169	Event:1096	morphological change	UBERON	UBERON:0001096	Decreased	GO	GO:0001096	Decreased	process
Aop:170	Event:1083	increased	CL	CL:0000700	dopaminergic neuron	GO	GO:0001963	synaptic transmission, dopaminergic
Aop:170	Event:1084	increased	PR	PR:000013246	prolactin	GO	GO:0070459	prolactin secretion
Aop:170	Event:1085	increased	UBERON	UBERON:0001911	mammary gland	MESH	D006965	hyperplasia
Aop:170	Event:1080	increased				MP	MP:0010307	abnormal tumor latency
Aop:170	Event:1079	increased	MESH	D000236	Adenoma			
Aop:170	Event:1079	increased	MESH	D002277	Carcinoma			
Aop:171	Event:1097	occurrence	CL	CL:0001097	Agonism	VT	VT:0001097	Agonism	process
Aop:171	Event:1098	disrupted	MESH	MESH:0001098	Increase	HP	HP:0001098	Increase	process
Aop:171	Event:1099	morphological change	UBERON	UBERON:0001099	Decreased	GO	GO:0001099	Decreased	process
Aop:171	Event:1100	increased	PR	PR:0001100	Mitochondrial dysfun	MP	MP:0001100	Mitochondrial dysfun	process
Aop:171	Event:1101	decreased	CHEBI	CHEBI:0001101	Oxidative Stress	VT	VT:0001101	Oxidative Stress	process
Aop:171	Event:1102	occurrence	CL	CL:0001102	Increased	HP	HP:0001102	Increased	process
Aop:171	Event:1103	disrupted	MESH	MESH:0001103	Increased	GO	GO:0001103	Increased	process
Aop:171	Event:1104	morphological change	UBERON	UBERON:0001104	Increased	MP	MP:0001104	Increased	process
Aop:171	Event:1105	increased	PR	PR:0001105	Increased	VT	VT:0001105	Increased	process
Aop:171	Event:1106	decreased	CHEBI	CHEBI:0001106	Increased	HP	HP:0001106	Increased	process
Aop:171	Event:1107	occurrence	CL	CL:0001107	Increased	GO	GO:0001107	Increased	process
Aop:171	Event:1108	disrupted	MESH	MESH:0001108	Increase	MP	MP:0001108	Increase	process
Aop:171	Event:1109	morphological change	UBERON	UBERON:0001109	modulation	VT	VT:0001109	modulation	process
Aop:171	Event:1110	increased	PR	PR:0001110	Increased	HP	HP:0001110	Increased	process
Aop:171	Event:1111	decreased	CHEBI	CHEBI:0001111	Activation	GO	GO:0001111	Activation	process
Aop:171	Event:1112	occurrence	CL	CL:0001112	Activation	MP	MP:0001112	Activation	process
Aop:171	Event:1113	disrupted	MESH	MESH:0001113	Increased	VT	VT:0001113	Increased	process
Aop:171	Event:1114	morphological change	UBERON	UBERON:0001114	Altered	HP	HP:0001114	Altered	process
Aop:171	Event:1115	increased	PR	PR:0001115	Altered	GO	GO:0001115	Altered	process
Aop:171	Event:1116	decreased	CHEBI	CHEBI:0001116	Increased	MP	MP:0001116	Increased	process
Aop:171	Event:1117	occurrence	CL	CL:0001117	Increased	VT	VT:0001117	Increased	process
Aop:171	Event:1118	disrupted	MESH	MESH:0001118	N/A	HP	HP:0001118	N/A	process
Aop:172	Event:1119	occurrence	CL	CL:0001119	Activation	VT	VT:0001119	Activation	process
Aop:172	Event:1120	disrupted	MESH	MESH:0001120	Induction	HP	HP:0001120	Induction	process
Aop:172	Event:1121	morphological change	UBERON	UBERON:0001121	Induction	GO	GO:0001121	Induction	process
Aop:172	Event:1122	increased	PR	PR:0001122	Increased	MP	MP:0001122	Increased	process
Aop:172	Event:1123	decreased	CHEBI	CHEBI:0001123	Decline	VT	VT:0001123	Decline	process
Aop:172	Event:1124	occurrence	CL	CL:0001124	Alteration	HP	HP:0001124	Alteration	process
Aop:173	Event:1125	occurrence	CL	CL:0001125	Binding to (interfer	VT	VT:0001125	Binding to (interfer	process
Aop:173	Event:1126	disrupted	MESH	MESH:0001126	Increase	HP	HP:0001126	Increase	process
Aop:173	Event:1127	morphological change	UBERON	UBERON:0001127	MLL chromosomal tran	GO	GO:0001127	MLL chromosomal tran	process
Aop:173	Event:1128	increased	PR	PR:0001128	Infant leukaemia	MP	MP:0001128	Infant leukaemia	process
Aop:174	Event:1129	occurrence	CL	CL:0001129	Inhibition	VT	VT:0001129	Inhibition	process
Aop:174	Event:1130	disrupted	MESH	MESH:0001130	Increased	HP	HP:0001130	Increased	process
Aop:174	Event:1131	morphological change	UBERON	UBERON:0001131	Increase	GO	GO:0001131	Increase	process
Aop:174	Event:1132	increased	PR	PR:0001132	increased mantel dis	MP	MP:0001132	increased mantel dis	process
Aop:174	Event:1133	decreased	CHEBI	CHEBI:0001133	Induced parturition	VT	VT:0001133	Induced parturition	process
Aop:174	Event:1134	occurrence	CL	CL:0001134	Increased	HP	HP:0001134	Increased	process
Aop:174	Event:1135	disrupted	MESH	MESH:0001135	Decreased	GO	GO:0001135	Decreased	process
Aop:174	Event:1136	morphological change	UBERON	UBERON:0001136	Decrease	MP	MP:0001136	Decrease	process
Aop:175	Event:1137	occurrence	CL	CL:0001137	Inhibition	VT	VT:0001137	Inhibition	process
Aop:175	Event:1138	disrupted	MESH	MESH:0001138	Increased	HP	HP:0001138	Increased	process
Aop:175	Event:1139	morphological change	UBERON	UBERON:0001139	Increase	GO	GO:0001139	Increase	process
Aop:175	Event:1140	increased	PR	PR:0001140	Induced parturition	MP	MP:0001140	Induced parturition	process
Aop:175	Event:1141	decreased	CHEBI	CHEBI:0001141	increased mantel dis	VT	VT:0001141	increased mantel dis	process
Aop:175	Event:1142	occurrence	CL	CL:0001142	Increased	HP	HP:0001142	Increased	process
Aop:175	Event:1143	disrupted	MESH	MESH:0001143	Increased	GO	GO:0001143	Increased	process
Aop:175	Event:1144	morphological change	UBERON	UBERON:0001144	Increased	MP	MP:0001144	Increased	process
Aop:176	Event:1145	occurrence	CL	CL:0001145	Decompartmentalizati	VT	VT:0001145	Decompartmentalizati	process
Aop:176	Event:1146	disrupted	MESH	MESH:0001146	Direct mitochondrial	HP	HP:0001146	Direct mitochondrial	process
Aop:176	Event:1147	morphological change	UBERON	UBERON:0001147	narcosis	GO	GO:0001147	narcosis	process
Aop:176	Event:1148	increased	PR	PR:0001148	Mitochondrial dysfun	MP	MP:0001148	Mitochondrial dysfun	process
Aop:176	Event:1149	decreased	CHEBI	CHEBI:0001149	Apoptosis	VT	VT:0001149	Apoptosis	process
Aop:176	Event:1150	occurrence	CL	CL:0001150	Necrosis	HP	HP:0001150	Necrosis	process
Aop:177	Event:1151	occurrence	CL	CL:0001151	Inactivation of PPAR	VT	VT:0001151	Inactivation of PPAR	process
Aop:177	Event:1152	disrupted	MESH	MESH:0001152	Activation of TGF- 	HP	HP:0001152	Activation of TGF- 	process
Aop:177	Event:1153	morphological change	UBERON	UBERON:0001153	Increase	GO	GO:0001153	Increase	process
Aop:177	Event:1154	increased	PR	PR:0001154	Collagen Deposition	MP	MP:0001154	Collagen Deposition	process
Aop:177	Event:1155	decreased	CHEBI	CHEBI:0001155	Epithelial Mesenchym	VT	VT:0001155	Epithelial Mesenchym	process
Aop:177	Event:1156	occurrence	CL	CL:0001156	Lung fibrosis	HP	HP:0001156	Lung fibrosis	process
Aop:178	Event:1157	occurrence	CL	CL:0001157	Activation	VT	VT:0001157	Activation	process
Aop:178	Event:1158	disrupted	MESH	MESH:0001158	Increase	HP	HP:0001158	Increase	process
Aop:178	Event:1159	morphological change	UBERON	UBERON:0001159	Increase	GO	GO:0001159	Increase	process
Aop:178	Event:1160	increased	PR	PR:0001160	Activation	MP	MP:0001160	Activation	process
Aop:178	Event:1161	decreased	CHEBI	CHEBI:0001161	Increased	VT	VT:0001161	Increased	process
Aop:178	Event:1162	occurrence	CL	CL:0001162	Mitochondrial dysfun	HP	HP:0001162	Mitochondrial dysfun	process
Aop:178	Event:1163	disrupted	MESH	MESH:0001163	Apoptosis	GO	GO:0001163	Apoptosis	process
Aop:178	Event:1164	morphological change	UBERON	UBERON:0001164	Reproductive failure	MP	MP:0001164	Reproductive failure	process
Aop:179	Event:1165	occurrence	CL	CL:0001165	Activation	VT	VT:0001165	Activation	process
Aop:179	Event:1166	disrupted	MESH	MESH:0001166	Activation	HP	HP:0001166	Activation	process
Aop:179	Event:1167	morphological change	UBERON	UBERON:0001167	Reproductive failure	GO	GO:0001167	Reproductive failure	process
Aop:180	Event:1168	occurrence	CL	CL:0001168	Up Regulation	VT	VT:0001168	Up Regulation	process
Aop:180	Event:1169	disrupted	MESH	MESH:0001169	Up Regulation	HP	HP:0001169	Up Regulation	process
Aop:180	Event:1170	morphological change	UBERON	UBERON:0001170	Down Regulation	GO	GO:0001170	Down Regulation	process
Aop:180	Event:1171	increased	PR	PR:0001171	Glutathione synthesi	MP	MP:0001171	Glutathione synthesi	process
Aop:180	Event:1172	decreased	CHEBI	CHEBI:0001172	Activation	VT	VT:0001172	Activation	process
Aop:180	Event:1173	occurrence	CL	CL:0001173	Perturbation of chol	HP	HP:0001173	Perturbation of chol	process
Aop:180	Event:1174	disrupted	MESH	MESH:0001174	Glutathione homeosta	GO	GO:0001174	Glutathione homeosta	process
Aop:180	Event:1175	morphological change	UBERON	UBERON:0001175	Hepatotoxicity	MP	MP:0001175	Hepatotoxicity	process
Aop:181	Event:1176	occurrence	CL	CL:0001176	Peptide Oxidation	VT	VT:0001176	Peptide Oxidation	process
Aop:181	Event:1177	disrupted	MESH	MESH:0001177	Activation	HP	HP:0001177	Activation	process
Aop:181	Event:1178	morphological change	UBERON	UBERON:0001178	Activation	GO	GO:0001178	Activation	process
Aop:181	Event:1179	increased	PR	PR:0001179	Inhibition	MP	MP:0001179	Inhibition	process
Aop:181	Event:1180	decreased	CHEBI	CHEBI:0001180	Defect of Embryogene	VT	VT:0001180	Defect of Embryogene	process
Aop:181	Event:1181	occurrence	CL	CL:0001181	Reproductive failure	HP	HP:0001181	Reproductive failure	process
Aop:182	Event:560	abnormal				GO	GO:0060756	foraging behavior
Aop:182	Event:1107	increased				MESH	D056631	colony collapse
Aop:182	Event:563	increased				MESH	D056631	colony collapse
Aop:183	Event:1182	occurrence	CL	CL:0001182	Histone deacetylase 	VT	VT:0001182	Histone deacetylase 	process
Aop:183	Event:1183	disrupted	MESH	MESH:0001183	Histone acetylation	HP	HP:0001183	Histone acetylation	process
Aop:183	Event:1184	morphological change	UBERON	UBERON:0001184	Cell cycle	GO	GO:0001184	Cell cycle	process
Aop:183	Event:1185	increased	PR	PR:0001185	Apoptosis	MP	MP:0001185	Apoptosis	process
Aop:183	Event:1186	decreased	CHEBI	CHEBI:0001186	Spermatocyte depleti	VT	VT:0001186	Spermatocyte depleti	process
Aop:183	Event:1187	occurrence	CL	CL:0001187	Testicular atrophy	HP	HP:0001187	Testicular atrophy	process
Aop:184	Event:1188	occurrence	CL	CL:0001188	Inhibition	VT	VT:0001188	Inhibition	process
Aop:184	Event:1189	disrupted	MESH	MESH:0001189	Increase	HP	HP:0001189	Increase	process
Aop:184	Event:1190	morphological change	UBERON	UBERON:0001190	Increased	GO	GO:0001190	Increased	process
Aop:184	Event:1191	increased	PR	PR:0001191	Increase	MP	MP:0001191	Increase	process
Aop:184	Event:1192	decreased	CHEBI	CHEBI:0001192	Increased	VT	VT:0001192	Increased	process
Aop:184	Event:1193	occurrence	CL	CL:0001193	N/A	HP	HP:0001193	N/A	process
Aop:185	Event:1194	occurrence	CL	CL:0001194	Inhibit	VT	VT:0001194	Inhibit	process
Aop:185	Event:1195	disrupted	MESH	MESH:0001195	Decreased	HP	HP:0001195	Decreased	process
Aop:185	Event:1196	morphological change	UBERON	UBERON:0001196	Decreased	GO	GO:0001196	Decreased	process
Aop:185	Event:1197	increased	PR	PR:0001197	Decreased	MP	MP:0001197	Decreased	process
Aop:185	Event:1198	decreased	CHEBI	CHEBI:0001198	Increased	VT	VT:0001198	Increased	process
Aop:185	Event:1199	occurrence	CL	CL:0001199	Decreased	HP	HP:0001199	Decreased	process
Aop:185	Event:1200	disrupted	MESH	MESH:0001200	Increased	GO	GO:0001200	Increased	process
Aop:185	Event:1201	morphological change	UBERON	UBERON:0001201	Increased	MP	MP:0001201	Increased	process
Aop:185	Event:1202	increased	PR	PR:0001202	Decreased	VT	VT:0001202	Decreased	process
Aop:185	Event:1203	decreased	CHEBI	CHEBI:0001203	Decreased	HP	HP:0001203	Decreased	process
Aop:185	Event:1204	occurrence	CL	CL:0001204	Decreased	GO	GO:0001204	Decreased	process
Aop:185	Event:1205	disrupted	MESH	MESH:0001205	Increased	MP	MP:0001205	Increased	process
Aop:185	Event:1206	morphological change	UBERON	UBERON:0001206	Inactivated	VT	VT:0001206	Inactivated	process
Aop:185	Event:1207	increased	PR	PR:0001207	Reduce expression	HP	HP:0001207	Reduce expression	process
Aop:185	Event:1208	decreased	CHEBI	CHEBI:0001208	Decreased	GO	GO:0001208	Decreased	process
Aop:185	Event:1209	occurrence	CL	CL:0001209	Increase	MP	MP:0001209	Increase	process
Aop:185	Event:1210	disrupted	MESH	MESH:0001210	Activation	VT	VT:0001210	Activation	process
Aop:185	Event:1211	morphological change	UBERON	UBERON:0001211	Reduced	HP	HP:0001211	Reduced	process
Aop:185	Event:1212	increased	PR	PR:0001212	Activation	GO	GO:0001212	Activation	process
Aop:185	Event:1213	decreased	CHEBI	CHEBI:0001213	Activate	MP	MP:0001213	Activate	process
Aop:185	Event:1214	occurrence	CL	CL:0001214	Increase	VT	VT:0001214	Increase	process
Aop:185	Event:1215	disrupted	MESH	MESH:0001215	Increase	HP	HP:0001215	Increase	process
Aop:185	Event:1216	morphological change	UBERON	UBERON:0001216	Activate	GO	GO:0001216	Activate	process
Aop:185	Event:1217	increased	PR	PR:0001217	Increase	MP	MP:0001217	Increase	process
Aop:185	Event:1218	decreased	CHEBI	CHEBI:0001218	Increase	VT	VT:0001218	Increase	process
Aop:185	Event:1219	occurrence	CL	CL:0001219	Increased	HP	HP:0001219	Increased	process
Aop:185	Event:1220	disrupted	MESH	MESH:0001220	Increased	GO	GO:0001220	Increased	process
Aop:185	Event:1221	morphological change	UBERON	UBERON:0001221	Increased	MP	MP:0001221	Increased	process
Aop:185	Event:1222	increased	PR	PR:0001222	Increase	VT	VT:0001222	Increase	process
Aop:186	Event:1223	occurrence	CL	CL:0001223	Activated	VT	VT:0001223	Activated	process
Aop:186	Event:1224	disrupted	MESH	MESH:0001224	Increased	HP	HP:0001224	Increased	process
Aop:186	Event:1225	morphological change	UBERON	UBERON:0001225	Activated	GO	GO:0001225	Activated	process
Aop:186	Event:1226	increased	PR	PR:0001226	Increased	MP	MP:0001226	Increased	process
Aop:186	Event:1227	decreased	CHEBI	CHEBI:0001227	Activated	VT	VT:0001227	Activated	process
Aop:186	Event:1228	occurrence	CL	CL:0001228	Binding to voltage-g	HP	HP:0001228	Binding to voltage-g	process
Aop:186	Event:1229	disrupted	MESH	MESH:0001229	Treat	GO	GO:0001229	Treat	process
Aop:186	Event:1230	morphological change	UBERON	UBERON:0001230	Activated	MP	MP:0001230	Activated	process
Aop:186	Event:1231	increased	PR	PR:0001231	Inactive	VT	VT:0001231	Inactive	process
Aop:186	Event:1232	decreased	CHEBI	CHEBI:0001232	Increased	HP	HP:0001232	Increased	process
Aop:186	Event:1233	occurrence	CL	CL:0001233	Repress	GO	GO:0001233	Repress	process
Aop:186	Event:1234	disrupted	MESH	MESH:0001234	Activate	MP	MP:0001234	Activate	process
Aop:186	Event:1235	morphological change	UBERON	UBERON:0001235	Activate	VT	VT:0001235	Activate	process
Aop:186	Event:1236	increased	PR	PR:0001236	Increase	HP	HP:0001236	Increase	process
Aop:186	Event:1237	decreased	CHEBI	CHEBI:0001237	Increased	GO	GO:0001237	Increased	process
Aop:186	Event:1238	occurrence	CL	CL:0001238	Increase	MP	MP:0001238	Increase	process
Aop:186	Event:1239	disrupted	MESH	MESH:0001239	Increased	VT	VT:0001239	Increased	process
Aop:186	Event:1240	morphological change	UBERON	UBERON:0001240	Increased	HP	HP:0001240	Increased	process
Aop:187	Event:1241	occurrence	CL	CL:0001241	Deposition of Energy	VT	VT:0001241	Deposition of Energy	process
Aop:187	Event:1242	disrupted	MESH	MESH:0001242	Increase	HP	HP:0001242	Increase	process
Aop:187	Event:1243	morphological change	UBERON	UBERON:0001243	Increase	GO	GO:0001243	Increase	process
Aop:187	Event:1244	increased	PR	PR:0001244	Decrease	MP	MP:0001244	Decrease	process
Aop:187	Event:1245	decreased	CHEBI	CHEBI:0001245	Reduction	VT	VT:0001245	Reduction	process
Aop:187	Event:1246	occurrence	CL	CL:0001246	Decrease	HP	HP:0001246	Decrease	process
Aop:188	Event:1247	occurrence	CL	CL:0001247	Inhibition	VT	VT:0001247	Inhibition	process
Aop:188	Event:1248	disrupted	MESH	MESH:0001248	Activation	HP	HP:0001248	Activation	process
Aop:188	Event:1249	morphological change	UBERON	UBERON:0001249	Activation	GO	GO:0001249	Activation	process
Aop:188	Event:1250	increased	PR	PR:0001250	Inhibition	MP	MP:0001250	Inhibition	process
Aop:188	Event:1251	decreased	CHEBI	CHEBI:0001251	Increase	VT	VT:0001251	Increase	process
Aop:188	Event:1252	occurrence	CL	CL:0001252	Increase	HP	HP:0001252	Increase	process
Aop:188	Event:1253	disrupted	MESH	MESH:0001253	Increase	GO	GO:0001253	Increase	process
Aop:188	Event:1254	morphological change	UBERON	UBERON:0001254	Increase	MP	MP:0001254	Increase	process
Aop:188	Event:1255	increased	PR	PR:0001255	Increase	VT	VT:0001255	Increase	process
Aop:188	Event:1256	decreased	CHEBI	CHEBI:0001256	Decrease	HP	HP:0001256	Decrease	process
Aop:188	Event:1257	occurrence	CL	CL:0001257	Increase	GO	GO:0001257	Increase	process
Aop:188	Event:1258	disrupted	MESH	MESH:0001258	Activate	MP	MP:0001258	Activate	process
Aop:188	Event:1259	morphological change	UBERON	UBERON:0001259	Activate	VT	VT:0001259	Activate	process
Aop:188	Event:1260	increased	PR	PR:0001260	Increase	HP	HP:0001260	Increase	process
Aop:188	Event:1261	decreased	CHEBI	CHEBI:0001261	Decrease	GO	GO:0001261	Decrease	process
Aop:188	Event:1262	occurrence	CL	CL:0001262	Activate	MP	MP:0001262	Activate	process
Aop:188	Event:1263	disrupted	MESH	MESH:0001263	Increase	VT	VT:0001263	Increase	process
Aop:188	Event:1264	morphological change	UBERON	UBERON:0001264	Inhibit	HP	HP:0001264	Inhibit	process
Aop:188	Event:1265	increased	PR	PR:0001265	Activated	GO	GO:0001265	Activated	process
Aop:189	Event:1266	occurrence	CL	CL:0001266	CYP7B activity	VT	VT:0001266	CYP7B activity	process
Aop:189	Event:1267	disrupted	MESH	MESH:0001267	7-hydroxypregnenolone synthesis in the brain	HP	HP:0001267	7-hydroxypregnenolone synthesis in the brain	process
Aop:189	Event:1268	morphological change	UBERON	UBERON:0001268	Dopamine release in the brain	GO	GO:0001268	Dopamine release in the brain	process
Aop:189	Event:1269	increased	PR	PR:0001269	Locomotor activity	MP	MP:0001269	Locomotor activity	process
Aop:189	Event:1270	decreased	CHEBI	CHEBI:0001270	Decreased	VT	VT:0001270	Decreased	process
Aop:189	Event:1271	occurrence	CL	CL:0001271	Decrease	HP	HP:0001271	Decrease	process
Aop:190	Event:1272	occurrence	CL	CL:0001272	CYP7B activity	VT	VT:0001272	CYP7B activity	process
Aop:190	Event:1273	disrupted	MESH	MESH:0001273	7-hydroxypregnenolone synthesis in the brain	HP	HP:0001273	7-hydroxypregnenolone synthesis in the brain	process
Aop:190	Event:1274	morphological change	UBERON	UBERON:0001274	Dopamine release in the brain	GO	GO:0001274	Dopamine release in the brain	process
Aop:190	Event:1275	increased	PR	PR:0001275	Sexual behavior	MP	MP:0001275	Sexual behavior	process
Aop:190	Event:1276	decreased	CHEBI	CHEBI:0001276	Decreased	VT	VT:0001276	Decreased	process
Aop:190	Event:1277	occurrence	CL	CL:0001277	Decrease	HP	HP:0001277	Decrease	process
Aop:191	Event:1278	occurrence	CL	CL:0001278	Activation of Cyp2E1	VT	VT:0001278	Activation of Cyp2E1	process
Aop:191	Event:1279	disrupted	MESH	MESH:0001279	Oxidative Stress	HP	HP:0001279	Oxidative Stress	process
Aop:191	Event:1280	morphological change	UBERON	UBERON:0001280	Hepatocytotoxicity	GO	GO:0001280	Hepatocytotoxicity	process
Aop:191	Event:1281	increased	PR	PR:0001281	Induction	MP	MP:0001281	Induction	process
Aop:191	Event:1282	decreased	CHEBI	CHEBI:0001282	Liver Cancer	VT	VT:0001282	Liver Cancer	process
Aop:192	Event:1283	occurrence	CL	CL:0001283	Increased	VT	VT:0001283	Increased	process
Aop:192	Event:1284	disrupted	MESH	MESH:0001284	Reduced	HP	HP:0001284	Reduced	process
Aop:192	Event:1285	morphological change	UBERON	UBERON:0001285	Decreased	GO	GO:0001285	Decreased	process
Aop:192	Event:1286	increased	PR	PR:0001286	Inactivated	MP	MP:0001286	Inactivated	process
Aop:192	Event:1287	decreased	CHEBI	CHEBI:0001287	Decreased	VT	VT:0001287	Decreased	process
Aop:192	Event:1288	occurrence	CL	CL:0001288	Decreased	HP	HP:0001288	Decreased	process
Aop:192	Event:1289	disrupted	MESH	MESH:0001289	Decreased	GO	GO:0001289	Decreased	process
Aop:192	Event:1290	morphological change	UBERON	UBERON:0001290	Decreased	MP	MP:0001290	Decreased	process
Aop:192	Event:1291	increased	PR	PR:0001291	Decreased	VT	VT:0001291	Decreased	process
Aop:192	Event:1292	decreased	CHEBI	CHEBI:0001292	Increased	HP	HP:0001292	Increased	process
Aop:192	Event:1293	occurrence	CL	CL:0001293	Reduce expression	GO	GO:0001293	Reduce expression	process
Aop:192	Event:1294	disrupted	MESH	MESH:0001294	Increased	MP	MP:0001294	Increased	process
Aop:193	Event:1295	occurrence	CL	CL:0001295	Increased	VT	VT:0001295	Increased	process
Aop:193	Event:1296	disrupted	MESH	MESH:0001296	Reduced	HP	HP:0001296	Reduced	process
Aop:193	Event:1297	morphological change	UBERON	UBERON:0001297	Reduce expression	GO	GO:0001297	Reduce expression	process
Aop:193	Event:1298	increased	PR	PR:0001298	Inactivated	MP	MP:0001298	Inactivated	process
Aop:193	Event:1299	decreased	CHEBI	CHEBI:0001299	Decreased	VT	VT:0001299	Decreased	process
Aop:193	Event:1300	occurrence	CL	CL:0001300	Decreased	HP	HP:0001300	Decreased	process
Aop:193	Event:1301	disrupted	MESH	MESH:0001301	Decreased	GO	GO:0001301	Decreased	process
Aop:193	Event:1302	morphological change	UBERON	UBERON:0001302	Increased	MP	MP:0001302	Increased	process
Aop:193	Event:1303	increased	PR	PR:0001303	Decreased	VT	VT:0001303	Decreased	process
Aop:193	Event:1304	decreased	CHEBI	CHEBI:0001304	Decreased	HP	HP:0001304	Decreased	process
Aop:193	Event:1305	occurrence	CL	CL:0001305	Decreased	GO	GO:0001305	Decreased	process
Aop:193	Event:1306	disrupted	MESH	MESH:0001306	Increased	MP	MP:0001306	Increased	process
Aop:194	Event:1307	occurrence	CL	CL:0001307	Increased	VT	VT:0001307	Increased	process
Aop:194	Event:1308	disrupted	MESH	MESH:0001308	Increased	HP	HP:0001308	Increased	process
Aop:194	Event:1309	morphological change	UBERON	UBERON:0001309	Decreased	GO	GO:0001309	Decreased	process
Aop:194	Event:1310	increased	PR	PR:0001310	Increased	MP	MP:0001310	Increased	process
Aop:194	Event:1311	decreased	CHEBI	CHEBI:0001311	Increased	VT	VT:0001311	Increased	process
Aop:194	Event:1312	occurrence	CL	CL:0001312	Increased	HP	HP:0001312	Increased	process
Aop:194	Event:1313	disrupted	MESH	MESH:0001313	Decreased	GO	GO:0001313	Decreased	process
Aop:194	Event:1314	morphological change	UBERON	UBERON:0001314	Increased	MP	MP:0001314	Increased	process
Aop:195	Event:1315	occurrence	CL	CL:0001315	Increased	VT	VT:0001315	Increased	process
Aop:195	Event:1316	disrupted	MESH	MESH:0001316	Increased	HP	HP:0001316	Increased	process
Aop:195	Event:1317	morphological change	UBERON	UBERON:0001317	Increased	GO	GO:0001317	Increased	process
Aop:195	Event:1318	increased	PR	PR:0001318	Increased	MP	MP:0001318	Increased	process
Aop:195	Event:1319	decreased	CHEBI	CHEBI:0001319	Increased	VT	VT:0001319	Increased	process
Aop:195	Event:1320	occurrence	CL	CL:0001320	Decreased	HP	HP:0001320	Decreased	process
Aop:195	Event:1321	disrupted	MESH	MESH:0001321	Inactivated	GO	GO:0001321	Inactivated	process
Aop:195	Event:1322	morphological change	UBERON	UBERON:0001322	Reduce expression	MP	MP:0001322	Reduce expression	process
Aop:195	Event:1323	increased	PR	PR:0001323	Decreased	VT	VT:0001323	Decreased	process
Aop:195	Event:1324	decreased	CHEBI	CHEBI:0001324	Increased	HP	HP:0001324	Increased	process
Aop:196	Event:1325	occurrence	CL	CL:0001325	Increased	VT	VT:0001325	Increased	process
Aop:196	Event:1326	disrupted	MESH	MESH:0001326	Increased	HP	HP:0001326	Increased	process
Aop:196	Event:1327	morphological change	UBERON	UBERON:0001327	Increased	GO	GO:0001327	Increased	process
Aop:196	Event:1328	increased	PR	PR:0001328	Increased	MP	MP:0001328	Increased	process
Aop:196	Event:1329	decreased	CHEBI	CHEBI:0001329	Decreased	VT	VT:0001329	Decreased	process
Aop:196	Event:1330	occurrence	CL	CL:0001330	Inactivated	HP	HP:0001330	Inactivated	process
Aop:196	Event:1331	disrupted	MESH	MESH:0001331	Reduce expression	GO	GO:0001331	Reduce expression	process
Aop:196	Event:1332	morphological change	UBERON	UBERON:0001332	Decreased	MP	MP:0001332	Decreased	process
Aop:196	Event:1333	increased	PR	PR:0001333	Increased	VT	VT:0001333	Increased	process
Aop:196	Event:1334	decreased	CHEBI	CHEBI:0001334	Increased	HP	HP:0001334	Increased	process
Aop:197	Event:1335	occurrence	CL	CL:0001335	Decreased	VT	VT:0001335	Decreased	process
Aop:197	Event:1336	disrupted	MESH	MESH:0001336	Decreased	HP	HP:0001336	Decreased	process
Aop:197	Event:1337	morphological change	UBERON	UBERON:0001337	Decreased	GO	GO:0001337	Decreased	process
Aop:197	Event:1338	increased	PR	PR:0001338	Decreased	MP	MP:0001338	Decreased	process
Aop:197	Event:1339	decreased	CHEBI	CHEBI:0001339	Increased	VT	VT:0001339	Increased	process
Aop:197	Event:1340	occurrence	CL	CL:0001340	Decreased	HP	HP:0001340	Decreased	process
Aop:197	Event:1341	disrupted	MESH	MESH:0001341	Activation	GO	GO:0001341	Activation	process
Aop:197	Event:1342	morphological change	UBERON	UBERON:0001342	Activate	MP	MP:0001342	Activate	process
Aop:197	Event:1343	increased	PR	PR:0001343	Increase	VT	VT:0001343	Increase	process
Aop:197	Event:1344	decreased	CHEBI	CHEBI:0001344	Increase	HP	HP:0001344	Increase	process
Aop:197	Event:1345	occurrence	CL	CL:0001345	Activate	GO	GO:0001345	Activate	process
Aop:197	Event:1346	disrupted	MESH	MESH:0001346	Increase	MP	MP:0001346	Increase	process
Aop:197	Event:1347	morphological change	UBERON	UBERON:0001347	Increase	VT	VT:0001347	Increase	process
Aop:197	Event:1348	increased	PR	PR:0001348	Increase	HP	HP:0001348	Increase	process
Aop:198	Event:1349	occurrence	CL	CL:0001349	Reduced	VT	VT:0001349	Reduced	process
Aop:198	Event:1350	disrupted	MESH	MESH:0001350	Reduced	HP	HP:0001350	Reduced	process
Aop:198	Event:1351	morphological change	UBERON	UBERON:0001351	Decreased	GO	GO:0001351	Decreased	process
Aop:198	Event:1352	increased	PR	PR:0001352	Reduced	MP	MP:0001352	Reduced	process
Aop:198	Event:1353	decreased	CHEBI	CHEBI:0001353	Decreased	VT	VT:0001353	Decreased	process
Aop:198	Event:1354	occurrence	CL	CL:0001354	Decreased	HP	HP:0001354	Decreased	process
Aop:198	Event:1355	disrupted	MESH	MESH:0001355	Activated	GO	GO:0001355	Activated	process
Aop:199	Event:1356	occurrence	CL	CL:0001356	Reduced	VT	VT:0001356	Reduced	process
Aop:199	Event:1357	disrupted	MESH	MESH:0001357	Decreased	HP	HP:0001357	Decreased	process
Aop:199	Event:1358	morphological change	UBERON	UBERON:0001358	Increased	GO	GO:0001358	Increased	process
Aop:199	Event:1359	increased	PR	PR:0001359	Increased	MP	MP:0001359	Increased	process
Aop:199	Event:1360	decreased	CHEBI	CHEBI:0001360	Activated	VT	VT:0001360	Activated	process
Aop:200	Event:1361	occurrence	CL	CL:0001361	Helicobacter pylori 	VT	VT:0001361	Helicobacter pylori 	process
Aop:200	Event:1362	disrupted	MESH	MESH:0001362	Increase	HP	HP:0001362	Increase	process
Aop:200	Event:1363	morphological change	UBERON	UBERON:0001363	Activate	GO	GO:0001363	Activate	process
Aop:200	Event:1364	increased	PR	PR:0001364	Decrease	MP	MP:0001364	Decrease	process
Aop:200	Event:1365	decreased	CHEBI	CHEBI:0001365	Reduced	VT	VT:0001365	Reduced	process
Aop:200	Event:1366	occurrence	CL	CL:0001366	Activated	HP	HP:0001366	Activated	process
Aop:201	Event:1367	occurrence	CL	CL:0001367	Activated	VT	VT:0001367	Activated	process
Aop:201	Event:1368	disrupted	MESH	MESH:0001368	Increased	HP	HP:0001368	Increased	process
Aop:201	Event:1369	morphological change	UBERON	UBERON:0001369	Activated	GO	GO:0001369	Activated	process
Aop:201	Event:1370	increased	PR	PR:0001370	Increased	MP	MP:0001370	Increased	process
Aop:201	Event:1371	decreased	CHEBI	CHEBI:0001371	Activated	VT	VT:0001371	Activated	process
Aop:201	Event:1372	occurrence	CL	CL:0001372	Treat	HP	HP:0001372	Treat	process
Aop:201	Event:1373	disrupted	MESH	MESH:0001373	Binding to voltage-g	GO	GO:0001373	Binding to voltage-g	process
Aop:201	Event:1374	morphological change	UBERON	UBERON:0001374	Activated	MP	MP:0001374	Activated	process
Aop:201	Event:1375	increased	PR	PR:0001375	Increased	VT	VT:0001375	Increased	process
Aop:201	Event:1376	decreased	CHEBI	CHEBI:0001376	Increased	HP	HP:0001376	Increased	process
Aop:201	Event:1377	occurrence	CL	CL:0001377	Increased	GO	GO:0001377	Increased	process
Aop:202	Event:1378	occurrence	CL	CL:0001378	Reduced	VT	VT:0001378	Reduced	process
Aop:202	Event:1379	disrupted	MESH	MESH:0001379	Decreased	HP	HP:0001379	Decreased	process
Aop:202	Event:1380	morphological change	UBERON	UBERON:0001380	Reduced	GO	GO:0001380	Reduced	process
Aop:202	Event:1381	increased	PR	PR:0001381	Decreased	MP	MP:0001381	Decreased	process
Aop:202	Event:1382	decreased	CHEBI	CHEBI:0001382	Activated	VT	VT:0001382	Activated	process
Aop:202	Event:1383	occurrence	CL	CL:0001383	Increased	HP	HP:0001383	Increased	process
Aop:202	Event:1384	disrupted	MESH	MESH:0001384	Increased	GO	GO:0001384	Increased	process
Aop:202	Event:1385	morphological change	UBERON	UBERON:0001385	Increased	MP	MP:0001385	Increased	process
Aop:202	Event:1386	increased	PR	PR:0001386	Increased	VT	VT:0001386	Increased	process
Aop:203	Event:1387	occurrence	CL	CL:0001387	NFE2/Nrf2 repression	VT	VT:0001387	NFE2/Nrf2 repression	process
Aop:203	Event:1388	disrupted	MESH	MESH:0001388	Reduced	HP	HP:0001388	Reduced	process
Aop:203	Event:1389	morphological change	UBERON	UBERON:0001389	Reduced	GO	GO:0001389	Reduced	process
Aop:203	Event:1390	increased	PR	PR:0001390	Activated	MP	MP:0001390	Activated	process
Aop:203	Event:1391	decreased	CHEBI	CHEBI:0001391	Reduced	VT	VT:0001391	Reduced	process
Aop:203	Event:1392	occurrence	CL	CL:0001392	Reduced	HP	HP:0001392	Reduced	process
Aop:203	Event:1393	disrupted	MESH	MESH:0001393	Reduced	GO	GO:0001393	Reduced	process
Aop:203	Event:1394	morphological change	UBERON	UBERON:0001394	Increased	MP	MP:0001394	Increased	process
Aop:204	Event:1395	occurrence	CL	CL:0001395	Mu Opioid Receptor A	VT	VT:0001395	Mu Opioid Receptor A	process
Aop:204	Event:1396	disrupted	MESH	MESH:0001396	Release of G Protein	HP	HP:0001396	Release of G Protein	process
Aop:204	Event:1397	morphological change	UBERON	UBERON:0001397	Opening of G protein	GO	GO:0001397	Opening of G protein	process
Aop:204	Event:1398	increased	PR	PR:0001398	hyperpolarisation	MP	MP:0001398	hyperpolarisation	process
Aop:204	Event:1399	decreased	CHEBI	CHEBI:0001399	Analgesia	VT	VT:0001399	Analgesia	process
Aop:205	Event:1400	occurrence	CL	CL:0001400	Mu Opioid Receptor A	VT	VT:0001400	Mu Opioid Receptor A	process
Aop:205	Event:1401	disrupted	MESH	MESH:0001401	Release of G Protein	HP	HP:0001401	Release of G Protein	process
Aop:205	Event:1402	morphological change	UBERON	UBERON:0001402	Inhibition of N-type	GO	GO:0001402	Inhibition of N-type	process
Aop:205	Event:1403	increased	PR	PR:0001403	Inhibition of neurot	MP	MP:0001403	Inhibition of neurot	process
Aop:205	Event:1404	decreased	CHEBI	CHEBI:0001404	Analgesia	VT	VT:0001404	Analgesia	process
Aop:206	Event:1405	occurrence	CL	CL:0001405	Serotonin 1A Recepto	VT	VT:0001405	Serotonin 1A Recepto	process
Aop:206	Event:1406	disrupted	MESH	MESH:0001406	Release of G Protein	HP	HP:0001406	Release of G Protein	process
Aop:206	Event:1407	morphological change	UBERON	UBERON:0001407	Opening of G protein	GO	GO:0001407	Opening of G protein	process
Aop:206	Event:1408	increased	PR	PR:0001408	hyperpolarisation	MP	MP:0001408	hyperpolarisation	process
Aop:206	Event:1409	decreased	CHEBI	CHEBI:0001409	Anti-depressant Acti	VT	VT:0001409	Anti-depressant Acti	process
Aop:207	Event:1410	occurrence	CL	CL:0001410	Serotonin 1A Recepto	VT	VT:0001410	Serotonin 1A Recepto	process
Aop:207	Event:1411	disrupted	MESH	MESH:0001411	Release of G Protein	HP	HP:0001411	Release of G Protein	process
Aop:207	Event:1412	morphological change	UBERON	UBERON:0001412	Inhibition of N-type	GO	GO:0001412	Inhibition of N-type	process
Aop:207	Event:1413	increased	PR	PR:0001413	Inhibition of neurot	MP	MP:0001413	Inhibition of neurot	process
Aop:207	Event:1414	decreased	CHEBI	CHEBI:0001414	Anti-depressant Acti	VT	VT:0001414	Anti-depressant Acti	process
Aop:208	Event:1415	occurrence	CL	CL:0001415	Substance interactio	VT	VT:0001415	Substance interactio	process
Aop:208	Event:1416	disrupted	MESH	MESH:0001416	Increased	HP	HP:0001416	Increased	process
Aop:208	Event:1417	morphological change	UBERON	UBERON:0001417	Transcription of genes encoding acute phase proteins	GO	GO:0001417	Transcription of genes encoding acute phase proteins	process
Aop:208	Event:1418	increased	PR	PR:0001418	Systemic acute phase	MP	MP:0001418	Systemic acute phase	process
Aop:208	Event:1419	decreased	CHEBI	CHEBI:0001419	Atherosclerosis	VT	VT:0001419	Atherosclerosis	process
Aop:209	Event:1420	occurrence	CL	CL:0001420	Deposition of Energy	VT	VT:0001420	Deposition of Energy	process
Aop:209	Event:1421	disrupted	MESH	MESH:0001421	Increase	HP	HP:0001421	Increase	process
Aop:209	Event:1422	morphological change	UBERON	UBERON:0001422	Increase	GO	GO:0001422	Increase	process
Aop:209	Event:1423	increased	PR	PR:0001423	Decrease	MP	MP:0001423	Decrease	process
Aop:209	Event:1424	decreased	CHEBI	CHEBI:0001424	Reduction	VT	VT:0001424	Reduction	process
Aop:209	Event:1425	occurrence	CL	CL:0001425	Decrease	HP	HP:0001425	Decrease	process
Aop:210	Event:209	increased				MP	MP:0003674	oxidative stress
Aop:210	Event:1292	increased	MESH	D048031	JNK Mitogen-Activated Protein Kinases	GO	GO:0023052	signaling
Aop:210	Event:1293	increased	PR	PR:O16850	forkhead box protein O (Caenorhabditis elegans)	GO	GO:0023052	signaling
Aop:210	Event:1294	abnormal	GO	GO:1990909	Wnt signalosome	GO	GO:0023052	signaling
Aop:210	Event:1295	abnormal				GO	GO:0009790	embryo development
Aop:210	Event:1277	decreased				GO	GO:0000003	reproduction
Aop:212	Event:1426	occurrence	CL	CL:0001426	Activation	VT	VT:0001426	Activation	process
Aop:212	Event:1427	disrupted	MESH	MESH:0001427	Increase	HP	HP:0001427	Increase	process
Aop:212	Event:1428	morphological change	UBERON	UBERON:0001428	Epithelial Mesenchym	GO	GO:0001428	Epithelial Mesenchym	process
Aop:212	Event:1429	increased	PR	PR:0001429	Accumulation	MP	MP:0001429	Accumulation	process
Aop:212	Event:1430	decreased	CHEBI	CHEBI:0001430	Activation	VT	VT:0001430	Activation	process
Aop:212	Event:1431	occurrence	CL	CL:0001431	Pulmonary fibrosis	HP	HP:0001431	Pulmonary fibrosis	process
Aop:213	Event:1432	occurrence	CL	CL:0001432	Thiol group of chemi	VT	VT:0001432	Thiol group of chemi	process
Aop:213	Event:1433	disrupted	MESH	MESH:0001433	Inhibition of lysyl 	HP	HP:0001433	Inhibition of lysyl 	process
Aop:213	Event:1434	morphological change	UBERON	UBERON:0001434	Reduction of collage	GO	GO:0001434	Reduction of collage	process
Aop:213	Event:1435	increased	PR	PR:0001435	Weak collagen matrix	MP	MP:0001435	Weak collagen matrix	process
Aop:213	Event:1436	decreased	CHEBI	CHEBI:0001436	Notochord distortion	VT	VT:0001436	Notochord distortion	process
Aop:213	Event:1437	occurrence	CL	CL:0001437	Reduced	HP	HP:0001437	Reduced	process
Aop:213	Event:1438	disrupted	MESH	MESH:0001438	Growth	GO	GO:0001438	Growth	process
Aop:213	Event:1439	morphological change	UBERON	UBERON:0001439	Decreased	MP	MP:0001439	Decreased	process
Aop:214	Event:1440	occurrence	CL	CL:0001440	Increase	VT	VT:0001440	Increase	process
Aop:214	Event:1441	disrupted	MESH	MESH:0001441	Decrease	HP	HP:0001441	Decrease	process
Aop:214	Event:1442	morphological change	UBERON	UBERON:0001442	Decrease	GO	GO:0001442	Decrease	process
Aop:214	Event:1443	increased	PR	PR:0001443	Decrease	MP	MP:0001443	Decrease	process
Aop:214	Event:1444	decreased	CHEBI	CHEBI:0001444	Decrease	VT	VT:0001444	Decrease	process
Aop:214	Event:1445	occurrence	CL	CL:0001445	Decrease	HP	HP:0001445	Decrease	process
Aop:214	Event:1446	disrupted	MESH	MESH:0001446	Decrease	GO	GO:0001446	Decrease	process
Aop:214	Event:1447	morphological change	UBERON	UBERON:0001447	Decrease	MP	MP:0001447	Decrease	process
Aop:214	Event:1448	increased	PR	PR:0001448	Decrease	VT	VT:0001448	Decrease	process
Aop:214	Event:1449	decreased	CHEBI	CHEBI:0001449	Decrease	HP	HP:0001449	Decrease	process
Aop:214	Event:1450	occurrence	CL	CL:0001450	Decrease	GO	GO:0001450	Decrease	process
Aop:215	Event:1451	occurrence	CL	CL:0001451	Inhibition of mitoch	VT	VT:0001451	Inhibition of mitoch	process
Aop:215	Event:1452	disrupted	MESH	MESH:0001452	Depletion	HP	HP:0001452	Depletion	process
Aop:215	Event:1453	morphological change	UBERON	UBERON:0001453	Mitochondrial dysfun	GO	GO:0001453	Mitochondrial dysfun	process
Aop:215	Event:1454	increased	PR	PR:0001454	Increase	MP	MP:0001454	Increase	process
Aop:215	Event:1455	decreased	CHEBI	CHEBI:0001455	Occurrence	VT	VT:0001455	Occurrence	process
Aop:216	Event:1456	occurrence	CL	CL:0001456	Binding of substrate	VT	VT:0001456	Binding of substrate	process
Aop:216	Event:1457	disrupted	MESH	MESH:0001457	Disturbance	HP	HP:0001457	Disturbance	process
Aop:216	Event:1458	morphological change	UBERON	UBERON:0001458	Disruption	GO	GO:0001458	Disruption	process
Aop:216	Event:1459	increased	PR	PR:0001459	Increase	MP	MP:0001459	Increase	process
Aop:216	Event:1460	decreased	CHEBI	CHEBI:0001460	Occurrence	VT	VT:0001460	Occurrence	process
Aop:217	Event:1461	occurrence	CL	CL:0001461	Alkylation	VT	VT:0001461	Alkylation	process
Aop:217	Event:1462	disrupted	MESH	MESH:0001462	Mitochondrial dysfun	HP	HP:0001462	Mitochondrial dysfun	process
Aop:217	Event:1463	morphological change	UBERON	UBERON:0001463	Decrease	GO	GO:0001463	Decrease	process
Aop:217	Event:1464	increased	PR	PR:0001464	Increase	MP	MP:0001464	Increase	process
Aop:217	Event:1465	decreased	CHEBI	CHEBI:0001465	Occurrence	VT	VT:0001465	Occurrence	process
Aop:218	Event:360	decreased	PCO	PCO:0000001	population of organisms	PCO	PCO:0000008	population growth rate
Aop:219	Event:1466	occurrence	CL	CL:0001466	CYP2E1 Activation	VT	VT:0001466	CYP2E1 Activation	process
Aop:219	Event:1467	disrupted	MESH	MESH:0001467	Protein Adduct Forma	HP	HP:0001467	Protein Adduct Forma	process
Aop:219	Event:1468	morphological change	UBERON	UBERON:0001468	Oxidative Stress	GO	GO:0001468	Oxidative Stress	process
Aop:219	Event:1469	increased	PR	PR:0001469	Lipid Peroxidation	MP	MP:0001469	Lipid Peroxidation	process
Aop:219	Event:1470	decreased	CHEBI	CHEBI:0001470	Unfolded Protein Res	VT	VT:0001470	Unfolded Protein Res	process
Aop:219	Event:1471	occurrence	CL	CL:0001471	General Apoptosis	HP	HP:0001471	General Apoptosis	process
Aop:219	Event:1472	disrupted	MESH	MESH:0001472	Neurodegeneration	GO	GO:0001472	Neurodegeneration	process
Aop:220	Event:1473	occurrence	CL	CL:0001473	Blockade	VT	VT:0001473	Blockade	process
Aop:220	Event:1474	disrupted	MESH	MESH:0001474	Decrease	HP	HP:0001474	Decrease	process
Aop:220	Event:1475	morphological change	UBERON	UBERON:0001475	Decrease	GO	GO:0001475	Decrease	process
Aop:220	Event:1476	increased	PR	PR:0001476	Decrease	MP	MP:0001476	Decrease	process
Aop:220	Event:1477	decreased	CHEBI	CHEBI:0001477	Decrease	VT	VT:0001477	Decrease	process
Aop:220	Event:1478	occurrence	CL	CL:0001478	Disruption	HP	HP:0001478	Disruption	process
Aop:220	Event:1479	disrupted	MESH	MESH:0001479	Disruption	GO	GO:0001479	Disruption	process
Aop:220	Event:1480	morphological change	UBERON	UBERON:0001480	Heart failure	MP	MP:0001480	Heart failure	process
Aop:221	Event:1320	increased	GO	GO:0005576	extracellular region	MP	MP:0010069	increased serotonin level
Aop:221	Event:1320	increased	CHEBI	CHEBI:28790	serotonin	MP	MP:0010069	increased serotonin level
Aop:222	Event:1481	occurrence	CL	CL:0001481	Decrease	VT	VT:0001481	Decrease	process
Aop:222	Event:1482	disrupted	MESH	MESH:0001482	Decrease	HP	HP:0001482	Decrease	process
Aop:222	Event:1483	morphological change	UBERON	UBERON:0001483	Decrease	GO	GO:0001483	Decrease	process
Aop:222	Event:1484	increased	PR	PR:0001484	Decrease	MP	MP:0001484	Decrease	process
Aop:223	Event:1485	occurrence	CL	CL:0001485	Decrease	VT	VT:0001485	Decrease	process
Aop:223	Event:1486	disrupted	MESH	MESH:0001486	Decrease	HP	HP:0001486	Decrease	process
Aop:223	Event:1487	morphological change	UBERON	UBERON:0001487	Increase	GO	GO:0001487	Increase	process
Aop:223	Event:1488	increased	PR	PR:0001488	Decrease	MP	MP:0001488	Decrease	process
Aop:224	Event:1489	occurrence	CL	CL:0001489	Decrease	VT	VT:0001489	Decrease	process
Aop:224	Event:1490	disrupted	MESH	MESH:0001490	Increase	HP	HP:0001490	Increase	process
Aop:224	Event:1491	morphological change	UBERON	UBERON:0001491	Increase	GO	GO:0001491	Increase	process
Aop:224	Event:1492	increased	PR	PR:0001492	Decrease	MP	MP:0001492	Decrease	process
Aop:225	Event:1493	occurrence	CL	CL:0001493	Decrease	VT	VT:0001493	Decrease	process
Aop:225	Event:1494	disrupted	MESH	MESH:0001494	Decrease	HP	HP:0001494	Decrease	process
Aop:225	Event:1495	morphological change	UBERON	UBERON:0001495	Decreased Na/K ATPas	GO	GO:0001495	Decreased Na/K ATPas	process
Aop:225	Event:1496	increased	PR	PR:0001496	Increase	MP	MP:0001496	Increase	process
Aop:225	Event:1497	decreased	CHEBI	CHEBI:0001497	Increase	VT	VT:0001497	Increase	process
Aop:225	Event:1498	occurrence	CL	CL:0001498	Decrease	HP	HP:0001498	Decrease	process
Aop:226	Event:1499	occurrence	CL	CL:0001499	Decrease	VT	VT:0001499	Decrease	process
Aop:226	Event:1500	disrupted	MESH	MESH:0001500	Increase	HP	HP:0001500	Increase	process
Aop:226	Event:1501	morphological change	UBERON	UBERON:0001501	Decrease	GO	GO:0001501	Decrease	process
Aop:226	Event:1502	increased	PR	PR:0001502	Decrease	MP	MP:0001502	Decrease	process
Aop:226	Event:1503	decreased	CHEBI	CHEBI:0001503	Decrease	VT	VT:0001503	Decrease	process
Aop:227	Event:1504	occurrence	CL	CL:0001504	Decrease	VT	VT:0001504	Decrease	process
Aop:227	Event:1505	disrupted	MESH	MESH:0001505	Increase	HP	HP:0001505	Increase	process
Aop:227	Event:1506	morphological change	UBERON	UBERON:0001506	Increase	GO	GO:0001506	Increase	process
Aop:227	Event:1507	increased	PR	PR:0001507	Decrease	MP	MP:0001507	Decrease	process
Aop:230	Event:1508	occurrence	CL	CL:0001508	Thyroperoxidase	VT	VT:0001508	Thyroperoxidase	process
Aop:230	Event:1509	disrupted	MESH	MESH:0001509	Thyroid hormone synthesis	HP	HP:0001509	Thyroid hormone synthesis	process
Aop:230	Event:1510	morphological change	UBERON	UBERON:0001510	Reduction	GO	GO:0001510	Reduction	process
Aop:230	Event:1511	increased	PR	PR:0001511	Reduction	MP	MP:0001511	Reduction	process
Aop:230	Event:1512	decreased	CHEBI	CHEBI:0001512	Reduction	VT	VT:0001512	Reduction	process
Aop:231	Event:1513	occurrence	CL	CL:0001513	Deposition of Energy	VT	VT:0001513	Deposition of Energy	process
Aop:231	Event:1514	disrupted	MESH	MESH:0001514	Increase	HP	HP:0001514	Increase	process
Aop:231	Event:1515	morphological change	UBERON	UBERON:0001515	Inadequate DNA repai	GO	GO:0001515	Inadequate DNA repai	process
Aop:231	Event:1516	increased	PR	PR:0001516	Increase	MP	MP:0001516	Increase	process
Aop:231	Event:1517	decreased	CHEBI	CHEBI:0001517	Increase	VT	VT:0001517	Increase	process
Aop:231	Event:1518	occurrence	CL	CL:0001518	Increase	HP	HP:0001518	Increase	process
Aop:231	Event:1519	disrupted	MESH	MESH:0001519	Increase	GO	GO:0001519	Increase	process
Aop:232	Event:1520	occurrence	CL	CL:0001520	Increase	VT	VT:0001520	Increase	process
Aop:232	Event:1521	disrupted	MESH	MESH:0001521	Mitochondrial Comple	HP	HP:0001521	Mitochondrial Comple	process
Aop:232	Event:1522	morphological change	UBERON	UBERON:0001522	Mitochondrial Comple	GO	GO:0001522	Mitochondrial Comple	process
Aop:232	Event:1523	increased	PR	PR:0001523	Binding of inhibitor	MP	MP:0001523	Binding of inhibitor	process
Aop:232	Event:1524	decreased	CHEBI	CHEBI:0001524	Inhibition	VT	VT:0001524	Inhibition	process
Aop:232	Event:1525	occurrence	CL	CL:0001525	Binding of inhibitor	HP	HP:0001525	Binding of inhibitor	process
Aop:232	Event:1526	disrupted	MESH	MESH:0001526	Binding of inhibitor	GO	GO:0001526	Binding of inhibitor	process
Aop:232	Event:1527	morphological change	UBERON	UBERON:0001527	Binding of inhibitor	MP	MP:0001527	Binding of inhibitor	process
Aop:232	Event:1528	increased	PR	PR:0001528	Decrease in mitochon	VT	VT:0001528	Decrease in mitochon	process
Aop:232	Event:1529	decreased	CHEBI	CHEBI:0001529	Increase	HP	HP:0001529	Increase	process
Aop:232	Event:1530	occurrence	CL	CL:0001530	Mitochondrial Injury	GO	GO:0001530	Mitochondrial Injury	process
Aop:232	Event:1531	disrupted	MESH	MESH:0001531	Impaired	MP	MP:0001531	Impaired	process
Aop:232	Event:1532	morphological change	UBERON	UBERON:0001532	Increase	VT	VT:0001532	Increase	process
Aop:232	Event:1533	increased	PR	PR:0001533	Mitochondrial dysfun	HP	HP:0001533	Mitochondrial dysfun	process
Aop:232	Event:1534	decreased	CHEBI	CHEBI:0001534	Necrotic Tissue	GO	GO:0001534	Necrotic Tissue	process
Aop:232	Event:1535	occurrence	CL	CL:0001535	Liver Injury	MP	MP:0001535	Liver Injury	process
Aop:233	Event:1536	occurrence	CL	CL:0001536	Histone deacetylase 	VT	VT:0001536	Histone deacetylase 	process
Aop:233	Event:1537	disrupted	MESH	MESH:0001537	Neural crest cell migration	HP	HP:0001537	Neural crest cell migration	process
Aop:233	Event:1538	morphological change	UBERON	UBERON:0001538	Collagen production	GO	GO:0001538	Collagen production	process
Aop:233	Event:1539	increased	PR	PR:0001539	Facial cartilage str	MP	MP:0001539	Facial cartilage str	process
Aop:234	Event:1540	occurrence	CL	CL:0001540	Histone deacetylase 	VT	VT:0001540	Histone deacetylase 	process
Aop:234	Event:1541	disrupted	MESH	MESH:0001541	Histone acetylation	HP	HP:0001541	Histone acetylation	process
Aop:234	Event:1542	morphological change	UBERON	UBERON:0001542	Altered	GO	GO:0001542	Altered	process
Aop:234	Event:1543	increased	PR	PR:0001543	Altered differentiat	MP	MP:0001543	Altered differentiat	process
Aop:234	Event:1544	decreased	CHEBI	CHEBI:0001544	Neural tube defects	VT	VT:0001544	Neural tube defects	process
Aop:235	Event:1545	occurrence	CL	CL:0001545	Binding of inhibitor	VT	VT:0001545	Binding of inhibitor	process
Aop:235	Event:1546	disrupted	MESH	MESH:0001546	Inhibition	HP	HP:0001546	Inhibition	process
Aop:235	Event:1547	morphological change	UBERON	UBERON:0001547	Decrease	GO	GO:0001547	Decrease	process
Aop:235	Event:1548	increased	PR	PR:0001548	Decreased Na/K ATPas	MP	MP:0001548	Decreased Na/K ATPas	process
Aop:235	Event:1549	decreased	CHEBI	CHEBI:0001549	Decreased proximal t	VT	VT:0001549	Decreased proximal t	process
Aop:235	Event:1550	occurrence	CL	CL:0001550	Chemical induced Fan	HP	HP:0001550	Chemical induced Fan	process
Aop:236	Event:1551	occurrence	CL	CL:0001551	Impaired IL-1R1 sign	VT	VT:0001551	Impaired IL-1R1 sign	process
Aop:236	Event:1552	disrupted	MESH	MESH:0001552	Inhibition	HP	HP:0001552	Inhibition	process
Aop:236	Event:1553	morphological change	UBERON	UBERON:0001553	Suppression of T cel	GO	GO:0001553	Suppression of T cel	process
Aop:236	Event:1554	increased	PR	PR:0001554	Impairment	MP	MP:0001554	Impairment	process
Aop:237	Event:1555	occurrence	CL	CL:0001555	Inhibition	VT	VT:0001555	Inhibition	process
Aop:237	Event:1556	disrupted	MESH	MESH:0001556	Inhibition	HP	HP:0001556	Inhibition	process
Aop:237	Event:1557	morphological change	UBERON	UBERON:0001557	Activation	GO	GO:0001557	Activation	process
Aop:237	Event:1558	increased	PR	PR:0001558	Increase	MP	MP:0001558	Increase	process
Aop:237	Event:1559	decreased	CHEBI	CHEBI:0001559	Activation	VT	VT:0001559	Activation	process
Aop:237	Event:1560	occurrence	CL	CL:0001560	Increase	HP	HP:0001560	Increase	process
Aop:237	Event:1561	disrupted	MESH	MESH:0001561	Necrotic Tissue	GO	GO:0001561	Necrotic Tissue	process
Aop:237	Event:1562	morphological change	UBERON	UBERON:0001562	Liver Injury	MP	MP:0001562	Liver Injury	process
Aop:238	Event:1563	occurrence	CL	CL:0001563	Binding of microtubu	VT	VT:0001563	Binding of microtubu	process
Aop:238	Event:1564	disrupted	MESH	MESH:0001564	Disturbance in micro	HP	HP:0001564	Disturbance in micro	process
Aop:238	Event:1565	morphological change	UBERON	UBERON:0001565	Impaired axonial tra	GO	GO:0001565	Impaired axonial tra	process
Aop:238	Event:1566	increased	PR	PR:0001566	Sensory axonal perip	MP	MP:0001566	Sensory axonal perip	process
Aop:239	Event:1567	occurrence	CL	CL:0001567	Interaction of -dik	VT	VT:0001567	Interaction of -dik	process
Aop:239	Event:1568	disrupted	MESH	MESH:0001568	Proteasomal dysfunct	HP	HP:0001568	Proteasomal dysfunct	process
Aop:239	Event:1569	morphological change	UBERON	UBERON:0001569	Airway epithelial in	GO	GO:0001569	Airway epithelial in	process
Aop:239	Event:1570	increased	PR	PR:0001570	Increase	MP	MP:0001570	Increase	process
Aop:239	Event:1571	decreased	CHEBI	CHEBI:0001571	Epithelial Mesenchym	VT	VT:0001571	Epithelial Mesenchym	process
Aop:239	Event:1572	occurrence	CL	CL:0001572	Fibroproliferative a	HP	HP:0001572	Fibroproliferative a	process
Aop:239	Event:1573	disrupted	MESH	MESH:0001573	Bronchiolitis oblite	GO	GO:0001573	Bronchiolitis oblite	process
Aop:240	Event:1574	occurrence	CL	CL:0001574	Acetylcholinesterase	VT	VT:0001574	Acetylcholinesterase	process
Aop:240	Event:1575	disrupted	MESH	MESH:0001575	Acetylcholine accumu	HP	HP:0001575	Acetylcholine accumu	process
Aop:240	Event:1576	morphological change	UBERON	UBERON:0001576	Increased Muscarinic	GO	GO:0001576	Increased Muscarinic	process
Aop:240	Event:1577	increased	PR	PR:0001577	Occurrence	MP	MP:0001577	Occurrence	process
Aop:240	Event:1578	decreased	CHEBI	CHEBI:0001578	Increased	VT	VT:0001578	Increased	process
Aop:240	Event:1579	occurrence	CL	CL:0001579	Overactivation	HP	HP:0001579	Overactivation	process
Aop:240	Event:1580	disrupted	MESH	MESH:0001580	Status epilepticus	GO	GO:0001580	Status epilepticus	process
Aop:240	Event:1581	morphological change	UBERON	UBERON:0001581	Increased	MP	MP:0001581	Increased	process
Aop:240	Event:1582	increased	PR	PR:0001582	Increase	VT	VT:0001582	Increase	process
Aop:240	Event:1583	decreased	CHEBI	CHEBI:0001583	N/A	HP	HP:0001583	N/A	process
Aop:241	Event:1584	occurrence	CL	CL:0001584	Increase	VT	VT:0001584	Increase	process
Aop:241	Event:1585	disrupted	MESH	MESH:0001585	Oxidation of membran	HP	HP:0001585	Oxidation of membran	process
Aop:241	Event:1586	morphological change	UBERON	UBERON:0001586	Oxidation/denatuatio	GO	GO:0001586	Oxidation/denatuatio	process
Aop:241	Event:1587	increased	PR	PR:0001587	Inflamatory events i	MP	MP:0001587	Inflamatory events i	process
Aop:242	Event:1005	decreased				NBO	NBO:0000371	aquatic locomotion
Aop:242	Event:636	decreased				VT	VT:0005372	life span trait
Aop:243	Event:1588	occurrence	CL	CL:0001588	Binding	VT	VT:0001588	Binding	process
Aop:243	Event:1589	disrupted	MESH	MESH:0001589	Oxidation	HP	HP:0001589	Oxidation	process
Aop:243	Event:1590	morphological change	UBERON	UBERON:0001590	Decreased protection	GO	GO:0001590	Decreased protection	process
Aop:243	Event:1591	increased	PR	PR:0001591	Oxidative Stress	MP	MP:0001591	Oxidative Stress	process
Aop:243	Event:1592	decreased	CHEBI	CHEBI:0001592	Disruption	VT	VT:0001592	Disruption	process
Aop:243	Event:1593	occurrence	CL	CL:0001593	Increase	HP	HP:0001593	Increase	process
Aop:243	Event:1594	disrupted	MESH	MESH:0001594	Chronic kidney disea	GO	GO:0001594	Chronic kidney disea	process
Aop:244	Event:1595	occurrence	CL	CL:0001595	Inhibition of N-link	VT	VT:0001595	Inhibition of N-link	process
Aop:244	Event:1596	disrupted	MESH	MESH:0001596	Accumulation of misf	HP	HP:0001596	Accumulation of misf	process
Aop:244	Event:1597	morphological change	UBERON	UBERON:0001597	Unfolded Protein Res	GO	GO:0001597	Unfolded Protein Res	process
Aop:244	Event:1598	increased	PR	PR:0001598	Apoptosis	MP	MP:0001598	Apoptosis	process
Aop:244	Event:1599	decreased	CHEBI	CHEBI:0001599	Activation of hepati	VT	VT:0001599	Activation of hepati	process
Aop:244	Event:1600	occurrence	CL	CL:0001600	Increased	HP	HP:0001600	Increased	process
Aop:244	Event:1601	disrupted	MESH	MESH:0001601	Liver Injury	GO	GO:0001601	Liver Injury	process
Aop:245	Event:1602	occurrence	CL	CL:0001602	Increase	VT	VT:0001602	Increase	process
Aop:245	Event:1603	disrupted	MESH	MESH:0001603	Decrease	HP	HP:0001603	Decrease	process
Aop:245	Event:1604	morphological change	UBERON	UBERON:0001604	Decrease	GO	GO:0001604	Decrease	process
Aop:245	Event:1605	increased	PR	PR:0001605	Decrease	MP	MP:0001605	Decrease	process
Aop:246	Event:1606	occurrence	CL	CL:0001606	Increase	VT	VT:0001606	Increase	process
Aop:246	Event:1607	disrupted	MESH	MESH:0001607	Decrease	HP	HP:0001607	Decrease	process
Aop:246	Event:1608	morphological change	UBERON	UBERON:0001608	Increase	GO	GO:0001608	Increase	process
Aop:246	Event:1609	increased	PR	PR:0001609	Decrease	MP	MP:0001609	Decrease	process
Aop:247	Event:1610	occurrence	CL	CL:0001610	Inhibition	VT	VT:0001610	Inhibition	process
Aop:247	Event:1611	disrupted	MESH	MESH:0001611	Reduction	HP	HP:0001611	Reduction	process
Aop:247	Event:1612	morphological change	UBERON	UBERON:0001612	Reduction	GO	GO:0001612	Reduction	process
Aop:247	Event:1613	increased	PR	PR:0001613	Decrease	MP	MP:0001613	Decrease	process
Aop:247	Event:1614	decreased	CHEBI	CHEBI:0001614	Decrease	VT	VT:0001614	Decrease	process
Aop:247	Event:1615	occurrence	CL	CL:0001615	Decrease	HP	HP:0001615	Decrease	process
Aop:247	Event:1616	disrupted	MESH	MESH:0001616	Impaired inguinoscro	GO	GO:0001616	Impaired inguinoscro	process
Aop:247	Event:1617	morphological change	UBERON	UBERON:0001617	Malformation	MP	MP:0001617	Malformation	process
Aop:248	Event:1618	occurrence	CL	CL:0001618	Inhibition	VT	VT:0001618	Inhibition	process
Aop:248	Event:1619	disrupted	MESH	MESH:0001619	Decrease	HP	HP:0001619	Decrease	process
Aop:248	Event:1620	morphological change	UBERON	UBERON:0001620	Reduction	GO	GO:0001620	Reduction	process
Aop:248	Event:1621	increased	PR	PR:0001621	Reduction	MP	MP:0001621	Reduction	process
Aop:248	Event:1622	decreased	CHEBI	CHEBI:0001622	Reduction	VT	VT:0001622	Reduction	process
Aop:248	Event:1623	occurrence	CL	CL:0001623	Decrease	HP	HP:0001623	Decrease	process
Aop:249	Event:1624	occurrence	CL	CL:0001624	Increase	VT	VT:0001624	Increase	process
Aop:249	Event:1625	disrupted	MESH	MESH:0001625	Decrease	HP	HP:0001625	Decrease	process
Aop:249	Event:1626	morphological change	UBERON	UBERON:0001626	Decrease	GO	GO:0001626	Decrease	process
Aop:249	Event:1627	increased	PR	PR:0001627	Decrease	MP	MP:0001627	Decrease	process
Aop:250	Event:1628	occurrence	CL	CL:0001628	Increase	VT	VT:0001628	Increase	process
Aop:250	Event:1629	disrupted	MESH	MESH:0001629	Decrease	HP	HP:0001629	Decrease	process
Aop:250	Event:1630	morphological change	UBERON	UBERON:0001630	Increase	GO	GO:0001630	Increase	process
Aop:250	Event:1631	increased	PR	PR:0001631	Decrease	MP	MP:0001631	Decrease	process
Aop:251	Event:1632	occurrence	CL	CL:0001632	Inhibition of tyrosi	VT	VT:0001632	Inhibition of tyrosi	process
Aop:251	Event:1633	disrupted	MESH	MESH:0001633	Reduction of L-Dopaq	HP	HP:0001633	Reduction of L-Dopaq	process
Aop:251	Event:1634	morphological change	UBERON	UBERON:0001634	Reduction in melanin	GO	GO:0001634	Reduction in melanin	process
Aop:251	Event:1635	increased	PR	PR:0001635	Reduction of melanos	MP	MP:0001635	Reduction of melanos	process
Aop:251	Event:1636	decreased	CHEBI	CHEBI:0001636	Reduction fo Pigment	VT	VT:0001636	Reduction fo Pigment	process
Aop:251	Event:1637	occurrence	CL	CL:0001637	Decrease	HP	HP:0001637	Decrease	process
Aop:252	Event:1638	occurrence	CL	CL:0001638	Increase	VT	VT:0001638	Increase	process
Aop:252	Event:1639	disrupted	MESH	MESH:0001639	Tissue resident cell	HP	HP:0001639	Tissue resident cell	process
Aop:252	Event:1640	morphological change	UBERON	UBERON:0001640	Increased Pro-inflam	GO	GO:0001640	Increased Pro-inflam	process
Aop:252	Event:1641	increased	PR	PR:0001641	Increase in reactive	MP	MP:0001641	Increase in reactive	process
Aop:252	Event:1642	decreased	CHEBI	CHEBI:0001642	Leukocyte recruitmen	VT	VT:0001642	Leukocyte recruitmen	process
Aop:252	Event:1643	occurrence	CL	CL:0001643	Increase	HP	HP:0001643	Increase	process
Aop:252	Event:1644	disrupted	MESH	MESH:0001644	Increase	GO	GO:0001644	Increase	process
Aop:252	Event:1645	morphological change	UBERON	UBERON:0001645	Increased	MP	MP:0001645	Increased	process
Aop:252	Event:1646	increased	PR	PR:0001646	N/A	VT	VT:0001646	N/A	process
Aop:253	Event:1647	occurrence	CL	CL:0001647	Increase in reactive	VT	VT:0001647	Increase in reactive	process
Aop:253	Event:1648	disrupted	MESH	MESH:0001648	Increase	HP	HP:0001648	Increase	process
Aop:253	Event:1649	morphological change	UBERON	UBERON:0001649	Tissue resident cell	GO	GO:0001649	Tissue resident cell	process
Aop:253	Event:1650	increased	PR	PR:0001650	Increased Pro-inflam	MP	MP:0001650	Increased Pro-inflam	process
Aop:253	Event:1651	decreased	CHEBI	CHEBI:0001651	Leukocyte recruitmen	VT	VT:0001651	Leukocyte recruitmen	process
Aop:253	Event:1652	occurrence	CL	CL:0001652	Increase	HP	HP:0001652	Increase	process
Aop:253	Event:1653	disrupted	MESH	MESH:0001653	Increase	GO	GO:0001653	Increase	process
Aop:253	Event:1654	morphological change	UBERON	UBERON:0001654	Increased	MP	MP:0001654	Increased	process
Aop:253	Event:1655	increased	PR	PR:0001655	N/A	VT	VT:0001655	N/A	process
Aop:255	Event:1656	occurrence	CL	CL:0001656	Increase	VT	VT:0001656	Increase	process
Aop:255	Event:1657	disrupted	MESH	MESH:0001657	Inadequate DNA repai	HP	HP:0001657	Inadequate DNA repai	process
Aop:255	Event:1658	morphological change	UBERON	UBERON:0001658	Increase	GO	GO:0001658	Increase	process
Aop:255	Event:1659	increased	PR	PR:0001659	Increase	MP	MP:0001659	Increase	process
Aop:255	Event:1660	decreased	CHEBI	CHEBI:0001660	Increase	VT	VT:0001660	Increase	process
Aop:256	Event:1661	occurrence	CL	CL:0001661	Retinaldehyde dehydr	VT	VT:0001661	Retinaldehyde dehydr	process
Aop:256	Event:1662	disrupted	MESH	MESH:0001662	Altered	HP	HP:0001662	Altered	process
Aop:256	Event:1663	morphological change	UBERON	UBERON:0001663	Decreased retinoic a	GO	GO:0001663	Decreased retinoic a	process
Aop:256	Event:1664	increased	PR	PR:0001664	Decreased plasma RA 	MP	MP:0001664	Decreased plasma RA 	process
Aop:256	Event:1665	decreased	CHEBI	CHEBI:0001665	Altered	VT	VT:0001665	Altered	process
Aop:256	Event:1666	occurrence	CL	CL:0001666	Decrease	HP	HP:0001666	Decrease	process
Aop:257	Event:1667	occurrence	CL	CL:0001667	Increase	VT	VT:0001667	Increase	process
Aop:257	Event:1668	disrupted	MESH	MESH:0001668	Increase	HP	HP:0001668	Increase	process
Aop:257	Event:1669	morphological change	UBERON	UBERON:0001669	beta-catenin activat	GO	GO:0001669	beta-catenin activat	process
Aop:257	Event:1670	increased	PR	PR:0001670	Epithelial Mesenchym	MP	MP:0001670	Epithelial Mesenchym	process
Aop:257	Event:1671	decreased	CHEBI	CHEBI:0001671	Treatment-resistant 	VT	VT:0001671	Treatment-resistant 	process
Aop:258	Event:1672	occurrence	CL	CL:0001672	Deposition of Energy	VT	VT:0001672	Deposition of Energy	process
Aop:258	Event:1673	disrupted	MESH	MESH:0001673	Increase	HP	HP:0001673	Increase	process
Aop:258	Event:1674	morphological change	UBERON	UBERON:0001674	Increase	GO	GO:0001674	Increase	process
Aop:258	Event:1675	increased	PR	PR:0001675	Decrease	MP	MP:0001675	Decrease	process
Aop:258	Event:1676	decreased	CHEBI	CHEBI:0001676	Increase	VT	VT:0001676	Increase	process
Aop:258	Event:1677	occurrence	CL	CL:0001677	Reduction	HP	HP:0001677	Reduction	process
Aop:258	Event:1678	disrupted	MESH	MESH:0001678	Decrease	GO	GO:0001678	Decrease	process
Aop:259	Event:1679	occurrence	CL	CL:0001679	Antagonism	VT	VT:0001679	Antagonism	process
Aop:259	Event:1680	disrupted	MESH	MESH:0001680	Hippocampal gene expression	HP	HP:0001680	Hippocampal gene expression	process
Aop:259	Event:1681	morphological change	UBERON	UBERON:0001681	Hippocampal anatomy	GO	GO:0001681	Hippocampal anatomy	process
Aop:259	Event:1682	increased	PR	PR:0001682	Hippocampal Physiology	MP	MP:0001682	Hippocampal Physiology	process
Aop:259	Event:1683	decreased	CHEBI	CHEBI:0001683	Cognitive function	VT	VT:0001683	Cognitive function	process
Aop:260	Event:1684	occurrence	CL	CL:0001684	Inhibition of cystat	VT	VT:0001684	Inhibition of cystat	process
Aop:260	Event:1685	disrupted	MESH	MESH:0001685	Increased Homocystei	HP	HP:0001685	Increased Homocystei	process
Aop:260	Event:1686	morphological change	UBERON	UBERON:0001686	Increased	GO	GO:0001686	Increased	process
Aop:260	Event:1687	increased	PR	PR:0001687	Induced	MP	MP:0001687	Induced	process
Aop:260	Event:1688	decreased	CHEBI	CHEBI:0001688	Impaired	VT	VT:0001688	Impaired	process
Aop:261	Event:1689	occurrence	CL	CL:0001689	Inhibition of lung s	VT	VT:0001689	Inhibition of lung s	process
Aop:261	Event:1690	disrupted	MESH	MESH:0001690	Alveolar collapse	HP	HP:0001690	Alveolar collapse	process
Aop:261	Event:1691	morphological change	UBERON	UBERON:0001691	Loss of alveolar cap	GO	GO:0001691	Loss of alveolar cap	process
Aop:261	Event:1692	increased	PR	PR:0001692	Reduced tidal volume	MP	MP:0001692	Reduced tidal volume	process
Aop:261	Event:1693	decreased	CHEBI	CHEBI:0001693	Decrease	VT	VT:0001693	Decrease	process
Aop:262	Event:1694	occurrence	CL	CL:0001694	Frustrated phagocyto	VT	VT:0001694	Frustrated phagocyto	process
Aop:262	Event:1695	disrupted	MESH	MESH:0001695	Release	HP	HP:0001695	Release	process
Aop:262	Event:1696	morphological change	UBERON	UBERON:0001696	Increased	GO	GO:0001696	Increased	process
Aop:262	Event:1697	increased	PR	PR:0001697	Increase	MP	MP:0001697	Increase	process
Aop:262	Event:1698	decreased	CHEBI	CHEBI:0001698	Increased	VT	VT:0001698	Increased	process
Aop:262	Event:1699	occurrence	CL	CL:0001699	Increase	HP	HP:0001699	Increase	process
Aop:262	Event:1700	disrupted	MESH	MESH:0001700	Lung cancer	GO	GO:0001700	Lung cancer	process
Aop:263	Event:1701	occurrence	CL	CL:0001701	Inhibition	VT	VT:0001701	Inhibition	process
Aop:263	Event:1702	disrupted	MESH	MESH:0001702	Disruption	HP	HP:0001702	Disruption	process
Aop:263	Event:1703	morphological change	UBERON	UBERON:0001703	Disruption	GO	GO:0001703	Disruption	process
Aop:263	Event:1704	increased	PR	PR:0001704	Impairment	MP	MP:0001704	Impairment	process
Aop:263	Event:1705	decreased	CHEBI	CHEBI:0001705	Abnormalities	VT	VT:0001705	Abnormalities	process
Aop:263	Event:1706	occurrence	CL	CL:0001706	Anomalies	HP	HP:0001706	Anomalies	process
Aop:264	Event:1707	occurrence	CL	CL:0001707	Inhibition	VT	VT:0001707	Inhibition	process
Aop:264	Event:1708	disrupted	MESH	MESH:0001708	Decrease	HP	HP:0001708	Decrease	process
Aop:264	Event:1709	morphological change	UBERON	UBERON:0001709	Decrease	GO	GO:0001709	Decrease	process
Aop:264	Event:1710	increased	PR	PR:0001710	Altered	MP	MP:0001710	Altered	process
Aop:264	Event:1711	decreased	CHEBI	CHEBI:0001711	anogenital distance (AGD)	VT	VT:0001711	anogenital distance (AGD)	process
Aop:265	Event:1712	occurrence	CL	CL:0001712	Antagonism	VT	VT:0001712	Antagonism	process
Aop:265	Event:1713	disrupted	MESH	MESH:0001713	Decrease	HP	HP:0001713	Decrease	process
Aop:265	Event:1714	morphological change	UBERON	UBERON:0001714	Altered	GO	GO:0001714	Altered	process
Aop:265	Event:1715	increased	PR	PR:0001715	anogenital distance (AGD)	MP	MP:0001715	anogenital distance (AGD)	process
Aop:266	Event:1716	occurrence	CL	CL:0001716	Decrease	VT	VT:0001716	Decrease	process
Aop:266	Event:1717	disrupted	MESH	MESH:0001717	Decrease	HP	HP:0001717	Decrease	process
Aop:266	Event:1718	morphological change	UBERON	UBERON:0001718	Altered	GO	GO:0001718	Altered	process
Aop:266	Event:1719	increased	PR	PR:0001719	Decrease	MP	MP:0001719	Decrease	process
Aop:266	Event:1720	decreased	CHEBI	CHEBI:0001720	anogenital distance (AGD)	VT	VT:0001720	anogenital distance (AGD)	process
Aop:267	Event:1721	occurrence	CL	CL:0001721	Antagonism	VT	VT:0001721	Antagonism	process
Aop:267	Event:1722	disrupted	MESH	MESH:0001722	Reduction	HP	HP:0001722	Reduction	process
Aop:267	Event:1723	morphological change	UBERON	UBERON:0001723	Decreased	GO	GO:0001723	Decreased	process
Aop:267	Event:1724	increased	PR	PR:0001724	Reduction	MP	MP:0001724	Reduction	process
Aop:267	Event:1725	decreased	CHEBI	CHEBI:0001725	Impaired ovulation	VT	VT:0001725	Impaired ovulation	process
Aop:267	Event:1726	occurrence	CL	CL:0001726	Decrease of egg prod	HP	HP:0001726	Decrease of egg prod	process
Aop:267	Event:1727	disrupted	MESH	MESH:0001727	Decline	GO	GO:0001727	Decline	process
Aop:268	Event:1728	occurrence	CL	CL:0001728	Activation	VT	VT:0001728	Activation	process
Aop:268	Event:1729	disrupted	MESH	MESH:0001729	dimerization	HP	HP:0001729	dimerization	process
Aop:268	Event:1730	morphological change	UBERON	UBERON:0001730	Increase	GO	GO:0001730	Increase	process
Aop:268	Event:1731	increased	PR	PR:0001731	Increase	MP	MP:0001731	Increase	process
Aop:268	Event:1732	decreased	CHEBI	CHEBI:0001732	Decrease	VT	VT:0001732	Decrease	process
Aop:268	Event:1733	occurrence	CL	CL:0001733	Reduction	HP	HP:0001733	Reduction	process
Aop:268	Event:1734	disrupted	MESH	MESH:0001734	Reduction	GO	GO:0001734	Reduction	process
Aop:268	Event:1735	morphological change	UBERON	UBERON:0001735	Reduction	MP	MP:0001735	Reduction	process
Aop:268	Event:1736	increased	PR	PR:0001736	Reduction	VT	VT:0001736	Reduction	process
Aop:268	Event:1737	decreased	CHEBI	CHEBI:0001737	Reduction	HP	HP:0001737	Reduction	process
Aop:268	Event:1738	occurrence	CL	CL:0001738	Reduction	GO	GO:0001738	Reduction	process
Aop:268	Event:1739	disrupted	MESH	MESH:0001739	Decrease	MP	MP:0001739	Decrease	process
Aop:269	Event:1740	occurrence	CL	CL:0001740	Deposition of Energy	VT	VT:0001740	Deposition of Energy	process
Aop:269	Event:1741	disrupted	MESH	MESH:0001741	Increase	HP	HP:0001741	Increase	process
Aop:269	Event:1742	morphological change	UBERON	UBERON:0001742	Increase	GO	GO:0001742	Increase	process
Aop:269	Event:1743	increased	PR	PR:0001743	Decrease	MP	MP:0001743	Decrease	process
Aop:269	Event:1744	decreased	CHEBI	CHEBI:0001744	Increase	VT	VT:0001744	Increase	process
Aop:269	Event:1745	occurrence	CL	CL:0001745	Reduction	HP	HP:0001745	Reduction	process
Aop:269	Event:1746	disrupted	MESH	MESH:0001746	Decrease	GO	GO:0001746	Decrease	process
Aop:270	Event:1747	occurrence	CL	CL:0001747	Acetylcholinesterase	VT	VT:0001747	Acetylcholinesterase	process
Aop:270	Event:1748	disrupted	MESH	MESH:0001748	Acetylcholine accumu	HP	HP:0001748	Acetylcholine accumu	process
Aop:270	Event:1749	morphological change	UBERON	UBERON:0001749	Increased Cholinergi	GO	GO:0001749	Increased Cholinergi	process
Aop:270	Event:1750	increased	PR	PR:0001750	Impaired coordinatio	MP	MP:0001750	Impaired coordinatio	process
Aop:270	Event:1751	decreased	CHEBI	CHEBI:0001751	Increased Mortality	VT	VT:0001751	Increased Mortality	process
Aop:270	Event:1752	occurrence	CL	CL:0001752	Decrease	HP	HP:0001752	Decrease	process
Aop:271	Event:1753	occurrence	CL	CL:0001753	Stimulation	VT	VT:0001753	Stimulation	process
Aop:271	Event:1754	disrupted	MESH	MESH:0001754	Maturation of TNF/iN	HP	HP:0001754	Maturation of TNF/iN	process
Aop:271	Event:1755	morphological change	UBERON	UBERON:0001755	Increase	GO	GO:0001755	Increase	process
Aop:271	Event:1756	increased	PR	PR:0001756	Th17 cell migration 	MP	MP:0001756	Th17 cell migration 	process
Aop:271	Event:1757	decreased	CHEBI	CHEBI:0001757	Psoriatic skin disea	VT	VT:0001757	Psoriatic skin disea	process
Aop:272	Event:1758	occurrence	CL	CL:0001758	Binding to estrogen 	VT	VT:0001758	Binding to estrogen 	process
Aop:272	Event:1759	disrupted	MESH	MESH:0001759	Induction of GATA3 e	HP	HP:0001759	Induction of GATA3 e	process
Aop:272	Event:1760	morphological change	UBERON	UBERON:0001760	Increase of Th2 cell	GO	GO:0001760	Increase of Th2 cell	process
Aop:272	Event:1761	increased	PR	PR:0001761	Increase of anti-DNA	MP	MP:0001761	Increase of anti-DNA	process
Aop:272	Event:1762	decreased	CHEBI	CHEBI:0001762	Exacerbation of syst	VT	VT:0001762	Exacerbation of syst	process
Aop:273	Event:1763	occurrence	CL	CL:0001763	Inhibition of JAK3	VT	VT:0001763	Inhibition of JAK3	process
Aop:273	Event:1764	disrupted	MESH	MESH:0001764	Blockade of STAT5 ph	HP	HP:0001764	Blockade of STAT5 ph	process
Aop:273	Event:1765	morphological change	UBERON	UBERON:0001765	Suppression of STAT5	GO	GO:0001765	Suppression of STAT5	process
Aop:273	Event:1766	increased	PR	PR:0001766	Suppression of IL-4 	MP	MP:0001766	Suppression of IL-4 	process
Aop:273	Event:1767	decreased	CHEBI	CHEBI:0001767	Impairment of T-cell	VT	VT:0001767	Impairment of T-cell	process
Aop:274	Event:1768	occurrence	CL	CL:0001768	Trypsin inhibition	VT	VT:0001768	Trypsin inhibition	process
Aop:274	Event:1769	disrupted	MESH	MESH:0001769	Increased intestinal	HP	HP:0001769	Increased intestinal	process
Aop:274	Event:1770	morphological change	UBERON	UBERON:0001770	Increased blood CCK 	GO	GO:0001770	Increased blood CCK 	process
Aop:274	Event:1771	increased	PR	PR:0001771	Increased exocrine s	MP	MP:0001771	Increased exocrine s	process
Aop:274	Event:1772	decreased	CHEBI	CHEBI:0001772	Acinar cell prolifer	VT	VT:0001772	Acinar cell prolifer	process
Aop:274	Event:1773	occurrence	CL	CL:0001773	Pancreatic acinar ce	HP	HP:0001773	Pancreatic acinar ce	process
Aop:275	Event:1774	occurrence	CL	CL:0001774	Activation	VT	VT:0001774	Activation	process
Aop:275	Event:1775	disrupted	MESH	MESH:0001775	Decrease	HP	HP:0001775	Decrease	process
Aop:275	Event:1776	morphological change	UBERON	UBERON:0001776	Decreased	GO	GO:0001776	Decreased	process
Aop:275	Event:1777	increased	PR	PR:0001777	Accumulation	MP	MP:0001777	Accumulation	process
Aop:275	Event:1778	decreased	CHEBI	CHEBI:0001778	Increased	VT	VT:0001778	Increased	process
Aop:276	Event:1779	occurrence	CL	CL:0001779	Induced dysregulatio	VT	VT:0001779	Induced dysregulatio	process
Aop:276	Event:1780	disrupted	MESH	MESH:0001780	Dysregulation	HP	HP:0001780	Dysregulation	process
Aop:276	Event:1781	morphological change	UBERON	UBERON:0001781	Increased Angiotensi	GO	GO:0001781	Increased Angiotensi	process
Aop:276	Event:1782	increased	PR	PR:0001782	Binding of agonist	MP	MP:0001782	Binding of agonist	process
Aop:276	Event:1783	decreased	CHEBI	CHEBI:0001783	Increase	VT	VT:0001783	Increase	process
Aop:276	Event:1784	occurrence	CL	CL:0001784	Increased activation	HP	HP:0001784	Increased activation	process
Aop:276	Event:1785	disrupted	MESH	MESH:0001785	Accumulation	GO	GO:0001785	Accumulation	process
Aop:276	Event:1786	morphological change	UBERON	UBERON:0001786	Increased	MP	MP:0001786	Increased	process
Aop:276	Event:1787	increased	PR	PR:0001787	Lung fibrosis	VT	VT:0001787	Lung fibrosis	process
Aop:277	Event:1788	occurrence	CL	CL:0001788	Binding to ACE2	VT	VT:0001788	Binding to ACE2	process
Aop:277	Event:1789	disrupted	MESH	MESH:0001789	SARS-CoV-2 cell entr	HP	HP:0001789	SARS-CoV-2 cell entr	process
Aop:277	Event:1790	morphological change	UBERON	UBERON:0001790	Interferon-I antiviral response	GO	GO:0001790	Interferon-I antiviral response	process
Aop:277	Event:1791	increased	PR	PR:0001791	Increased SARS-CoV-2	MP	MP:0001791	Increased SARS-CoV-2	process
Aop:277	Event:1792	decreased	CHEBI	CHEBI:0001792	Toll Like Receptor (	VT	VT:0001792	Toll Like Receptor (	process
Aop:277	Event:1793	occurrence	CL	CL:0001793	Increased	HP	HP:0001793	Increased	process
Aop:277	Event:1794	disrupted	MESH	MESH:0001794	Increased inflammato	GO	GO:0001794	Increased inflammato	process
Aop:277	Event:1795	morphological change	UBERON	UBERON:0001795	Increase	MP	MP:0001795	Increase	process
Aop:277	Event:1796	increased	PR	PR:0001796	Increased Mortality	VT	VT:0001796	Increased Mortality	process
Aop:278	Event:202	decreased	PR	PR:000001753	transcription factor NF-kappa-B subunit	GO	GO:0007249	I-kappaB kinase/NF-kappaB signaling
Aop:278	Event:55	increased				GO	GO:0008219	cell death
Aop:279	Event:1797	occurrence	CL	CL:0001797	Alkylation	VT	VT:0001797	Alkylation	process
Aop:279	Event:1798	disrupted	MESH	MESH:0001798	Inadequate DNA repai	HP	HP:0001798	Inadequate DNA repai	process
Aop:279	Event:1799	morphological change	UBERON	UBERON:0001799	Increase	GO	GO:0001799	Increase	process
Aop:279	Event:1800	increased	PR	PR:0001800	Increase	MP	MP:0001800	Increase	process
Aop:279	Event:1801	decreased	CHEBI	CHEBI:0001801	Reduce	VT	VT:0001801	Reduce	process
Aop:280	Event:1802	occurrence	CL	CL:0001802	Activation	VT	VT:0001802	Activation	process
Aop:280	Event:1803	disrupted	MESH	MESH:0001803	Decreased	HP	HP:0001803	Decreased	process
Aop:280	Event:1804	morphological change	UBERON	UBERON:0001804	Decreased	GO	GO:0001804	Decreased	process
Aop:280	Event:1805	increased	PR	PR:0001805	Impaired	MP	MP:0001805	Impaired	process
Aop:280	Event:1806	decreased	CHEBI	CHEBI:0001806	Decreased	VT	VT:0001806	Decreased	process
Aop:280	Event:1807	occurrence	CL	CL:0001807	Decrease	HP	HP:0001807	Decrease	process
Aop:281	Event:1808	occurrence	CL	CL:0001808	Increase	VT	VT:0001808	Increase	process
Aop:281	Event:1809	disrupted	MESH	MESH:0001809	Increase	HP	HP:0001809	Increase	process
Aop:281	Event:1810	morphological change	UBERON	UBERON:0001810	Increase	GO	GO:0001810	Increase	process
Aop:281	Event:1811	increased	PR	PR:0001811	Decrease	MP	MP:0001811	Decrease	process
Aop:282	Event:1812	occurrence	CL	CL:0001812	Increase	VT	VT:0001812	Increase	process
Aop:282	Event:1813	disrupted	MESH	MESH:0001813	Increase	HP	HP:0001813	Increase	process
Aop:282	Event:1814	morphological change	UBERON	UBERON:0001814	Increase	GO	GO:0001814	Increase	process
Aop:282	Event:1815	increased	PR	PR:0001815	Decrease	MP	MP:0001815	Decrease	process
Aop:283	Event:1816	occurrence	CL	CL:0001816	Increase	VT	VT:0001816	Increase	process
Aop:283	Event:1817	disrupted	MESH	MESH:0001817	Increase	HP	HP:0001817	Increase	process
Aop:283	Event:1818	morphological change	UBERON	UBERON:0001818	Increase	GO	GO:0001818	Increase	process
Aop:283	Event:1819	increased	PR	PR:0001819	Decrease	MP	MP:0001819	Decrease	process
Aop:284	Event:1820	occurrence	CL	CL:0001820	Increase	VT	VT:0001820	Increase	process
Aop:284	Event:1821	disrupted	MESH	MESH:0001821	Increase	HP	HP:0001821	Increase	process
Aop:284	Event:1822	morphological change	UBERON	UBERON:0001822	Increase	GO	GO:0001822	Increase	process
Aop:284	Event:1823	increased	PR	PR:0001823	Increase	MP	MP:0001823	Increase	process
Aop:284	Event:1824	decreased	CHEBI	CHEBI:0001824	Increase	VT	VT:0001824	Increase	process
Aop:285	Event:1825	occurrence	CL	CL:0001825	Increase	VT	VT:0001825	Increase	process
Aop:285	Event:1826	disrupted	MESH	MESH:0001826	Decrease	HP	HP:0001826	Decrease	process
Aop:285	Event:1827	morphological change	UBERON	UBERON:0001827	Decrease	GO	GO:0001827	Decrease	process
Aop:285	Event:1828	increased	PR	PR:0001828	Decrease	MP	MP:0001828	Decrease	process
Aop:285	Event:1829	decreased	CHEBI	CHEBI:0001829	Increase	VT	VT:0001829	Increase	process
Aop:286	Event:1830	occurrence	CL	CL:0001830	Increase	VT	VT:0001830	Increase	process
Aop:286	Event:1831	disrupted	MESH	MESH:0001831	Increase	HP	HP:0001831	Increase	process
Aop:286	Event:1832	morphological change	UBERON	UBERON:0001832	Decrease	GO	GO:0001832	Decrease	process
Aop:286	Event:1833	increased	PR	PR:0001833	Decrease	MP	MP:0001833	Decrease	process
Aop:286	Event:1834	decreased	CHEBI	CHEBI:0001834	Increase	VT	VT:0001834	Increase	process
Aop:287	Event:1835	occurrence	CL	CL:0001835	Increase	VT	VT:0001835	Increase	process
Aop:287	Event:1836	disrupted	MESH	MESH:0001836	Increase	HP	HP:0001836	Increase	process
Aop:287	Event:1837	morphological change	UBERON	UBERON:0001837	Increase	GO	GO:0001837	Increase	process
Aop:287	Event:1838	increased	PR	PR:0001838	Increase	MP	MP:0001838	Increase	process
Aop:287	Event:1839	decreased	CHEBI	CHEBI:0001839	Increase	VT	VT:0001839	Increase	process
Aop:288	Event:1840	occurrence	CL	CL:0001840	Increase	VT	VT:0001840	Increase	process
Aop:288	Event:1841	disrupted	MESH	MESH:0001841	Increase	HP	HP:0001841	Increase	process
Aop:288	Event:1842	morphological change	UBERON	UBERON:0001842	Cell cycle	GO	GO:0001842	Cell cycle	process
Aop:288	Event:1843	increased	PR	PR:0001843	Decrease	MP	MP:0001843	Decrease	process
Aop:288	Event:1844	decreased	CHEBI	CHEBI:0001844	Increase	VT	VT:0001844	Increase	process
Aop:288	Event:1845	occurrence	CL	CL:0001845	Decrease	HP	HP:0001845	Decrease	process
Aop:289	Event:1846	occurrence	CL	CL:0001846	Increase	VT	VT:0001846	Increase	process
Aop:289	Event:1847	disrupted	MESH	MESH:0001847	Increase	HP	HP:0001847	Increase	process
Aop:289	Event:1848	morphological change	UBERON	UBERON:0001848	Cell cycle	GO	GO:0001848	Cell cycle	process
Aop:289	Event:1849	increased	PR	PR:0001849	Decrease	MP	MP:0001849	Decrease	process
Aop:289	Event:1850	decreased	CHEBI	CHEBI:0001850	Decrease	VT	VT:0001850	Decrease	process
Aop:290	Event:1851	occurrence	CL	CL:0001851	Increase	VT	VT:0001851	Increase	process
Aop:290	Event:1852	disrupted	MESH	MESH:0001852	Decrease	HP	HP:0001852	Decrease	process
Aop:290	Event:1853	morphological change	UBERON	UBERON:0001853	Decrease	GO	GO:0001853	Decrease	process
Aop:290	Event:1854	increased	PR	PR:0001854	Decrease	MP	MP:0001854	Decrease	process
Aop:290	Event:1855	decreased	CHEBI	CHEBI:0001855	Decrease	VT	VT:0001855	Decrease	process
Aop:291	Event:1856	occurrence	CL	CL:0001856	Activation	VT	VT:0001856	Activation	process
Aop:291	Event:1857	disrupted	MESH	MESH:0001857	Altered Cell Differe	HP	HP:0001857	Altered Cell Differe	process
Aop:291	Event:1858	morphological change	UBERON	UBERON:0001858	Altered Bone Cell Ho	GO	GO:0001858	Altered Bone Cell Ho	process
Aop:291	Event:1859	increased	PR	PR:0001859	Inhibition	MP	MP:0001859	Inhibition	process
Aop:291	Event:1860	decreased	CHEBI	CHEBI:0001860	Reduced	VT	VT:0001860	Reduced	process
Aop:291	Event:1861	occurrence	CL	CL:0001861	Decrease	HP	HP:0001861	Decrease	process
Aop:292	Event:1862	occurrence	CL	CL:0001862	Mitochondrial dysfun	VT	VT:0001862	Mitochondrial dysfun	process
Aop:292	Event:1863	disrupted	MESH	MESH:0001863	Urothelial cell inju	HP	HP:0001863	Urothelial cell inju	process
Aop:292	Event:1864	morphological change	UBERON	UBERON:0001864	Increase	GO	GO:0001864	Increase	process
Aop:292	Event:1865	increased	PR	PR:0001865	Increase	MP	MP:0001865	Increase	process
Aop:292	Event:1866	decreased	CHEBI	CHEBI:0001866	Urothelial Tumor	VT	VT:0001866	Urothelial Tumor	process
Aop:293	Event:1867	occurrence	CL	CL:0001867	Increase	VT	VT:0001867	Increase	process
Aop:293	Event:1868	disrupted	MESH	MESH:0001868	Decrease	HP	HP:0001868	Decrease	process
Aop:293	Event:1869	morphological change	UBERON	UBERON:0001869	Increase	GO	GO:0001869	Increase	process
Aop:293	Event:1870	increased	PR	PR:0001870	Increase	MP	MP:0001870	Increase	process
Aop:293	Event:1871	decreased	CHEBI	CHEBI:0001871	Decrease	VT	VT:0001871	Decrease	process
Aop:293	Event:1872	occurrence	CL	CL:0001872	Decrease	HP	HP:0001872	Decrease	process
Aop:293	Event:1873	disrupted	MESH	MESH:0001873	Decrease	GO	GO:0001873	Decrease	process
Aop:294	Event:1874	occurrence	CL	CL:0001874	Increase	VT	VT:0001874	Increase	process
Aop:294	Event:1875	disrupted	MESH	MESH:0001875	Decrease	HP	HP:0001875	Decrease	process
Aop:294	Event:1876	morphological change	UBERON	UBERON:0001876	Increase	GO	GO:0001876	Increase	process
Aop:294	Event:1877	increased	PR	PR:0001877	Increase	MP	MP:0001877	Increase	process
Aop:294	Event:1878	decreased	CHEBI	CHEBI:0001878	Increase	VT	VT:0001878	Increase	process
Aop:294	Event:1879	occurrence	CL	CL:0001879	Decrease	HP	HP:0001879	Decrease	process
Aop:294	Event:1880	disrupted	MESH	MESH:0001880	Decrease	GO	GO:0001880	Decrease	process
Aop:294	Event:1881	morphological change	UBERON	UBERON:0001881	Decrease	MP	MP:0001881	Decrease	process
Aop:295	Event:1882	occurrence	CL	CL:0001882	Increase	VT	VT:0001882	Increase	process
Aop:295	Event:1883	disrupted	MESH	MESH:0001883	Increase	HP	HP:0001883	Increase	process
Aop:295	Event:1884	morphological change	UBERON	UBERON:0001884	Increase	GO	GO:0001884	Increase	process
Aop:295	Event:1885	increased	PR	PR:0001885	Increase	MP	MP:0001885	Increase	process
Aop:295	Event:1886	decreased	CHEBI	CHEBI:0001886	Decrease	VT	VT:0001886	Decrease	process
Aop:295	Event:1887	occurrence	CL	CL:0001887	Decrease	HP	HP:0001887	Decrease	process
Aop:295	Event:1888	disrupted	MESH	MESH:0001888	Decrease	GO	GO:0001888	Decrease	process
Aop:296	Event:1889	occurrence	CL	CL:0001889	Increase	VT	VT:0001889	Increase	process
Aop:296	Event:1890	disrupted	MESH	MESH:0001890	Increase	HP	HP:0001890	Increase	process
Aop:296	Event:1891	morphological change	UBERON	UBERON:0001891	Increase	GO	GO:0001891	Increase	process
Aop:296	Event:1892	increased	PR	PR:0001892	Increase	MP	MP:0001892	Increase	process
Aop:296	Event:1893	decreased	CHEBI	CHEBI:0001893	Increase	VT	VT:0001893	Increase	process
Aop:296	Event:1894	occurrence	CL	CL:0001894	Decrease	HP	HP:0001894	Decrease	process
Aop:296	Event:1895	disrupted	MESH	MESH:0001895	Decrease	GO	GO:0001895	Decrease	process
Aop:296	Event:1896	morphological change	UBERON	UBERON:0001896	Decrease	MP	MP:0001896	Decrease	process
Aop:297	Event:1897	occurrence	CL	CL:0001897	Increase	VT	VT:0001897	Increase	process
Aop:297	Event:1898	disrupted	MESH	MESH:0001898	Decrease	HP	HP:0001898	Decrease	process
Aop:297	Event:1899	morphological change	UBERON	UBERON:0001899	Decrease	GO	GO:0001899	Decrease	process
Aop:297	Event:1900	increased	PR	PR:0001900	Increase	MP	MP:0001900	Increase	process
Aop:297	Event:1901	decreased	CHEBI	CHEBI:0001901	Increase	VT	VT:0001901	Increase	process
Aop:297	Event:1902	occurrence	CL	CL:0001902	Decrease	HP	HP:0001902	Decrease	process
Aop:297	Event:1903	disrupted	MESH	MESH:0001903	Decrease	GO	GO:0001903	Decrease	process
Aop:297	Event:1904	morphological change	UBERON	UBERON:0001904	Decrease	MP	MP:0001904	Decrease	process
Aop:298	Event:1905	occurrence	CL	CL:0001905	Increase	VT	VT:0001905	Increase	process
Aop:298	Event:1906	disrupted	MESH	MESH:0001906	Decrease	HP	HP:0001906	Decrease	process
Aop:298	Event:1907	morphological change	UBERON	UBERON:0001907	Decrease	GO	GO:0001907	Decrease	process
Aop:298	Event:1908	increased	PR	PR:0001908	Increase	MP	MP:0001908	Increase	process
Aop:298	Event:1909	decreased	CHEBI	CHEBI:0001909	Increase	VT	VT:0001909	Increase	process
Aop:298	Event:1910	occurrence	CL	CL:0001910	Increase	HP	HP:0001910	Increase	process
Aop:298	Event:1911	disrupted	MESH	MESH:0001911	Decrease	GO	GO:0001911	Decrease	process
Aop:298	Event:1912	morphological change	UBERON	UBERON:0001912	Decrease	MP	MP:0001912	Decrease	process
Aop:298	Event:1913	increased	PR	PR:0001913	Decrease	VT	VT:0001913	Decrease	process
Aop:299	Event:1914	occurrence	CL	CL:0001914	Inhibition	VT	VT:0001914	Inhibition	process
Aop:299	Event:1915	disrupted	MESH	MESH:0001915	Decrease	HP	HP:0001915	Decrease	process
Aop:299	Event:1916	morphological change	UBERON	UBERON:0001916	Increase	GO	GO:0001916	Increase	process
Aop:299	Event:1917	increased	PR	PR:0001917	Increase	MP	MP:0001917	Increase	process
Aop:300	Event:1918	occurrence	CL	CL:0001918	Increase	VT	VT:0001918	Increase	process
Aop:300	Event:1919	disrupted	MESH	MESH:0001919	Increase	HP	HP:0001919	Increase	process
Aop:300	Event:1920	morphological change	UBERON	UBERON:0001920	Increase	GO	GO:0001920	Increase	process
Aop:300	Event:1921	increased	PR	PR:0001921	Decrease	MP	MP:0001921	Decrease	process
Aop:300	Event:1922	decreased	CHEBI	CHEBI:0001922	Increase	VT	VT:0001922	Increase	process
Aop:300	Event:1923	occurrence	CL	CL:0001923	Increase	HP	HP:0001923	Increase	process
Aop:301	Event:1924	occurrence	CL	CL:0001924	Antagonism	VT	VT:0001924	Antagonism	process
Aop:301	Event:1925	disrupted	MESH	MESH:0001925	Decrease	HP	HP:0001925	Decrease	process
Aop:301	Event:1926	morphological change	UBERON	UBERON:0001926	Altered	GO	GO:0001926	Altered	process
Aop:301	Event:1927	increased	PR	PR:0001927	Nipple retention (NR)	MP	MP:0001927	Nipple retention (NR)	process
Aop:302	Event:1928	occurrence	CL	CL:0001928	Antagonism	VT	VT:0001928	Antagonism	process
Aop:302	Event:1929	disrupted	MESH	MESH:0001929	Decrease	HP	HP:0001929	Decrease	process
Aop:302	Event:1930	morphological change	UBERON	UBERON:0001930	Altered	GO	GO:0001930	Altered	process
Aop:302	Event:1931	increased	PR	PR:0001931	Granulosa cell proliferation of gonadotropin-independent follicles	MP	MP:0001931	Granulosa cell proliferation of gonadotropin-independent follicles	process
Aop:302	Event:1932	decreased	CHEBI	CHEBI:0001932	disrupted	VT	VT:0001932	disrupted	process
Aop:302	Event:1933	occurrence	CL	CL:0001933	decreased	HP	HP:0001933	decreased	process
Aop:303	Event:1934	occurrence	CL	CL:0001934	Inhibition	VT	VT:0001934	Inhibition	process
Aop:303	Event:1935	disrupted	MESH	MESH:0001935	Reduction	HP	HP:0001935	Reduction	process
Aop:303	Event:1936	morphological change	UBERON	UBERON:0001936	Increased	GO	GO:0001936	Increased	process
Aop:303	Event:1937	increased	PR	PR:0001937	Increased	MP	MP:0001937	Increased	process
Aop:303	Event:1938	decreased	CHEBI	CHEBI:0001938	Decrease	VT	VT:0001938	Decrease	process
Aop:304	Event:1939	occurrence	CL	CL:0001939	Toll-like receptor 4	VT	VT:0001939	Toll-like receptor 4	process
Aop:304	Event:1940	disrupted	MESH	MESH:0001940	Inactivation of PPAR	HP	HP:0001940	Inactivation of PPAR	process
Aop:304	Event:1941	morphological change	UBERON	UBERON:0001941	Activation	GO	GO:0001941	Activation	process
Aop:304	Event:1942	increased	PR	PR:0001942	Activator protein 1 	MP	MP:0001942	Activator protein 1 	process
Aop:304	Event:1943	decreased	CHEBI	CHEBI:0001943	Pin-1 activation	VT	VT:0001943	Pin-1 activation	process
Aop:304	Event:1944	occurrence	CL	CL:0001944	Latent Transforming 	HP	HP:0001944	Latent Transforming 	process
Aop:304	Event:1945	disrupted	MESH	MESH:0001945	Activation	GO	GO:0001945	Activation	process
Aop:304	Event:1946	morphological change	UBERON	UBERON:0001946	Epithelial Mesenchym	MP	MP:0001946	Epithelial Mesenchym	process
Aop:304	Event:1947	increased	PR	PR:0001947	Pulmonary fibrosis	VT	VT:0001947	Pulmonary fibrosis	process
Aop:305	Event:1948	occurrence	CL	CL:0001948	Inhibition of 11-HS	VT	VT:0001948	Inhibition of 11-HS	process
Aop:305	Event:1949	disrupted	MESH	MESH:0001949	Decreased	HP	HP:0001949	Decreased	process
Aop:305	Event:1950	morphological change	UBERON	UBERON:0001950	Impaired	GO	GO:0001950	Impaired	process
Aop:305	Event:1951	increased	PR	PR:0001951	decreased	MP	MP:0001951	decreased	process
Aop:305	Event:1952	decreased	CHEBI	CHEBI:0001952	Decrease	VT	VT:0001952	Decrease	process
Aop:306	Event:1953	occurrence	CL	CL:0001953	11-hydroxylase inhi	VT	VT:0001953	11-hydroxylase inhi	process
Aop:306	Event:1954	disrupted	MESH	MESH:0001954	Cortisol and 11-(OH	HP	HP:0001954	Cortisol and 11-(OH	process
Aop:306	Event:1955	morphological change	UBERON	UBERON:0001955	Decreased	GO	GO:0001955	Decreased	process
Aop:306	Event:1956	increased	PR	PR:0001956	Decreased plasma Cor	MP	MP:0001956	Decreased plasma Cor	process
Aop:306	Event:1957	decreased	CHEBI	CHEBI:0001957	Decreased spermatoge	VT	VT:0001957	Decreased spermatoge	process
Aop:306	Event:1958	occurrence	CL	CL:0001958	decreased oocyte mat	HP	HP:0001958	decreased oocyte mat	process
Aop:306	Event:1959	disrupted	MESH	MESH:0001959	decreased	GO	GO:0001959	decreased	process
Aop:306	Event:1960	morphological change	UBERON	UBERON:0001960	Decrease	MP	MP:0001960	Decrease	process
Aop:307	Event:1961	occurrence	CL	CL:0001961	Inhibition	VT	VT:0001961	Inhibition	process
Aop:307	Event:1962	disrupted	MESH	MESH:0001962	Decrease	HP	HP:0001962	Decrease	process
Aop:307	Event:1963	morphological change	UBERON	UBERON:0001963	Increase	GO	GO:0001963	Increase	process
Aop:307	Event:1964	increased	PR	PR:0001964	Increase	MP	MP:0001964	Increase	process
Aop:308	Event:1965	occurrence	CL	CL:0001965	Inhibition	VT	VT:0001965	Inhibition	process
Aop:308	Event:1966	disrupted	MESH	MESH:0001966	Decrease	HP	HP:0001966	Decrease	process
Aop:308	Event:1967	morphological change	UBERON	UBERON:0001967	Increase	GO	GO:0001967	Increase	process
Aop:308	Event:1968	increased	PR	PR:0001968	Increase	MP	MP:0001968	Increase	process
Aop:309	Event:1969	occurrence	CL	CL:0001969	Inhibition	VT	VT:0001969	Inhibition	process
Aop:309	Event:1970	disrupted	MESH	MESH:0001970	Decrease	HP	HP:0001970	Decrease	process
Aop:309	Event:1971	morphological change	UBERON	UBERON:0001971	Increase	GO	GO:0001971	Increase	process
Aop:309	Event:1972	increased	PR	PR:0001972	Increase	MP	MP:0001972	Increase	process
Aop:310	Event:1973	occurrence	CL	CL:0001973	Increase	VT	VT:0001973	Increase	process
Aop:310	Event:1974	disrupted	MESH	MESH:0001974	Increase	HP	HP:0001974	Increase	process
Aop:310	Event:1975	morphological change	UBERON	UBERON:0001975	Increase	GO	GO:0001975	Increase	process
Aop:310	Event:1976	increased	PR	PR:0001976	Decrease	MP	MP:0001976	Decrease	process
Aop:310	Event:1977	decreased	CHEBI	CHEBI:0001977	Increase	VT	VT:0001977	Increase	process
Aop:310	Event:1978	occurrence	CL	CL:0001978	Increase	HP	HP:0001978	Increase	process
Aop:311	Event:1979	occurrence	CL	CL:0001979	benzoquinone imine a	VT	VT:0001979	benzoquinone imine a	process
Aop:311	Event:1980	disrupted	MESH	MESH:0001980	Mitochondrial dysfun	HP	HP:0001980	Mitochondrial dysfun	process
Aop:311	Event:1981	morphological change	UBERON	UBERON:0001981	Activation of ER str	GO	GO:0001981	Activation of ER str	process
Aop:311	Event:1982	increased	PR	PR:0001982	Apoptotic cell death	MP	MP:0001982	Apoptotic cell death	process
Aop:311	Event:1983	decreased	CHEBI	CHEBI:0001983	Immune cell activati	VT	VT:0001983	Immune cell activati	process
Aop:311	Event:1984	occurrence	CL	CL:0001984	IFN signaling	HP	HP:0001984	IFN signaling	process
Aop:311	Event:1985	disrupted	MESH	MESH:0001985	Increase in inflamma	GO	GO:0001985	Increase in inflamma	process
Aop:311	Event:1986	morphological change	UBERON	UBERON:0001986	Immune mediated hepa	MP	MP:0001986	Immune mediated hepa	process
Aop:312	Event:1987	occurrence	CL	CL:0001987	Thyroperoxidase	VT	VT:0001987	Thyroperoxidase	process
Aop:312	Event:1988	disrupted	MESH	MESH:0001988	Thyroid hormone synthesis	HP	HP:0001988	Thyroid hormone synthesis	process
Aop:312	Event:1989	morphological change	UBERON	UBERON:0001989	Thyroxine (T4) in serum	GO	GO:0001989	Thyroxine (T4) in serum	process
Aop:312	Event:1990	increased	PR	PR:0001990	Decreased	MP	MP:0001990	Decreased	process
Aop:312	Event:1991	decreased	CHEBI	CHEBI:0001991	Altered	VT	VT:0001991	Altered	process
Aop:312	Event:1992	occurrence	CL	CL:0001992	Altered	HP	HP:0001992	Altered	process
Aop:312	Event:1993	disrupted	MESH	MESH:0001993	Increased Mortality	GO	GO:0001993	Increased Mortality	process
Aop:312	Event:1994	morphological change	UBERON	UBERON:0001994	Decrease	MP	MP:0001994	Decrease	process
Aop:313	Event:1995	occurrence	CL	CL:0001995	Thyroperoxidase	VT	VT:0001995	Thyroperoxidase	process
Aop:313	Event:1996	disrupted	MESH	MESH:0001996	Thyroid hormone synthesis	HP	HP:0001996	Thyroid hormone synthesis	process
Aop:313	Event:1997	morphological change	UBERON	UBERON:0001997	Thyroxine (T4) in serum	GO	GO:0001997	Thyroxine (T4) in serum	process
Aop:313	Event:1998	increased	PR	PR:0001998	Decreased	MP	MP:0001998	Decreased	process
Aop:313	Event:1999	decreased	CHEBI	CHEBI:0001999	Decreased	VT	VT:0001999	Decreased	process
Aop:313	Event:2000	occurrence	CL	CL:0002000	Altered	HP	HP:0002000	Altered	process
Aop:313	Event:2001	disrupted	MESH	MESH:0002001	Increased Mortality	GO	GO:0002001	Increased Mortality	process
Aop:313	Event:2002	morphological change	UBERON	UBERON:0002002	Decrease	MP	MP:0002002	Decrease	process
Aop:314	Event:2003	occurrence	CL	CL:0002003	Thyroperoxidase	VT	VT:0002003	Thyroperoxidase	process
Aop:314	Event:2004	disrupted	MESH	MESH:0002004	Thyroid hormone synthesis	HP	HP:0002004	Thyroid hormone synthesis	process
Aop:314	Event:2005	morphological change	UBERON	UBERON:0002005	Thyroxine (T4) in serum	GO	GO:0002005	Thyroxine (T4) in serum	process
Aop:314	Event:2006	increased	PR	PR:0002006	Decreased	MP	MP:0002006	Decreased	process
Aop:314	Event:2007	decreased	CHEBI	CHEBI:0002007	Altered	VT	VT:0002007	Altered	process
Aop:314	Event:2008	occurrence	CL	CL:0002008	Altered	HP	HP:0002008	Altered	process
Aop:314	Event:2009	disrupted	MESH	MESH:0002009	Increased Mortality	GO	GO:0002009	Increased Mortality	process
Aop:314	Event:2010	morphological change	UBERON	UBERON:0002010	Decrease	MP	MP:0002010	Decrease	process
Aop:315	Event:2011	occurrence	CL	CL:0002011	Binding	VT	VT:0002011	Binding	process
Aop:315	Event:2012	disrupted	MESH	MESH:0002012	Displacement	HP	HP:0002012	Displacement	process
Aop:315	Event:2013	morphological change	UBERON	UBERON:0002013	Increased	GO	GO:0002013	Increased	process
Aop:315	Event:2014	increased	PR	PR:0002014	Increased	MP	MP:0002014	Increased	process
Aop:315	Event:2015	decreased	CHEBI	CHEBI:0002015	Increased	VT	VT:0002015	Increased	process
Aop:315	Event:2016	occurrence	CL	CL:0002016	Thyroxine (T4) in serum	HP	HP:0002016	Thyroxine (T4) in serum	process
Aop:315	Event:2017	disrupted	MESH	MESH:0002017	Altered	GO	GO:0002017	Altered	process
Aop:316	Event:2018	occurrence	CL	CL:0002018	Binding	VT	VT:0002018	Binding	process
Aop:316	Event:2019	disrupted	MESH	MESH:0002019	Displacement	HP	HP:0002019	Displacement	process
Aop:316	Event:2020	morphological change	UBERON	UBERON:0002020	Increased	GO	GO:0002020	Increased	process
Aop:316	Event:2021	increased	PR	PR:0002021	Increased	MP	MP:0002021	Increased	process
Aop:316	Event:2022	decreased	CHEBI	CHEBI:0002022	Increased	VT	VT:0002022	Increased	process
Aop:316	Event:2023	occurrence	CL	CL:0002023	Thyroxine (T4) in serum	HP	HP:0002023	Thyroxine (T4) in serum	process
Aop:316	Event:2024	disrupted	MESH	MESH:0002024	Altered	GO	GO:0002024	Altered	process
Aop:317	Event:2025	occurrence	CL	CL:0002025	Inhibition	VT	VT:0002025	Inhibition	process
Aop:317	Event:2026	disrupted	MESH	MESH:0002026	Increase	HP	HP:0002026	Increase	process
Aop:317	Event:2027	morphological change	UBERON	UBERON:0002027	Increased	GO	GO:0002027	Increased	process
Aop:318	Event:122	increased	PR	PR:000011406	glucocorticoid receptor	GO	GO:0004883	glucocorticoid receptor activity
Aop:318	Event:860	decreased	CHEBI	CHEBI:35366	fatty acid	GO	GO:0006635	fatty acid beta-oxidation
Aop:318	Event:459	increased				HP	HP:0001397	Hepatic steatosis
Aop:318	Event:291	increased	CHEBI	CHEBI:17855	triglyceride			
Aop:319	Event:68	increased	CHEBI	CHEBI:3815	collagen	GO	GO:0032964	collagen biosynthetic process
Aop:319	Event:1115	increased	CHEBI	CHEBI:26523	reactive oxygen species	GO	GO:1903409	reactive oxygen species biosynthetic process
Aop:319	Event:1172	increased				GO	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling
Aop:319	Event:1496	increased	FMA	FMA:84050	Cytokine	GO	GO:0002534	cytokine production involved in inflammatory response
Aop:319	Event:1496	increased	FMA	FMA:241981	Chemokine	GO	GO:0090195	chemokine secretion
Aop:319	Event:1496	increased				GO	GO:0006956	complement activation
Aop:319	Event:1496	increased	FMA	FMA:86578	Interleukin			
Aop:319	Event:1854	increased	PR	PR:000003622	angiotensin-converting enzyme 2	GO	GO:0009299	mRNA transcription
Aop:319	Event:1854	increased	PR	PR:000003622	angiotensin-converting enzyme 2	GO	GO:0004180	carboxypeptidase activity
Aop:319	Event:1854	decreased	PR	PR:000003622	angiotensin-converting enzyme 2	GO	GO:0034394	protein localization to cell surface
Aop:319	Event:1854	increased	PR	PR:000003622	angiotensin-converting enzyme 2			
Aop:320	Event:1496	increased	FMA	FMA:84050	Cytokine	GO	GO:0002534	cytokine production involved in inflammatory response
Aop:320	Event:1496	increased	FMA	FMA:241981	Chemokine	GO	GO:0090195	chemokine secretion
Aop:320	Event:1496	increased				GO	GO:0006956	complement activation
Aop:320	Event:1496	increased	FMA	FMA:86578	Interleukin			
Aop:320	Event:1738	occurrence	PR	PR:000016456	transmembrane protease serine 2	GO	GO:0061025	membrane fusion
Aop:320	Event:1738	occurrence	PR	PR:P07711	cathepsin L1 (human)	GO	GO:0075509	endocytosis involved in viral entry into host cell
Aop:320	Event:1738	occurrence	GO	GO:0019015	viral genome	GO	GO:0046718	viral entry into host cell
Aop:320	Event:1738	occurrence	PR	PR:000036197	viral protein	GO	GO:0046718	viral entry into host cell
Aop:320	Event:1739	occurrence	PR	PR:000003622	angiotensin-converting enzyme 2	GO	GO:0005102	receptor binding
Aop:320	Event:351	increased				MESH	D009026	mortality
Aop:320	Event:1847	increased	GO	GO:0031381	viral RNA-directed RNA polymerase complex	GO	GO:0039694	viral RNA genome replication
Aop:320	Event:1847	increased	GO	GO:0031381	viral RNA-directed RNA polymerase complex	GO	GO:0039690	positive stranded viral RNA replication
Aop:320	Event:1847	increased	GO	GO:0072516	viral assembly compartment	GO	GO:0019074	viral RNA genome packaging
Aop:320	Event:1847	increased	GO	GO:0019024	ssRNA viral genome	GO	GO:0009299	mRNA transcription
Aop:320	Event:1847	increased	GO	GO:0019024	ssRNA viral genome	GO	GO:0019081	viral translation
Aop:320	Event:1901	decreased	PR	PR:000024938	interferon alpha	GO	GO:0060337	type I interferon signaling pathway
Aop:320	Event:1901	decreased	PR	PR:000024939	interferon beta	GO	GO:0060337	type I interferon signaling pathway
Aop:320	Event:1901	occurrence	GO	GO:0019022	RNA viral genome	GO	GO:0071360	cellular response to exogenous dsRNA
Aop:321	Event:2028	occurrence	CL	CL:0002028	Antagonism	VT	VT:0002028	Antagonism	process
Aop:321	Event:2029	disrupted	MESH	MESH:0002029	Decrease	HP	HP:0002029	Decrease	process
Aop:321	Event:2030	morphological change	UBERON	UBERON:0002030	Altered	GO	GO:0002030	Altered	process
Aop:321	Event:2031	increased	PR	PR:0002031	Malformation	MP	MP:0002031	Malformation	process
Aop:321	Event:2032	decreased	CHEBI	CHEBI:0002032	Testicular Cancer	VT	VT:0002032	Testicular Cancer	process
Aop:322	Event:97	increased	CHEBI	CHEBI:16991	deoxyribonucleic acid	GO	GO:0006305	DNA alkylation
Aop:322	Event:155	abnormal	CHEBI	CHEBI:16991	deoxyribonucleic acid	GO	GO:0006281	DNA repair
Aop:322	Event:1635	increased	FMA	FMA:74412	Deoxyribonucleic acid	NCI	NCI:C25830	DNA Strand Break
Aop:323	Event:2033	occurrence	CL	CL:0002033	Binding to ACE2	VT	VT:0002033	Binding to ACE2	process
Aop:323	Event:2034	disrupted	MESH	MESH:0002034	Neuroinflammation	HP	HP:0002034	Neuroinflammation	process
Aop:323	Event:2035	morphological change	UBERON	UBERON:0002035	N/A	GO	GO:0002035	N/A	process
Aop:323	Event:2036	increased	PR	PR:0002036	Encephalitis	MP	MP:0002036	Encephalitis	process
Aop:324	Event:1634	occurrence	CHEBI	CHEBI:26523	reactive oxygen species	GO	GO:1901031	regulation of response to reactive oxygen species
Aop:324	Event:55	increased				GO	GO:0008219	cell death
Aop:324	Event:1521	decreased	UBERON	UBERON:0000468	multicellular organism	GO	GO:0040007	growth
Aop:324	Event:1115	increased	CHEBI	CHEBI:26523	reactive oxygen species	GO	GO:1903409	reactive oxygen species biosynthetic process
Aop:325	Event:2037	occurrence	CL	CL:0002037	Agonism	VT	VT:0002037	Agonism	process
Aop:325	Event:2038	disrupted	MESH	MESH:0002038	Increased	HP	HP:0002038	Increased	process
Aop:325	Event:2039	morphological change	UBERON	UBERON:0002039	Increased	GO	GO:0002039	Increased	process
Aop:325	Event:2040	increased	PR	PR:0002040	Decrease	MP	MP:0002040	Decrease	process
Aop:326	Event:2041	occurrence	CL	CL:0002041	Prolonged TLR9 activ	VT	VT:0002041	Prolonged TLR9 activ	process
Aop:326	Event:2042	disrupted	MESH	MESH:0002042	increased MyD88 acti	HP	HP:0002042	increased MyD88 acti	process
Aop:326	Event:2043	morphological change	UBERON	UBERON:0002043	NLRP3 inflammasome activity	GO	GO:0002043	NLRP3 inflammasome activity	process
Aop:326	Event:2044	increased	PR	PR:0002044	Increased activation	MP	MP:0002044	Increased activation	process
Aop:326	Event:2045	decreased	CHEBI	CHEBI:0002045	Release	VT	VT:0002045	Release	process
Aop:326	Event:2046	occurrence	CL	CL:0002046	Increased Pro-inflam	HP	HP:0002046	Increased Pro-inflam	process
Aop:326	Event:2047	disrupted	MESH	MESH:0002047	Increased	GO	GO:0002047	Increased	process
Aop:326	Event:2048	morphological change	UBERON	UBERON:0002048	Th17 cell migration 	MP	MP:0002048	Th17 cell migration 	process
Aop:326	Event:2049	increased	PR	PR:0002049	Oxidative Stress	VT	VT:0002049	Oxidative Stress	process
Aop:326	Event:2050	decreased	CHEBI	CHEBI:0002050	Diminished protectiv	HP	HP:0002050	Diminished protectiv	process
Aop:326	Event:2051	occurrence	CL	CL:0002051	Mitochondrial dysfun	GO	GO:0002051	Mitochondrial dysfun	process
Aop:326	Event:2052	disrupted	MESH	MESH:0002052	Increase	MP	MP:0002052	Increase	process
Aop:326	Event:2053	morphological change	UBERON	UBERON:0002053	Increase	VT	VT:0002053	Increase	process
Aop:326	Event:2054	increased	PR	PR:0002054	Increase	HP	HP:0002054	Increase	process
Aop:326	Event:2055	decreased	CHEBI	CHEBI:0002055	increased release of	GO	GO:0002055	increased release of	process
Aop:326	Event:2056	occurrence	CL	CL:0002056	Toll Like Receptor (	MP	MP:0002056	Toll Like Receptor (	process
Aop:326	Event:2057	disrupted	MESH	MESH:0002057	increased platelet s	VT	VT:0002057	increased platelet s	process
Aop:326	Event:2058	morphological change	UBERON	UBERON:0002058	formation of neutrop	HP	HP:0002058	formation of neutrop	process
Aop:326	Event:2059	increased	PR	PR:0002059	Platelet-neutrophil interactions	GO	GO:0002059	Platelet-neutrophil interactions	process
Aop:326	Event:2060	decreased	CHEBI	CHEBI:0002060	Thrombosis and Disse	MP	MP:0002060	Thrombosis and Disse	process
Aop:326	Event:2061	occurrence	CL	CL:0002061	Increased	VT	VT:0002061	Increased	process
Aop:326	Event:2062	disrupted	MESH	MESH:0002062	Hyperinflammation	HP	HP:0002062	Hyperinflammation	process
Aop:326	Event:2063	morphological change	UBERON	UBERON:0002063	Inflammation	GO	GO:0002063	Inflammation	process
Aop:326	Event:2064	increased	PR	PR:0002064	systemic inflammator	MP	MP:0002064	systemic inflammator	process
Aop:326	Event:2065	decreased	CHEBI	CHEBI:0002065	Increase	VT	VT:0002065	Increase	process
Aop:326	Event:2066	occurrence	CL	CL:0002066	Heart failure	HP	HP:0002066	Heart failure	process
Aop:326	Event:2067	disrupted	MESH	MESH:0002067	Occurrence	GO	GO:0002067	Occurrence	process
Aop:326	Event:2068	morphological change	UBERON	UBERON:0002068	Increased	MP	MP:0002068	Increased	process
Aop:326	Event:2069	increased	PR	PR:0002069	Multi Organ Failure 	VT	VT:0002069	Multi Organ Failure 	process
Aop:326	Event:2070	decreased	CHEBI	CHEBI:0002070	Increased Mortality	HP	HP:0002070	Increased Mortality	process
Aop:327	Event:2071	occurrence	CL	CL:0002071	Toll Like Receptor (	VT	VT:0002071	Toll Like Receptor (	process
Aop:328	Event:2072	occurrence	CL	CL:0002072	Binding to ACE2	VT	VT:0002072	Binding to ACE2	process
Aop:328	Event:2073	disrupted	MESH	MESH:0002073	SARS-CoV-2 cell entr	HP	HP:0002073	SARS-CoV-2 cell entr	process
Aop:328	Event:2074	morphological change	UBERON	UBERON:0002074	Interferon-I antiviral response	GO	GO:0002074	Interferon-I antiviral response	process
Aop:328	Event:2075	increased	PR	PR:0002075	Increased SARS-CoV-2	MP	MP:0002075	Increased SARS-CoV-2	process
Aop:328	Event:2076	decreased	CHEBI	CHEBI:0002076	Diminished protectiv	VT	VT:0002076	Diminished protectiv	process
Aop:328	Event:2077	occurrence	CL	CL:0002077	Coagulation	HP	HP:0002077	Coagulation	process
Aop:328	Event:2078	disrupted	MESH	MESH:0002078	Thrombosis and Disse	GO	GO:0002078	Thrombosis and Disse	process
Aop:329	Event:2079	occurrence	CL	CL:0002079	Binding to ACE2	VT	VT:0002079	Binding to ACE2	process
Aop:329	Event:2080	disrupted	MESH	MESH:0002080	Downregulation	HP	HP:0002080	Downregulation	process
Aop:329	Event:2081	morphological change	UBERON	UBERON:0002081	Increased Angiotensi	GO	GO:0002081	Increased Angiotensi	process
Aop:329	Event:2082	increased	PR	PR:0002082	Imbalanced salty and	MP	MP:0002082	Imbalanced salty and	process
Aop:329	Event:2083	decreased	CHEBI	CHEBI:0002083	Impaired gustatory n	VT	VT:0002083	Impaired gustatory n	process
Aop:329	Event:2084	occurrence	CL	CL:0002084	dysgeusia	HP	HP:0002084	dysgeusia	process
Aop:330	Event:2085	occurrence	CL	CL:0002085	Binding of agonist	VT	VT:0002085	Binding of agonist	process
Aop:330	Event:2086	disrupted	MESH	MESH:0002086	Increase	HP	HP:0002086	Increase	process
Aop:330	Event:2087	morphological change	UBERON	UBERON:0002087	Increased activation	GO	GO:0002087	Increased activation	process
Aop:330	Event:2088	increased	PR	PR:0002088	Increased	MP	MP:0002088	Increased	process
Aop:330	Event:2089	decreased	CHEBI	CHEBI:0002089	Accumulation	VT	VT:0002089	Accumulation	process
Aop:330	Event:2090	occurrence	CL	CL:0002090	Lung fibrosis	HP	HP:0002090	Lung fibrosis	process
Aop:331	Event:2091	occurrence	CL	CL:0002091	Induced dysregulatio	VT	VT:0002091	Induced dysregulatio	process
Aop:331	Event:2092	disrupted	MESH	MESH:0002092	Increase plasma Ang 	HP	HP:0002092	Increase plasma Ang 	process
Aop:331	Event:2093	morphological change	UBERON	UBERON:0002093	Increased Ang II typ	GO	GO:0002093	Increased Ang II typ	process
Aop:331	Event:2094	increased	PR	PR:0002094	Increase	MP	MP:0002094	Increase	process
Aop:331	Event:2095	decreased	CHEBI	CHEBI:0002095	Increased	VT	VT:0002095	Increased	process
Aop:331	Event:2096	occurrence	CL	CL:0002096	N/A	HP	HP:0002096	N/A	process
Aop:332	Event:2097	occurrence	CL	CL:0002097	Hyperactivation of A	VT	VT:0002097	Hyperactivation of A	process
Aop:332	Event:2098	disrupted	MESH	MESH:0002098	Increased Angiotensi	HP	HP:0002098	Increased Angiotensi	process
Aop:332	Event:2099	morphological change	UBERON	UBERON:0002099	Increased Ang II typ	GO	GO:0002099	Increased Ang II typ	process
Aop:332	Event:2100	increased	PR	PR:0002100	Increase	MP	MP:0002100	Increase	process
Aop:332	Event:2101	decreased	CHEBI	CHEBI:0002101	Increased Sodium-sen	VT	VT:0002101	Increased Sodium-sen	process
Aop:332	Event:2102	occurrence	CL	CL:0002102	Chronic kidney disea	HP	HP:0002102	Chronic kidney disea	process
Aop:333	Event:2103	occurrence	CL	CL:0002103	Binding to ACE2	VT	VT:0002103	Binding to ACE2	process
Aop:333	Event:2104	disrupted	MESH	MESH:0002104	Dysregulation	HP	HP:0002104	Dysregulation	process
Aop:333	Event:2105	morphological change	UBERON	UBERON:0002105	Downregulation	GO	GO:0002105	Downregulation	process
Aop:333	Event:2106	increased	PR	PR:0002106	Increased Angiotensi	MP	MP:0002106	Increased Angiotensi	process
Aop:333	Event:2107	decreased	CHEBI	CHEBI:0002107	Occurrence	VT	VT:0002107	Occurrence	process
Aop:334	Event:2108	occurrence	CL	CL:0002108	Deposition of Energy	VT	VT:0002108	Deposition of Energy	process
Aop:334	Event:2109	disrupted	MESH	MESH:0002109	Increase	HP	HP:0002109	Increase	process
Aop:334	Event:2110	morphological change	UBERON	UBERON:0002110	Increase	GO	GO:0002110	Increase	process
Aop:334	Event:2111	increased	PR	PR:0002111	Decrease	MP	MP:0002111	Decrease	process
Aop:334	Event:2112	decreased	CHEBI	CHEBI:0002112	Decrease	VT	VT:0002112	Decrease	process
Aop:334	Event:2113	occurrence	CL	CL:0002113	Decrease	HP	HP:0002113	Decrease	process
Aop:334	Event:2114	disrupted	MESH	MESH:0002114	Decrease	GO	GO:0002114	Decrease	process
Aop:334	Event:2115	morphological change	UBERON	UBERON:0002115	Decrease	MP	MP:0002115	Decrease	process
Aop:335	Event:2116	occurrence	CL	CL:0002116	Deposition of Energy	VT	VT:0002116	Deposition of Energy	process
Aop:335	Event:2117	disrupted	MESH	MESH:0002117	Increase	HP	HP:0002117	Increase	process
Aop:335	Event:2118	morphological change	UBERON	UBERON:0002118	Decrease	GO	GO:0002118	Decrease	process
Aop:335	Event:2119	increased	PR	PR:0002119	Decrease	MP	MP:0002119	Decrease	process
Aop:335	Event:2120	decreased	CHEBI	CHEBI:0002120	Decrease	VT	VT:0002120	Decrease	process
Aop:335	Event:2121	occurrence	CL	CL:0002121	Decrease	HP	HP:0002121	Decrease	process
Aop:335	Event:2122	disrupted	MESH	MESH:0002122	Decrease	GO	GO:0002122	Decrease	process
Aop:335	Event:2123	morphological change	UBERON	UBERON:0002123	Decrease	MP	MP:0002123	Decrease	process
Aop:336	Event:2124	occurrence	CL	CL:0002124	Deposition of Energy	VT	VT:0002124	Deposition of Energy	process
Aop:336	Event:2125	disrupted	MESH	MESH:0002125	Increase	HP	HP:0002125	Increase	process
Aop:336	Event:2126	morphological change	UBERON	UBERON:0002126	Increase	GO	GO:0002126	Increase	process
Aop:336	Event:2127	increased	PR	PR:0002127	Decrease	MP	MP:0002127	Decrease	process
Aop:336	Event:2128	decreased	CHEBI	CHEBI:0002128	Decrease	VT	VT:0002128	Decrease	process
Aop:337	Event:2129	occurrence	CL	CL:0002129	Increase	VT	VT:0002129	Increase	process
Aop:337	Event:2130	disrupted	MESH	MESH:0002130	Decrease	HP	HP:0002130	Decrease	process
Aop:337	Event:2131	morphological change	UBERON	UBERON:0002131	Decrease	GO	GO:0002131	Decrease	process
Aop:337	Event:2132	increased	PR	PR:0002132	Decrease	MP	MP:0002132	Decrease	process
Aop:337	Event:2133	decreased	CHEBI	CHEBI:0002133	Decrease	VT	VT:0002133	Decrease	process
Aop:337	Event:2134	occurrence	CL	CL:0002134	Decrease	HP	HP:0002134	Decrease	process
Aop:337	Event:2135	disrupted	MESH	MESH:0002135	Decrease	GO	GO:0002135	Decrease	process
Aop:338	Event:2136	occurrence	CL	CL:0002136	Fibrinolysis	VT	VT:0002136	Fibrinolysis	process
Aop:338	Event:2137	disrupted	MESH	MESH:0002137	Bradykinin system	HP	HP:0002137	Bradykinin system	process
Aop:338	Event:2138	morphological change	UBERON	UBERON:0002138	Increased	GO	GO:0002138	Increased	process
Aop:338	Event:2139	increased	PR	PR:0002139	Increased	MP	MP:0002139	Increased	process
Aop:338	Event:2140	decreased	CHEBI	CHEBI:0002140	Hyperinflammation	VT	VT:0002140	Hyperinflammation	process
Aop:339	Event:2141	occurrence	CL	CL:0002141	Increased	VT	VT:0002141	Increased	process
Aop:339	Event:2142	disrupted	MESH	MESH:0002142	Cell cycle	HP	HP:0002142	Cell cycle	process
Aop:339	Event:2143	morphological change	UBERON	UBERON:0002143	Altered	GO	GO:0002143	Altered	process
Aop:339	Event:2144	increased	PR	PR:0002144	systemic inflammator	MP	MP:0002144	systemic inflammator	process
Aop:339	Event:2145	decreased	CHEBI	CHEBI:0002145	Increase cell prolif	VT	VT:0002145	Increase cell prolif	process
Aop:339	Event:2146	occurrence	CL	CL:0002146	Apoptosis	HP	HP:0002146	Apoptosis	process
Aop:340	Event:2147	occurrence	CL	CL:0002147	Binding to ACE2	VT	VT:0002147	Binding to ACE2	process
Aop:340	Event:2148	disrupted	MESH	MESH:0002148	SARS-CoV-2 cell entr	HP	HP:0002148	SARS-CoV-2 cell entr	process
Aop:340	Event:2149	morphological change	UBERON	UBERON:0002149	Increased SARS-CoV-2	GO	GO:0002149	Increased SARS-CoV-2	process
Aop:340	Event:2150	increased	PR	PR:0002150	Sustentacular cells	MP	MP:0002150	Sustentacular cells	process
Aop:340	Event:2151	decreased	CHEBI	CHEBI:0002151	olfactory sensory neurons	VT	VT:0002151	olfactory sensory neurons	process
Aop:340	Event:2152	occurrence	CL	CL:0002152	Olfactory epithelium	HP	HP:0002152	Olfactory epithelium	process
Aop:340	Event:2153	disrupted	MESH	MESH:0002153	impaired olfactory f	GO	GO:0002153	impaired olfactory f	process
Aop:341	Event:2154	occurrence	CL	CL:0002154	Binding to ACE2	VT	VT:0002154	Binding to ACE2	process
Aop:341	Event:2155	disrupted	MESH	MESH:0002155	SARS-CoV-2 cell entr	HP	HP:0002155	SARS-CoV-2 cell entr	process
Aop:341	Event:2156	morphological change	UBERON	UBERON:0002156	blood brain barrier 	GO	GO:0002156	blood brain barrier 	process
Aop:341	Event:2157	increased	PR	PR:0002157	Thrombosis and Disse	MP	MP:0002157	Thrombosis and Disse	process
Aop:341	Event:2158	decreased	CHEBI	CHEBI:0002158	Cerebrovascular dise	VT	VT:0002158	Cerebrovascular dise	process
Aop:342	Event:2159	occurrence	CL	CL:0002159	Deposition of Ionizi	VT	VT:0002159	Deposition of Ionizi	process
Aop:342	Event:2160	disrupted	MESH	MESH:0002160	Oxidative Stress	HP	HP:0002160	Oxidative Stress	process
Aop:342	Event:2161	morphological change	UBERON	UBERON:0002161	Altered	GO	GO:0002161	Altered	process
Aop:342	Event:2162	increased	PR	PR:0002162	Increase	MP	MP:0002162	Increase	process
Aop:342	Event:2163	decreased	CHEBI	CHEBI:0002163	Increase	VT	VT:0002163	Increase	process
Aop:342	Event:2164	occurrence	CL	CL:0002164	Decreased spermatoge	HP	HP:0002164	Decreased spermatoge	process
Aop:342	Event:2165	disrupted	MESH	MESH:0002165	Increase	GO	GO:0002165	Increase	process
Aop:342	Event:2166	morphological change	UBERON	UBERON:0002166	decreased	MP	MP:0002166	decreased	process
Aop:342	Event:2167	increased	PR	PR:0002167	Cell cycle	VT	VT:0002167	Cell cycle	process
Aop:342	Event:2168	decreased	CHEBI	CHEBI:0002168	Decrease	HP	HP:0002168	Decrease	process
Aop:342	Event:2169	occurrence	CL	CL:0002169	Decrease of egg prod	GO	GO:0002169	Decrease of egg prod	process
Aop:342	Event:2170	disrupted	MESH	MESH:0002170	Decrease	MP	MP:0002170	Decrease	process
Aop:342	Event:2171	morphological change	UBERON	UBERON:0002171	Decreased	VT	VT:0002171	Decreased	process
Aop:343	Event:2172	occurrence	CL	CL:0002172	Bulky DNA adducts	VT	VT:0002172	Bulky DNA adducts	process
Aop:343	Event:2173	disrupted	MESH	MESH:0002173	Inadequate DNA repai	HP	HP:0002173	Inadequate DNA repai	process
Aop:343	Event:2174	morphological change	UBERON	UBERON:0002174	Increase	GO	GO:0002174	Increase	process
Aop:344	Event:2175	occurrence	CL	CL:0002175	Decreased	VT	VT:0002175	Decreased	process
Aop:344	Event:2176	disrupted	MESH	MESH:0002176	Decreased	HP	HP:0002176	Decreased	process
Aop:344	Event:2177	morphological change	UBERON	UBERON:0002177	Disrupted	GO	GO:0002177	Disrupted	process
Aop:344	Event:2178	increased	PR	PR:0002178	Decreased	MP	MP:0002178	Decreased	process
Aop:344	Event:2179	decreased	CHEBI	CHEBI:0002179	disrupted	VT	VT:0002179	disrupted	process
Aop:344	Event:2180	occurrence	CL	CL:0002180	decreased	HP	HP:0002180	decreased	process
Aop:345	Event:2181	occurrence	CL	CL:0002181	Inhibition of Fyna	VT	VT:0002181	Inhibition of Fyna	process
Aop:345	Event:2182	disrupted	MESH	MESH:0002182	Inhibition of Plxna2	HP	HP:0002182	Inhibition of Plxna2	process
Aop:345	Event:2183	morphological change	UBERON	UBERON:0002183	Overexpression of ra	GO	GO:0002183	Overexpression of ra	process
Aop:345	Event:2184	increased	PR	PR:0002184	Decrease	MP	MP:0002184	Decrease	process
Aop:345	Event:2185	decreased	CHEBI	CHEBI:0002185	Decreased	VT	VT:0002185	Decreased	process
Aop:345	Event:2186	occurrence	CL	CL:0002186	Altered	HP	HP:0002186	Altered	process
Aop:345	Event:2187	disrupted	MESH	MESH:0002187	Increased Mortality	GO	GO:0002187	Increased Mortality	process
Aop:345	Event:2188	morphological change	UBERON	UBERON:0002188	Decrease	MP	MP:0002188	Decrease	process
Aop:346	Event:2189	occurrence	CL	CL:0002189	Increased (ectopic) 	VT	VT:0002189	Increased (ectopic) 	process
Aop:346	Event:2190	disrupted	MESH	MESH:0002190	Premature initiation	HP	HP:0002190	Premature initiation	process
Aop:346	Event:2191	morphological change	UBERON	UBERON:0002191	Decrease (loss of) f	GO	GO:0002191	Decrease (loss of) f	process
Aop:346	Event:2192	increased	PR	PR:0002192	Reduce	MP	MP:0002192	Reduce	process
Aop:347	Event:2193	occurrence	CL	CL:0002193	protein-coupled estr	VT	VT:0002193	protein-coupled estr	process
Aop:347	Event:2194	disrupted	MESH	MESH:0002194	Activation	HP	HP:0002194	Activation	process
Aop:347	Event:2195	morphological change	UBERON	UBERON:0002195	Activation	GO	GO:0002195	Activation	process
Aop:347	Event:2196	increased	PR	PR:0002196	Activation	MP	MP:0002196	Activation	process
Aop:347	Event:2197	decreased	CHEBI	CHEBI:0002197	Activation	VT	VT:0002197	Activation	process
Aop:347	Event:2198	occurrence	CL	CL:0002198	Abnormal lipid metab	HP	HP:0002198	Abnormal lipid metab	process
Aop:347	Event:2199	disrupted	MESH	MESH:0002199	Down Regulation	GO	GO:0002199	Down Regulation	process
Aop:347	Event:2200	morphological change	UBERON	UBERON:0002200	Up Regulation	MP	MP:0002200	Up Regulation	process
Aop:347	Event:2201	increased	PR	PR:0002201	Up Regulation	VT	VT:0002201	Up Regulation	process
Aop:347	Event:2202	decreased	CHEBI	CHEBI:0002202	N/A	HP	HP:0002202	N/A	process
Aop:348	Event:2203	occurrence	CL	CL:0002203	Thyroperoxidase	VT	VT:0002203	Thyroperoxidase	process
Aop:348	Event:2204	disrupted	MESH	MESH:0002204	Thyroid hormone synthesis	HP	HP:0002204	Thyroid hormone synthesis	process
Aop:348	Event:2205	morphological change	UBERON	UBERON:0002205	Decrease	GO	GO:0002205	Decrease	process
Aop:348	Event:2206	increased	PR	PR:0002206	Brain thyroid hormon	MP	MP:0002206	Brain thyroid hormon	process
Aop:348	Event:2207	decreased	CHEBI	CHEBI:0002207	Altered	VT	VT:0002207	Altered	process
Aop:348	Event:2208	occurrence	CL	CL:0002208	Abnormal	HP	HP:0002208	Abnormal	process
Aop:348	Event:2209	disrupted	MESH	MESH:0002209	Periventricular hete	GO	GO:0002209	Periventricular hete	process
Aop:348	Event:2210	morphological change	UBERON	UBERON:0002210	Increase	MP	MP:0002210	Increase	process
Aop:349	Event:1756	decreased	CHEBI	CHEBI:34133	11-Keto-testosterone	GO	GO:0006702	androgen biosynthetic process
Aop:349	Event:360	decreased	PCO	PCO:0000001	population of organisms	PCO	PCO:0000008	population growth rate
Aop:349	Event:406	decreased				MESH	D005298	fertility
Aop:349	Event:406	decreased	MESH	D005298	fertility	GO	GO:0009566	fertilization
Aop:351	Event:2211	occurrence	CL	CL:0002211	Acetylcholinesterase	VT	VT:0002211	Acetylcholinesterase	process
Aop:351	Event:2212	disrupted	MESH	MESH:0002212	Acetylcholine accumu	HP	HP:0002212	Acetylcholine accumu	process
Aop:351	Event:2213	morphological change	UBERON	UBERON:0002213	Increased Cholinergi	GO	GO:0002213	Increased Cholinergi	process
Aop:351	Event:2214	increased	PR	PR:0002214	Decrease of neuronal	MP	MP:0002214	Decrease of neuronal	process
Aop:351	Event:2215	decreased	CHEBI	CHEBI:0002215	Cognitive function	VT	VT:0002215	Cognitive function	process
Aop:352	Event:2216	occurrence	CL	CL:0002216	Binding to ACE2	VT	VT:0002216	Binding to ACE2	process
Aop:352	Event:2217	disrupted	MESH	MESH:0002217	SARS-CoV-2 cell entr	HP	HP:0002217	SARS-CoV-2 cell entr	process
Aop:352	Event:2218	morphological change	UBERON	UBERON:0002218	Increased SARS-CoV-2	GO	GO:0002218	Increased SARS-CoV-2	process
Aop:352	Event:2219	increased	PR	PR:0002219	Diminished protectiv	MP	MP:0002219	Diminished protectiv	process
Aop:352	Event:2220	decreased	CHEBI	CHEBI:0002220	NLRP3 inflammasome activity	VT	VT:0002220	NLRP3 inflammasome activity	process
Aop:352	Event:2221	occurrence	CL	CL:0002221	Hyperinflammation	HP	HP:0002221	Hyperinflammation	process
Aop:353	Event:2222	occurrence	CL	CL:0002222	Binding to ACE2	VT	VT:0002222	Binding to ACE2	process
Aop:353	Event:2223	disrupted	MESH	MESH:0002223	SARS-CoV-2 cell entr	HP	HP:0002223	SARS-CoV-2 cell entr	process
Aop:353	Event:2224	morphological change	UBERON	UBERON:0002224	Increased SARS-CoV-2	GO	GO:0002224	Increased SARS-CoV-2	process
Aop:353	Event:2225	increased	PR	PR:0002225	Diminished protectiv	MP	MP:0002225	Diminished protectiv	process
Aop:353	Event:2226	decreased	CHEBI	CHEBI:0002226	NLRP3 inflammasome activity	VT	VT:0002226	NLRP3 inflammasome activity	process
Aop:353	Event:2227	occurrence	CL	CL:0002227	Pyroptosis	HP	HP:0002227	Pyroptosis	process
Aop:355	Event:2228	occurrence	CL	CL:0002228	Frustrated phagocyto	VT	VT:0002228	Frustrated phagocyto	process
Aop:355	Event:2229	disrupted	MESH	MESH:0002229	Increased	HP	HP:0002229	Increased	process
Aop:355	Event:2230	morphological change	UBERON	UBERON:0002230	Increased	GO	GO:0002230	Increased	process
Aop:355	Event:2231	increased	PR	PR:0002231	Increase	MP	MP:0002231	Increase	process
Aop:355	Event:2232	decreased	CHEBI	CHEBI:0002232	Increased	VT	VT:0002232	Increased	process
Aop:355	Event:2233	occurrence	CL	CL:0002233	Genomic instability	HP	HP:0002233	Genomic instability	process
Aop:355	Event:2234	disrupted	MESH	MESH:0002234	Increase	GO	GO:0002234	Increase	process
Aop:355	Event:2235	morphological change	UBERON	UBERON:0002235	Increased	MP	MP:0002235	Increased	process
Aop:356	Event:2236	occurrence	CL	CL:0002236	GSK3beta inactivatio	VT	VT:0002236	GSK3beta inactivatio	process
Aop:356	Event:2237	disrupted	MESH	MESH:0002237	Repression of Gbx2 e	HP	HP:0002237	Repression of Gbx2 e	process
Aop:356	Event:2238	morphological change	UBERON	UBERON:0002238	foxi1 expression	GO	GO:0002238	foxi1 expression	process
Aop:356	Event:2239	increased	PR	PR:0002239	six1b expression	MP	MP:0002239	six1b expression	process
Aop:356	Event:2240	decreased	CHEBI	CHEBI:0002240	eya1 expression	VT	VT:0002240	eya1 expression	process
Aop:356	Event:2241	occurrence	CL	CL:0002241	Increase	HP	HP:0002241	Increase	process
Aop:356	Event:2242	disrupted	MESH	MESH:0002242	altered	GO	GO:0002242	altered	process
Aop:356	Event:2243	morphological change	UBERON	UBERON:0002243	Reduced	MP	MP:0002243	Reduced	process
Aop:356	Event:2244	increased	PR	PR:0002244	Increased Mortality	VT	VT:0002244	Increased Mortality	process
Aop:356	Event:2245	decreased	CHEBI	CHEBI:0002245	Decrease	HP	HP:0002245	Decrease	process
Aop:357	Event:2246	occurrence	CL	CL:0002246	Oxidative Stress	VT	VT:0002246	Oxidative Stress	process
Aop:357	Event:2247	disrupted	MESH	MESH:0002247	Cilia Beat Frequency	HP	HP:0002247	Cilia Beat Frequency	process
Aop:357	Event:2248	morphological change	UBERON	UBERON:0002248	Mucociliary Clearance	GO	GO:0002248	Mucociliary Clearance	process
Aop:357	Event:2249	increased	PR	PR:0002249	Decrease	MP	MP:0002249	Decrease	process
Aop:358	Event:2250	occurrence	CL	CL:0002250	Endothelial cell dys	VT	VT:0002250	Endothelial cell dys	process
Aop:358	Event:2251	disrupted	MESH	MESH:0002251	Release	HP	HP:0002251	Release	process
Aop:358	Event:2252	morphological change	UBERON	UBERON:0002252	Platelet activation	GO	GO:0002252	Platelet activation	process
Aop:358	Event:2253	increased	PR	PR:0002253	Neutrophil activation	MP	MP:0002253	Neutrophil activation	process
Aop:358	Event:2254	decreased	CHEBI	CHEBI:0002254	Platelet-neutrophil interactions	VT	VT:0002254	Platelet-neutrophil interactions	process
Aop:358	Event:2255	occurrence	CL	CL:0002255	Thromboinflammation	HP	HP:0002255	Thromboinflammation	process
Aop:359	Event:2256	occurrence	CL	CL:0002256	Oxidation	VT	VT:0002256	Oxidation	process
Aop:359	Event:2257	disrupted	MESH	MESH:0002257	Increase	HP	HP:0002257	Increase	process
Aop:359	Event:2258	morphological change	UBERON	UBERON:0002258	Increase	GO	GO:0002258	Increase	process
Aop:359	Event:2259	increased	PR	PR:0002259	Increase	MP	MP:0002259	Increase	process
Aop:359	Event:2260	decreased	CHEBI	CHEBI:0002260	Increased	VT	VT:0002260	Increased	process
Aop:359	Event:2261	occurrence	CL	CL:0002261	Increased Mortality	HP	HP:0002261	Increased Mortality	process
Aop:360	Event:2262	occurrence	CL	CL:0002262	Activation	VT	VT:0002262	Activation	process
Aop:360	Event:2263	disrupted	MESH	MESH:0002263	Altered gene expression	HP	HP:0002263	Altered gene expression	process
Aop:360	Event:2264	morphological change	UBERON	UBERON:0002264	Epithelial Mesenchym	GO	GO:0002264	Epithelial Mesenchym	process
Aop:360	Event:2265	increased	PR	PR:0002265	Increased	MP	MP:0002265	Increased	process
Aop:360	Event:2266	decreased	CHEBI	CHEBI:0002266	Lung fibrosis	VT	VT:0002266	Lung fibrosis	process
Aop:361	Event:2267	occurrence	CL	CL:0002267	Activation	VT	VT:0002267	Activation	process
Aop:361	Event:2268	disrupted	MESH	MESH:0002268	Altered gene expression	HP	HP:0002268	Altered gene expression	process
Aop:361	Event:2269	morphological change	UBERON	UBERON:0002269	Epithelial Mesenchym	GO	GO:0002269	Epithelial Mesenchym	process
Aop:361	Event:2270	increased	PR	PR:0002270	Increased	MP	MP:0002270	Increased	process
Aop:361	Event:2271	decreased	CHEBI	CHEBI:0002271	Lung fibrosis	VT	VT:0002271	Lung fibrosis	process
Aop:362	Event:2272	occurrence	CL	CL:0002272	Activation	VT	VT:0002272	Activation	process
Aop:362	Event:2273	disrupted	MESH	MESH:0002273	Altered gene expression	HP	HP:0002273	Altered gene expression	process
Aop:362	Event:2274	morphological change	UBERON	UBERON:0002274	Increased	GO	GO:0002274	Increased	process
Aop:362	Event:2275	increased	PR	PR:0002275	Increase	MP	MP:0002275	Increase	process
Aop:362	Event:2276	decreased	CHEBI	CHEBI:0002276	Increased	VT	VT:0002276	Increased	process
Aop:362	Event:2277	occurrence	CL	CL:0002277	Lung cancer	HP	HP:0002277	Lung cancer	process
Aop:363	Event:2278	occurrence	CL	CL:0002278	Activation	VT	VT:0002278	Activation	process
Aop:363	Event:2279	disrupted	MESH	MESH:0002279	Altered gene expression	HP	HP:0002279	Altered gene expression	process
Aop:363	Event:2280	morphological change	UBERON	UBERON:0002280	Increased	GO	GO:0002280	Increased	process
Aop:363	Event:2281	increased	PR	PR:0002281	Increased	MP	MP:0002281	Increased	process
Aop:363	Event:2282	decreased	CHEBI	CHEBI:0002282	Lung cancer	VT	VT:0002282	Lung cancer	process
Aop:364	Event:2283	occurrence	CL	CL:0002283	Activation	VT	VT:0002283	Activation	process
Aop:364	Event:2284	disrupted	MESH	MESH:0002284	Altered gene expression	HP	HP:0002284	Altered gene expression	process
Aop:364	Event:2285	morphological change	UBERON	UBERON:0002285	Increase	GO	GO:0002285	Increase	process
Aop:364	Event:2286	increased	PR	PR:0002286	Increase	MP	MP:0002286	Increase	process
Aop:364	Event:2287	decreased	CHEBI	CHEBI:0002287	Decrease	VT	VT:0002287	Decrease	process
Aop:365	Event:2288	occurrence	CL	CL:0002288	Activation	VT	VT:0002288	Activation	process
Aop:365	Event:2289	disrupted	MESH	MESH:0002289	Altered gene expression	HP	HP:0002289	Altered gene expression	process
Aop:365	Event:2290	morphological change	UBERON	UBERON:0002290	Apoptosis	GO	GO:0002290	Apoptosis	process
Aop:365	Event:2291	increased	PR	PR:0002291	Decrease	MP	MP:0002291	Decrease	process
Aop:366	Event:2292	occurrence	CL	CL:0002292	Activation	VT	VT:0002292	Activation	process
Aop:366	Event:2293	disrupted	MESH	MESH:0002293	Altered gene expression	HP	HP:0002293	Altered gene expression	process
Aop:366	Event:2294	morphological change	UBERON	UBERON:0002294	Increase	GO	GO:0002294	Increase	process
Aop:366	Event:2295	increased	PR	PR:0002295	Lung cancer	MP	MP:0002295	Lung cancer	process
Aop:367	Event:2296	occurrence	CL	CL:0002296	Altered gene expression	VT	VT:0002296	Altered gene expression	process
Aop:368	Event:2297	occurrence	CL	CL:0002297	Binding to ACE2	VT	VT:0002297	Binding to ACE2	process
Aop:368	Event:2298	disrupted	MESH	MESH:0002298	SARS-CoV-2 cell entr	HP	HP:0002298	SARS-CoV-2 cell entr	process
Aop:368	Event:2299	morphological change	UBERON	UBERON:0002299	Interferon-I antiviral response	GO	GO:0002299	Interferon-I antiviral response	process
Aop:368	Event:2300	increased	PR	PR:0002300	Increased SARS-CoV-2	MP	MP:0002300	Increased SARS-CoV-2	process
Aop:368	Event:2301	decreased	CHEBI	CHEBI:0002301	Intestinal barrier	VT	VT:0002301	Intestinal barrier	process
Aop:369	Event:2302	occurrence	CL	CL:0002302	Activation	VT	VT:0002302	Activation	process
Aop:369	Event:2303	disrupted	MESH	MESH:0002303	Increase	HP	HP:0002303	Increase	process
Aop:369	Event:2304	morphological change	UBERON	UBERON:0002304	Releasing	GO	GO:0002304	Releasing	process
Aop:369	Event:2305	increased	PR	PR:0002305	Mitochondrial dysfun	MP	MP:0002305	Mitochondrial dysfun	process
Aop:369	Event:2306	decreased	CHEBI	CHEBI:0002306	Increase	VT	VT:0002306	Increase	process
Aop:369	Event:2307	occurrence	CL	CL:0002307	Apoptotic cell death	HP	HP:0002307	Apoptotic cell death	process
Aop:370	Event:2308	occurrence	CL	CL:0002308	Oxidative Stress	VT	VT:0002308	Oxidative Stress	process
Aop:370	Event:2309	disrupted	MESH	MESH:0002309	Cystic Fibrosis Transmembrane Regulator Function	HP	HP:0002309	Cystic Fibrosis Transmembrane Regulator Function	process
Aop:370	Event:2310	morphological change	UBERON	UBERON:0002310	Airway Surface Liquid Height	GO	GO:0002310	Airway Surface Liquid Height	process
Aop:370	Event:2311	increased	PR	PR:0002311	Cilia Beat Frequency	MP	MP:0002311	Cilia Beat Frequency	process
Aop:370	Event:2312	decreased	CHEBI	CHEBI:0002312	Mucociliary Clearance	VT	VT:0002312	Mucociliary Clearance	process
Aop:370	Event:2313	occurrence	CL	CL:0002313	Decrease	HP	HP:0002313	Decrease	process
Aop:371	Event:2314	occurrence	CL	CL:0002314	Oxidative Stress	VT	VT:0002314	Oxidative Stress	process
Aop:371	Event:2315	disrupted	MESH	MESH:0002315	FOXJ1 Protein	HP	HP:0002315	FOXJ1 Protein	process
Aop:371	Event:2316	morphological change	UBERON	UBERON:0002316	Motile Cilia Number/Length	GO	GO:0002316	Motile Cilia Number/Length	process
Aop:371	Event:2317	increased	PR	PR:0002317	Cilia Beat Frequency	MP	MP:0002317	Cilia Beat Frequency	process
Aop:371	Event:2318	decreased	CHEBI	CHEBI:0002318	Mucociliary Clearance	VT	VT:0002318	Mucociliary Clearance	process
Aop:371	Event:2319	occurrence	CL	CL:0002319	Decrease	HP	HP:0002319	Decrease	process
Aop:372	Event:2320	occurrence	CL	CL:0002320	Binding to ACE2	VT	VT:0002320	Binding to ACE2	process
Aop:372	Event:2321	disrupted	MESH	MESH:0002321	Heart failure	HP	HP:0002321	Heart failure	process
Aop:372	Event:2322	morphological change	UBERON	UBERON:0002322	SARS-CoV-2 cell entr	GO	GO:0002322	SARS-CoV-2 cell entr	process
Aop:372	Event:2323	increased	PR	PR:0002323	Increased inflammato	MP	MP:0002323	Increased inflammato	process
Aop:372	Event:2324	decreased	CHEBI	CHEBI:0002324	Endothelial cell dys	VT	VT:0002324	Endothelial cell dys	process
Aop:372	Event:2325	occurrence	CL	CL:0002325	Induced	HP	HP:0002325	Induced	process
Aop:372	Event:2326	disrupted	MESH	MESH:0002326	Impaired mechanotran	GO	GO:0002326	Impaired mechanotran	process
Aop:372	Event:2327	morphological change	UBERON	UBERON:0002327	Pericyte dysfunction	MP	MP:0002327	Pericyte dysfunction	process
Aop:372	Event:2328	increased	PR	PR:0002328	Increased ACE2 expre	VT	VT:0002328	Increased ACE2 expre	process
Aop:372	Event:2329	decreased	CHEBI	CHEBI:0002329	Myocardial Infarctio	HP	HP:0002329	Myocardial Infarctio	process
Aop:373	Event:2330	occurrence	CL	CL:0002330	Binding to ACE2	VT	VT:0002330	Binding to ACE2	process
Aop:373	Event:2331	disrupted	MESH	MESH:0002331	Downregulation	HP	HP:0002331	Downregulation	process
Aop:373	Event:2332	morphological change	UBERON	UBERON:0002332	Angiotensin (1-7) le	GO	GO:0002332	Angiotensin (1-7) le	process
Aop:373	Event:2333	increased	PR	PR:0002333	Angiotensin II degra	MP	MP:0002333	Angiotensin II degra	process
Aop:373	Event:2334	decreased	CHEBI	CHEBI:0002334	Induced	VT	VT:0002334	Induced	process
Aop:373	Event:2335	occurrence	CL	CL:0002335	Hyperactivation of A	HP	HP:0002335	Hyperactivation of A	process
Aop:373	Event:2336	disrupted	MESH	MESH:0002336	ADAM17 expression in	GO	GO:0002336	ADAM17 expression in	process
Aop:373	Event:2337	morphological change	UBERON	UBERON:0002337	ACE2 increased shedd	MP	MP:0002337	ACE2 increased shedd	process
Aop:373	Event:2338	increased	PR	PR:0002338	Heart failure	VT	VT:0002338	Heart failure	process
Aop:374	Event:2339	occurrence	CL	CL:0002339	Binding to ACE2	VT	VT:0002339	Binding to ACE2	process
Aop:374	Event:2340	disrupted	MESH	MESH:0002340	Dysregulation	HP	HP:0002340	Dysregulation	process
Aop:374	Event:2341	morphological change	UBERON	UBERON:0002341	Gut microbiota	GO	GO:0002341	Gut microbiota	process
Aop:375	Event:2342	occurrence	CL	CL:0002342	Mitochondrial dysfun	VT	VT:0002342	Mitochondrial dysfun	process
Aop:375	Event:2343	disrupted	MESH	MESH:0002343	Oxidative Stress	HP	HP:0002343	Oxidative Stress	process
Aop:375	Event:2344	morphological change	UBERON	UBERON:0002344	Hyperphosphorylation	GO	GO:0002344	Hyperphosphorylation	process
Aop:375	Event:2345	increased	PR	PR:0002345	Dysfunctional Autoph	MP	MP:0002345	Dysfunctional Autoph	process
Aop:375	Event:2346	decreased	CHEBI	CHEBI:0002346	Accumulation	VT	VT:0002346	Accumulation	process
Aop:375	Event:2347	occurrence	CL	CL:0002347	Synaptic dysfunction	HP	HP:0002347	Synaptic dysfunction	process
Aop:375	Event:2348	disrupted	MESH	MESH:0002348	Impaired axonial tra	GO	GO:0002348	Impaired axonial tra	process
Aop:375	Event:2349	morphological change	UBERON	UBERON:0002349	Neuroinflammation	MP	MP:0002349	Neuroinflammation	process
Aop:375	Event:2350	increased	PR	PR:0002350	Decrease of neuronal	VT	VT:0002350	Decrease of neuronal	process
Aop:375	Event:2351	decreased	CHEBI	CHEBI:0002351	Memory Loss	HP	HP:0002351	Memory Loss	process
Aop:376	Event:2352	occurrence	CL	CL:0002352	Binding to ACE2	VT	VT:0002352	Binding to ACE2	process
Aop:376	Event:2353	disrupted	MESH	MESH:0002353	SARS-CoV-2 cell entr	HP	HP:0002353	SARS-CoV-2 cell entr	process
Aop:376	Event:2354	morphological change	UBERON	UBERON:0002354	Interferon-I antiviral response	GO	GO:0002354	Interferon-I antiviral response	process
Aop:376	Event:2355	increased	PR	PR:0002355	Increased SARS-CoV-2	MP	MP:0002355	Increased SARS-CoV-2	process
Aop:376	Event:2356	decreased	CHEBI	CHEBI:0002356	Viral infection and host-to-host transmission	VT	VT:0002356	Viral infection and host-to-host transmission	process
Aop:377	Event:2357	occurrence	CL	CL:0002357	Increase	VT	VT:0002357	Increase	process
Aop:377	Event:2358	disrupted	MESH	MESH:0002358	Decrease	HP	HP:0002358	Decrease	process
Aop:377	Event:2359	morphological change	UBERON	UBERON:0002359	Decrease	GO	GO:0002359	Decrease	process
Aop:377	Event:2360	increased	PR	PR:0002360	Abnormal	MP	MP:0002360	Abnormal	process
Aop:377	Event:2361	decreased	CHEBI	CHEBI:0002361	Gestational diabetes	VT	VT:0002361	Gestational diabetes	process
Aop:378	Event:2362	occurrence	CL	CL:0002362	Deposition of Energy	VT	VT:0002362	Deposition of Energy	process
Aop:378	Event:2363	disrupted	MESH	MESH:0002363	Increase in reactive	HP	HP:0002363	Increase in reactive	process
Aop:378	Event:2364	morphological change	UBERON	UBERON:0002364	Increase	GO	GO:0002364	Increase	process
Aop:378	Event:2365	increased	PR	PR:0002365	Inadequate DNA repai	MP	MP:0002365	Inadequate DNA repai	process
Aop:378	Event:2366	decreased	CHEBI	CHEBI:0002366	Increase	VT	VT:0002366	Increase	process
Aop:378	Event:2367	occurrence	CL	CL:0002367	Increase	HP	HP:0002367	Increase	process
Aop:378	Event:2368	disrupted	MESH	MESH:0002368	Increased Pro-inflam	GO	GO:0002368	Increased Pro-inflam	process
Aop:378	Event:2369	morphological change	UBERON	UBERON:0002369	Suppression	MP	MP:0002369	Suppression	process
Aop:378	Event:2370	increased	PR	PR:0002370	Acute Myeloid Leukem	VT	VT:0002370	Acute Myeloid Leukem	process
Aop:379	Event:2371	occurrence	CL	CL:0002371	hERG channel blockad	VT	VT:0002371	hERG channel blockad	process
Aop:379	Event:2372	disrupted	MESH	MESH:0002372	Inhibition of rapid 	HP	HP:0002372	Inhibition of rapid 	process
Aop:379	Event:2373	morphological change	UBERON	UBERON:0002373	Prolongation of Acti	GO	GO:0002373	Prolongation of Acti	process
Aop:379	Event:2374	increased	PR	PR:0002374	Prolongation of QT i	MP	MP:0002374	Prolongation of QT i	process
Aop:379	Event:2375	decreased	CHEBI	CHEBI:0002375	Torsades de Pointes	VT	VT:0002375	Torsades de Pointes	process
Aop:379	Event:2376	occurrence	CL	CL:0002376	Sudden cardiac death	HP	HP:0002376	Sudden cardiac death	process
Aop:381	Event:2377	occurrence	CL	CL:0002377	Deposition of Energy	VT	VT:0002377	Deposition of Energy	process
Aop:381	Event:2378	disrupted	MESH	MESH:0002378	Increase	HP	HP:0002378	Increase	process
Aop:381	Event:2379	morphological change	UBERON	UBERON:0002379	Altered	GO	GO:0002379	Altered	process
Aop:381	Event:2380	increased	PR	PR:0002380	Increase	MP	MP:0002380	Increase	process
Aop:381	Event:2381	decreased	CHEBI	CHEBI:0002381	Decrease	VT	VT:0002381	Decrease	process
Aop:381	Event:2382	occurrence	CL	CL:0002382	Decreased	HP	HP:0002382	Decreased	process
Aop:382	Event:2383	occurrence	CL	CL:0002383	Decreased	VT	VT:0002383	Decreased	process
Aop:382	Event:2384	disrupted	MESH	MESH:0002384	Decreased	HP	HP:0002384	Decreased	process
Aop:382	Event:2385	morphological change	UBERON	UBERON:0002385	Disruption	GO	GO:0002385	Disruption	process
Aop:382	Event:2386	increased	PR	PR:0002386	Neural crest cell migration	MP	MP:0002386	Neural crest cell migration	process
Aop:382	Event:2387	decreased	CHEBI	CHEBI:0002387	transposition of the	VT	VT:0002387	transposition of the	process
Aop:383	Event:2388	occurrence	CL	CL:0002388	Inhibition	VT	VT:0002388	Inhibition	process
Aop:383	Event:2389	disrupted	MESH	MESH:0002389	Oxidative Stress	HP	HP:0002389	Oxidative Stress	process
Aop:383	Event:2390	morphological change	UBERON	UBERON:0002390	Mitochondrial dysfun	GO	GO:0002390	Mitochondrial dysfun	process
Aop:383	Event:2391	increased	PR	PR:0002391	Increase	MP	MP:0002391	Increase	process
Aop:383	Event:2392	decreased	CHEBI	CHEBI:0002392	Occurrence	VT	VT:0002392	Occurrence	process
Aop:384	Event:1115	increased	CHEBI	CHEBI:26523	reactive oxygen species	GO	GO:1903409	reactive oxygen species biosynthetic process
Aop:385	Event:2393	occurrence	CL	CL:0002393	Activation	VT	VT:0002393	Activation	process
Aop:385	Event:2394	disrupted	MESH	MESH:0002394	Increase	HP	HP:0002394	Increase	process
Aop:385	Event:2395	morphological change	UBERON	UBERON:0002395	Apoptosis	GO	GO:0002395	Apoptosis	process
Aop:385	Event:2396	increased	PR	PR:0002396	Increased	MP	MP:0002396	Increased	process
Aop:385	Event:2397	decreased	CHEBI	CHEBI:0002397	Increased	VT	VT:0002397	Increased	process
Aop:385	Event:2398	occurrence	CL	CL:0002398	Increased	HP	HP:0002398	Increased	process
Aop:385	Event:2399	disrupted	MESH	MESH:0002399	Increase	GO	GO:0002399	Increase	process
Aop:385	Event:2400	morphological change	UBERON	UBERON:0002400	Increased	MP	MP:0002400	Increased	process
Aop:385	Event:2401	increased	PR	PR:0002401	metastatic breast ca	VT	VT:0002401	metastatic breast ca	process
Aop:386	Event:2402	occurrence	CL	CL:0002402	Suppression	VT	VT:0002402	Suppression	process
Aop:386	Event:2403	disrupted	MESH	MESH:0002403	Increased	HP	HP:0002403	Increased	process
Aop:386	Event:2404	morphological change	UBERON	UBERON:0002404	Increased	GO	GO:0002404	Increased	process
Aop:386	Event:2405	increased	PR	PR:0002405	Increased	MP	MP:0002405	Increased	process
Aop:386	Event:2406	decreased	CHEBI	CHEBI:0002406	Increased	VT	VT:0002406	Increased	process
Aop:386	Event:2407	occurrence	CL	CL:0002407	Increased	HP	HP:0002407	Increased	process
Aop:386	Event:2408	disrupted	MESH	MESH:0002408	Hyperplasia	GO	GO:0002408	Hyperplasia	process
Aop:386	Event:2409	morphological change	UBERON	UBERON:0002409	Promotion	MP	MP:0002409	Promotion	process
Aop:386	Event:2410	increased	PR	PR:0002410	Promotion	VT	VT:0002410	Promotion	process
Aop:387	Event:2411	occurrence	CL	CL:0002411	Deposition of Energy	VT	VT:0002411	Deposition of Energy	process
Aop:387	Event:2412	disrupted	MESH	MESH:0002412	Increase	HP	HP:0002412	Increase	process
Aop:387	Event:2413	morphological change	UBERON	UBERON:0002413	Activation of Tumor 	GO	GO:0002413	Activation of Tumor 	process
Aop:387	Event:2414	increased	PR	PR:0002414	Premature cell diffe	MP	MP:0002414	Premature cell diffe	process
Aop:387	Event:2415	decreased	CHEBI	CHEBI:0002415	Apoptosis	VT	VT:0002415	Apoptosis	process
Aop:387	Event:2416	occurrence	CL	CL:0002416	decline	HP	HP:0002416	decline	process
Aop:387	Event:2417	disrupted	MESH	MESH:0002417	Increase risk	GO	GO:0002417	Increase risk	process
Aop:388	Event:2418	occurrence	CL	CL:0002418	Binding to voltage-g	VT	VT:0002418	Binding to voltage-g	process
Aop:388	Event:2419	disrupted	MESH	MESH:0002419	Disruption of sodium	HP	HP:0002419	Disruption of sodium	process
Aop:388	Event:2420	morphological change	UBERON	UBERON:0002420	Disruption	GO	GO:0002420	Disruption	process
Aop:388	Event:2421	increased	PR	PR:0002421	Altered neurotransmi	MP	MP:0002421	Altered neurotransmi	process
Aop:388	Event:2422	decreased	CHEBI	CHEBI:0002422	Hippocampal anatomy	VT	VT:0002422	Hippocampal anatomy	process
Aop:388	Event:2423	occurrence	CL	CL:0002423	Hippocampal Physiology	HP	HP:0002423	Hippocampal Physiology	process
Aop:388	Event:2424	disrupted	MESH	MESH:0002424	Cognitive function	GO	GO:0002424	Cognitive function	process
Aop:389	Event:2425	occurrence	CL	CL:0002425	Increased	VT	VT:0002425	Increased	process
Aop:389	Event:2426	disrupted	MESH	MESH:0002426	Inadequate DNA repai	HP	HP:0002426	Inadequate DNA repai	process
Aop:389	Event:2427	morphological change	UBERON	UBERON:0002427	Increase	GO	GO:0002427	Increase	process
Aop:389	Event:2428	increased	PR	PR:0002428	Increase Chromosomal	MP	MP:0002428	Increase Chromosomal	process
Aop:389	Event:2429	decreased	CHEBI	CHEBI:0002429	Increased microRNA e	VT	VT:0002429	Increased microRNA e	process
Aop:389	Event:2430	occurrence	CL	CL:0002430	Decreased SIRT1 expr	HP	HP:0002430	Decreased SIRT1 expr	process
Aop:389	Event:2431	disrupted	MESH	MESH:0002431	Increased activation	GO	GO:0002431	Increased activation	process
Aop:389	Event:2432	morphological change	UBERON	UBERON:0002432	Antagonism	MP	MP:0002432	Antagonism	process
Aop:389	Event:2433	increased	PR	PR:0002433	Epithelial Mesenchym	VT	VT:0002433	Epithelial Mesenchym	process
Aop:389	Event:2434	decreased	CHEBI	CHEBI:0002434	metastatic breast ca	HP	HP:0002434	metastatic breast ca	process
Aop:390	Event:2435	occurrence	CL	CL:0002435	Deposition of Energy	VT	VT:0002435	Deposition of Energy	process
Aop:390	Event:2436	disrupted	MESH	MESH:0002436	Increase in reactive	HP	HP:0002436	Increase in reactive	process
Aop:390	Event:2437	morphological change	UBERON	UBERON:0002437	Increase	GO	GO:0002437	Increase	process
Aop:390	Event:2438	increased	PR	PR:0002438	Oxidative Stress	MP	MP:0002438	Oxidative Stress	process
Aop:390	Event:2439	decreased	CHEBI	CHEBI:0002439	Increase	VT	VT:0002439	Increase	process
Aop:390	Event:2440	occurrence	CL	CL:0002440	Decreased spermatoge	HP	HP:0002440	Decreased spermatoge	process
Aop:390	Event:2441	disrupted	MESH	MESH:0002441	Decrease	GO	GO:0002441	Decrease	process
Aop:390	Event:2442	morphological change	UBERON	UBERON:0002442	Decrease	MP	MP:0002442	Decrease	process
Aop:390	Event:2443	increased	PR	PR:0002443	Decrease	VT	VT:0002443	Decrease	process
Aop:391	Event:2444	occurrence	CL	CL:0002444	Activation	VT	VT:0002444	Activation	process
Aop:391	Event:2445	disrupted	MESH	MESH:0002445	Increased	HP	HP:0002445	Increased	process
Aop:391	Event:2446	morphological change	UBERON	UBERON:0002446	Decreased	GO	GO:0002446	Decreased	process
Aop:391	Event:2447	increased	PR	PR:0002447	Decreased	MP	MP:0002447	Decreased	process
Aop:391	Event:2448	decreased	CHEBI	CHEBI:0002448	Decreased	VT	VT:0002448	Decreased	process
Aop:391	Event:2449	occurrence	CL	CL:0002449	Impaired	HP	HP:0002449	Impaired	process
Aop:391	Event:2450	disrupted	MESH	MESH:0002450	Increased	GO	GO:0002450	Increased	process
Aop:391	Event:2451	morphological change	UBERON	UBERON:0002451	Impaired	MP	MP:0002451	Impaired	process
Aop:392	Event:1866	increased				GO	GO:0051918	negative regulation of fibrinolysis
Aop:392	Event:1866	decreased				GO	GO:0030195	negative regulation of blood coagulation
Aop:392	Event:1867	increased				MP	MP:0003070	increased vascular permeability
Aop:392	Event:1867	increased				GO	GO:0042311	vasodilation
Aop:392	Event:1867	increased				MP	MP:0001863	vascular inflammation
Aop:392	Event:1496	increased	FMA	FMA:84050	Cytokine	GO	GO:0002534	cytokine production involved in inflammatory response
Aop:392	Event:1496	increased	FMA	FMA:241981	Chemokine	GO	GO:0090195	chemokine secretion
Aop:392	Event:1496	increased				GO	GO:0006956	complement activation
Aop:392	Event:1496	increased	FMA	FMA:86578	Interleukin			
Aop:392	Event:1497	increased	CL	CL:0009002	inflammatory cell	GO	GO:0006954	inflammatory response
Aop:392	Event:1497	increased	CL	CL:0000235	macrophage	GO	GO:0042116	macrophage activation
Aop:392	Event:1868	increased				GO	GO:0002544	chronic inflammatory response
Aop:392	Event:1868	increased				GO	GO:0002676	regulation of chronic inflammatory response
Aop:392	Event:1868	increased	PR	PR:000001393	interleukin-6	GO	GO:0032635	interleukin-6 production
Aop:392	Event:1868	increased	PR	PR:000001136	interleukin-1 beta	GO	GO:0032611	interleukin-1 beta production
Aop:392	Event:1868	increased	PR	PR:000000134	tumor necrosis factor alpha	GO	GO:1990774	tumor necrosis factor secretion
Aop:392	Event:1868	increased				HP	HP:0012649	Increased inflammatory response
Aop:392	Event:1868	increased	CHEBI	CHEBI:82594	Ferritin	HP	HP:0003281	Increased serum ferritin
Aop:392	Event:1868	increased				GO	GO:0004457	lactate dehydrogenase activity
Aop:392	Event:1868	increased	PR	PR:000005897	C-reactive protein	HP	HP:0011227	Elevated C-reactive protein level
Aop:392	Event:1868	decreased	CL	CL:0000542	lymphocyte	HP	HP:0001888	Lymphopenia
Aop:393	Event:2452	occurrence	CL	CL:0002452	Inhibition	VT	VT:0002452	Inhibition	process
Aop:393	Event:2453	disrupted	MESH	MESH:0002453	Decrease	HP	HP:0002453	Decrease	process
Aop:393	Event:2454	morphological change	UBERON	UBERON:0002454	Mitochondrial dysfun	GO	GO:0002454	Mitochondrial dysfun	process
Aop:393	Event:2455	increased	PR	PR:0002455	Altered gene expression	MP	MP:0002455	Altered gene expression	process
Aop:393	Event:2456	decreased	CHEBI	CHEBI:0002456	Inhibition	VT	VT:0002456	Inhibition	process
Aop:393	Event:2457	occurrence	CL	CL:0002457	Activation of ER str	HP	HP:0002457	Activation of ER str	process
Aop:393	Event:2458	disrupted	MESH	MESH:0002458	Oxidative Stress	GO	GO:0002458	Oxidative Stress	process
Aop:393	Event:2459	morphological change	UBERON	UBERON:0002459	Increase	MP	MP:0002459	Increase	process
Aop:393	Event:2460	increased	PR	PR:0002460	Increase in inflamma	VT	VT:0002460	Increase in inflamma	process
Aop:393	Event:2461	decreased	CHEBI	CHEBI:0002461	Occurrence	HP	HP:0002461	Occurrence	process
Aop:393	Event:2462	occurrence	CL	CL:0002462	Occurrence	GO	GO:0002462	Occurrence	process
Aop:393	Event:2463	disrupted	MESH	MESH:0002463	Increased	MP	MP:0002463	Increased	process
Aop:394	Event:1739	occurrence	PR	PR:000003622	angiotensin-converting enzyme 2	GO	GO:0005102	receptor binding
Aop:394	Event:1738	occurrence	PR	PR:000016456	transmembrane protease serine 2	GO	GO:0061025	membrane fusion
Aop:394	Event:1738	occurrence	PR	PR:P07711	cathepsin L1 (human)	GO	GO:0075509	endocytosis involved in viral entry into host cell
Aop:394	Event:1738	occurrence	GO	GO:0019015	viral genome	GO	GO:0046718	viral entry into host cell
Aop:394	Event:1738	occurrence	PR	PR:000036197	viral protein	GO	GO:0046718	viral entry into host cell
Aop:394	Event:1847	increased	GO	GO:0031381	viral RNA-directed RNA polymerase complex	GO	GO:0039694	viral RNA genome replication
Aop:394	Event:1847	increased	GO	GO:0031381	viral RNA-directed RNA polymerase complex	GO	GO:0039690	positive stranded viral RNA replication
Aop:394	Event:1847	increased	GO	GO:0072516	viral assembly compartment	GO	GO:0019074	viral RNA genome packaging
Aop:394	Event:1847	increased	GO	GO:0019024	ssRNA viral genome	GO	GO:0009299	mRNA transcription
Aop:394	Event:1847	increased	GO	GO:0019024	ssRNA viral genome	GO	GO:0019081	viral translation
Aop:395	Event:2464	occurrence	CL	CL:0002464	Inhibition of Cerami	VT	VT:0002464	Inhibition of Cerami	process
Aop:395	Event:2465	disrupted	MESH	MESH:0002465	Reduced complex sphi	HP	HP:0002465	Reduced complex sphi	process
Aop:395	Event:2466	morphological change	UBERON	UBERON:0002466	Affected folate tran	GO	GO:0002466	Affected folate tran	process
Aop:395	Event:2467	increased	PR	PR:0002467	decreased folate upt	MP	MP:0002467	decreased folate upt	process
Aop:395	Event:2468	decreased	CHEBI	CHEBI:0002468	Increased sphingolip	VT	VT:0002468	Increased sphingolip	process
Aop:395	Event:2469	occurrence	CL	CL:0002469	Histone deacetylase 	HP	HP:0002469	Histone deacetylase 	process
Aop:395	Event:2470	disrupted	MESH	MESH:0002470	Neural tube defects	GO	GO:0002470	Neural tube defects	process
Aop:396	Event:2471	occurrence	CL	CL:0002471	Acetylcholinesterase	VT	VT:0002471	Acetylcholinesterase	process
Aop:396	Event:2472	disrupted	MESH	MESH:0002472	Activation of Cyp2E1	HP	HP:0002472	Activation of Cyp2E1	process
Aop:396	Event:2473	morphological change	UBERON	UBERON:0002473	Oxidative Stress	GO	GO:0002473	Oxidative Stress	process
Aop:396	Event:2474	increased	PR	PR:0002474	N/A	MP	MP:0002474	N/A	process
Aop:396	Event:2475	decreased	CHEBI	CHEBI:0002475	Decreased	VT	VT:0002475	Decreased	process
Aop:396	Event:2476	occurrence	CL	CL:0002476	Sensory axonal perip	HP	HP:0002476	Sensory axonal perip	process
Aop:396	Event:2477	disrupted	MESH	MESH:0002477	Increased Mortality	GO	GO:0002477	Increased Mortality	process
Aop:397	Event:2478	occurrence	CL	CL:0002478	Substance interactio	VT	VT:0002478	Substance interactio	process
Aop:397	Event:2479	disrupted	MESH	MESH:0002479	Increased	HP	HP:0002479	Increased	process
Aop:397	Event:2480	morphological change	UBERON	UBERON:0002480	Increased	GO	GO:0002480	Increased	process
Aop:397	Event:2481	increased	PR	PR:0002481	Increase	MP	MP:0002481	Increase	process
Aop:397	Event:2482	decreased	CHEBI	CHEBI:0002482	Increase	VT	VT:0002482	Increase	process
Aop:397	Event:2483	occurrence	CL	CL:0002483	Secondary genotoxici	HP	HP:0002483	Secondary genotoxici	process
Aop:397	Event:2484	disrupted	MESH	MESH:0002484	Increased	GO	GO:0002484	Increased	process
Aop:397	Event:2485	morphological change	UBERON	UBERON:0002485	Increase	MP	MP:0002485	Increase	process
Aop:397	Event:2486	increased	PR	PR:0002486	Lung cancer	VT	VT:0002486	Lung cancer	process
Aop:398	Event:2487	occurrence	CL	CL:0002487	Non-coding RNA expre	VT	VT:0002487	Non-coding RNA expre	process
Aop:398	Event:2488	disrupted	MESH	MESH:0002488	Activation of inflam	HP	HP:0002488	Activation of inflam	process
Aop:398	Event:2489	morphological change	UBERON	UBERON:0002489	Oxidative Stress	GO	GO:0002489	Oxidative Stress	process
Aop:398	Event:2490	increased	PR	PR:0002490	Epithelial Mesenchym	MP	MP:0002490	Epithelial Mesenchym	process
Aop:398	Event:2491	decreased	CHEBI	CHEBI:0002491	Fibroblast prolifera	VT	VT:0002491	Fibroblast prolifera	process
Aop:398	Event:2492	occurrence	CL	CL:0002492	Apoptosis	HP	HP:0002492	Apoptosis	process
Aop:398	Event:2493	disrupted	MESH	MESH:0002493	Dysfunctional Autoph	GO	GO:0002493	Dysfunctional Autoph	process
Aop:398	Event:2494	morphological change	UBERON	UBERON:0002494	Pulmonary inflammati	MP	MP:0002494	Pulmonary inflammati	process
Aop:398	Event:2495	increased	PR	PR:0002495	Emphysema	VT	VT:0002495	Emphysema	process
Aop:398	Event:2496	decreased	CHEBI	CHEBI:0002496	Airway remodeling	HP	HP:0002496	Airway remodeling	process
Aop:398	Event:2497	occurrence	CL	CL:0002497	Chronic obstructive 	GO	GO:0002497	Chronic obstructive 	process
Aop:399	Event:1884	decreased	PR	PR:Q6EWH2	tyrosine-protein kinase fyna (zebrafish)	GO	GO:0004713	protein tyrosine kinase activity
Aop:399	Event:1821	decreased	GO	GO:0005623	cell	GO	GO:0008283	cell proliferation
Aop:399	Event:1878	decreased	UBERON	UBERON:0000970	eye	MP	MP:0001297	microphthalmia
Aop:399	Event:351	increased				MESH	D009026	mortality
Aop:399	Event:360	decreased	PCO	PCO:0000001	population of organisms	PCO	PCO:0000008	population growth rate
Aop:399	Event:1643	functional change	UBERON	UBERON:0000970	eye	VT	VT:0002090	vision trait
Aop:400	Event:2498	occurrence	CL	CL:0002498	Endoplasmic reticulu	VT	VT:0002498	Endoplasmic reticulu	process
Aop:400	Event:2499	disrupted	MESH	MESH:0002499	Insulin resistance	HP	HP:0002499	Insulin resistance	process
Aop:400	Event:2500	morphological change	UBERON	UBERON:0002500	Non-alcoholic fatty 	GO	GO:0002500	Non-alcoholic fatty 	process
Aop:400	Event:2501	increased	PR	PR:0002501	Inhibition	MP	MP:0002501	Inhibition	process
Aop:401	Event:2502	occurrence	CL	CL:0002502	Activation	VT	VT:0002502	Activation	process
Aop:401	Event:2503	disrupted	MESH	MESH:0002503	dimerization	HP	HP:0002503	dimerization	process
Aop:401	Event:2504	morphological change	UBERON	UBERON:0002504	Increase	GO	GO:0002504	Increase	process
Aop:401	Event:2505	increased	PR	PR:0002505	Decrease	MP	MP:0002505	Decrease	process
Aop:401	Event:2506	decreased	CHEBI	CHEBI:0002506	Increase	VT	VT:0002506	Increase	process
Aop:401	Event:2507	occurrence	CL	CL:0002507	Facial cartilage str	HP	HP:0002507	Facial cartilage str	process
Aop:402	Event:2508	occurrence	CL	CL:0002508	Activation	VT	VT:0002508	Activation	process
Aop:402	Event:2509	disrupted	MESH	MESH:0002509	dimerization	HP	HP:0002509	dimerization	process
Aop:402	Event:2510	morphological change	UBERON	UBERON:0002510	Increase	GO	GO:0002510	Increase	process
Aop:402	Event:2511	increased	PR	PR:0002511	Decrease	MP	MP:0002511	Decrease	process
Aop:402	Event:2512	decreased	CHEBI	CHEBI:0002512	Altered	VT	VT:0002512	Altered	process
Aop:402	Event:2513	occurrence	CL	CL:0002513	Increase	HP	HP:0002513	Increase	process
Aop:403	Event:2514	occurrence	CL	CL:0002514	Succinate dehydrogenase	VT	VT:0002514	Succinate dehydrogenase	process
Aop:403	Event:2515	disrupted	MESH	MESH:0002515	Superoxide generation	HP	HP:0002515	Superoxide generation	process
Aop:403	Event:2516	morphological change	UBERON	UBERON:0002516	Oxidative Stress	GO	GO:0002516	Oxidative Stress	process
Aop:403	Event:2517	increased	PR	PR:0002517	Thyroid hormone synthesis	MP	MP:0002517	Thyroid hormone synthesis	process
Aop:403	Event:2518	decreased	CHEBI	CHEBI:0002518	Thyroxine (T4) in serum	VT	VT:0002518	Thyroxine (T4) in serum	process
Aop:403	Event:2519	occurrence	CL	CL:0002519	Insulin resistance	HP	HP:0002519	Insulin resistance	process
Aop:404	Event:2520	occurrence	CL	CL:0002520	Activation	VT	VT:0002520	Activation	process
Aop:404	Event:2521	disrupted	MESH	MESH:0002521	Induction	HP	HP:0002521	Induction	process
Aop:404	Event:2522	morphological change	UBERON	UBERON:0002522	Increased	GO	GO:0002522	Increased	process
Aop:404	Event:2523	increased	PR	PR:0002523	Thyroxine (T4) in serum	MP	MP:0002523	Thyroxine (T4) in serum	process
Aop:404	Event:2524	decreased	CHEBI	CHEBI:0002524	Thyroxine (T4) in neuronal tissue	VT	VT:0002524	Thyroxine (T4) in neuronal tissue	process
Aop:404	Event:2525	occurrence	CL	CL:0002525	Hippocampal gene expression	HP	HP:0002525	Hippocampal gene expression	process
Aop:404	Event:2526	disrupted	MESH	MESH:0002526	Hippocampal Physiology	GO	GO:0002526	Hippocampal Physiology	process
Aop:404	Event:2527	morphological change	UBERON	UBERON:0002527	Cognitive function	MP	MP:0002527	Cognitive function	process
Aop:405	Event:2528	occurrence	CL	CL:0002528	Activation	VT	VT:0002528	Activation	process
Aop:405	Event:2529	disrupted	MESH	MESH:0002529	Induction	HP	HP:0002529	Induction	process
Aop:405	Event:2530	morphological change	UBERON	UBERON:0002530	Oxidative Stress	GO	GO:0002530	Oxidative Stress	process
Aop:405	Event:2531	increased	PR	PR:0002531	Thyroid hormone synthesis	MP	MP:0002531	Thyroid hormone synthesis	process
Aop:405	Event:2532	decreased	CHEBI	CHEBI:0002532	Thyroxine (T4) in serum	VT	VT:0002532	Thyroxine (T4) in serum	process
Aop:405	Event:2533	occurrence	CL	CL:0002533	Thyroxine (T4) in neuronal tissue	HP	HP:0002533	Thyroxine (T4) in neuronal tissue	process
Aop:405	Event:2534	disrupted	MESH	MESH:0002534	Hippocampal gene expression	GO	GO:0002534	Hippocampal gene expression	process
Aop:405	Event:2535	morphological change	UBERON	UBERON:0002535	Hippocampal Physiology	MP	MP:0002535	Hippocampal Physiology	process
Aop:405	Event:2536	increased	PR	PR:0002536	Cognitive function	VT	VT:0002536	Cognitive function	process
Aop:406	Event:2537	occurrence	CL	CL:0002537	Antagonism	VT	VT:0002537	Antagonism	process
Aop:406	Event:2538	disrupted	MESH	MESH:0002538	Decrease	HP	HP:0002538	Decrease	process
Aop:406	Event:2539	morphological change	UBERON	UBERON:0002539	Decrease	GO	GO:0002539	Decrease	process
Aop:406	Event:2540	increased	PR	PR:0002540	Decrease	MP	MP:0002540	Decrease	process
Aop:406	Event:2541	decreased	CHEBI	CHEBI:0002541	Apoptosis	VT	VT:0002541	Apoptosis	process
Aop:406	Event:2542	occurrence	CL	CL:0002542	Decrease	HP	HP:0002542	Decrease	process
Aop:406	Event:2543	disrupted	MESH	MESH:0002543	Decrease	GO	GO:0002543	Decrease	process
Aop:406	Event:2544	morphological change	UBERON	UBERON:0002544	Decrease	MP	MP:0002544	Decrease	process
Aop:406	Event:2545	increased	PR	PR:0002545	Increase	VT	VT:0002545	Increase	process
Aop:407	Event:1739	occurrence	PR	PR:000003622	angiotensin-converting enzyme 2	GO	GO:0005102	receptor binding
Aop:407	Event:1738	occurrence	PR	PR:000016456	transmembrane protease serine 2	GO	GO:0061025	membrane fusion
Aop:407	Event:1738	occurrence	PR	PR:P07711	cathepsin L1 (human)	GO	GO:0075509	endocytosis involved in viral entry into host cell
Aop:407	Event:1738	occurrence	GO	GO:0019015	viral genome	GO	GO:0046718	viral entry into host cell
Aop:407	Event:1738	occurrence	PR	PR:000036197	viral protein	GO	GO:0046718	viral entry into host cell
Aop:407	Event:1847	increased	GO	GO:0031381	viral RNA-directed RNA polymerase complex	GO	GO:0039694	viral RNA genome replication
Aop:407	Event:1847	increased	GO	GO:0031381	viral RNA-directed RNA polymerase complex	GO	GO:0039690	positive stranded viral RNA replication
Aop:407	Event:1847	increased	GO	GO:0072516	viral assembly compartment	GO	GO:0019074	viral RNA genome packaging
Aop:407	Event:1847	increased	GO	GO:0019024	ssRNA viral genome	GO	GO:0009299	mRNA transcription
Aop:407	Event:1847	increased	GO	GO:0019024	ssRNA viral genome	GO	GO:0019081	viral translation
Aop:407	Event:1869	increased	CHEBI	CHEBI:26523	reactive oxygen species	GO	GO:0034599	cellular response to oxidative stress
Aop:407	Event:1869	increased	CHEBI	CHEBI:26523	reactive oxygen species	GO	GO:0000302	response to reactive oxygen species
Aop:407	Event:1895	increased	GO	GO:0072559	NLRP3 inflammasome complex	GO	GO:0044546	NLRP3 inflammasome complex assembly
Aop:408	Event:2546	occurrence	CL	CL:0002546	Increase	VT	VT:0002546	Increase	process
Aop:408	Event:2547	disrupted	MESH	MESH:0002547	Oxidative Stress	HP	HP:0002547	Oxidative Stress	process
Aop:408	Event:2548	morphological change	UBERON	UBERON:0002548	Increase	GO	GO:0002548	Increase	process
Aop:408	Event:2549	increased	PR	PR:0002549	Infiltration	MP	MP:0002549	Infiltration	process
Aop:408	Event:2550	decreased	CHEBI	CHEBI:0002550	Activation	VT	VT:0002550	Activation	process
Aop:408	Event:2551	occurrence	CL	CL:0002551	Increased	HP	HP:0002551	Increased	process
Aop:408	Event:2552	disrupted	MESH	MESH:0002552	Foam cell formation	GO	GO:0002552	Foam cell formation	process
Aop:409	Event:2553	occurrence	CL	CL:0002553	liver dysfunction	VT	VT:0002553	liver dysfunction	process
Aop:410	Event:2554	occurrence	CL	CL:0002554	Activation of metabo	VT	VT:0002554	Activation of metabo	process
Aop:410	Event:2555	disrupted	MESH	MESH:0002555	Inositol triphosphat	HP	HP:0002555	Inositol triphosphat	process
Aop:410	Event:2556	morphological change	UBERON	UBERON:0002556	Overactivation	GO	GO:0002556	Overactivation	process
Aop:410	Event:2557	increased	PR	PR:0002557	Inhibition GABAA rec	MP	MP:0002557	Inhibition GABAA rec	process
Aop:410	Event:2558	decreased	CHEBI	CHEBI:0002558	Opening	VT	VT:0002558	Opening	process
Aop:410	Event:2559	occurrence	CL	CL:0002559	Increase	HP	HP:0002559	Increase	process
Aop:410	Event:2560	disrupted	MESH	MESH:0002560	Increased	GO	GO:0002560	Increased	process
Aop:410	Event:2561	morphological change	UBERON	UBERON:0002561	Activation of calpai	MP	MP:0002561	Activation of calpai	process
Aop:410	Event:2562	increased	PR	PR:0002562	Endoplasmic reticulu	VT	VT:0002562	Endoplasmic reticulu	process
Aop:410	Event:2563	decreased	CHEBI	CHEBI:0002563	Unfolded Protein Res	HP	HP:0002563	Unfolded Protein Res	process
Aop:410	Event:2564	occurrence	CL	CL:0002564	Mitochondrial dysfun	GO	GO:0002564	Mitochondrial dysfun	process
Aop:410	Event:2565	disrupted	MESH	MESH:0002565	Proteasomal dysfunct	MP	MP:0002565	Proteasomal dysfunct	process
Aop:410	Event:2566	morphological change	UBERON	UBERON:0002566	Accumulation of misf	VT	VT:0002566	Accumulation of misf	process
Aop:410	Event:2567	increased	PR	PR:0002567	Oxidative Stress	HP	HP:0002567	Oxidative Stress	process
Aop:410	Event:2568	decreased	CHEBI	CHEBI:0002568	Mitochondrial Injury	GO	GO:0002568	Mitochondrial Injury	process
Aop:410	Event:2569	occurrence	CL	CL:0002569	Increase	MP	MP:0002569	Increase	process
Aop:410	Event:2570	disrupted	MESH	MESH:0002570	Activation	VT	VT:0002570	Activation	process
Aop:410	Event:2571	morphological change	UBERON	UBERON:0002571	Increase	HP	HP:0002571	Increase	process
Aop:410	Event:2572	increased	PR	PR:0002572	Parkinsonian motor d	GO	GO:0002572	Parkinsonian motor d	process
Aop:411	Event:2573	occurrence	CL	CL:0002573	Increase	VT	VT:0002573	Increase	process
Aop:411	Event:2574	disrupted	MESH	MESH:0002574	Increased	HP	HP:0002574	Increased	process
Aop:411	Event:2575	morphological change	UBERON	UBERON:0002575	Increase	GO	GO:0002575	Increase	process
Aop:411	Event:2576	increased	PR	PR:0002576	Delay	MP	MP:0002576	Delay	process
Aop:411	Event:2577	decreased	CHEBI	CHEBI:0002577	Increase	VT	VT:0002577	Increase	process
Aop:411	Event:2578	occurrence	CL	CL:0002578	Increase	HP	HP:0002578	Increase	process
Aop:411	Event:2579	disrupted	MESH	MESH:0002579	Increase	GO	GO:0002579	Increase	process
Aop:411	Event:2580	morphological change	UBERON	UBERON:0002580	Increase	MP	MP:0002580	Increase	process
Aop:412	Event:2581	occurrence	CL	CL:0002581	Decrease	VT	VT:0002581	Decrease	process
Aop:412	Event:2582	disrupted	MESH	MESH:0002582	Decrease	HP	HP:0002582	Decrease	process
Aop:412	Event:2583	morphological change	UBERON	UBERON:0002583	Increase	GO	GO:0002583	Increase	process
Aop:412	Event:2584	increased	PR	PR:0002584	Increase	MP	MP:0002584	Increase	process
Aop:412	Event:2585	decreased	CHEBI	CHEBI:0002585	Increase	VT	VT:0002585	Increase	process
Aop:412	Event:2586	occurrence	CL	CL:0002586	Increase	HP	HP:0002586	Increase	process
Aop:412	Event:2587	disrupted	MESH	MESH:0002587	Increase	GO	GO:0002587	Increase	process
Aop:412	Event:2588	morphological change	UBERON	UBERON:0002588	Increase	MP	MP:0002588	Increase	process
Aop:412	Event:2589	increased	PR	PR:0002589	Decrease	VT	VT:0002589	Decrease	process
Aop:413	Event:2590	occurrence	CL	CL:0002590	Decrease	VT	VT:0002590	Decrease	process
Aop:413	Event:2591	disrupted	MESH	MESH:0002591	Decrease	HP	HP:0002591	Decrease	process
Aop:413	Event:2592	morphological change	UBERON	UBERON:0002592	Decrease	GO	GO:0002592	Decrease	process
Aop:413	Event:2593	increased	PR	PR:0002593	Decrease	MP	MP:0002593	Decrease	process
Aop:413	Event:2594	decreased	CHEBI	CHEBI:0002594	Weak	VT	VT:0002594	Weak	process
Aop:413	Event:2595	occurrence	CL	CL:0002595	Decrease	HP	HP:0002595	Decrease	process
Aop:413	Event:2596	disrupted	MESH	MESH:0002596	Increase	GO	GO:0002596	Increase	process
Aop:413	Event:2597	morphological change	UBERON	UBERON:0002597	Increase	MP	MP:0002597	Increase	process
Aop:413	Event:2598	increased	PR	PR:0002598	Increase	VT	VT:0002598	Increase	process
Aop:414	Event:2599	occurrence	CL	CL:0002599	Binding to ACE2	VT	VT:0002599	Binding to ACE2	process
Aop:414	Event:2600	disrupted	MESH	MESH:0002600	SARS-CoV-2 cell entr	HP	HP:0002600	SARS-CoV-2 cell entr	process
Aop:414	Event:2601	morphological change	UBERON	UBERON:0002601	Interferon-I antiviral response	GO	GO:0002601	Interferon-I antiviral response	process
Aop:414	Event:2602	increased	PR	PR:0002602	Increased SARS-CoV-2	MP	MP:0002602	Increased SARS-CoV-2	process
Aop:414	Event:2603	decreased	CHEBI	CHEBI:0002603	Increase	VT	VT:0002603	Increase	process
Aop:414	Event:2604	occurrence	CL	CL:0002604	Increased	HP	HP:0002604	Increased	process
Aop:414	Event:2605	disrupted	MESH	MESH:0002605	Increased	GO	GO:0002605	Increased	process
Aop:414	Event:2606	morphological change	UBERON	UBERON:0002606	Hyperinflammation	MP	MP:0002606	Hyperinflammation	process
Aop:415	Event:18	increased	PR	PR:000003858	aryl hydrocarbon receptor	GO	GO:0004874	aryl hydrocarbon receptor activity
Aop:415	Event:18	increased	PR	PR:000003858	aryl hydrocarbon receptor	GO	GO:0017162	aryl hydrocarbon receptor binding
Aop:415	Event:1457	occurrence	FMA	FMA:66768	Epithelial cell	GO	GO:0001837	epithelial to mesenchymal transition
Aop:416	Event:2607	occurrence	CL	CL:0002607	Deposition of Energy	VT	VT:0002607	Deposition of Energy	process
Aop:416	Event:2608	disrupted	MESH	MESH:0002608	Oxidative Stress	HP	HP:0002608	Oxidative Stress	process
Aop:416	Event:2609	morphological change	UBERON	UBERON:0002609	Increase	GO	GO:0002609	Increase	process
Aop:416	Event:2610	increased	PR	PR:0002610	Increased Pro-inflam	MP	MP:0002610	Increased Pro-inflam	process
Aop:416	Event:2611	decreased	CHEBI	CHEBI:0002611	Altered Stress Respo	VT	VT:0002611	Altered Stress Respo	process
Aop:416	Event:2612	occurrence	CL	CL:0002612	Altered	HP	HP:0002612	Altered	process
Aop:416	Event:2613	disrupted	MESH	MESH:0002613	Increase	GO	GO:0002613	Increase	process
Aop:416	Event:2614	morphological change	UBERON	UBERON:0002614	Occurrence	MP	MP:0002614	Occurrence	process
Aop:417	Event:2615	occurrence	CL	CL:0002615	Increase	VT	VT:0002615	Increase	process
Aop:417	Event:2616	disrupted	MESH	MESH:0002616	N/A	HP	HP:0002616	N/A	process
Aop:417	Event:2617	morphological change	UBERON	UBERON:0002617	Loss of drebrin	GO	GO:0002617	Loss of drebrin	process
Aop:417	Event:2618	increased	PR	PR:0002618	Neurological disorde	MP	MP:0002618	Neurological disorde	process
Aop:417	Event:2619	decreased	CHEBI	CHEBI:0002619	Decrease	VT	VT:0002619	Decrease	process
Aop:417	Event:2620	occurrence	CL	CL:0002620	Decrease	HP	HP:0002620	Decrease	process
Aop:417	Event:2621	disrupted	MESH	MESH:0002621	Decrease	GO	GO:0002621	Decrease	process
Aop:417	Event:2622	morphological change	UBERON	UBERON:0002622	Neuroinflammation	MP	MP:0002622	Neuroinflammation	process
Aop:417	Event:2623	increased	PR	PR:0002623	Oxidative Stress	VT	VT:0002623	Oxidative Stress	process
Aop:417	Event:2624	decreased	CHEBI	CHEBI:0002624	Decreased	HP	HP:0002624	Decreased	process
Aop:417	Event:2625	occurrence	CL	CL:0002625	Acetylcholine accumu	GO	GO:0002625	Acetylcholine accumu	process
Aop:417	Event:2626	disrupted	MESH	MESH:0002626	Acetylcholinesterase	MP	MP:0002626	Acetylcholinesterase	process
Aop:417	Event:2627	morphological change	UBERON	UBERON:0002627	Impaired axonial tra	VT	VT:0002627	Impaired axonial tra	process
Aop:417	Event:2628	increased	PR	PR:0002628	Sensory axonal perip	HP	HP:0002628	Sensory axonal perip	process
Aop:417	Event:2629	decreased	CHEBI	CHEBI:0002629	Overactivation	GO	GO:0002629	Overactivation	process
Aop:417	Event:2630	occurrence	CL	CL:0002630	Neuronal dysfunction	MP	MP:0002630	Neuronal dysfunction	process
Aop:417	Event:2631	disrupted	MESH	MESH:0002631	Degeneration of dopa	VT	VT:0002631	Degeneration of dopa	process
Aop:417	Event:2632	morphological change	UBERON	UBERON:0002632	Synaptic dysfunction	HP	HP:0002632	Synaptic dysfunction	process
Aop:417	Event:2633	increased	PR	PR:0002633	Disruption	GO	GO:0002633	Disruption	process
Aop:417	Event:2634	decreased	CHEBI	CHEBI:0002634	Activation	MP	MP:0002634	Activation	process
Aop:417	Event:2635	occurrence	CL	CL:0002635	Activated	VT	VT:0002635	Activated	process
Aop:417	Event:2636	disrupted	MESH	MESH:0002636	Decreased	HP	HP:0002636	Decreased	process
Aop:417	Event:2637	morphological change	UBERON	UBERON:0002637	Increased	GO	GO:0002637	Increased	process
Aop:417	Event:2638	increased	PR	PR:0002638	Induction	MP	MP:0002638	Induction	process
Aop:417	Event:2639	decreased	CHEBI	CHEBI:0002639	Increased	VT	VT:0002639	Increased	process
Aop:417	Event:2640	occurrence	CL	CL:0002640	impaired	HP	HP:0002640	impaired	process
Aop:417	Event:2641	disrupted	MESH	MESH:0002641	Encephalitis	GO	GO:0002641	Encephalitis	process
Aop:417	Event:2642	morphological change	UBERON	UBERON:0002642	Parkinsonian motor d	MP	MP:0002642	Parkinsonian motor d	process
Aop:417	Event:2643	increased	PR	PR:0002643	Increase	VT	VT:0002643	Increase	process
Aop:417	Event:2644	decreased	CHEBI	CHEBI:0002644	Increased	HP	HP:0002644	Increased	process
Aop:417	Event:2645	occurrence	CL	CL:0002645	Increase	GO	GO:0002645	Increase	process
Aop:417	Event:2646	disrupted	MESH	MESH:0002646	Inhibition	MP	MP:0002646	Inhibition	process
Aop:418	Event:18	increased	PR	PR:000003858	aryl hydrocarbon receptor	GO	GO:0004874	aryl hydrocarbon receptor activity
Aop:418	Event:18	increased	PR	PR:000003858	aryl hydrocarbon receptor	GO	GO:0017162	aryl hydrocarbon receptor binding
Aop:418	Event:1115	increased	CHEBI	CHEBI:26523	reactive oxygen species	GO	GO:1903409	reactive oxygen species biosynthetic process
Aop:418	Event:1825	increased	CL	CL:0001035	bone cell	GO	GO:0008219	cell death
Aop:418	Event:1825	increased	GO	GO:0005623	cell	GO	GO:0008219	cell death
Aop:418	Event:1250	decreased				VT	VT:0002327	respiratory function trait
Aop:419	Event:2647	occurrence	CL	CL:0002647	Deposition of Energy	VT	VT:0002647	Deposition of Energy	process
Aop:419	Event:2648	disrupted	MESH	MESH:0002648	Increase in reactive	HP	HP:0002648	Increase in reactive	process
Aop:419	Event:2649	morphological change	UBERON	UBERON:0002649	increase oxidation o	GO	GO:0002649	increase oxidation o	process
Aop:419	Event:2650	increased	PR	PR:0002650	Decreased	MP	MP:0002650	Decreased	process
Aop:419	Event:2651	decreased	CHEBI	CHEBI:0002651	Cognitive	VT	VT:0002651	Cognitive	process
Aop:419	Event:2652	occurrence	CL	CL:0002652	Increase	HP	HP:0002652	Increase	process
Aop:419	Event:2653	disrupted	MESH	MESH:0002653	Increase	GO	GO:0002653	Increase	process
Aop:419	Event:2654	morphological change	UBERON	UBERON:0002654	Decrease	MP	MP:0002654	Decrease	process
Aop:419	Event:2655	increased	PR	PR:0002655	Decreased	VT	VT:0002655	Decreased	process
Aop:420	Event:2656	occurrence	CL	CL:0002656	Succinate dehydrogenase	VT	VT:0002656	Succinate dehydrogenase	process
Aop:420	Event:2657	disrupted	MESH	MESH:0002657	Succinate Accumulati	HP	HP:0002657	Succinate Accumulati	process
Aop:420	Event:2658	morphological change	UBERON	UBERON:0002658	Increase	GO	GO:0002658	Increase	process
Aop:420	Event:2659	increased	PR	PR:0002659	Epithelial Mesenchym	MP	MP:0002659	Epithelial Mesenchym	process
Aop:420	Event:2660	decreased	CHEBI	CHEBI:0002660	Increase	VT	VT:0002660	Increase	process
Aop:421	Event:2661	occurrence	CL	CL:0002661	Binding of agonist	VT	VT:0002661	Binding of agonist	process
Aop:421	Event:2662	disrupted	MESH	MESH:0002662	Overactivation	HP	HP:0002662	Overactivation	process
Aop:421	Event:2663	morphological change	UBERON	UBERON:0002663	Increased	GO	GO:0002663	Increased	process
Aop:421	Event:2664	increased	PR	PR:0002664	Loss of drebrin	MP	MP:0002664	Loss of drebrin	process
Aop:421	Event:2665	decreased	CHEBI	CHEBI:0002665	Abnormality	VT	VT:0002665	Abnormality	process
Aop:421	Event:2666	occurrence	CL	CL:0002666	Synaptic dysfunction	HP	HP:0002666	Synaptic dysfunction	process
Aop:421	Event:2667	disrupted	MESH	MESH:0002667	Decrease of neuronal	GO	GO:0002667	Decrease of neuronal	process
Aop:421	Event:2668	morphological change	UBERON	UBERON:0002668	Impairment	MP	MP:0002668	Impairment	process
Aop:422	Event:2669	occurrence	CL	CL:0002669	Increase	VT	VT:0002669	Increase	process
Aop:422	Event:2670	disrupted	MESH	MESH:0002670	Disruption	HP	HP:0002670	Disruption	process
Aop:422	Event:2671	morphological change	UBERON	UBERON:0002671	Antagonism	GO	GO:0002671	Antagonism	process
Aop:422	Event:2672	increased	PR	PR:0002672	Oxidative Stress	MP	MP:0002672	Oxidative Stress	process
Aop:422	Event:2673	decreased	CHEBI	CHEBI:0002673	Increase	VT	VT:0002673	Increase	process
Aop:422	Event:2674	occurrence	CL	CL:0002674	Mitochondrial dysfun	HP	HP:0002674	Mitochondrial dysfun	process
Aop:422	Event:2675	disrupted	MESH	MESH:0002675	Increased	GO	GO:0002675	Increased	process
Aop:422	Event:2676	morphological change	UBERON	UBERON:0002676	Apoptosis	MP	MP:0002676	Apoptosis	process
Aop:422	Event:2677	increased	PR	PR:0002677	Depletion	VT	VT:0002677	Depletion	process
Aop:422	Event:2678	decreased	CHEBI	CHEBI:0002678	Impaired	HP	HP:0002678	Impaired	process
Aop:422	Event:2679	occurrence	CL	CL:0002679	Increased apoptosis	GO	GO:0002679	Increased apoptosis	process
Aop:422	Event:2680	disrupted	MESH	MESH:0002680	Reduction	MP	MP:0002680	Reduction	process
Aop:422	Event:2681	morphological change	UBERON	UBERON:0002681	Decreased sperm quantity or quality in the adult	VT	VT:0002681	Decreased sperm quantity or quality in the adult	process
Aop:422	Event:2682	increased	PR	PR:0002682	anogenital distance (AGD)	HP	HP:0002682	anogenital distance (AGD)	process
Aop:422	Event:2683	decreased	CHEBI	CHEBI:0002683	Malformation	GO	GO:0002683	Malformation	process
Aop:422	Event:2684	occurrence	CL	CL:0002684	Decrease	MP	MP:0002684	Decrease	process
Aop:423	Event:2685	occurrence	CL	CL:0002685	Antagonism	VT	VT:0002685	Antagonism	process
Aop:423	Event:2686	disrupted	MESH	MESH:0002686	Decrease	HP	HP:0002686	Decrease	process
Aop:423	Event:2687	morphological change	UBERON	UBERON:0002687	Hypospadias	GO	GO:0002687	Hypospadias	process
Aop:424	Event:2688	occurrence	CL	CL:0002688	Deposition of Energy	VT	VT:0002688	Deposition of Energy	process
Aop:424	Event:2689	disrupted	MESH	MESH:0002689	Increased Modified P	HP	HP:0002689	Increased Modified P	process
Aop:424	Event:2690	morphological change	UBERON	UBERON:0002690	Increase	GO	GO:0002690	Increase	process
Aop:424	Event:2691	increased	PR	PR:0002691	Increase	MP	MP:0002691	Increase	process
Aop:424	Event:2692	decreased	CHEBI	CHEBI:0002692	Inadequate DNA repai	VT	VT:0002692	Inadequate DNA repai	process
Aop:424	Event:2693	occurrence	CL	CL:0002693	Increase	HP	HP:0002693	Increase	process
Aop:424	Event:2694	disrupted	MESH	MESH:0002694	Increase	GO	GO:0002694	Increase	process
Aop:424	Event:2695	morphological change	UBERON	UBERON:0002695	Increase	MP	MP:0002695	Increase	process
Aop:424	Event:2696	increased	PR	PR:0002696	Oxidative Stress	VT	VT:0002696	Oxidative Stress	process
Aop:424	Event:2697	decreased	CHEBI	CHEBI:0002697	Occurrence of Catara	HP	HP:0002697	Occurrence of Catara	process
Aop:425	Event:2698	occurrence	CL	CL:0002698	Inhibition	VT	VT:0002698	Inhibition	process
Aop:425	Event:2699	disrupted	MESH	MESH:0002699	Mitochondrial dysfun	HP	HP:0002699	Mitochondrial dysfun	process
Aop:425	Event:2700	morphological change	UBERON	UBERON:0002700	Oxidative Stress	GO	GO:0002700	Oxidative Stress	process
Aop:425	Event:2701	increased	PR	PR:0002701	Increase	MP	MP:0002701	Increase	process
Aop:425	Event:2702	decreased	CHEBI	CHEBI:0002702	Increase	VT	VT:0002702	Increase	process
Aop:425	Event:2703	occurrence	CL	CL:0002703	Decrease	HP	HP:0002703	Decrease	process
Aop:425	Event:2704	disrupted	MESH	MESH:0002704	Decrease Left Ventri	GO	GO:0002704	Decrease Left Ventri	process
Aop:426	Event:2705	occurrence	CL	CL:0002705	Inhibition	VT	VT:0002705	Inhibition	process
Aop:426	Event:2706	disrupted	MESH	MESH:0002706	Mitochondrial dysfun	HP	HP:0002706	Mitochondrial dysfun	process
Aop:426	Event:2707	morphological change	UBERON	UBERON:0002707	Decrease	GO	GO:0002707	Decrease	process
Aop:426	Event:2708	increased	PR	PR:0002708	Decrease	MP	MP:0002708	Decrease	process
Aop:426	Event:2709	decreased	CHEBI	CHEBI:0002709	Decrease Left Ventri	VT	VT:0002709	Decrease Left Ventri	process
Aop:427	Event:2710	occurrence	CL	CL:0002710	Increase	VT	VT:0002710	Increase	process
Aop:427	Event:2711	disrupted	MESH	MESH:0002711	Oxidative Stress	HP	HP:0002711	Oxidative Stress	process
Aop:427	Event:2712	morphological change	UBERON	UBERON:0002712	Mitochondrial dysfun	GO	GO:0002712	Mitochondrial dysfun	process
Aop:427	Event:2713	increased	PR	PR:0002713	Airway epithelial in	MP	MP:0002713	Airway epithelial in	process
Aop:427	Event:2714	decreased	CHEBI	CHEBI:0002714	Activation	VT	VT:0002714	Activation	process
Aop:427	Event:2715	occurrence	CL	CL:0002715	Pulmonary epithelial	HP	HP:0002715	Pulmonary epithelial	process
Aop:427	Event:2716	disrupted	MESH	MESH:0002716	Activation	GO	GO:0002716	Activation	process
Aop:427	Event:2717	morphological change	UBERON	UBERON:0002717	Airway inflammation	MP	MP:0002717	Airway inflammation	process
Aop:427	Event:2718	increased	PR	PR:0002718	Pulmonary inflammati	VT	VT:0002718	Pulmonary inflammati	process
Aop:427	Event:2719	decreased	CHEBI	CHEBI:0002719	Pulmonary fibrosis	HP	HP:0002719	Pulmonary fibrosis	process
Aop:427	Event:2720	occurrence	CL	CL:0002720	Increased incidence 	GO	GO:0002720	Increased incidence 	process
Aop:427	Event:2721	disrupted	MESH	MESH:0002721	Dysfunction of respi	MP	MP:0002721	Dysfunction of respi	process
Aop:428	Event:2722	occurrence	CL	CL:0002722	Deposition of Energy	VT	VT:0002722	Deposition of Energy	process
Aop:428	Event:2723	disrupted	MESH	MESH:0002723	Oxidative Stress	HP	HP:0002723	Oxidative Stress	process
Aop:428	Event:2724	morphological change	UBERON	UBERON:0002724	Altered Cell Differe	GO	GO:0002724	Altered Cell Differe	process
Aop:428	Event:2725	increased	PR	PR:0002725	Increase	MP	MP:0002725	Increase	process
Aop:428	Event:2726	decreased	CHEBI	CHEBI:0002726	Altered Bone Cell Ho	VT	VT:0002726	Altered Bone Cell Ho	process
Aop:428	Event:2727	occurrence	CL	CL:0002727	Increase	HP	HP:0002727	Increase	process
Aop:428	Event:2728	disrupted	MESH	MESH:0002728	Occurrence	GO	GO:0002728	Occurrence	process
Aop:429	Event:2729	occurrence	CL	CL:0002729	Deposition of Energy	VT	VT:0002729	Deposition of Energy	process
Aop:429	Event:2730	disrupted	MESH	MESH:0002730	Oxidative Stress	HP	HP:0002730	Oxidative Stress	process
Aop:429	Event:2731	morphological change	UBERON	UBERON:0002731	Altered Stress Respo	GO	GO:0002731	Altered Stress Respo	process
Aop:429	Event:2732	increased	PR	PR:0002732	Tissue resident cell	MP	MP:0002732	Tissue resident cell	process
Aop:429	Event:2733	decreased	CHEBI	CHEBI:0002733	Increase	VT	VT:0002733	Increase	process
Aop:429	Event:2734	occurrence	CL	CL:0002734	Increase	HP	HP:0002734	Increase	process
Aop:429	Event:2735	disrupted	MESH	MESH:0002735	Increase	GO	GO:0002735	Increase	process
Aop:429	Event:2736	morphological change	UBERON	UBERON:0002736	Impairment	MP	MP:0002736	Impairment	process
Aop:430	Event:1739	occurrence	PR	PR:000003622	angiotensin-converting enzyme 2	GO	GO:0005102	receptor binding
Aop:430	Event:1738	occurrence	PR	PR:000016456	transmembrane protease serine 2	GO	GO:0061025	membrane fusion
Aop:430	Event:1738	occurrence	PR	PR:P07711	cathepsin L1 (human)	GO	GO:0075509	endocytosis involved in viral entry into host cell
Aop:430	Event:1738	occurrence	GO	GO:0019015	viral genome	GO	GO:0046718	viral entry into host cell
Aop:430	Event:1738	occurrence	PR	PR:000036197	viral protein	GO	GO:0046718	viral entry into host cell
Aop:430	Event:1901	decreased	PR	PR:000024938	interferon alpha	GO	GO:0060337	type I interferon signaling pathway
Aop:430	Event:1901	decreased	PR	PR:000024939	interferon beta	GO	GO:0060337	type I interferon signaling pathway
Aop:430	Event:1901	occurrence	GO	GO:0019022	RNA viral genome	GO	GO:0071360	cellular response to exogenous dsRNA
Aop:430	Event:1847	increased	GO	GO:0031381	viral RNA-directed RNA polymerase complex	GO	GO:0039694	viral RNA genome replication
Aop:430	Event:1847	increased	GO	GO:0031381	viral RNA-directed RNA polymerase complex	GO	GO:0039690	positive stranded viral RNA replication
Aop:430	Event:1847	increased	GO	GO:0072516	viral assembly compartment	GO	GO:0019074	viral RNA genome packaging
Aop:430	Event:1847	increased	GO	GO:0019024	ssRNA viral genome	GO	GO:0009299	mRNA transcription
Aop:430	Event:1847	increased	GO	GO:0019024	ssRNA viral genome	GO	GO:0019081	viral translation
Aop:430	Event:1939	increased				GO	GO:0019076	viral release from host cell
Aop:431	Event:2737	occurrence	CL	CL:0002737	Antagonism	VT	VT:0002737	Antagonism	process
Aop:431	Event:2738	disrupted	MESH	MESH:0002738	Decreased	HP	HP:0002738	Decreased	process
Aop:431	Event:2739	morphological change	UBERON	UBERON:0002739	Decreased	GO	GO:0002739	Decreased	process
Aop:431	Event:2740	increased	PR	PR:0002740	Impaired	MP	MP:0002740	Impaired	process
Aop:431	Event:2741	decreased	CHEBI	CHEBI:0002741	Hypomyelination	VT	VT:0002741	Hypomyelination	process
Aop:431	Event:2742	occurrence	CL	CL:0002742	Altered	HP	HP:0002742	Altered	process
Aop:431	Event:2743	disrupted	MESH	MESH:0002743	Cognitive function	GO	GO:0002743	Cognitive function	process
Aop:432	Event:2744	occurrence	CL	CL:0002744	Binding	VT	VT:0002744	Binding	process
Aop:432	Event:2745	disrupted	MESH	MESH:0002745	Disrupted binding	HP	HP:0002745	Disrupted binding	process
Aop:432	Event:2746	morphological change	UBERON	UBERON:0002746	Decreased	GO	GO:0002746	Decreased	process
Aop:432	Event:2747	increased	PR	PR:0002747	Disturbed	MP	MP:0002747	Disturbed	process
Aop:432	Event:2748	decreased	CHEBI	CHEBI:0002748	Decreased	VT	VT:0002748	Decreased	process
Aop:432	Event:2749	occurrence	CL	CL:0002749	Disturbed	HP	HP:0002749	Disturbed	process
Aop:432	Event:2750	disrupted	MESH	MESH:0002750	Cognitive function	GO	GO:0002750	Cognitive function	process
Aop:433	Event:2751	occurrence	CL	CL:0002751	Unknown	VT	VT:0002751	Unknown	process
Aop:433	Event:2752	disrupted	MESH	MESH:0002752	Altered	HP	HP:0002752	Altered	process
Aop:433	Event:2753	morphological change	UBERON	UBERON:0002753	Decreased	GO	GO:0002753	Decreased	process
Aop:433	Event:2754	increased	PR	PR:0002754	Hypomyelination	MP	MP:0002754	Hypomyelination	process
Aop:433	Event:2755	decreased	CHEBI	CHEBI:0002755	Altered	VT	VT:0002755	Altered	process
Aop:433	Event:2756	occurrence	CL	CL:0002756	Cognitive function	HP	HP:0002756	Cognitive function	process
Aop:434	Event:2757	occurrence	CL	CL:0002757	Increase	VT	VT:0002757	Increase	process
Aop:434	Event:2758	disrupted	MESH	MESH:0002758	Oxidative Stress	HP	HP:0002758	Oxidative Stress	process
Aop:434	Event:2759	morphological change	UBERON	UBERON:0002759	Diminished protectiv	GO	GO:0002759	Diminished protectiv	process
Aop:434	Event:2760	increased	PR	PR:0002760	Decreased	MP	MP:0002760	Decreased	process
Aop:434	Event:2761	decreased	CHEBI	CHEBI:0002761	Hypomyelination	VT	VT:0002761	Hypomyelination	process
Aop:434	Event:2762	occurrence	CL	CL:0002762	Altered	HP	HP:0002762	Altered	process
Aop:434	Event:2763	disrupted	MESH	MESH:0002763	Cognitive function	GO	GO:0002763	Cognitive function	process
Aop:435	Event:2764	occurrence	CL	CL:0002764	Binding to voltage-g	VT	VT:0002764	Binding to voltage-g	process
Aop:435	Event:2765	disrupted	MESH	MESH:0002765	Disruption of sodium	HP	HP:0002765	Disruption of sodium	process
Aop:435	Event:2766	morphological change	UBERON	UBERON:0002766	Decreased	GO	GO:0002766	Decreased	process
Aop:435	Event:2767	increased	PR	PR:0002767	Hypomyelination	MP	MP:0002767	Hypomyelination	process
Aop:435	Event:2768	decreased	CHEBI	CHEBI:0002768	Altered	VT	VT:0002768	Altered	process
Aop:435	Event:2769	occurrence	CL	CL:0002769	Cognitive function	HP	HP:0002769	Cognitive function	process
Aop:436	Event:2770	occurrence	CL	CL:0002770	Ryanodine receptor a	VT	VT:0002770	Ryanodine receptor a	process
Aop:436	Event:2771	disrupted	MESH	MESH:0002771	Inositol triphosphat	HP	HP:0002771	Inositol triphosphat	process
Aop:436	Event:2772	morphological change	UBERON	UBERON:0002772	Increased	GO	GO:0002772	Increased	process
Aop:436	Event:2773	increased	PR	PR:0002773	decreased	MP	MP:0002773	decreased	process
Aop:436	Event:2774	decreased	CHEBI	CHEBI:0002774	increased	VT	VT:0002774	increased	process
Aop:436	Event:2775	occurrence	CL	CL:0002775	Activation	HP	HP:0002775	Activation	process
Aop:436	Event:2776	disrupted	MESH	MESH:0002776	Neuroinflammation	GO	GO:0002776	Neuroinflammation	process
Aop:436	Event:2777	morphological change	UBERON	UBERON:0002777	Increase	MP	MP:0002777	Increase	process
Aop:436	Event:2778	increased	PR	PR:0002778	Hippocampal Physiology	VT	VT:0002778	Hippocampal Physiology	process
Aop:436	Event:2779	decreased	CHEBI	CHEBI:0002779	Impairment	HP	HP:0002779	Impairment	process
Aop:436	Event:2780	occurrence	CL	CL:0002780	decreased	GO	GO:0002780	decreased	process
Aop:436	Event:2781	disrupted	MESH	MESH:0002781	increased	MP	MP:0002781	increased	process
Aop:437	Event:2782	occurrence	CL	CL:0002782	Decrease	VT	VT:0002782	Decrease	process
Aop:437	Event:2783	disrupted	MESH	MESH:0002783	Decrease	HP	HP:0002783	Decrease	process
Aop:437	Event:2784	morphological change	UBERON	UBERON:0002784	Decrease	GO	GO:0002784	Decrease	process
Aop:437	Event:2785	increased	PR	PR:0002785	Decrease	MP	MP:0002785	Decrease	process
Aop:437	Event:2786	decreased	CHEBI	CHEBI:0002786	Apoptosis	VT	VT:0002786	Apoptosis	process
Aop:437	Event:2787	occurrence	CL	CL:0002787	Increase	HP	HP:0002787	Increase	process
Aop:438	Event:2788	occurrence	CL	CL:0002788	Conjugation	VT	VT:0002788	Conjugation	process
Aop:438	Event:2789	disrupted	MESH	MESH:0002789	Depletion	HP	HP:0002789	Depletion	process
Aop:438	Event:2790	morphological change	UBERON	UBERON:0002790	Increase	GO	GO:0002790	Increase	process
Aop:438	Event:2791	increased	PR	PR:0002791	Increase	MP	MP:0002791	Increase	process
Aop:438	Event:2792	decreased	CHEBI	CHEBI:0002792	decreased	VT	VT:0002792	decreased	process
Aop:439	Event:2793	occurrence	CL	CL:0002793	Estrogen receptor al	VT	VT:0002793	Estrogen receptor al	process
Aop:439	Event:2794	disrupted	MESH	MESH:0002794	Increased	HP	HP:0002794	Increased	process
Aop:439	Event:2795	morphological change	UBERON	UBERON:0002795	Insulin resistance	GO	GO:0002795	Insulin resistance	process
Aop:439	Event:2796	increased	PR	PR:0002796	Increased adipocyte 	MP	MP:0002796	Increased adipocyte 	process
Aop:439	Event:2797	decreased	CHEBI	CHEBI:0002797	Increased adipocyte 	VT	VT:0002797	Increased adipocyte 	process
Aop:439	Event:2798	occurrence	CL	CL:0002798	Increased fat mass	HP	HP:0002798	Increased fat mass	process
Aop:439	Event:2799	disrupted	MESH	MESH:0002799	increased lipid accu	GO	GO:0002799	increased lipid accu	process
Aop:439	Event:2800	morphological change	UBERON	UBERON:0002800	Increased pro-inflam	MP	MP:0002800	Increased pro-inflam	process
Aop:439	Event:2801	increased	PR	PR:0002801	Increase in inflamma	VT	VT:0002801	Increase in inflamma	process
Aop:439	Event:2802	decreased	CHEBI	CHEBI:0002802	Metabolically unheal	HP	HP:0002802	Metabolically unheal	process
Aop:440	Event:2803	occurrence	CL	CL:0002803	Activation	VT	VT:0002803	Activation	process
Aop:440	Event:2804	disrupted	MESH	MESH:0002804	Increased	HP	HP:0002804	Increased	process
Aop:440	Event:2805	morphological change	UBERON	UBERON:0002805	Increase	GO	GO:0002805	Increase	process
Aop:440	Event:2806	increased	PR	PR:0002806	Activation	MP	MP:0002806	Activation	process
Aop:440	Event:2807	decreased	CHEBI	CHEBI:0002807	Increased	VT	VT:0002807	Increased	process
Aop:440	Event:2808	occurrence	CL	CL:0002808	N/A	HP	HP:0002808	N/A	process
Aop:441	Event:2809	occurrence	CL	CL:0002809	Agonism	VT	VT:0002809	Agonism	process
Aop:441	Event:2810	disrupted	MESH	MESH:0002810	Altered	HP	HP:0002810	Altered	process
Aop:441	Event:2811	morphological change	UBERON	UBERON:0002811	Increase	GO	GO:0002811	Increase	process
Aop:441	Event:2812	increased	PR	PR:0002812	Decreased	MP	MP:0002812	Decreased	process
Aop:441	Event:2813	decreased	CHEBI	CHEBI:0002813	Inflamatory events i	VT	VT:0002813	Inflamatory events i	process
Aop:441	Event:2814	occurrence	CL	CL:0002814	Alterations	HP	HP:0002814	Alterations	process
Aop:441	Event:2815	disrupted	MESH	MESH:0002815	Increased	GO	GO:0002815	Increased	process
Aop:441	Event:2816	morphological change	UBERON	UBERON:0002816	prostatic intraepith	MP	MP:0002816	prostatic intraepith	process
Aop:441	Event:2817	increased	PR	PR:0002817	Prostate cancer	VT	VT:0002817	Prostate cancer	process
Aop:442	Event:2818	occurrence	CL	CL:0002818	Agonism	VT	VT:0002818	Agonism	process
Aop:442	Event:2819	disrupted	MESH	MESH:0002819	Altered	HP	HP:0002819	Altered	process
Aop:442	Event:2820	morphological change	UBERON	UBERON:0002820	Increase	GO	GO:0002820	Increase	process
Aop:442	Event:2821	increased	PR	PR:0002821	Decrease	MP	MP:0002821	Decrease	process
Aop:442	Event:2822	decreased	CHEBI	CHEBI:0002822	Reduction	VT	VT:0002822	Reduction	process
Aop:442	Event:2823	occurrence	CL	CL:0002823	Reduction	HP	HP:0002823	Reduction	process
Aop:442	Event:2824	disrupted	MESH	MESH:0002824	Reduction	GO	GO:0002824	Reduction	process
Aop:442	Event:2825	morphological change	UBERON	UBERON:0002825	Reduction	MP	MP:0002825	Reduction	process
Aop:442	Event:2826	increased	PR	PR:0002826	Reduction	VT	VT:0002826	Reduction	process
Aop:442	Event:2827	decreased	CHEBI	CHEBI:0002827	Decreased	HP	HP:0002827	Decreased	process
Aop:443	Event:2828	occurrence	CL	CL:0002828	Estrogen receptor al	VT	VT:0002828	Estrogen receptor al	process
Aop:443	Event:2829	disrupted	MESH	MESH:0002829	Decrease	HP	HP:0002829	Decrease	process
Aop:443	Event:2830	morphological change	UBERON	UBERON:0002830	Increase	GO	GO:0002830	Increase	process
Aop:443	Event:2831	increased	PR	PR:0002831	Mitochondrial dysfun	MP	MP:0002831	Mitochondrial dysfun	process
Aop:443	Event:2832	decreased	CHEBI	CHEBI:0002832	Oxidative Stress	VT	VT:0002832	Oxidative Stress	process
Aop:443	Event:2833	occurrence	CL	CL:0002833	Impaired insulin sig	HP	HP:0002833	Impaired insulin sig	process
Aop:443	Event:2834	disrupted	MESH	MESH:0002834	Insulin resistance	GO	GO:0002834	Insulin resistance	process
Aop:443	Event:2835	morphological change	UBERON	UBERON:0002835	Metabolic syndrome	MP	MP:0002835	Metabolic syndrome	process
Aop:444	Event:2836	occurrence	CL	CL:0002836	Increased LCN2/iron 	VT	VT:0002836	Increased LCN2/iron 	process
Aop:444	Event:2837	disrupted	MESH	MESH:0002837	Increased intracellu	HP	HP:0002837	Increased intracellu	process
Aop:444	Event:2838	morphological change	UBERON	UBERON:0002838	Neuronal dysfunction	GO	GO:0002838	Neuronal dysfunction	process
Aop:444	Event:2839	increased	PR	PR:0002839	Neurological disorde	MP	MP:0002839	Neurological disorde	process
Aop:445	Event:2840	occurrence	CL	CL:0002840	Activation of mitogen-activated protein kinase kinase	VT	VT:0002840	Activation of mitogen-activated protein kinase kinase	process
Aop:445	Event:2841	disrupted	MESH	MESH:0002841	Increase	HP	HP:0002841	Increase	process
Aop:445	Event:2842	morphological change	UBERON	UBERON:0002842	Disruption	GO	GO:0002842	Disruption	process
Aop:445	Event:2843	increased	PR	PR:0002843	Impairment	MP	MP:0002843	Impairment	process
Aop:446	Event:2844	occurrence	CL	CL:0002844	Activation of mitogen-activated protein kinase kinase	VT	VT:0002844	Activation of mitogen-activated protein kinase kinase	process
Aop:446	Event:2845	disrupted	MESH	MESH:0002845	Increase	HP	HP:0002845	Increase	process
Aop:446	Event:2846	morphological change	UBERON	UBERON:0002846	Mitochondrial dysfun	GO	GO:0002846	Mitochondrial dysfun	process
Aop:446	Event:2847	increased	PR	PR:0002847	Increase	MP	MP:0002847	Increase	process
Aop:446	Event:2848	decreased	CHEBI	CHEBI:0002848	Apoptosis	VT	VT:0002848	Apoptosis	process
Aop:446	Event:2849	occurrence	CL	CL:0002849	N/A	HP	HP:0002849	N/A	process
Aop:446	Event:2850	disrupted	MESH	MESH:0002850	Impairment	GO	GO:0002850	Impairment	process
Aop:447	Event:2851	occurrence	CL	CL:0002851	Increased intracellu	VT	VT:0002851	Increased intracellu	process
Aop:447	Event:2852	disrupted	MESH	MESH:0002852	Oxidative Stress	HP	HP:0002852	Oxidative Stress	process
Aop:447	Event:2853	morphological change	UBERON	UBERON:0002853	Decrease of neuronal	GO	GO:0002853	Decrease of neuronal	process
Aop:447	Event:2854	increased	PR	PR:0002854	Neurological disorde	MP	MP:0002854	Neurological disorde	process
Aop:448	Event:2855	occurrence	CL	CL:0002855	Decrease	VT	VT:0002855	Decrease	process
Aop:448	Event:2856	disrupted	MESH	MESH:0002856	Decrease	HP	HP:0002856	Decrease	process
Aop:448	Event:2857	morphological change	UBERON	UBERON:0002857	Decrease	GO	GO:0002857	Decrease	process
Aop:448	Event:2858	increased	PR	PR:0002858	Apoptosis	MP	MP:0002858	Apoptosis	process
Aop:448	Event:2859	decreased	CHEBI	CHEBI:0002859	Decrease	VT	VT:0002859	Decrease	process
Aop:448	Event:2860	occurrence	CL	CL:0002860	Decrease	HP	HP:0002860	Decrease	process
Aop:448	Event:2861	disrupted	MESH	MESH:0002861	Increase	GO	GO:0002861	Increase	process
Aop:449	Event:2862	occurrence	CL	CL:0002862	Activation	VT	VT:0002862	Activation	process
Aop:449	Event:2863	disrupted	MESH	MESH:0002863	Epigenetic modificat	HP	HP:0002863	Epigenetic modificat	process
Aop:449	Event:2864	morphological change	UBERON	UBERON:0002864	Expression of factors ruling proliferation	GO	GO:0002864	Expression of factors ruling proliferation	process
Aop:449	Event:2865	increased	PR	PR:0002865	Increase	MP	MP:0002865	Increase	process
Aop:449	Event:2866	decreased	CHEBI	CHEBI:0002866	Genomic instability	VT	VT:0002866	Genomic instability	process
Aop:449	Event:2867	occurrence	CL	CL:0002867	Uterine adenocarcino	HP	HP:0002867	Uterine adenocarcino	process
Aop:450	Event:2868	occurrence	CL	CL:0002868	Inhibition of Sulfot	VT	VT:0002868	Inhibition of Sulfot	process
Aop:450	Event:2869	disrupted	MESH	MESH:0002869	Estradiol availability	HP	HP:0002869	Estradiol availability	process
Aop:450	Event:2870	morphological change	UBERON	UBERON:0002870	Activation	GO	GO:0002870	Activation	process
Aop:451	Event:2871	occurrence	CL	CL:0002871	Increase	VT	VT:0002871	Increase	process
Aop:451	Event:2872	disrupted	MESH	MESH:0002872	Oxidative Stress	HP	HP:0002872	Oxidative Stress	process
Aop:451	Event:2873	morphological change	UBERON	UBERON:0002873	Increase	GO	GO:0002873	Increase	process
Aop:451	Event:2874	increased	PR	PR:0002874	General Apoptosis	MP	MP:0002874	General Apoptosis	process
Aop:451	Event:2875	decreased	CHEBI	CHEBI:0002875	Increase	VT	VT:0002875	Increase	process
Aop:452	Event:2876	occurrence	CL	CL:0002876	Influenza A Virus (I	VT	VT:0002876	Influenza A Virus (I	process
Aop:452	Event:2877	disrupted	MESH	MESH:0002877	Influenza A virus (I	HP	HP:0002877	Influenza A virus (I	process
Aop:452	Event:2878	morphological change	UBERON	UBERON:0002878	Influenza A Virus pr	GO	GO:0002878	Influenza A Virus pr	process
Aop:452	Event:2879	increased	PR	PR:0002879	Immune mechanisms an	MP	MP:0002879	Immune mechanisms an	process
Aop:452	Event:2880	decreased	CHEBI	CHEBI:0002880	Influenza A Virus (I	VT	VT:0002880	Influenza A Virus (I	process
Aop:452	Event:2881	occurrence	CL	CL:0002881	Influenza A Virus (I	HP	HP:0002881	Influenza A Virus (I	process
Aop:453	Event:2882	occurrence	CL	CL:0002882	NFE2/Nrf2 repression	VT	VT:0002882	NFE2/Nrf2 repression	process
Aop:453	Event:2883	disrupted	MESH	MESH:0002883	Oxidative Stress	HP	HP:0002883	Oxidative Stress	process
Aop:453	Event:2884	morphological change	UBERON	UBERON:0002884	Activation of inflam	GO	GO:0002884	Activation of inflam	process
Aop:453	Event:2885	increased	PR	PR:0002885	increasedVascular e	MP	MP:0002885	increasedVascular e	process
Aop:453	Event:2886	decreased	CHEBI	CHEBI:0002886	Angiogenesis dysfunc	VT	VT:0002886	Angiogenesis dysfunc	process
Aop:453	Event:2887	occurrence	CL	CL:0002887	Increase	HP	HP:0002887	Increase	process
Aop:454	Event:2888	occurrence	CL	CL:0002888	NFE2/Nrf2 repression	VT	VT:0002888	NFE2/Nrf2 repression	process
Aop:454	Event:2889	disrupted	MESH	MESH:0002889	Activation	HP	HP:0002889	Activation	process
Aop:454	Event:2890	morphological change	UBERON	UBERON:0002890	Activation Sema6A	GO	GO:0002890	Activation Sema6A	process
Aop:454	Event:2891	increased	PR	PR:0002891	Activation	MP	MP:0002891	Activation	process
Aop:454	Event:2892	decreased	CHEBI	CHEBI:0002892	increasedVascular e	VT	VT:0002892	increasedVascular e	process
Aop:454	Event:2893	occurrence	CL	CL:0002893	Angiogenesis dysfunc	HP	HP:0002893	Angiogenesis dysfunc	process
Aop:454	Event:2894	disrupted	MESH	MESH:0002894	Increase	GO	GO:0002894	Increase	process
Aop:455	Event:2895	occurrence	CL	CL:0002895	NFE2/Nrf2 repression	VT	VT:0002895	NFE2/Nrf2 repression	process
Aop:455	Event:2896	disrupted	MESH	MESH:0002896	Oxidative Stress	HP	HP:0002896	Oxidative Stress	process
Aop:455	Event:2897	morphological change	UBERON	UBERON:0002897	Increase	GO	GO:0002897	Increase	process
Aop:455	Event:2898	increased	PR	PR:0002898	Mitochondrial dysfun	MP	MP:0002898	Mitochondrial dysfun	process
Aop:455	Event:2899	decreased	CHEBI	CHEBI:0002899	increasedVascular e	VT	VT:0002899	increasedVascular e	process
Aop:455	Event:2900	occurrence	CL	CL:0002900	Angiogenesis dysfunc	HP	HP:0002900	Angiogenesis dysfunc	process
Aop:455	Event:2901	disrupted	MESH	MESH:0002901	Increase	GO	GO:0002901	Increase	process
Aop:456	Event:2902	occurrence	CL	CL:0002902	peroxisome prolifera	VT	VT:0002902	peroxisome prolifera	process
Aop:456	Event:2903	disrupted	MESH	MESH:0002903	Activation of PPAR	HP	HP:0002903	Activation of PPAR	process
Aop:456	Event:2904	morphological change	UBERON	UBERON:0002904	Oxidative Stress	GO	GO:0002904	Oxidative Stress	process
Aop:456	Event:2905	increased	PR	PR:0002905	Abnormal expression 	MP	MP:0002905	Abnormal expression 	process
Aop:456	Event:2906	decreased	CHEBI	CHEBI:0002906	Activation of MMP-2 	VT	VT:0002906	Activation of MMP-2 	process
Aop:456	Event:2907	occurrence	CL	CL:0002907	Activation of angiop	HP	HP:0002907	Activation of angiop	process
Aop:456	Event:2908	disrupted	MESH	MESH:0002908	Activation of Angiog	GO	GO:0002908	Activation of Angiog	process
Aop:456	Event:2909	morphological change	UBERON	UBERON:0002909	increasedVascular e	MP	MP:0002909	increasedVascular e	process
Aop:456	Event:2910	increased	PR	PR:0002910	Angiogenesis dysfunc	VT	VT:0002910	Angiogenesis dysfunc	process
Aop:456	Event:2911	decreased	CHEBI	CHEBI:0002911	Increase	HP	HP:0002911	Increase	process
Aop:457	Event:2912	occurrence	CL	CL:0002912	Increase	VT	VT:0002912	Increase	process
Aop:457	Event:2913	disrupted	MESH	MESH:0002913	Oxidative Stress	HP	HP:0002913	Oxidative Stress	process
Aop:457	Event:2914	morphological change	UBERON	UBERON:0002914	Activation of inflam	GO	GO:0002914	Activation of inflam	process
Aop:457	Event:2915	increased	PR	PR:0002915	Activated ANG/Tie2 p	MP	MP:0002915	Activated ANG/Tie2 p	process
Aop:457	Event:2916	decreased	CHEBI	CHEBI:0002916	Activation	VT	VT:0002916	Activation	process
Aop:457	Event:2917	occurrence	CL	CL:0002917	Activated BMP/TGF-be	HP	HP:0002917	Activated BMP/TGF-be	process
Aop:457	Event:2918	disrupted	MESH	MESH:0002918	Activated Wnt/Frizzl	GO	GO:0002918	Activated Wnt/Frizzl	process
Aop:457	Event:2919	morphological change	UBERON	UBERON:0002919	KE4 : Uncoupling	MP	MP:0002919	KE4 : Uncoupling	process
Aop:457	Event:2920	increased	PR	PR:0002920	Activated AKT/ERK/PI	VT	VT:0002920	Activated AKT/ERK/PI	process
Aop:457	Event:2921	decreased	CHEBI	CHEBI:0002921	Inhibition VEGF/VEGF	HP	HP:0002921	Inhibition VEGF/VEGF	process
Aop:457	Event:2922	occurrence	CL	CL:0002922	Mitochondrial dysfun	GO	GO:0002922	Mitochondrial dysfun	process
Aop:457	Event:2923	disrupted	MESH	MESH:0002923	Vascular barrier dis	MP	MP:0002923	Vascular barrier dis	process
Aop:457	Event:2924	morphological change	UBERON	UBERON:0002924	Impaired Platelet Ag	VT	VT:0002924	Impaired Platelet Ag	process
Aop:457	Event:2925	increased	PR	PR:0002925	increasedVascular e	HP	HP:0002925	increasedVascular e	process
Aop:457	Event:2926	decreased	CHEBI	CHEBI:0002926	Angiogenesis dysfunc	GO	GO:0002926	Angiogenesis dysfunc	process
Aop:457	Event:2927	occurrence	CL	CL:0002927	Increase	MP	MP:0002927	Increase	process
Aop:458	Event:2928	occurrence	CL	CL:0002928	Decreased	VT	VT:0002928	Decreased	process
Aop:459	Event:2929	occurrence	CL	CL:0002929	Increase	VT	VT:0002929	Increase	process
Aop:459	Event:2930	disrupted	MESH	MESH:0002930	Decreased	HP	HP:0002930	Decreased	process
Aop:459	Event:2931	morphological change	UBERON	UBERON:0002931	Alteration	GO	GO:0002931	Alteration	process
Aop:459	Event:2932	increased	PR	PR:0002932	General Apoptosis	MP	MP:0002932	General Apoptosis	process
Aop:459	Event:2933	decreased	CHEBI	CHEBI:0002933	Increase	VT	VT:0002933	Increase	process
Aop:460	Event:2027	decreased	PR	PR:000015288	smoothened	GO	GO:0010469	regulation of receptor activity
Aop:460	Event:2028	decreased	PR	PR:000008026	zinc finger protein GLI1	GO	GO:0000060	protein import into nucleus, translocation
Aop:460	Event:2028	decreased	PR	PR:000008027	zinc finger protein GLI2	GO	GO:0000060	protein import into nucleus, translocation
Aop:460	Event:2040	decreased	PR	PR:000008026	zinc finger protein GLI1	GO	GO:0010467	gene expression
Aop:460	Event:2040	decreased	PR	PR:000008027	zinc finger protein GLI2	GO	GO:0010467	gene expression
Aop:460	Event:1821	decreased	GO	GO:0005623	cell	GO	GO:0008283	cell proliferation
Aop:460	Event:2041	increased	UBERON	UBERON:0005620	primary palate	MP	MP:0009888	palatal shelves fail to meet at midline
Aop:460	Event:2041	increased	UBERON	UBERON:0001716	secondary palate	MP	MP:0009888	palatal shelves fail to meet at midline
Aop:460	Event:2042	increased				HP	HP:0000175	Cleft palate
Aop:460	Event:2042	increased				MP	MP:0005170	cleft upper lip
Aop:460	Event:2043	decreased	PR	PR:000014841	sonic hedgehog protein	GO	GO:0019932	second-messenger-mediated signaling
Aop:460	Event:2044	decreased	PR	PR:000015288	smoothened	GO	GO:0061512	protein localization to cilium
Aop:460	Event:1262	increased				GO	GO:0006915	apoptotic process
Aop:462	Event:2934	occurrence	CL	CL:0002934	Decreased Na/K ATPas	VT	VT:0002934	Decreased Na/K ATPas	process
Aop:462	Event:2935	disrupted	MESH	MESH:0002935	Hypertension	HP	HP:0002935	Hypertension	process
Aop:463	Event:2936	occurrence	CL	CL:0002936	Activation	VT	VT:0002936	Activation	process
Aop:463	Event:2937	disrupted	MESH	MESH:0002937	Up Regulation	HP	HP:0002937	Up Regulation	process
Aop:463	Event:2938	morphological change	UBERON	UBERON:0002938	Increase	GO	GO:0002938	Increase	process
Aop:463	Event:2939	increased	PR	PR:0002939	Accumulation	MP	MP:0002939	Accumulation	process
Aop:463	Event:2940	decreased	CHEBI	CHEBI:0002940	Increased	VT	VT:0002940	Increased	process
Aop:464	Event:2941	occurrence	CL	CL:0002941	Activation	VT	VT:0002941	Activation	process
Aop:464	Event:2942	disrupted	MESH	MESH:0002942	Increased	HP	HP:0002942	Increased	process
Aop:464	Event:2943	morphological change	UBERON	UBERON:0002943	Synthesis	GO	GO:0002943	Synthesis	process
Aop:464	Event:2944	increased	PR	PR:0002944	Accumulation	MP	MP:0002944	Accumulation	process
Aop:464	Event:2945	decreased	CHEBI	CHEBI:0002945	Increased	VT	VT:0002945	Increased	process
Aop:465	Event:2946	occurrence	CL	CL:0002946	Cardiac ion channels	VT	VT:0002946	Cardiac ion channels	process
Aop:465	Event:2947	disrupted	MESH	MESH:0002947	Prolongation of Acti	HP	HP:0002947	Prolongation of Acti	process
Aop:465	Event:2948	morphological change	UBERON	UBERON:0002948	Increased the early 	GO	GO:0002948	Increased the early 	process
Aop:465	Event:2949	increased	PR	PR:0002949	Increased incidence 	MP	MP:0002949	Increased incidence 	process
Aop:466	Event:2950	occurrence	CL	CL:0002950	Agonism	VT	VT:0002950	Agonism	process
Aop:466	Event:2951	disrupted	MESH	MESH:0002951	Altered expression o	HP	HP:0002951	Altered expression o	process
Aop:466	Event:2952	morphological change	UBERON	UBERON:0002952	Decreased proliferat	GO	GO:0002952	Decreased proliferat	process
Aop:466	Event:2953	increased	PR	PR:0002953	Altered brain morpho	MP	MP:0002953	Altered brain morpho	process
Aop:466	Event:2954	decreased	CHEBI	CHEBI:0002954	Impairment	VT	VT:0002954	Impairment	process
Aop:467	Event:2955	occurrence	CL	CL:0002955	Increased	VT	VT:0002955	Increased	process
Aop:467	Event:2956	disrupted	MESH	MESH:0002956	Increase	HP	HP:0002956	Increase	process
Aop:467	Event:2957	morphological change	UBERON	UBERON:0002957	Oxidative Stress	GO	GO:0002957	Oxidative Stress	process
Aop:467	Event:2958	increased	PR	PR:0002958	Increase	MP	MP:0002958	Increase	process
Aop:467	Event:2959	decreased	CHEBI	CHEBI:0002959	Increased	VT	VT:0002959	Increased	process
Aop:467	Event:2960	occurrence	CL	CL:0002960	Impaired	HP	HP:0002960	Impaired	process
Aop:467	Event:2961	disrupted	MESH	MESH:0002961	Decreased	GO	GO:0002961	Decreased	process
Aop:468	Event:2962	occurrence	CL	CL:0002962	Antagonism	VT	VT:0002962	Antagonism	process
Aop:468	Event:2963	disrupted	MESH	MESH:0002963	inhibition	HP	HP:0002963	inhibition	process
Aop:468	Event:2964	morphological change	UBERON	UBERON:0002964	Inhibition	GO	GO:0002964	Inhibition	process
Aop:468	Event:2965	increased	PR	PR:0002965	Aberrant	MP	MP:0002965	Aberrant	process
Aop:468	Event:2966	decreased	CHEBI	CHEBI:0002966	Decrease of neuronal	VT	VT:0002966	Decrease of neuronal	process
Aop:468	Event:2967	occurrence	CL	CL:0002967	autism-like behavior	HP	HP:0002967	autism-like behavior	process
Aop:469	Event:2968	occurrence	CL	CL:0002968	Agonism	VT	VT:0002968	Agonism	process
Aop:469	Event:2969	disrupted	MESH	MESH:0002969	Altered expression o	HP	HP:0002969	Altered expression o	process
Aop:469	Event:2970	morphological change	UBERON	UBERON:0002970	Decreased proliferat	GO	GO:0002970	Decreased proliferat	process
Aop:469	Event:2971	increased	PR	PR:0002971	Reduced cortical thi	MP	MP:0002971	Reduced cortical thi	process
Aop:469	Event:2972	decreased	CHEBI	CHEBI:0002972	Increase risk	VT	VT:0002972	Increase risk	process
Aop:470	Event:2973	occurrence	CL	CL:0002973	Human leukocyte antigen DQ2/8-gluten complexes	VT	VT:0002973	Human leukocyte antigen DQ2/8-gluten complexes	process
Aop:470	Event:2974	disrupted	MESH	MESH:0002974	Gluten-reactive T cell receptors	HP	HP:0002974	Gluten-reactive T cell receptors	process
Aop:470	Event:2975	morphological change	UBERON	UBERON:0002975	Gluten-reactive and transglutaminase 2 reactive B cell receptors	GO	GO:0002975	Gluten-reactive and transglutaminase 2 reactive B cell receptors	process
Aop:470	Event:2976	increased	PR	PR:0002976	Gluten reactive adaptive T-cells with antigen presenting cells	MP	MP:0002976	Gluten reactive adaptive T-cells with antigen presenting cells	process
Aop:470	Event:2977	decreased	CHEBI	CHEBI:0002977	Innate immune response	VT	VT:0002977	Innate immune response	process
Aop:470	Event:2978	occurrence	CL	CL:0002978	Gluten-reactive CD4+ T cells	HP	HP:0002978	Gluten-reactive CD4+ T cells	process
Aop:470	Event:2979	disrupted	MESH	MESH:0002979	Gluten-reactive B cells and transglutaminase 2-reactive B cells	GO	GO:0002979	Gluten-reactive B cells and transglutaminase 2-reactive B cells	process
Aop:470	Event:2980	morphological change	UBERON	UBERON:0002980	Intestinal barrier	MP	MP:0002980	Intestinal barrier	process
Aop:470	Event:2981	increased	PR	PR:0002981	Celiac disease	VT	VT:0002981	Celiac disease	process
Aop:471	Event:2982	occurrence	CL	CL:0002982	Binding of antagonis	VT	VT:0002982	Binding of antagonis	process
Aop:471	Event:2983	disrupted	MESH	MESH:0002983	Binding of antagonis	HP	HP:0002983	Binding of antagonis	process
Aop:471	Event:2984	morphological change	UBERON	UBERON:0002984	Binding of (ant)agon	GO	GO:0002984	Binding of (ant)agon	process
Aop:471	Event:2985	increased	PR	PR:0002985	Binding of (ant)agon	MP	MP:0002985	Binding of (ant)agon	process
Aop:471	Event:2986	decreased	CHEBI	CHEBI:0002986	Antagonism	VT	VT:0002986	Antagonism	process
Aop:471	Event:2987	occurrence	CL	CL:0002987	Antagonism	HP	HP:0002987	Antagonism	process
Aop:471	Event:2988	disrupted	MESH	MESH:0002988	Altered Liver X rece	GO	GO:0002988	Altered Liver X rece	process
Aop:471	Event:2989	morphological change	UBERON	UBERON:0002989	Altered peroxisome p	MP	MP:0002989	Altered peroxisome p	process
Aop:471	Event:2990	increased	PR	PR:0002990	Altered	VT	VT:0002990	Altered	process
Aop:471	Event:2991	decreased	CHEBI	CHEBI:0002991	Reduced number of ol	HP	HP:0002991	Reduced number of ol	process
Aop:471	Event:2992	occurrence	CL	CL:0002992	Hypomyelination	GO	GO:0002992	Hypomyelination	process
Aop:471	Event:2993	disrupted	MESH	MESH:0002993	Altered	MP	MP:0002993	Altered	process
Aop:471	Event:2994	morphological change	UBERON	UBERON:0002994	Impairment	VT	VT:0002994	Impairment	process
Aop:472	Event:2995	occurrence	CL	CL:0002995	Decreased	VT	VT:0002995	Decreased	process
Aop:472	Event:2996	disrupted	MESH	MESH:0002996	Decreased	HP	HP:0002996	Decreased	process
Aop:472	Event:2997	morphological change	UBERON	UBERON:0002997	Decrease	GO	GO:0002997	Decrease	process
Aop:472	Event:2998	increased	PR	PR:0002998	Epididymal agenesis	MP	MP:0002998	Epididymal agenesis	process
Aop:472	Event:2999	decreased	CHEBI	CHEBI:0002999	Impaired	VT	VT:0002999	Impaired	process
Aop:473	Event:3000	occurrence	CL	CL:0003000	Decreased	VT	VT:0003000	Decreased	process
Aop:473	Event:3001	disrupted	MESH	MESH:0003001	Decreased	HP	HP:0003001	Decreased	process
Aop:473	Event:3002	morphological change	UBERON	UBERON:0003002	Decrease	GO	GO:0003002	Decrease	process
Aop:473	Event:3003	increased	PR	PR:0003003	Impaired	MP	MP:0003003	Impaired	process
Aop:473	Event:3004	decreased	CHEBI	CHEBI:0003004	Hypospadias	VT	VT:0003004	Hypospadias	process
Aop:474	Event:3005	occurrence	CL	CL:0003005	Decreased	VT	VT:0003005	Decreased	process
Aop:474	Event:3006	disrupted	MESH	MESH:0003006	Impaired inguinoscro	HP	HP:0003006	Impaired inguinoscro	process
Aop:474	Event:3007	morphological change	UBERON	UBERON:0003007	Malformation	GO	GO:0003007	Malformation	process
Aop:475	Event:3008	occurrence	CL	CL:0003008	Stressor binding PPA	VT	VT:0003008	Stressor binding PPA	process
Aop:475	Event:3009	disrupted	MESH	MESH:0003009	Disrupted PPAR isofo	HP	HP:0003009	Disrupted PPAR isofo	process
Aop:475	Event:3010	morphological change	UBERON	UBERON:0003010	Dysregulation of tra	GO	GO:0003010	Dysregulation of tra	process
Aop:475	Event:3011	increased	PR	PR:0003011	Decrease	MP	MP:0003011	Decrease	process
Aop:475	Event:3012	decreased	CHEBI	CHEBI:0003012	Disrupted Lipid Stor	VT	VT:0003012	Disrupted Lipid Stor	process
Aop:475	Event:3013	occurrence	CL	CL:0003013	Accumulation	HP	HP:0003013	Accumulation	process
Aop:475	Event:3014	disrupted	MESH	MESH:0003014	Accumulation	GO	GO:0003014	Accumulation	process
Aop:475	Event:3015	morphological change	UBERON	UBERON:0003015	Increased	MP	MP:0003015	Increased	process
Aop:476	Event:3016	occurrence	CL	CL:0003016	Endocytotic lysosoma	VT	VT:0003016	Endocytotic lysosoma	process
Aop:476	Event:3017	disrupted	MESH	MESH:0003017	Disruption	HP	HP:0003017	Disruption	process
Aop:476	Event:3018	morphological change	UBERON	UBERON:0003018	Mitochondrial dysfun	GO	GO:0003018	Mitochondrial dysfun	process
Aop:476	Event:3019	increased	PR	PR:0003019	Increase	MP	MP:0003019	Increase	process
Aop:476	Event:3020	decreased	CHEBI	CHEBI:0003020	Intestinal barrier	VT	VT:0003020	Intestinal barrier	process
Aop:477	Event:2082	abnormal	UBERON	UBERON:0000989	penis	GO	GO:0048568	embryonic organ development
Aop:477	Event:26	decreased	PR	PR:000004191	androgen receptor	GO	GO:0004882	androgen receptor activity
Aop:477	Event:1614	decreased	PR	PR:000004191	androgen receptor	GO	GO:0004882	androgen receptor activity
Aop:478	Event:3021	occurrence	CL	CL:0003021	Agonism	VT	VT:0003021	Agonism	process
Aop:478	Event:3022	disrupted	MESH	MESH:0003022	Cerebellar gene expr	HP	HP:0003022	Cerebellar gene expr	process
Aop:478	Event:3023	morphological change	UBERON	UBERON:0003023	Cerebellar neuronal 	GO	GO:0003023	Cerebellar neuronal 	process
Aop:478	Event:3024	increased	PR	PR:0003024	Cerebellar hypoplasi	MP	MP:0003024	Cerebellar hypoplasi	process
Aop:478	Event:3025	decreased	CHEBI	CHEBI:0003025	Locomotor function. 	VT	VT:0003025	Locomotor function. 	process
Aop:479	Event:3026	occurrence	CL	CL:0003026	Antagonism	VT	VT:0003026	Antagonism	process
Aop:479	Event:3027	disrupted	MESH	MESH:0003027	Altered	HP	HP:0003027	Altered	process
Aop:479	Event:3028	morphological change	UBERON	UBERON:0003028	Decrease of GABAergi	GO	GO:0003028	Decrease of GABAergi	process
Aop:479	Event:3029	increased	PR	PR:0003029	Decrease of synaptog	MP	MP:0003029	Decrease of synaptog	process
Aop:479	Event:3030	decreased	CHEBI	CHEBI:0003030	Decrease of neuronal	VT	VT:0003030	Decrease of neuronal	process
Aop:479	Event:3031	occurrence	CL	CL:0003031	Impairment	HP	HP:0003031	Impairment	process
Aop:480	Event:3032	occurrence	CL	CL:0003032	Succinate dehydrogenase	VT	VT:0003032	Succinate dehydrogenase	process
Aop:480	Event:3033	disrupted	MESH	MESH:0003033	Decrease	HP	HP:0003033	Decrease	process
Aop:480	Event:3034	morphological change	UBERON	UBERON:0003034	Increase	GO	GO:0003034	Increase	process
Aop:480	Event:3035	increased	PR	PR:0003035	Oxidative Stress	MP	MP:0003035	Oxidative Stress	process
Aop:480	Event:3036	decreased	CHEBI	CHEBI:0003036	Increase mutations	VT	VT:0003036	Increase mutations	process
Aop:480	Event:3037	occurrence	CL	CL:0003037	Increase	HP	HP:0003037	Increase	process
Aop:481	Event:3038	occurrence	CL	CL:0003038	protein-coupled estr	VT	VT:0003038	protein-coupled estr	process
Aop:481	Event:3039	disrupted	MESH	MESH:0003039	Increased	HP	HP:0003039	Increased	process
Aop:481	Event:3040	morphological change	UBERON	UBERON:0003040	Decreased	GO	GO:0003040	Decreased	process
Aop:481	Event:3041	increased	PR	PR:0003041	Oxidative Stress	MP	MP:0003041	Oxidative Stress	process
Aop:481	Event:3042	decreased	CHEBI	CHEBI:0003042	Apoptosis	VT	VT:0003042	Apoptosis	process
Aop:481	Event:3043	occurrence	CL	CL:0003043	Aberrant	HP	HP:0003043	Aberrant	process
Aop:481	Event:3044	disrupted	MESH	MESH:0003044	Disruption	GO	GO:0003044	Disruption	process
Aop:481	Event:3045	morphological change	UBERON	UBERON:0003045	Neuroinflammation	MP	MP:0003045	Neuroinflammation	process
Aop:481	Event:3046	increased	PR	PR:0003046	Impairment	VT	VT:0003046	Impairment	process
Aop:482	Event:3047	occurrence	CL	CL:0003047	Agonism	VT	VT:0003047	Agonism	process
Aop:482	Event:3048	disrupted	MESH	MESH:0003048	Increase	HP	HP:0003048	Increase	process
Aop:482	Event:3049	morphological change	UBERON	UBERON:0003049	Increase	GO	GO:0003049	Increase	process
Aop:482	Event:3050	increased	PR	PR:0003050	Increase	MP	MP:0003050	Increase	process
Aop:482	Event:3051	decreased	CHEBI	CHEBI:0003051	Increased Mortality	VT	VT:0003051	Increased Mortality	process
Aop:482	Event:3052	occurrence	CL	CL:0003052	Decrease	HP	HP:0003052	Decrease	process
Aop:483	Event:3053	occurrence	CL	CL:0003053	Agonism	VT	VT:0003053	Agonism	process
Aop:483	Event:3054	disrupted	MESH	MESH:0003054	Increase	HP	HP:0003054	Increase	process
Aop:483	Event:3055	morphological change	UBERON	UBERON:0003055	Increase	GO	GO:0003055	Increase	process
Aop:483	Event:3056	increased	PR	PR:0003056	Impaired development of	MP	MP:0003056	Impaired development of	process
Aop:483	Event:3057	decreased	CHEBI	CHEBI:0003057	Reduction	VT	VT:0003057	Reduction	process
Aop:484	Event:3058	occurrence	CL	CL:0003058	Oxidative Stress	VT	VT:0003058	Oxidative Stress	process
Aop:484	Event:3059	disrupted	MESH	MESH:0003059	The NO synthase path	HP	HP:0003059	The NO synthase path	process
Aop:484	Event:3060	morphological change	UBERON	UBERON:0003060	increasedVascular e	GO	GO:0003060	increasedVascular e	process
Aop:484	Event:3061	increased	PR	PR:0003061	Ferroptosis related 	MP	MP:0003061	Ferroptosis related 	process
Aop:484	Event:3062	decreased	CHEBI	CHEBI:0003062	Increase	VT	VT:0003062	Increase	process
Aop:485	Event:3063	occurrence	CL	CL:0003063	Decreased Na/K ATPas	VT	VT:0003063	Decreased Na/K ATPas	process
Aop:485	Event:3064	disrupted	MESH	MESH:0003064	Decreased	HP	HP:0003064	Decreased	process
Aop:485	Event:3065	morphological change	UBERON	UBERON:0003065	Decreased	GO	GO:0003065	Decreased	process
Aop:485	Event:3066	increased	PR	PR:0003066	Decreased	MP	MP:0003066	Decreased	process
Aop:485	Event:3067	decreased	CHEBI	CHEBI:0003067	Increased	VT	VT:0003067	Increased	process
Aop:485	Event:3068	occurrence	CL	CL:0003068	Increased	HP	HP:0003068	Increased	process
Aop:485	Event:3069	disrupted	MESH	MESH:0003069	Heart failure	GO	GO:0003069	Heart failure	process
Aop:486	Event:3070	occurrence	CL	CL:0003070	Increase	VT	VT:0003070	Increase	process
Aop:486	Event:3071	disrupted	MESH	MESH:0003071	Oxidative Stress	HP	HP:0003071	Oxidative Stress	process
Aop:486	Event:3072	morphological change	UBERON	UBERON:0003072	Apoptosis	GO	GO:0003072	Apoptosis	process
Aop:486	Event:3073	increased	PR	PR:0003073	Reduction	MP	MP:0003073	Reduction	process
Aop:486	Event:3074	decreased	CHEBI	CHEBI:0003074	Reduction	VT	VT:0003074	Reduction	process
Aop:486	Event:3075	occurrence	CL	CL:0003075	Reduction	HP	HP:0003075	Reduction	process
Aop:486	Event:3076	disrupted	MESH	MESH:0003076	Reduction	GO	GO:0003076	Reduction	process
Aop:486	Event:3077	morphological change	UBERON	UBERON:0003077	Reduction	MP	MP:0003077	Reduction	process
Aop:486	Event:3078	increased	PR	PR:0003078	Decrease	VT	VT:0003078	Decrease	process
Aop:487	Event:402	decreased				GO	GO:0007611	learning or memory
Aop:487	Event:402	decreased				GO	GO:0050890	cognition
Aop:488	Event:3079	occurrence	CL	CL:0003079	Neuropathy target esterase	VT	VT:0003079	Neuropathy target esterase	process
Aop:488	Event:3080	disrupted	MESH	MESH:0003080	Lysolecithin	HP	HP:0003080	Lysolecithin	process
Aop:488	Event:3081	morphological change	UBERON	UBERON:0003081	Lysolecithin cell membrane integration	GO	GO:0003081	Lysolecithin cell membrane integration	process
Aop:488	Event:3082	increased	PR	PR:0003082	Oligodendrocyte death	MP	MP:0003082	Oligodendrocyte death	process
Aop:488	Event:3083	decreased	CHEBI	CHEBI:0003083	Demyelination	VT	VT:0003083	Demyelination	process
Aop:488	Event:3084	occurrence	CL	CL:0003084	Delayed neuropathy	HP	HP:0003084	Delayed neuropathy	process
Aop:489	Event:3085	occurrence	CL	CL:0003085	Neuropathy target esterase	VT	VT:0003085	Neuropathy target esterase	process
Aop:489	Event:3086	disrupted	MESH	MESH:0003086	Lysolecithin	HP	HP:0003086	Lysolecithin	process
Aop:489	Event:3087	morphological change	UBERON	UBERON:0003087	Increase	GO	GO:0003087	Increase	process
Aop:489	Event:3088	increased	PR	PR:0003088	Oligodendrocyte death	MP	MP:0003088	Oligodendrocyte death	process
Aop:489	Event:3089	decreased	CHEBI	CHEBI:0003089	Demyelination	VT	VT:0003089	Demyelination	process
Aop:489	Event:3090	occurrence	CL	CL:0003090	Delayed neuropathy	HP	HP:0003090	Delayed neuropathy	process
Aop:490	Event:3091	occurrence	CL	CL:0003091	Activation	VT	VT:0003091	Activation	process
Aop:490	Event:3092	disrupted	MESH	MESH:0003092	Decreased	HP	HP:0003092	Decreased	process
Aop:490	Event:3093	morphological change	UBERON	UBERON:0003093	Increased	GO	GO:0003093	Increased	process
Aop:490	Event:3094	increased	PR	PR:0003094	Increased	MP	MP:0003094	Increased	process
Aop:490	Event:3095	decreased	CHEBI	CHEBI:0003095	Increased	VT	VT:0003095	Increased	process
Aop:491	Event:3096	occurrence	CL	CL:0003096	Succinate dehydrogenase	VT	VT:0003096	Succinate dehydrogenase	process
Aop:491	Event:3097	disrupted	MESH	MESH:0003097	Succinate Accumulati	HP	HP:0003097	Succinate Accumulati	process
Aop:491	Event:3098	morphological change	UBERON	UBERON:0003098	Inhibition	GO	GO:0003098	Inhibition	process
Aop:491	Event:3099	increased	PR	PR:0003099	N/A	MP	MP:0003099	N/A	process
Aop:491	Event:3100	decreased	CHEBI	CHEBI:0003100	Increase	VT	VT:0003100	Increase	process
Aop:492	Event:3101	occurrence	CL	CL:0003101	Agonism	VT	VT:0003101	Agonism	process
Aop:492	Event:3102	disrupted	MESH	MESH:0003102	Androgen receptor activation	HP	HP:0003102	Androgen receptor activation	process
Aop:492	Event:3103	morphological change	UBERON	UBERON:0003103	Altered	GO	GO:0003103	Altered	process
Aop:493	Event:3104	occurrence	CL	CL:0003104	Activation	VT	VT:0003104	Activation	process
Aop:493	Event:3105	disrupted	MESH	MESH:0003105	Decreased	HP	HP:0003105	Decreased	process
Aop:493	Event:3106	morphological change	UBERON	UBERON:0003106	Increased	GO	GO:0003106	Increased	process
Aop:493	Event:3107	increased	PR	PR:0003107	Increased	MP	MP:0003107	Increased	process
Aop:493	Event:3108	decreased	CHEBI	CHEBI:0003108	Increased	VT	VT:0003108	Increased	process
Aop:494	Event:3109	occurrence	CL	CL:0003109	Inhibition	VT	VT:0003109	Inhibition	process
Aop:494	Event:3110	disrupted	MESH	MESH:0003110	Inhibition	HP	HP:0003110	Inhibition	process
Aop:494	Event:3111	morphological change	UBERON	UBERON:0003111	Reduction	GO	GO:0003111	Reduction	process
Aop:494	Event:3112	increased	PR	PR:0003112	Reduction	MP	MP:0003112	Reduction	process
Aop:494	Event:3113	decreased	CHEBI	CHEBI:0003113	Reduction	VT	VT:0003113	Reduction	process
Aop:494	Event:3114	occurrence	CL	CL:0003114	Growth	HP	HP:0003114	Growth	process
Aop:494	Event:3115	disrupted	MESH	MESH:0003115	Reduction	GO	GO:0003115	Reduction	process
Aop:494	Event:3116	morphological change	UBERON	UBERON:0003116	Decreased	MP	MP:0003116	Decreased	process
Aop:495	Event:3117	occurrence	CL	CL:0003117	Increased LMNA Mutat	VT	VT:0003117	Increased LMNA Mutat	process
Aop:495	Event:3118	disrupted	MESH	MESH:0003118	Structural changes i	HP	HP:0003118	Structural changes i	process
Aop:495	Event:3119	morphological change	UBERON	UBERON:0003119	Altered Signaling Pa	GO	GO:0003119	Altered Signaling Pa	process
Aop:495	Event:3120	increased	PR	PR:0003120	IncreasedCardiac fi	MP	MP:0003120	IncreasedCardiac fi	process
Aop:495	Event:3121	decreased	CHEBI	CHEBI:0003121	Heart failure	VT	VT:0003121	Heart failure	process
Aop:496	Event:3122	occurrence	CL	CL:0003122	Increased Muscarinic	VT	VT:0003122	Increased Muscarinic	process
Aop:496	Event:3123	disrupted	MESH	MESH:0003123	Increased	HP	HP:0003123	Increased	process
Aop:496	Event:3124	morphological change	UBERON	UBERON:0003124	Disruption	GO	GO:0003124	Disruption	process
Aop:496	Event:3125	increased	PR	PR:0003125	Increased delay in h	MP	MP:0003125	Increased delay in h	process
Aop:496	Event:3126	decreased	CHEBI	CHEBI:0003126	Occurrence	VT	VT:0003126	Occurrence	process
Aop:497	Event:3127	occurrence	CL	CL:0003127	Blockade	VT	VT:0003127	Blockade	process
Aop:497	Event:3128	disrupted	MESH	MESH:0003128	Altered	HP	HP:0003128	Altered	process
Aop:497	Event:3129	morphological change	UBERON	UBERON:0003129	Prolongation of QT i	GO	GO:0003129	Prolongation of QT i	process
Aop:497	Event:3130	increased	PR	PR:0003130	Torsades de Pointes	MP	MP:0003130	Torsades de Pointes	process
Aop:497	Event:3131	decreased	CHEBI	CHEBI:0003131	Increased uncoordina	VT	VT:0003131	Increased uncoordina	process
Aop:497	Event:3132	occurrence	CL	CL:0003132	Heart failure	HP	HP:0003132	Heart failure	process
Aop:498	Event:3133	occurrence	CL	CL:0003133	Inhibition	VT	VT:0003133	Inhibition	process
Aop:498	Event:3134	disrupted	MESH	MESH:0003134	Altered	HP	HP:0003134	Altered	process
Aop:498	Event:3135	morphological change	UBERON	UBERON:0003135	Decrease	GO	GO:0003135	Decrease	process
Aop:498	Event:3136	increased	PR	PR:0003136	Heart failure	MP	MP:0003136	Heart failure	process
Aop:499	Event:3137	occurrence	CL	CL:0003137	Activation	VT	VT:0003137	Activation	process
Aop:499	Event:3138	disrupted	MESH	MESH:0003138	Increased Intracellu	HP	HP:0003138	Increased Intracellu	process
Aop:499	Event:3139	morphological change	UBERON	UBERON:0003139	Increased the delaye	GO	GO:0003139	Increased the delaye	process
Aop:499	Event:3140	increased	PR	PR:0003140	Occurrence	MP	MP:0003140	Occurrence	process
Aop:500	Event:3141	occurrence	CL	CL:0003141	Inhibition	VT	VT:0003141	Inhibition	process
Aop:500	Event:3142	disrupted	MESH	MESH:0003142	Prolongation of Acti	HP	HP:0003142	Prolongation of Acti	process
Aop:500	Event:3143	morphological change	UBERON	UBERON:0003143	Prolongation of QT i	GO	GO:0003143	Prolongation of QT i	process
Aop:500	Event:3144	increased	PR	PR:0003144	Increased the early 	MP	MP:0003144	Increased the early 	process
Aop:500	Event:3145	decreased	CHEBI	CHEBI:0003145	Heart failure	VT	VT:0003145	Heart failure	process
Aop:501	Event:3146	occurrence	CL	CL:0003146	Decreased Na/K ATPas	VT	VT:0003146	Decreased Na/K ATPas	process
Aop:501	Event:3147	disrupted	MESH	MESH:0003147	Increased	HP	HP:0003147	Increased	process
Aop:501	Event:3148	morphological change	UBERON	UBERON:0003148	Impaired Sodium-Calc	GO	GO:0003148	Impaired Sodium-Calc	process
Aop:501	Event:3149	increased	PR	PR:0003149	Increased	MP	MP:0003149	Increased	process
Aop:501	Event:3150	decreased	CHEBI	CHEBI:0003150	Decrease	VT	VT:0003150	Decrease	process
Aop:501	Event:3151	occurrence	CL	CL:0003151	Heart failure	HP	HP:0003151	Heart failure	process
Aop:502	Event:3152	occurrence	CL	CL:0003152	Increased activity	VT	VT:0003152	Increased activity	process
Aop:502	Event:3153	disrupted	MESH	MESH:0003153	Abnormal Cardiac Str	HP	HP:0003153	Abnormal Cardiac Str	process
Aop:503	Event:3154	occurrence	CL	CL:0003154	Phosphodiesterase in	VT	VT:0003154	Phosphodiesterase in	process
Aop:503	Event:3155	disrupted	MESH	MESH:0003155	Increased	HP	HP:0003155	Increased	process
Aop:503	Event:3156	morphological change	UBERON	UBERON:0003156	Hyperphosphorylation	GO	GO:0003156	Hyperphosphorylation	process
Aop:503	Event:3157	increased	PR	PR:0003157	Increased	MP	MP:0003157	Increased	process
Aop:503	Event:3158	decreased	CHEBI	CHEBI:0003158	Decrease	VT	VT:0003158	Decrease	process
Aop:503	Event:3159	occurrence	CL	CL:0003159	Heart failure	HP	HP:0003159	Heart failure	process
Aop:504	Event:3160	occurrence	CL	CL:0003160	Acetylcholinesterase	VT	VT:0003160	Acetylcholinesterase	process
Aop:504	Event:3161	disrupted	MESH	MESH:0003161	Increased Muscarinic	HP	HP:0003161	Increased Muscarinic	process
Aop:504	Event:3162	morphological change	UBERON	UBERON:0003162	Altered	GO	GO:0003162	Altered	process
Aop:504	Event:3163	increased	PR	PR:0003163	Increased delay in h	MP	MP:0003163	Increased delay in h	process
Aop:504	Event:3164	decreased	CHEBI	CHEBI:0003164	Occurrence	VT	VT:0003164	Occurrence	process
Aop:505	Event:3165	occurrence	CL	CL:0003165	Inhibition of Funny 	VT	VT:0003165	Inhibition of Funny 	process
Aop:505	Event:3166	disrupted	MESH	MESH:0003166	Slowed Heart Rate	HP	HP:0003166	Slowed Heart Rate	process
Aop:505	Event:3167	morphological change	UBERON	UBERON:0003167	Altered Cardiac Elec	GO	GO:0003167	Altered Cardiac Elec	process
Aop:505	Event:3168	increased	PR	PR:0003168	Occurrence	MP	MP:0003168	Occurrence	process
Aop:506	Event:3169	occurrence	CL	CL:0003169	Aromatase	VT	VT:0003169	Aromatase	process
Aop:506	Event:3170	disrupted	MESH	MESH:0003170	Increased	HP	HP:0003170	Increased	process
Aop:506	Event:3171	morphological change	UBERON	UBERON:0003171	Plasma estradiol	GO	GO:0003171	Plasma estradiol	process
Aop:506	Event:3172	increased	PR	PR:0003172	Estradiol availability	MP	MP:0003172	Estradiol availability	process
Aop:506	Event:3173	decreased	CHEBI	CHEBI:0003173	Activation	VT	VT:0003173	Activation	process
Aop:507	Event:3174	occurrence	CL	CL:0003174	HCN Channel Inhibiti	VT	VT:0003174	HCN Channel Inhibiti	process
Aop:507	Event:3175	disrupted	MESH	MESH:0003175	Reduced Pacemaker Ac	HP	HP:0003175	Reduced Pacemaker Ac	process
Aop:507	Event:3176	morphological change	UBERON	UBERON:0003176	Slowed Heart Rate	GO	GO:0003176	Slowed Heart Rate	process
Aop:507	Event:3177	increased	PR	PR:0003177	Altered Cardiac Elec	MP	MP:0003177	Altered Cardiac Elec	process
Aop:507	Event:3178	decreased	CHEBI	CHEBI:0003178	Occurrence	VT	VT:0003178	Occurrence	process
Aop:508	Event:3179	occurrence	CL	CL:0003179	Activation	VT	VT:0003179	Activation	process
Aop:508	Event:3180	disrupted	MESH	MESH:0003180	dimerization	HP	HP:0003180	dimerization	process
Aop:508	Event:3181	morphological change	UBERON	UBERON:0003181	increased	GO	GO:0003181	increased	process
Aop:508	Event:3182	increased	PR	PR:0003182	Apoptosis	MP	MP:0003182	Apoptosis	process
Aop:508	Event:3183	decreased	CHEBI	CHEBI:0003183	Decreased	VT	VT:0003183	Decreased	process
Aop:508	Event:3184	occurrence	CL	CL:0003184	Premature ovarian In	HP	HP:0003184	Premature ovarian In	process
Aop:509	Event:3185	occurrence	CL	CL:0003185	Mitochondrial Comple	VT	VT:0003185	Mitochondrial Comple	process
Aop:509	Event:3186	disrupted	MESH	MESH:0003186	Altered	HP	HP:0003186	Altered	process
Aop:509	Event:3187	morphological change	UBERON	UBERON:0003187	Disruption	GO	GO:0003187	Disruption	process
Aop:509	Event:3188	increased	PR	PR:0003188	Decrease	MP	MP:0003188	Decrease	process
Aop:509	Event:3189	decreased	CHEBI	CHEBI:0003189	Disruption	VT	VT:0003189	Disruption	process
Aop:509	Event:3190	occurrence	CL	CL:0003190	Disruption	HP	HP:0003190	Disruption	process
Aop:509	Event:3191	disrupted	MESH	MESH:0003191	Abnormal	GO	GO:0003191	Abnormal	process
Aop:509	Event:3192	morphological change	UBERON	UBERON:0003192	impaired	MP	MP:0003192	impaired	process
Aop:509	Event:3193	increased	PR	PR:0003193	Increase	VT	VT:0003193	Increase	process
Aop:509	Event:3194	decreased	CHEBI	CHEBI:0003194	Increased Mortality	HP	HP:0003194	Increased Mortality	process
Aop:509	Event:3195	occurrence	CL	CL:0003195	Decrease	GO	GO:0003195	Decrease	process
Aop:510	Event:3196	occurrence	CL	CL:0003196	17-Hydroxysteroid dehydrogenase 2	VT	VT:0003196	17-Hydroxysteroid dehydrogenase 2	process
Aop:510	Event:3197	disrupted	MESH	MESH:0003197	Estradiol availability	HP	HP:0003197	Estradiol availability	process
Aop:510	Event:3198	morphological change	UBERON	UBERON:0003198	Activation	GO	GO:0003198	Activation	process
Aop:511	Event:3199	occurrence	CL	CL:0003199	Decreased	VT	VT:0003199	Decreased	process
Aop:511	Event:3200	disrupted	MESH	MESH:0003200	Decreased	HP	HP:0003200	Decreased	process
Aop:511	Event:3201	morphological change	UBERON	UBERON:0003201	Impaired ovulation	GO	GO:0003201	Impaired ovulation	process
Aop:511	Event:3202	increased	PR	PR:0003202	Increased plasma est	MP	MP:0003202	Increased plasma est	process
Aop:511	Event:3203	decreased	CHEBI	CHEBI:0003203	Estradiol availability	VT	VT:0003203	Estradiol availability	process
Aop:511	Event:3204	occurrence	CL	CL:0003204	Persistent vaginal c	HP	HP:0003204	Persistent vaginal c	process
Aop:512	Event:3205	occurrence	CL	CL:0003205	Binding of plastoqui	VT	VT:0003205	Binding of plastoqui	process
Aop:512	Event:3206	disrupted	MESH	MESH:0003206	Decrease	HP	HP:0003206	Decrease	process
Aop:512	Event:3207	morphological change	UBERON	UBERON:0003207	Decrease	GO	GO:0003207	Decrease	process
Aop:512	Event:3208	increased	PR	PR:0003208	Decrease in mitochon	MP	MP:0003208	Decrease in mitochon	process
Aop:512	Event:3209	decreased	CHEBI	CHEBI:0003209	Decrease	VT	VT:0003209	Decrease	process
Aop:512	Event:3210	occurrence	CL	CL:0003210	Decrease	HP	HP:0003210	Decrease	process
Aop:513	Event:3211	occurrence	CL	CL:0003211	Inhibition	VT	VT:0003211	Inhibition	process
Aop:513	Event:3212	disrupted	MESH	MESH:0003212	Increased	HP	HP:0003212	Increased	process
Aop:513	Event:3213	morphological change	UBERON	UBERON:0003213	Increased	GO	GO:0003213	Increased	process
Aop:513	Event:3214	increased	PR	PR:0003214	Inhibition	MP	MP:0003214	Inhibition	process
Aop:514	Event:3215	occurrence	CL	CL:0003215	Decreased DNA methyl	VT	VT:0003215	Decreased DNA methyl	process
Aop:514	Event:3216	disrupted	MESH	MESH:0003216	Elevated gene expres	HP	HP:0003216	Elevated gene expres	process
Aop:514	Event:3217	morphological change	UBERON	UBERON:0003217	Inhibition of PI3K-A	GO	GO:0003217	Inhibition of PI3K-A	process
Aop:514	Event:3218	increased	PR	PR:0003218	Increase	MP	MP:0003218	Increase	process
Aop:514	Event:3219	decreased	CHEBI	CHEBI:0003219	Increase	VT	VT:0003219	Increase	process
Aop:514	Event:3220	occurrence	CL	CL:0003220	decreased	HP	HP:0003220	decreased	process
Aop:515	Event:3221	occurrence	CL	CL:0003221	Decrease	VT	VT:0003221	Decrease	process
Aop:515	Event:3222	disrupted	MESH	MESH:0003222	Decrease	HP	HP:0003222	Decrease	process
Aop:515	Event:3223	morphological change	UBERON	UBERON:0003223	Decrease	GO	GO:0003223	Decrease	process
Aop:515	Event:3224	increased	PR	PR:0003224	Altered	MP	MP:0003224	Altered	process
Aop:515	Event:3225	decreased	CHEBI	CHEBI:0003225	Hypospadias	VT	VT:0003225	Hypospadias	process
Aop:516	Event:3226	occurrence	CL	CL:0003226	Inhibition	VT	VT:0003226	Inhibition	process
Aop:516	Event:3227	disrupted	MESH	MESH:0003227	Decrease	HP	HP:0003227	Decrease	process
Aop:516	Event:3228	morphological change	UBERON	UBERON:0003228	Decrease	GO	GO:0003228	Decrease	process
Aop:516	Event:3229	increased	PR	PR:0003229	Altered	MP	MP:0003229	Altered	process
Aop:516	Event:3230	decreased	CHEBI	CHEBI:0003230	Hypospadias	VT	VT:0003230	Hypospadias	process
Aop:517	Event:239	increased	PR	PR:000011397	nuclear receptor subfamily 1 group I member 2	GO	GO:0023052	signaling
Aop:517	Event:54	increased	PR	PR:000001905	platelet glycoprotein 4	GO	GO:0010467	gene expression
Aop:517	Event:115	increased	CHEBI	CHEBI:35366	fatty acid	GO	GO:2000193	positive regulation of fatty acid transport
Aop:517	Event:291	increased	CHEBI	CHEBI:17855	triglyceride			
Aop:517	Event:459	increased				HP	HP:0001397	Hepatic steatosis
Aop:518	Event:3231	occurrence	CL	CL:0003231	Inhibition	VT	VT:0003231	Inhibition	process
Aop:518	Event:3232	disrupted	MESH	MESH:0003232	Increase	HP	HP:0003232	Increase	process
Aop:518	Event:3233	morphological change	UBERON	UBERON:0003233	Increased	GO	GO:0003233	Increased	process
Aop:519	Event:3234	occurrence	CL	CL:0003234	Inhibition	VT	VT:0003234	Inhibition	process
Aop:519	Event:3235	disrupted	MESH	MESH:0003235	Increase	HP	HP:0003235	Increase	process
Aop:519	Event:3236	morphological change	UBERON	UBERON:0003236	Loss of olfactory fu	GO	GO:0003236	Loss of olfactory fu	process
Aop:520	Event:3237	occurrence	CL	CL:0003237	Decrease	VT	VT:0003237	Decrease	process
Aop:520	Event:3238	disrupted	MESH	MESH:0003238	Decrease	HP	HP:0003238	Decrease	process
Aop:520	Event:3239	morphological change	UBERON	UBERON:0003239	Decrease	GO	GO:0003239	Decrease	process
Aop:520	Event:3240	increased	PR	PR:0003240	Altered	MP	MP:0003240	Altered	process
Aop:520	Event:3241	decreased	CHEBI	CHEBI:0003241	Nipple retention (NR)	VT	VT:0003241	Nipple retention (NR)	process
Aop:521	Event:3242	occurrence	CL	CL:0003242	Inhibition	VT	VT:0003242	Inhibition	process
Aop:521	Event:3243	disrupted	MESH	MESH:0003243	Decrease	HP	HP:0003243	Decrease	process
Aop:521	Event:3244	morphological change	UBERON	UBERON:0003244	Decrease	GO	GO:0003244	Decrease	process
Aop:521	Event:3245	increased	PR	PR:0003245	Altered	MP	MP:0003245	Altered	process
Aop:521	Event:3246	decreased	CHEBI	CHEBI:0003246	Nipple retention (NR)	VT	VT:0003246	Nipple retention (NR)	process
Aop:522	Event:112	decreased	PR	PR:000007204	estrogen receptor	GO	GO:0030284	estrogen receptor activity
Aop:522	Event:195	decreased	GO	GO:0017146	NMDA selective glutamate receptor complex	GO	GO:0004972	NMDA glutamate receptor activity
Aop:522	Event:386	decreased				GO	GO:0099536	synaptic signaling
Aop:523	Event:3247	occurrence	CL	CL:0003247	Activation	VT	VT:0003247	Activation	process
Aop:523	Event:3248	disrupted	MESH	MESH:0003248	Over-expression of P	HP	HP:0003248	Over-expression of P	process
Aop:523	Event:3249	morphological change	UBERON	UBERON:0003249	Dysregulation of Tre	GO	GO:0003249	Dysregulation of Tre	process
Aop:523	Event:3250	increased	PR	PR:0003250	Lymphocytes T CD8+ c	MP	MP:0003250	Lymphocytes T CD8+ c	process
Aop:523	Event:3251	decreased	CHEBI	CHEBI:0003251	Increased	VT	VT:0003251	Increased	process
Aop:524	Event:2252	occurrence	FMA	FMA:84795	Human leukocyte antigen complex	VT	VT:0001835	antigen presentation trait
Aop:524	Event:2253	occurrence	GO	GO:0042105	alpha-beta T cell receptor complex	GO	GO:0035822	gene conversion
Aop:524	Event:2254	occurrence	GO	GO:0019815	B cell receptor complex	GO	GO:0002206	gene conversion of immunoglobulin genes
Aop:524	Event:2255	occurrence				GO	GO:0002376	immune system process
Aop:524	Event:2256	occurrence	CL	CL:0000236	B cell	GO	GO:0002312	B cell activation involved in immune response
Aop:524	Event:1931	disrupted	CL	CL:0000073	barrier epithelial cell			
Aop:524	Event:2257	pathological	CL	CL:0002563	intestinal epithelial cell	HP	HP:0002608	Celiac disease
Aop:524	Event:2260	occurrence	CL	CL:0000084	T cell	GO	GO:0002286	T cell activation involved in immune response
Aop:524	Event:2275	occurrence	CL	CL:0000084	T cell	GO	GO:0072678	T cell migration
Aop:524	Event:2275	occurrence	CL	CL:0000145	professional antigen presenting cell	GO	GO:0036336	dendritic cell migration
Aop:525	Event:3252	occurrence	CL	CL:0003252	Activation	VT	VT:0003252	Activation	process
Aop:525	Event:3253	disrupted	MESH	MESH:0003253	Accumulation	HP	HP:0003253	Accumulation	process
Aop:525	Event:3254	morphological change	UBERON	UBERON:0003254	Increase	GO	GO:0003254	Increase	process
Aop:525	Event:3255	increased	PR	PR:0003255	Increase	MP	MP:0003255	Increase	process
Aop:525	Event:3256	decreased	CHEBI	CHEBI:0003256	Increase	VT	VT:0003256	Increase	process
Aop:525	Event:3257	occurrence	CL	CL:0003257	Increase	HP	HP:0003257	Increase	process
Aop:525	Event:3258	disrupted	MESH	MESH:0003258	Increase	GO	GO:0003258	Increase	process
Aop:525	Event:3259	morphological change	UBERON	UBERON:0003259	Increase	MP	MP:0003259	Increase	process
Aop:526	Event:3260	occurrence	CL	CL:0003260	Activation	VT	VT:0003260	Activation	process
Aop:526	Event:3261	disrupted	MESH	MESH:0003261	Altered expression o	HP	HP:0003261	Altered expression o	process
Aop:526	Event:3262	morphological change	UBERON	UBERON:0003262	Decreased proliferat	GO	GO:0003262	Decreased proliferat	process
Aop:526	Event:3263	increased	PR	PR:0003263	Microcephaly	MP	MP:0003263	Microcephaly	process
Aop:526	Event:3264	decreased	CHEBI	CHEBI:0003264	Cognitive function	VT	VT:0003264	Cognitive function	process
Aop:527	Event:656	decreased	PR	PR:000011405	COUP transcription factor 2	GO	GO:0035624	receptor transactivation
Aop:527	Event:647	decreased				GO	GO:0050810	regulation of steroid biosynthetic process
Aop:527	Event:1613	decreased	CHEBI	CHEBI:79436	17beta-Hydroxy-2-oxa-5alpha-androstan-3-one	GO	GO:0042446	hormone biosynthetic process
Aop:527	Event:2213	abnormal	UBERON	UBERON:0000057	urethra	GO	GO:0048645	animal organ formation
Aop:527	Event:2082	abnormal	UBERON	UBERON:0000989	penis	GO	GO:0048568	embryonic organ development
Aop:528	Event:2214	decreased				GO	GO:0010467	gene expression
Aop:528	Event:1615	abnormal	UBERON	UBERON:0000991	gonad	GO	GO:0048513	animal organ development
Aop:528	Event:1616	abnormal				GO	GO:0048513	animal organ development
Aop:529	Event:327	increased	CHEBI	CHEBI:35366	fatty acid			
Aop:529	Event:459	increased				HP	HP:0001397	Hepatic steatosis
Aop:529	Event:179	decreased	CHEBI	CHEBI:35366	fatty acid	GO	GO:0006635	fatty acid beta-oxidation
Aop:529	Event:291	increased	CHEBI	CHEBI:17855	triglyceride			
Aop:529	Event:2224	disrupted				GO	GO:0010468	regulation of gene expression
Aop:529	Event:2225	disrupted				GO	GO:0019915	lipid storage
Aop:529	Event:2226	occurrence				GO	GO:0005102	receptor binding
Aop:529	Event:2227	disrupted				GO	GO:0035357	peroxisome proliferator activated receptor signaling pathway
Aop:530	Event:1539	increased	GO	GO:0005765	lysosomal membrane	GO	GO:0006897	endocytosis
Aop:530	Event:177	functional change	GO	GO:0005739	mitochondrion			
Aop:530	Event:55	increased				GO	GO:0008219	cell death
Aop:530	Event:1931	disrupted	CL	CL:0000073	barrier epithelial cell			
Aop:530	Event:898	occurrence	GO	GO:0005764	lysosome	GO	GO:1903008	organelle disassembly
Aop:532	Event:3265	occurrence	CL	CL:0003265	Inhibition	VT	VT:0003265	Inhibition	process
Aop:532	Event:3266	disrupted	MESH	MESH:0003266	Mitochondrial dysfun	HP	HP:0003266	Mitochondrial dysfun	process
Aop:532	Event:3267	morphological change	UBERON	UBERON:0003267	Degeneration of dopa	GO	GO:0003267	Degeneration of dopa	process
Aop:532	Event:3268	increased	PR	PR:0003268	Parkinsonian motor d	MP	MP:0003268	Parkinsonian motor d	process
Aop:533	Event:3269	occurrence	CL	CL:0003269	Succinate dehydrogenase	VT	VT:0003269	Succinate dehydrogenase	process
Aop:533	Event:3270	disrupted	MESH	MESH:0003270	Mitochondrial dysfun	HP	HP:0003270	Mitochondrial dysfun	process
Aop:533	Event:3271	morphological change	UBERON	UBERON:0003271	Degeneration of dopa	GO	GO:0003271	Degeneration of dopa	process
Aop:533	Event:3272	increased	PR	PR:0003272	Parkinsonian motor d	MP	MP:0003272	Parkinsonian motor d	process
Aop:534	Event:3273	occurrence	CL	CL:0003273	Mitochondrial Comple	VT	VT:0003273	Mitochondrial Comple	process
Aop:534	Event:3274	disrupted	MESH	MESH:0003274	Mitochondrial dysfun	HP	HP:0003274	Mitochondrial dysfun	process
Aop:534	Event:3275	morphological change	UBERON	UBERON:0003275	Degeneration of dopa	GO	GO:0003275	Degeneration of dopa	process
Aop:534	Event:3276	increased	PR	PR:0003276	Parkinsonian motor d	MP	MP:0003276	Parkinsonian motor d	process
Aop:535	Event:3277	occurrence	CL	CL:0003277	Increase of intracel	VT	VT:0003277	Increase of intracel	process
Aop:535	Event:3278	disrupted	MESH	MESH:0003278	Oligomerisation of d	HP	HP:0003278	Oligomerisation of d	process
Aop:535	Event:3279	morphological change	UBERON	UBERON:0003279	Loss of iron-sulfur 	GO	GO:0003279	Loss of iron-sulfur 	process
Aop:535	Event:3280	increased	PR	PR:0003280	Impaired	MP	MP:0003280	Impaired	process
Aop:535	Event:3281	decreased	CHEBI	CHEBI:0003281	Disruption of tricar	VT	VT:0003281	Disruption of tricar	process
Aop:535	Event:3282	occurrence	CL	CL:0003282	Decrease	HP	HP:0003282	Decrease	process
Aop:535	Event:3283	disrupted	MESH	MESH:0003283	Decrease	GO	GO:0003283	Decrease	process
Aop:535	Event:3284	morphological change	UBERON	UBERON:0003284	Cell death	MP	MP:0003284	Cell death	process
Aop:536	Event:111	increased	PR	PR:000007204	estrogen receptor	GO	GO:0030284	estrogen receptor activity
Aop:536	Event:307	increased	MESH	D014819	vitellogenins	GO	GO:0010467	gene expression
Aop:536	Event:220	increased	MESH	D014819	vitellogenins			
Aop:536	Event:252	increased				MESH	D007674	Kidney Diseases
Aop:536	Event:351	increased				MESH	D009026	mortality
Aop:536	Event:360	decreased	PCO	PCO:0000001	population of organisms	PCO	PCO:0000008	population growth rate
Aop:537	Event:111	increased	PR	PR:000007204	estrogen receptor	GO	GO:0030284	estrogen receptor activity
Aop:537	Event:307	increased	MESH	D014819	vitellogenins	GO	GO:0010467	gene expression
Aop:537	Event:220	increased	MESH	D014819	vitellogenins			
Aop:537	Event:364	abnormal	UBERON	UBERON:0003133	reproductive organ	GO	GO:0032502	developmental process
Aop:537	Event:78	decreased				VT	VT:1000294	egg quantity
Aop:538	Event:1392	increased				MP	MP:0003674	oxidative stress
Aop:539	Event:1562	decreased	GO	GO:0005890	sodium:potassium-exchanging ATPase complex	GO	GO:0005391	sodium:potassium-exchanging ATPase activity
Aop:539	Event:2236	decreased	UBERON	UBERON:0002535	gill	GO	GO:0097369	sodium ion import
Aop:539	Event:2237	decreased	UBERON	UBERON:0001969	blood plasma	MP	MP:0005634	decreased circulating sodium level
Aop:539	Event:2238	increased	UBERON	UBERON:0000178	blood	VT	VT:3000004	blood viscosity trait
Aop:539	Event:2239	increased	UBERON	UBERON:0000948	heart	MESH	D013312	Stress, Physiological
Aop:539	Event:1535	occurrence	UBERON	UBERON:0000948	heart	HP	HP:0001695	Cardiac arrest
Aop:539	Event:2261	decreased	UBERON	UBERON:0001969	blood plasma	GO	GO:0008015	blood circulation
Aop:540	Event:1115	increased	CHEBI	CHEBI:26523	reactive oxygen species	GO	GO:1903409	reactive oxygen species biosynthetic process
Aop:540	Event:1392	increased				MP	MP:0003674	oxidative stress
Aop:540	Event:1262	increased				GO	GO:0006915	apoptotic process
Aop:540	Event:3	decreased	CHEBI	CHEBI:16469	17beta-estradiol	GO	GO:0006703	estrogen biosynthetic process
Aop:540	Event:285	decreased	MESH	D014819	vitellogenins	GO	GO:0010467	gene expression
Aop:540	Event:285	decreased	MESH	D014819	vitellogenins	GO	GO:0009306	protein secretion
Aop:540	Event:221	decreased	MESH	D014819	vitellogenins			
Aop:540	Event:309	decreased	MESH	D014819	vitellogenins	GO	GO:0006898	receptor-mediated endocytosis
Aop:540	Event:309	decreased				GO	GO:0001555	oocyte growth
Aop:540	Event:309	decreased				GO	GO:0048599	oocyte development
Aop:540	Event:78	decreased				VT	VT:1000294	egg quantity
Aop:540	Event:360	decreased	PCO	PCO:0000001	population of organisms	PCO	PCO:0000008	population growth rate
Aop:543	Event:2262	decreased	PR	PR:000012946	neuropathy target esterase			
Aop:543	Event:2263	increased	CHEBI	CHEBI:60479	lysophosphatidylcholine			
Aop:543	Event:2265	increased	CL	CL:0000128	oligodendrocyte	GO	GO:0008219	cell death
Aop:543	Event:2266	increased				MP	MP:0000921	demyelination
Aop:543	Event:2266	increased				HP	HP:0007305	CNS demyelination
Aop:544	Event:2262	decreased	PR	PR:000012946	neuropathy target esterase			
Aop:544	Event:2263	increased	CHEBI	CHEBI:60479	lysophosphatidylcholine			
Aop:544	Event:149	increased				GO	GO:0006954	inflammatory response
Aop:544	Event:2265	increased	CL	CL:0000128	oligodendrocyte	GO	GO:0008219	cell death
Aop:544	Event:2266	increased				MP	MP:0000921	demyelination
Aop:544	Event:2266	increased				HP	HP:0007305	CNS demyelination
Aop:545	Event:239	increased	PR	PR:000011397	nuclear receptor subfamily 1 group I member 2	GO	GO:0023052	signaling
Aop:545	Event:2268	decreased	PR	PR:000009056	insulin-induced gene 1 protein	MP	MP:0005567	decreased circulating total protein level
Aop:545	Event:2269	increased	PR	PR:000015612	sterol regulatory element-binding protein 2	MP	MP:0005568	increased circulating total protein level
Aop:545	Event:2270	increased				GO	GO:0006695	cholesterol biosynthetic process
Aop:545	Event:2271	increased	CHEBI	CHEBI:47774	low-density lipoprotein cholesterol	MP	MP:0000182	increased circulating LDL cholesterol level
Aop:546	Event:2118	decreased				GO	GO:0000104	succinate dehydrogenase activity
Aop:546	Event:2118	decreased	GO	GO:0045281	succinate dehydrogenase complex	GO	GO:0046443	FAD metabolic process
Aop:546	Event:2118	decreased	GO	GO:0045281	succinate dehydrogenase complex	GO	GO:0006105	succinate metabolic process
Aop:546	Event:798	decreased	MESH	D064828	Prolyl hydroxylases	GO	GO:0003824	catalytic activity
Aop:546	Event:590	decreased				MP	MP:0005039	hypoxia
Aop:546	Event:885	increased	MESH	D009369	Neoplasms			
Aop:547	Event:2274	increased	PR	PR:000004191	androgen receptor	GO	GO:0060765	regulation of androgen receptor signaling pathway
Aop:547	Event:25	increased	PR	PR:000004191	androgen receptor	GO	GO:0004882	androgen receptor activity
Aop:547	Event:286	decreased	PR	PR:000004191	androgen receptor	GO	GO:0010468	regulation of gene expression
Aop:548	Event:239	increased	PR	PR:000011397	nuclear receptor subfamily 1 group I member 2	GO	GO:0023052	signaling
Aop:548	Event:2268	decreased	PR	PR:000009056	insulin-induced gene 1 protein	MP	MP:0005567	decreased circulating total protein level
Aop:548	Event:2269	increased	PR	PR:000015612	sterol regulatory element-binding protein 2	MP	MP:0005568	increased circulating total protein level
Aop:548	Event:2276	increased	PR	PR:000012440	proprotein convertase subtilisin/kexin type 9	MP	MP:0005568	increased circulating total protein level
Aop:548	Event:2271	increased	CHEBI	CHEBI:47774	low-density lipoprotein cholesterol	MP	MP:0000182	increased circulating LDL cholesterol level
Aop:549	Event:36	decreased	PR	PR:000006100	aromatase	GO	GO:0070330	aromatase activity
Aop:549	Event:219	decreased	CHEBI	CHEBI:16469	17beta-estradiol			
Aop:549	Event:221	decreased	MESH	D014819	vitellogenins			
Aop:549	Event:309	decreased	MESH	D014819	vitellogenins	GO	GO:0006898	receptor-mediated endocytosis
Aop:549	Event:309	decreased				GO	GO:0001555	oocyte growth
Aop:549	Event:309	decreased				GO	GO:0048599	oocyte development
Aop:549	Event:78	decreased				VT	VT:1000294	egg quantity
Aop:549	Event:442	decreased				PCO	PCO:0000008	population growth rate
Aop:550	Event:1535	occurrence	UBERON	UBERON:0000948	heart	HP	HP:0001695	Cardiac arrest
Aop:551	Event:1106	increased	MESH	D001145	Arrhythmias, Cardiac			
Aop:551	Event:1602	increased	PR	PR:000001488	muscarinic acetylcholine receptor	GO	GO:0031789	G-protein coupled acetylcholine receptor binding
Aop:551	Event:1098	increased	CHEBI	CHEBI:26216	potassium atom			
Aop:551	Event:1983	disrupted				GO	GO:0001508	action potential
Aop:552	Event:698	abnormal				GO	GO:0001508	action potential
Aop:552	Event:1535	occurrence	UBERON	UBERON:0000948	heart	HP	HP:0001695	Cardiac arrest
Aop:553	Event:584	decreased	PR	PR:000002095	sodium channel protein type 1 subunit alpha	GO	GO:0019871	sodium channel inhibitor activity
Aop:553	Event:584	decreased	PR	PR:000002095	sodium channel protein type 1 subunit alpha	GO	GO:0023052	signaling
Aop:553	Event:698	abnormal				GO	GO:0001508	action potential
Aop:553	Event:1535	occurrence	UBERON	UBERON:0000948	heart	HP	HP:0001695	Cardiac arrest
Aop:554	Event:1038	increased	PR	PR:000001193	beta-2 adrenergic receptor	GO	GO:0031698	beta-2 adrenergic receptor binding
Aop:554	Event:1106	increased	MESH	D001145	Arrhythmias, Cardiac			
Aop:555	Event:593	decreased	PR	PR:Q12809	potassium voltage-gated channel subfamily H member 2 (human)	GO	GO:0019870	potassium channel inhibitor activity
Aop:555	Event:1535	occurrence	UBERON	UBERON:0000948	heart	HP	HP:0001695	Cardiac arrest
Aop:556	Event:1535	occurrence	UBERON	UBERON:0000948	heart	HP	HP:0001695	Cardiac arrest
Aop:556	Event:389	increased	CHEBI	CHEBI:39124	calcium ion	GO	GO:0006816	calcium ion transport
Aop:556	Event:1562	decreased	GO	GO:0005890	sodium:potassium-exchanging ATPase complex	GO	GO:0005391	sodium:potassium-exchanging ATPase activity
Aop:557	Event:1039	increased	PR	PR:000001193	beta-2 adrenergic receptor	GO	GO:0004941	beta2-adrenergic receptor activity
Aop:558	Event:389	increased	CHEBI	CHEBI:39124	calcium ion	GO	GO:0006816	calcium ion transport
Aop:558	Event:1535	occurrence	UBERON	UBERON:0000948	heart	HP	HP:0001695	Cardiac arrest
Aop:558	Event:693	increased	CHEBI	CHEBI:58165	3',5'-cyclic AMP(1-)			
Aop:559	Event:12	decreased	PR	PR:000003626	acetylcholinesterase	GO	GO:0003990	acetylcholinesterase activity
Aop:559	Event:1602	increased	PR	PR:000001488	muscarinic acetylcholine receptor	GO	GO:0031789	G-protein coupled acetylcholine receptor binding
Aop:559	Event:698	abnormal				GO	GO:0001508	action potential
Aop:559	Event:1106	increased	MESH	D001145	Arrhythmias, Cardiac			
Aop:560	Event:1106	increased	MESH	D001145	Arrhythmias, Cardiac			
Aop:561	Event:2293	increased	PR	PR:000006100	aromatase	GO	GO:0070330	aromatase activity
Aop:561	Event:1076	increased	CHEBI	CHEBI:50114	estrogen			
Aop:561	Event:2251	increased	CHEBI	CHEBI:23965	estradiol			
Aop:561	Event:2251	increased	FMA	FMA:86488	Glandular part of endometrium	GO	GO:0035938	estradiol secretion
Aop:561	Event:1065	increased	PR	PR:000027727	estrogen receptor alpha complex	GO	GO:0030520	intracellular estrogen receptor signaling pathway
Aop:562	Event:1106	increased	MESH	D001145	Arrhythmias, Cardiac			
Aop:563	Event:18	increased	PR	PR:000003858	aryl hydrocarbon receptor	GO	GO:0004874	aryl hydrocarbon receptor activity
Aop:563	Event:18	increased	PR	PR:000003858	aryl hydrocarbon receptor	GO	GO:0017162	aryl hydrocarbon receptor binding
Aop:563	Event:944	increased	PR	PR:000003858	aryl hydrocarbon receptor	GO	GO:0046983	protein dimerization activity
Aop:563	Event:944	increased	PR	PR:000004303	aryl hydrocarbon receptor nuclear translocator	GO	GO:0046983	protein dimerization activity
Aop:563	Event:2124	increased	PR	PR:000002193	apoptosis regulator BAX			
Aop:563	Event:1262	increased				GO	GO:0006915	apoptotic process
Aop:563	Event:1883	decreased	UBERON	UBERON:0001305	ovarian follicle	GO	GO:0001541	ovarian follicle development
Aop:563	Event:2305	decreased	UBERON	UBERON:0001305	ovarian follicle	HP	HP:0008209	Premature ovarian failure
Aop:564	Event:2299	abnormal				GO	GO:0045454	cell redox homeostasis
Aop:564	Event:178	disrupted	GO	GO:0005746	mitochondrial respiratory chain			
Aop:564	Event:40	decreased	CHEBI	CHEBI:15422	ATP	GO	GO:0006754	ATP biosynthetic process
Aop:564	Event:2300	disrupted				GO	GO:0006006	glucose metabolic process
Aop:564	Event:2300	disrupted				MP	MP:0013245	abnormal lipid metabolism
Aop:564	Event:2151	decreased	CHEBI	CHEBI:25512	neurotransmitter	GO	GO:0023052	signaling
Aop:564	Event:2301	abnormal				GO	GO:0007610	behavior
Aop:564	Event:566	abnormal				GO	GO:0002164	larval development
Aop:564	Event:351	increased				MESH	D009026	mortality
Aop:564	Event:360	decreased	PCO	PCO:0000001	population of organisms	PCO	PCO:0000008	population growth rate
Aop:565	Event:2251	increased	CHEBI	CHEBI:23965	estradiol			
Aop:565	Event:2251	increased	FMA	FMA:86488	Glandular part of endometrium	GO	GO:0035938	estradiol secretion
Aop:565	Event:1065	increased	PR	PR:000027727	estrogen receptor alpha complex	GO	GO:0030520	intracellular estrogen receptor signaling pathway
Aop:566	Event:530	decreased	MESH	D007987	Gonadotropin Releasing Hormone	GO	GO:0046879	hormone secretion
Aop:566	Event:531	decreased	CHEBI	CHEBI:81568	Luteinizing hormone	GO	GO:0033684	regulation of luteinizing hormone secretion
Aop:566	Event:531	decreased	CHEBI	CHEBI:81568	Luteinizing hormone	GO	GO:0046879	hormone secretion
Aop:566	Event:1695	decreased	FMA	FMA:67343	Ovum	GO	GO:0030728	ovulation
Aop:566	Event:2251	increased	CHEBI	CHEBI:23965	estradiol			
Aop:566	Event:2251	increased	FMA	FMA:86488	Glandular part of endometrium	GO	GO:0035938	estradiol secretion
Aop:566	Event:2306	occurrence	UBERON	UBERON:0001344	epithelium of vagina	GO	GO:0070268	cornification
Aop:568	Event:619	decreased	PR	PR:000015189	sodium-dependent serotonin transporter	GO	GO:0098810	neurotransmitter reuptake
Aop:568	Event:619	decreased	PR	PR:000015189	sodium-dependent serotonin transporter	GO	GO:0051610	serotonin uptake
Aop:568	Event:1320	increased	GO	GO:0005576	extracellular region	MP	MP:0010069	increased serotonin level
Aop:568	Event:1320	increased	CHEBI	CHEBI:28790	serotonin	MP	MP:0010069	increased serotonin level
Aop:568	Event:2308	increased	FMA	FMA:86594	Surface of brain	GO	GO:0099589	serotonin receptor activity
Aop:568	Event:2308	increased	PR	PR:000001161	5-hydroxytryptamine receptor 1A	GO	GO:0007210	serotonin receptor signaling pathway
Aop:568	Event:2308	increased	PR	PR:000001168	5-hydroxytryptamine receptor 2C	GO	GO:0007210	serotonin receptor signaling pathway
Aop:568	Event:1016	decreased				NBO	NBO:0000079	feeding behavior
Aop:569	Event:1115	increased	CHEBI	CHEBI:26523	reactive oxygen species	GO	GO:1903409	reactive oxygen species biosynthetic process
Aop:570	Event:2298	decreased	CHEBI	CHEBI:17347	testosterone	GO	GO:0061370	testosterone biosynthetic process
Aop:570	Event:1690	decreased	CHEBI	CHEBI:17347	testosterone	GO	GO:0042446	hormone biosynthetic process
Aop:570	Event:1690	decreased	CHEBI	CHEBI:17347	testosterone	GO	GO:0061370	testosterone biosynthetic process
Aop:570	Event:1614	decreased	PR	PR:000004191	androgen receptor	GO	GO:0004882	androgen receptor activity
Aop:570	Event:286	decreased	PR	PR:000004191	androgen receptor	GO	GO:0010468	regulation of gene expression
Aop:570	Event:2082	abnormal	UBERON	UBERON:0000989	penis	GO	GO:0048568	embryonic organ development
Aop:571	Event:1613	decreased	CHEBI	CHEBI:79436	17beta-Hydroxy-2-oxa-5alpha-androstan-3-one	GO	GO:0042446	hormone biosynthetic process
Aop:571	Event:1614	decreased	PR	PR:000004191	androgen receptor	GO	GO:0004882	androgen receptor activity
Aop:571	Event:286	decreased	PR	PR:000004191	androgen receptor	GO	GO:0010468	regulation of gene expression
Aop:571	Event:2082	abnormal	UBERON	UBERON:0000989	penis	GO	GO:0048568	embryonic organ development
Aop:573	Event:1840	decreased	GO	GO:0005739	mitochondrion	GO	GO:0004129	cytochrome-c oxidase activity
Aop:573	Event:1825	increased	CL	CL:0001035	bone cell	GO	GO:0008219	cell death
Aop:573	Event:1825	increased	GO	GO:0005623	cell	GO	GO:0008219	cell death
Aop:573	Event:2316	increased	UBERON	UBERON:0002048	lung	HP	HP:0100598	Pulmonary edema
Aop:574	Event:1840	decreased	GO	GO:0005739	mitochondrion	GO	GO:0004129	cytochrome-c oxidase activity
Aop:574	Event:1825	increased	CL	CL:0001035	bone cell	GO	GO:0008219	cell death
Aop:574	Event:1825	increased	GO	GO:0005623	cell	GO	GO:0008219	cell death
Aop:574	Event:2317	decreased	FMA	FMA:46472	Nose	GO	GO:1990834	response to odorant
Aop:575	Event:2298	decreased	CHEBI	CHEBI:17347	testosterone	GO	GO:0061370	testosterone biosynthetic process
Aop:575	Event:1690	decreased	CHEBI	CHEBI:17347	testosterone	GO	GO:0042446	hormone biosynthetic process
Aop:575	Event:1690	decreased	CHEBI	CHEBI:17347	testosterone	GO	GO:0061370	testosterone biosynthetic process
Aop:575	Event:1614	decreased	PR	PR:000004191	androgen receptor	GO	GO:0004882	androgen receptor activity
Aop:575	Event:286	decreased	PR	PR:000004191	androgen receptor	GO	GO:0010468	regulation of gene expression
Aop:576	Event:1613	decreased	CHEBI	CHEBI:79436	17beta-Hydroxy-2-oxa-5alpha-androstan-3-one	GO	GO:0042446	hormone biosynthetic process
Aop:576	Event:1614	decreased	PR	PR:000004191	androgen receptor	GO	GO:0004882	androgen receptor activity
Aop:576	Event:286	decreased	PR	PR:000004191	androgen receptor	GO	GO:0010468	regulation of gene expression
Aop:578	Event:18	increased	PR	PR:000003858	aryl hydrocarbon receptor	GO	GO:0004874	aryl hydrocarbon receptor activity
Aop:578	Event:18	increased	PR	PR:000003858	aryl hydrocarbon receptor	GO	GO:0017162	aryl hydrocarbon receptor binding
Aop:578	Event:1971	increased	GO	GO:0070531	BRCA1-A complex	HP	HP:0003002	Breast carcinoma
Aop:581	Event:122	increased	PR	PR:000011406	glucocorticoid receptor	GO	GO:0004883	glucocorticoid receptor activity
Aop:581	Event:402	decreased				GO	GO:0007611	learning or memory
Aop:581	Event:402	decreased				GO	GO:0050890	cognition
